case O
28yearold O
previously O
healthy B-SYMPTOMS
man B-SEX
present O
6week O
history O
palpitation O
symptom O
occur O
rest O
23 O
time O
week O
last O
30 O
minute O
time O
associate O
dyspnea B-SYMPTOMS
grade O
26 O
holosystolic O
tricuspid O
regurgitation B-SYMPTOMS
murmur I-SYMPTOMS
well O
hear O
left O
sternal O
border O
inspiratory O
accentuation O
physical O
examination O
yield O
unremarkable O
finding O
electrocardiogram O
ecg O
reveal O
normal O
sinus O
rhythm O
wolff O
parkinson O
white O
preexcitation O
pattern O
fig1 O
produce O
rightside O
accessory B-DISEASE
pathway I-DISEASE
transthoracic O
echocardiography O
demonstrate O
presence O
ebstein O
anomaly O
tricuspid O
valve O
apical B-SYMPTOMS
displacement I-SYMPTOMS
valve O
formation O
atrialized B-DISEASE
right O
ventricle O
functional O
unit O
right O
atrium O
inlet O
inflow O
portion O
right O
ventricle O
fig2 O
anterior O
tricuspid O
valve O
leaflet O
elongate O
fig2c O
arrow O
septal O
leaflet O
rudimentary B-SYMPTOMS
fig2c O
arrowhead O
contrast O
echocardiography O
saline O
reveal O
patent O
foraman O
ovale O
righttoleft O
shunting O
bubble O
left O
atrium O
fig2d O
patient O
undergo O
electrophysiologic O
study O
mapping O
accessory O
pathway O
follow O
radiofrequency O
ablation O
interruption O
pathway O
heat O
generate O
electromagnetic O
wave O
tip O
ablation O
catheter O
postablation O
ecg O
show O
prolong O
pr O
interval O
odd O
second O
qrs O
complex O
lead O
iii O
avf O
v2v4 O
fig1bottom O
consequence O
abnormal B-DISEASE
impulse I-DISEASE
conduction I-DISEASE
atrialized O
right O
ventricle O
patient O
report O
recurrence O
palpitation O
followup O
6 O
month O
ablation O

patient O
34yrold O
man B-SEX
present O
complaint O
fever B-SYMPTOMS
chronic O
cough B-SYMPTOMS
smoker O
history O
pulmonary O
tuberculosis B-DISEASE
treat O
cure O
compute O
tomographic O
ct O
scan O
reveal O
multiple O
tiny O
nodule O
lung O
thoracoscopic O
lung O
biopsy O
take O
right O
upper O
lobe O
microscopic O
examination O
reveal O
typical B-SYMPTOMS
lch I-SYMPTOMS
tumor O
cell O
vesicular O
groove O
nucleus O
form O
small O
aggregation O
bronchiole O
fig1 O
tumor O
cell O
strongly O
positive O
s100 O
protein O
vimentin O
cd68 O
cd1a O
infiltration O
lymphocyte O
eosinophil O
tumor O
cell O
perform O
additional O
radiologic O
examination O
organ O
think O
involve O
quit O
smoking O
receive O
specific O
treatment O
follow O
year O
followup O
ct O
scan O
perform O
show O
4 O
cmsize O
mass B-SYMPTOMS
left O
low O
lobe O
addition O
multiple O
tiny O
nodule O
lung O
fig2 O
needle O
biopsy O
speciman O
reveal O
possibility O
sarcoma O
lobectomy O
perform O
grossly O
4 O
cmsize O
poorlycircumscribed O
lobulate O
graywhite O
mass O
find O
fig3 O
small O
satellite O
nodule O
main O
mass O
microscopically O
tumor O
cell O
aggregate O
large O
sheet O
show O
infiltrative O
growth O
cytologic O
feature O
tumor O
cell O
similar O
see O
typical O
lch O
tumor O
cell O
show O
overtly O
malignant O
cytologic O
feature O
pleomorphichyperchromatic O
nucleus O
prominent O
nucleolus O
fig4 O
multinucleate O
tumor O
giant O
cell O
find O
numerous O
mitotic O
figure O
range O
30 O
60 O
10 O
high O
power O
field O
abnormal O
foci O
typical O
lch O
remain O
main O
tumor O
mass O
immunohistochemically O
tumor O
cell O
strongly O
positive O
s100 O
protein O
fig5 O
vimentin O
positive O
cd68 O
dako O
n1577 O
clone O
kpi O
focally O
positive O
cd1a O
fig6 O
negative O
cytokeratin O
epithelial O
membrane O
antigen O
cd3 O
cd20 O
hmb45 O
ultrastructural O
analysis O
fail O
demonstrate O
birbeck O
granule O
cytoplasm O
tumor O
cell O
month O
lobectomy O
patient O
significant O
change O
radiologic O
finding O

23 B-AGE
year I-AGE
old I-AGE
white O
male B-SEX
4 O
year O
history O
crohns O
disease O
present O
acute O
day O
history O
malaise B-SYMPTOMS
fever B-SYMPTOMS
abdominal O
pain B-SYMPTOMS
vomiting B-SYMPTOMS
stomal O
diarrhoea B-SYMPTOMS
complain O
joint O
pain O
affect O
shoulder O
elbow O
wrist O
metacarpophalangeal O
knee O
ankle O
rash B-SYMPTOMS
elbow O
ankle O
foot O
begin O
erythematous O
macule O
evolve O
vesicopustular O
lesion O
follow O
crust O
history O
sexual O
exposure O
intercurrent O
infection B-SYMPTOMS
regular O
medication O
discontinue O
pentasa O
4 O
month O
early O
month O
early O
undergo O
laparotomy O
excise O
complex O
ileocutaneous O
fistula B-SYMPTOMS
blind O
tract O
week O
early O
defunctione O
ileostomy O
create O
view O
persistent O
abdominal O
pain O
cutaneous O
fistula O
present O
year O
associate O
terminal O
ileal O
stricture B-SYMPTOMS
ileorectal O
fistula O
2 O
year O
duration O
bowel O
disease O
resistant O
immunosuppressive O
drug O
include O
azathioprine O
corticosteroiod O
infusion O
infliximab O
year O
early O
extraintestinal O
manifestation O
admission O
hospital O
thin B-SYMPTOMS
afebrile B-SYMPTOMS
rest O
tachycardia B-SYMPTOMS
125minute O
rest O
cardiorespiratory O
examination O
normal O
abdoman O
minimally O
tender B-SYMPTOMS
ileostomy O
guard O
rebound O
tenderness O
examination O
skin O
reveal O
pustule O
crust O
elbow O
ankle O
foot O
fig O
1 O
2 O
buttock O
spare O
clinical O
sign O
synovitis B-SYMPTOMS
wrist O
proximal O
interphalangeal O
metacarpophalangeal O
joint O
ankle O
result O
laboratory O
test O
show O
haemoglobin O
131 O
gmdl O
white O
blood O
count O
158 O
   O
109l O
platelet O
585 O
   O
109l O
c O
reactive O
protein O
377 O
mgl O
erythrocyte O
sedimentation O
rate O
69 O
mmhr O
urea O
electrolyte O
complement O
urine O
analysis O
microscopy O
normal O
rheumatoid O
factor O
antinuclear O
antineutrophil O
cytoplasmic O
antibodie O
cryoglobulin O
hepatitis O
b O
c O
serology O
negative O
transthoracic O
echocardiogram O
show O
sign O
endocarditis O
multiple O
blood O
culture O
sterile O
skin O
biopsy O
ankle O
reveal O
perivascular O
lymphohistiocytic O
infiltrate O
prominent O
neutrophil O
associate O
fibrinoid O
necrosis B-SYMPTOMS
vessel O
consistent O
leukocytoclastic O
vasculitis B-DISEASE
commence O
60 O
mg O
prednisolone O
day O
lead O
prompt O
complete O
resolution O
feature O
dose O
prednisolone O
rapidly O
taper O
course O
month O
patient O
fast O
advise O
recurrence O
follow O
3 O
year O

30yearold O
female B-SEX
65 O
kg O
undergo O
rhinoplasty O
general O
anaesthesia O
induce O
combination O
bolus O
remifentanyl O
05 O
gkg O
propofol O
2 O
mgkg O
muscle B-DISEASE
paralysis B-DISEASE
obtain O
cisatracurium O
015 O
gkg O
transoral O
intubation O
perform O
macintosh O
blade O
no3 O
size O
7 O
mm O
diameter O
reinforce O
tracheal O
tube O
easily O
gently O
place O
trachea O
attempt O
fix O
right O
corner O
mouth O
problem O
encounter O
laryngoscopy O
intubation O
cuff O
tube O
inflate O
pressure O
   O
20 O
cm O
h2o O
adjustment O
cuff O
volume O
intraoperatively O
n2o O
inhalation O
anaesthesia O
throat O
pack O
place O
pharynx O
avoid O
passage O
blood O
aerodigestive O
tract O
general O
anaesthesia O
maintain O
sevofluorane O
oxygenair O
remifentanyl O
continuous O
infusion O
025 O
gkgmin O
moderate O
arterial B-SYMPTOMS
hypotension I-SYMPTOMS
maintain O
cuff O
systolic O
artery O
pressure O
approximately O
90 O
mmhg O
operation O
carry O
semisupine O
position O
head O
slightly O
incline O
forward O
laterally O
trunk O
slightly O
elevated O
duration O
operation O
100 O
minute O
patient O
extubate O
removal O
throat O
pack O
problem O
follow O
day O
patient O
complain O
difficulty O
swallow O
dysphonia B-SYMPTOMS
hoarseness B-SYMPTOMS
examination O
reveal O
deviation B-SYMPTOMS
tongue O
right O
vocal O
cord O
paralysis O
expression O
hypoglossal O
recurrent O
laryngeal O
nerve B-DISEASE
injury I-DISEASE
local O
oedema B-SYMPTOMS
haematoma B-SYMPTOMS
movement O
pharynx O
soft O
palate O
normal O
meticulous O
neurological O
examination O
include O
magnetic O
resonance O
imaging O
mrn O
reveal O
evidence O
central O
cranial O
nerve B-SYMPTOMS
involvement I-SYMPTOMS
conservative O
management O
include O
steroid O
vitamin O
speech O
swallow O
therapy O
recovery O
lingual O
laryngeal O
function O
obtain O
month O
surgery O

describe O
case O
60yearold O
man B-SEX
san O
francisco O
consume O
raw O
pork O
travel O
philippine O
june O
2003 O
man O
ill B-SYMPTOMS
fever B-SYMPTOMS
diaphoresis B-SYMPTOMS
headache B-SYMPTOMS
nausea B-SYMPTOMS
anorexia B-SYMPTOMS
return O
7month O
vacation O
philippine O
day O
symptom O
onset O
physician O
prescribe O
doxycycline O
symptom O
continue O
admit O
local O
hospital O
5 O
day O
later O
fever O
389c O
nuchal B-SYMPTOMS
rigidity I-SYMPTOMS
headache O
general O
malaise B-SYMPTOMS
patient O
describe O
recent O
contact O
sick O
person O
past O
medical O
history O
unremarkable O
physical O
examination O
somnolent B-SYMPTOMS
fully O
orient O
focal O
finding O
neurologic O
examination O
slight O
nuchal O
rigidity O
leukocyte O
count O
21000mm3 O
include O
16400mm3 O
neutrophil O
cerebrospinal O
fluid O
csf O
show O
leukocyte O
count O
487l O
80 O
polymorphonuclear O
cell O
18 O
lymphocyte O
glucose O
protein O
level O
20 O
mgdl O
167 O
mgdl O
respectively O
gram O
stain O
csf O
show O
grampositive O
cocci O
pair O
figure O
empiric O
therapy O
ceftriaxone B-SYMPTOMS
vancomycin O
ampicillin O
bacterial B-DISEASE
meningitis I-DISEASE
begin O
compute O
tomographic O
scan O
head O
show O
sinusitis B-SYMPTOMS
finding O
chest O
radiograph O
transesophageal O
echocardiogram O
negative O
hospital O
day O
2 O
blood O
culture O
grow O
grampositive O
cocci O
pair O
chain O
organism B-SYMPTOMS
catalasenegative O
bile O
esculinnegative O
pyrrolidonyl O
aminopeptidasenegative O
consistent O
streptococcus B-SYMPTOMS
spp I-SYMPTOMS
latex O
agglutination O
test O
detect O
streptococcus B-SYMPTOMS
pneumoniae I-SYMPTOMS
antigen I-SYMPTOMS
antimicrobial O
susceptibility O
testing O
show O
isolate O
sensitive O
penicillin O
mic O
   O
003 O
ceftriaxone O
vancomycin O
resistant O
tetracycline O
clindamycin O
antimicrobial O
therapy O
change O
penicillin O
g O
24 O
million O
unit O
intravenously O
day O
hospital O
day O
5 O
patient O
complain O
hear O
loss O
left O
ear O
result O
nasopharyngeal O
endoscopy O
negative O
hospital O
day O
7 O
organism O
identify O
api O
20 O
strep O
system O
biomerieux O
marcy O
letoile O
france O
s O
suis O
serotype O
2 O
patient O
subsequently O
state O
butcher O
culinary O
preference O
partially O
cook O
pork O
eat O
philippine O
week O
prior O
onset O
symptom O
hospital O
day O
9 O
formal O
audiology O
evaluation O
show O
severe O
bilateral O
sensorineural O
highfrequency O
hearing B-SYMPTOMS
loss I-SYMPTOMS
70 O
db O
patient O
complete O
10day O
course O
parenteral O
antimicrobial O
drug O
discharge O
continue O
oral O
therapy O
close O
followup O
month O
discharge O
patient O
report O
improved O
hearing O
sequelae B-SYMPTOMS

74yearold O
man B-SEX
refer O
hospital O
november O
2000 O
liver B-SYMPTOMS
dysfunction I-SYMPTOMS
detect O
medical O
checkup O
patient O
diagnose O
nephrotic B-DISEASE
syndrome I-DISEASE
1995 O
laboratory O
examination O
show O
elevate O
serum O
hepatobiliary O
enzyme O
igm O
presence O
antimitochondrial O
antibodie O
serologic O
marker O
hepatitis O
b O
c O
virus O
negative O
histopathologic O
examination O
liver O
biopsy O
speciman O
obtain O
laparoscopy O
reveal O
nonsuppurative O
destructive O
cholangitis B-DISEASE
portal O
area O
figure O
1 O
diagnosis O
pbc B-DISEASE
scheuer B-DISEASE
stage I-DISEASE
3 I-DISEASE
confirm O
ursodeoxycholic O
acid O
900 O
mg O
daily O
start O
january O
june O
2002 O
patient O
undergo O
endoscopic O
variceal O
ligation O
plus O
endoscopic O
injection O
sclerotherapy O
argon O
plasma O
coagulation O
worsen O
esophageal O
varix O
september O
2007 O
patient O
admit O
treatment O
recurrent O
esophageal O
varix O
platelet O
count O
range O
52 O
   O
109l O
69 O
   O
109l O
year O
note O
decrease O
61 O
   O
109l O
june O
2007 O
8 O
   O
109l O
admission O
deterioration O
thrombocytopenia B-SYMPTOMS
patient O
infectious O
disease O
receive O
medication O
admission O
patient O
purpura B-SYMPTOMS
bleed O
episode O
table O
1 O
show O
laboratory O
datum O
admission O
plateletassociate O
igg O
level O
markedly O
high O
bone O
marrow O
biopsy O
reveal O
normocellular B-SYMPTOMS
marrow I-SYMPTOMS
cellular B-SYMPTOMS
atypia I-SYMPTOMS
ultrasonography O
magnetic O
resonance O
imaging O
reveal O
cirrhotic B-SYMPTOMS
liver O
splenomegaly B-SYMPTOMS
ascite O
gallstone O
spleen O
size O
remain O
unchanged O
previous O
imaging O
examination O
base O
finding O
association O
pbc O
decompensate O
liver O
cirrhosis O
itp B-DISEASE
diagnose O
human O
leukocyte O
antigen O
hla O
genotype O
determine O
polymerase O
chain O
reactionsequencingbase O
typing O
polymerase O
chain O
reactionsequence O
specific O
primer O
srl O
inc O
tokyo O
japan O
detect O
a02010101 O
b400201 O
c030401 O
c07020101 O
dpb10501 O
dqa10103 O
dqa1030101 O
dqb1030201 O
dqb1060101 O
drb1080201 O
drb1080302 O
13c O
urea O
breath O
test O
h O
pylori O
infection O
negative O
figure O
2 O
show O
clinical O
course O
oral O
prednisolone O
30 O
mg O
daily O
itp O
start O
day O
11 O
diuretic O
therapy O
combine O
albumin O
infusion O
ascite O
perform O
platelet O
count O
increase O
notably O
pulse O
therapy O
intravenous O
methylprednisolone O
1 O
g O
daily O
add O
d O
22 O
24 O
response O
weak O
temporary O
d O
31 O
mild O
melena B-SYMPTOMS
identify O
patient O
give O
trial O
intravenous O
immune O
gamma O
globulin O
therapy O
25 O
g O
daily O
d O
32 O
36 O
combine O
second O
round O
intravenous O
methylprednisolone O
pulse O
therapy O
d O
32 O
34 O
moderate O
response O
observe O
prednisolone O
continue O
platelet O
count O
increase O
slowly O
ascite O
relatively O
control O
diuretic O
discharge O
consider O
decompensate O
liver O
cirrhosis O
platelet O
count O
determine O
patient O
require O
careful O
followup O
esophageal O
varix O
prophylactic O
endoscopic O
therapy O

18yearold O
male B-SEX
diagnose O
attentiondeficit O
hyperactivity O
disorder O
adhd B-DISEASE
2005 O
overweight B-SYMPTOMS
body O
mass O
index O
bmi O
40 O
start O
quetiapine O
fumarate O
seroquel O
900 O
mg O
daily O
april O
2005 O
methylphenidate O
concerta O
54 O
mg O
daily O
september O
2005 O
beginning O
august O
2006 O
admit O
local O
hospital O
severe O
dyspnoea B-SYMPTOMS
tachypnea B-SYMPTOMS
tachycardia B-SYMPTOMS
cyanosis B-SYMPTOMS
admission O
blood O
pressure O
12080 O
mmhg O
arterial O
blood O
gas O
reveal O
ph O
745 O
pco2 O
355 O
kpa O
pao2 O
776 O
kpa O
51 O
mmoll O
creactive O
protein O
elevate O
chest O
xray O
show O
enlarged B-SYMPTOMS
heart I-SYMPTOMS
develop O
hemoptysis B-SYMPTOMS
treat O
unfractionated O
heparin O
suspicion O
pulmonary O
embolism B-SYMPTOMS
subsequently O
develop O
cardiogenic B-DISEASE
shock I-DISEASE
treat O
vasoactive O
drug O
spite O
treatment O
oliguric B-SYMPTOMS
liver O
enzyme O
rise O
refer O
hospital O
treatment O
admission O
blood O
pressure O
9060 O
mmhg O
despite O
infusion O
noradrenaline O
heart O
rate O
130minute O
temperature O
384 O
c O
thoracic O
compute O
tomography O
scan O
pulmonary O
embolism O
echocardiography O
reveal O
biventricular B-SYMPTOMS
failure B-SYMPTOMS
leave O
ventricular O
end O
diastolic O
diameter O
7 O
cm O
left O
ventricle O
severely O
hypokinetic O
ejection O
fraction O
ef O
2025 O
left O
ventricular O
end O
diastolic O
pressure O
markedly O
elevate O
moderate O
mitral B-SYMPTOMS
regurgitation I-SYMPTOMS
intermittent O
hemodialysis O
initiate O
liver O
function O
improve O
slightly O
despite O
dialysis O
renal O
function O
deteriorate O
increase O
creatinine O
value O
day O
worsening O
left O
ventricular O
systolic O
function O
ejection O
fraction O
1012 O
mark O
pulmonary B-SYMPTOMS
hypertension I-SYMPTOMS
systolic O
pulmonary O
pressure O
estimate O
30 O
mmhg O
clinical O
picture O
resemble O
dilate O
cardiomyopathy B-DISEASE
low B-SYMPTOMS
output I-SYMPTOMS
failure I-SYMPTOMS
cause O
renal O
liver O
failure O
suspect O
druginduce O
cardiomyopathy O
methylphenidate O
quetiapine O
fumarate O
discontinue O
screen O
infectious O
pathogen O
immunological O
marker O
iron O
amyloid O
deposition O
negative O
day O
transfer O
national O
hospital O
rikshospitalet O
oslo O
ongoing O
noradrenaline O
dobutamine O
infusion O
shortly O
admission O
intraaortic O
balloon O
pump O
iabp O
insert O
noradrenaline O
replace O
nitroprusside O
coronary O
angiography O
normal O
endomyocardial O
biopsy O
right O
ventricle O
reveal O
distinct O
myocardial B-DISEASE
pathology I-DISEASE
treatment O
iabp O
nitroprusside O
dialysis O
clinical O
situation O
gradually O
improve O
liver O
function O
return O
normal O
renal O
function O
improve O
increase O
diuresis B-SYMPTOMS
creatinine O
fall O
798 O
98 O
moll O
ef O
markedly O
reduce O
15 O
behavioral O
problem O
adipose B-SYMPTOMS
stature I-SYMPTOMS
deny O
heart O
transplant O
treat O
iabp O
26 O
day O
28 O
day O
transfer O
hospital O
time O
liver O
renal O
function O
normal O
treat O
angiotensinconverte O
enzyme O
aceinhibitor O
betablocker O
diuretic O
follow O
week O
clinical O
status O
improve O
subsequently O
discharge O
home O
echocardiography O
show O
markedly O
dilate O
left O
ventricle O
ef O
20 O
march O
2007 O
clinical O
status O
improve O
function O
class O
ii O
new O
york O
heart O
association O
ef O
estimate O
echocardiography O
3035 O

19yearold O
man B-SEX
present O
emergency O
department O
12 O
h O
insertion O
high O
pressure O
container B-SYMPTOMS
tanning O
spray O
rectum O
plain O
abdominal O
radiograph O
figure O
1 O
show O
container O
rectosigmoid O
region O
sign O
perforation B-DISEASE
flexible O
sigmoidoscopy O
perform O
conscious O
sedation O
object B-SYMPTOMS
locate O
rectosigmoid O
junction O
container O
extract O
bimanual O
manipulation O
attempt O
remove O
object O
conventional O
endoscopic O
instrument O
polypectomy O
snare O
unsuccessful O
sigmoidoscope O
pass O
alongside O
foreign O
body O
proximal O
end O
guide O
wire O
leave O
sigmoidoscope O
remove O
subsequently O
40 O
mm O
pneumatic O
dilatation O
balloon O
rigiflex O
boston O
scientific O
normally O
achalasia O
patient O
insert O
guide O
wire O
inflate O
container O
figure O
2 O
safety O
purpose O
sigmoidoscope O
reintroduce O
alongside O
catheter O
balloon O
allow O
endoscopic O
visual O
control O
distal O
end O
container O
rectum O
gentle O
traction O
exert O
balloon O
catheter O
container O
successfully O
remove O
fluoroscopic O
endoscopic O
control O
figure O
3 O

63yearold O
woman B-SEX
know O
cardiac O
history O
present O
sudden O
onset O
dyspnea B-SYMPTOMS
require O
intubation O
ventilatory O
support O
hospital O
deny O
precede O
symptom O
chest O
discomfort B-SYMPTOMS
palpitation O
syncope B-SYMPTOMS
infection B-DISEASE
patient O
afebrile B-SYMPTOMS
normotensive B-SYMPTOMS
sinus O
tachycardia B-SYMPTOMS
140 O
beatsmin O
cardiorespiratory O
examination O
remarkable O
elevated O
jugular O
venous O
pressure O
angle O
jaw O
leftsided O
heart O
sound O
bibasilar O
crackle O
lung O
field O
complete O
blood O
cell O
count O
electrolyte O
cardiac O
biomarker O
normal O
limit O
initial O
electrocardiogram O
reveal O
st B-SYMPTOMS
depression I-SYMPTOMS
lead O
v2 O
v6 O
suggestive O
anterolateral B-DISEASE
ischemia I-DISEASE
figure O
1 O
chest O
radiograph O
demonstrate O
pulmonary O
vascular B-SYMPTOMS
congestion I-SYMPTOMS
consistent O
diagnosis O
pulmonary B-DISEASE
edema I-DISEASE
figure O
2 O
echocardiographic O
examination O
reveal O
normal O
cardiac O
dimension O
normal O
wall O
motion O
mild O
diastolic B-DISEASE
dysfunction I-DISEASE
early O
diastolic O
late O
diastolic O
transmitral O
ratio O
1 O
prolong O
deceleration O
time O
250 O
ms O
reduce O
early O
diastolic O
annular O
velocity O
lateral O
mitral O
valve O
annulus O
follow O
aggressive O
diuresis B-SYMPTOMS
require O
minimal O
ventilatory O
support O
patient O
extubate O
day O
follow O
initial O
presentation O
1 O
h O
extubation O
patient O
develop O
recurrent O
pulmonary O
edema O
clinically O
radiographically O
require O
mechanical O
ventilation O
cardiac O
catheterization O
perform O
reveal O
normal O
coronary O
artery O
day O
4 O
coronary O
care O
unit O
admission O
patient O
fail O
repeat O
attempt O
extubation O
compute O
tomographic O
scan O
reveal O
4 O
cm O
   O
9 O
cm O
multinodular O
goiter B-DISEASE
extend O
mediastinum O
suspect O
associated O
tracheal O
stenosis B-SYMPTOMS
figure O
3 O
diagnosis O
nppe B-DISEASE
secondary O
enlarged O
goiter O
patient O
undergo O
surgical O
intervention O
thyroidectomy O
intraoperative O
bronchoscopy O
reveal O
tracheal O
stenosis O
great O
50 O
postoperative O
course O
uncomplicated O
month O
follow O
discharge O
patient O
return O
previous O
activity O
level O
subjective O
dyspnea O

28yearold O
woman B-SEX
refer O
4week O
history O
continuous O
moderate O
right O
upper O
quadrant O
pain B-SYMPTOMS
associate O
jaundice B-SYMPTOMS
weight B-SYMPTOMS
loss I-SYMPTOMS
10 O
kg O
3 O
month O
liver O
mass B-SYMPTOMS
identify O
ultrasonography O
pain O
sensation O
different O
previous O
colicky O
attack O
patient O
experience O
undergo O
laparoscopic O
cholecystectomy O
7 O
year O
previously O
physical O
examination O
obese B-SYMPTOMS
body O
mass O
index O
378 O
icterus B-SYMPTOMS
note O
conjunctivae O
oral O
mucosa O
skin O
imaging O
modality O
include O
compute O
tomography O
ct O
positron O
emission O
tomography O
pet O
endoscopic O
cholangiopancreatography O
ercp O
fig1 O
patient O
underwent O
exploratory O
laparotomy O
intraoperative O
ultrasonography O
reveal O
cystic O
lesion B-SYMPTOMS
measure O
35 O
25 O
cm O
central O
portion O
liver O
anterior O
porta O
hepatis O
intraoperative O
cholangiography O
demonstrate O
extensive O
stricture B-SYMPTOMS
obliterate O
left O
hepatic O
duct O
partial O
occlusion B-SYMPTOMS
right O
hepatic O
duct O
extended O
left O
lobectomy O
en O
bloc O
biliary O
confluence O
frozensection O
examination O
margin O
excise O
speciman O
free O
malignant O
cell O
reconstruction O
perform O
rouxeny O
cholangiojejunostomy O
3 O
second O
bile O
duct O
radical O
right O
intraoperatively O
radiotherapy O
apply O
surgical O
margin O
patient O
undergo O
6 O
week O
imageguide O
external O
beam O
radiation O
centre O
resection O
field O
label O
surgery O
final O
pathology O
describe O
tumour O
infiltrate O
moderately O
differentiate O
squamous B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
associate O
severe O
dysplasia B-DISEASE
bileduct O
epithelium O
fig2 O
patient O
recover O
complication O
18 O
month O
initial O
surgical O
procedure O
unremarkable O
ct O
scan O

49yearold O
woman B-SEX
admit O
department O
radiology O
second O
affiliated O
hospital O
zhejiang O
university O
october O
2004 O
right O
upper O
quadrant O
pain B-SYMPTOMS
weight B-SYMPTOMS
loss I-SYMPTOMS
hepatitis B-DISEASE
b I-DISEASE
virus O
carrier O
fetoprotein O
level O
11853 O
ngml O
ultrasonography O
compute O
tomography O
ct O
reveal O
10 O
cm O
mass B-SYMPTOMS
posterior O
segment O
right O
liver O
lobe O
15 O
cm O
mass O
find O
left O
lateral O
segment O
clinical O
sign O
indicate O
patient O
inoperable O
hcc B-DISEASE
childpugh O
class O
cirrhosis B-DISEASE
tace O
offer O
patient O
angiogram O
demonstrate O
obvious O
hepatic O
arteriovenous O
shunt O
multiple O
small O
masse O
lobe O
liver O
emulsion O
oxaliplatin O
pirarubicin O
hydroxycamptothecin O
lipiodol O
prepare O
35 O
ml O
3 O
ml O
mixture O
administer O
intraarterially O
right O
leave O
hepatic O
artery O
respectively O
patient O
experience O
right O
upper O
quadrant O
pain O
tace O
uneventful O
recovery O
month O
later O
second O
tace O
procedure O
perform O
right O
hepatic O
artery O
40 O
ml O
mixture O
administer O
day O
experience O
sudden O
acute O
dyspnoea B-SYMPTOMS
peripheral O
oxygen O
saturation O
decrease O
90 O
chest O
xray O
show O
increase O
reticular O
shadow O
left O
lung O
especially O
low O
zone O
chest O
ct O
scan O
reveal O
multiple O
iodize O
oillike O
highdensity O
material O
parenchyma O
lung O
figure O
1 O
10 O
mg O
dexamethasone O
iv O
supportive O
therapy O
administer O
respiratory O
symptom O
attenuate O
day O
later O
patient O
suffer O
headache B-SYMPTOMS
transient O
consciousness B-SYMPTOMS
loss I-SYMPTOMS
accompany O
nausea B-SYMPTOMS
vomiting B-SYMPTOMS
follow O
confusion B-SYMPTOMS
low O
extremity O
weakness B-SYMPTOMS
noncontrast O
enhance O
ct O
scanning O
show O
multiple O
disseminate O
hyperintense O
lesion O
brain O
consistent O
deposition B-SYMPTOMS
iodized O
oil O
figure O
2 O
week O
later O
respiratory O
neurologic O
symptom O
disappear O
completely O
discharge O
patient O
consequently O
complete O
tace O
procedure O
similar O
symptom O
occur O

71yearold O
woman B-SEX
know O
diastolic O
congestive B-DISEASE
heart I-DISEASE
failure I-DISEASE
chf B-DISEASE
present O
er O
exacerbation O
chf O
decrease O
level O
consciousness O
brachial O
blood B-SYMPTOMS
pressure I-SYMPTOMS
bp B-SYMPTOMS
measure O
5540 O
mmhg O
patient O
recent O
admission O
exacerbation O
chf O
medical O
history O
significant O
autoimmune O
hepatitis B-DISEASE
preserve O
liver O
function O
esophageal O
varix O
bleed O
episode O
longterm O
corticosteroid O
therapy O
complicate O
adrenal B-DISEASE
insufficiency I-DISEASE
type B-DISEASE
2 I-DISEASE
diabetes I-DISEASE
mellitus I-DISEASE
osteoporosis B-DISEASE
recent O
echocardiography O
reveal O
moderate O
concentric O
leave O
ventricular O
hypertrophy B-DISEASE
diastolic O
dysfunction O
mild O
moderate O
mitral B-DISEASE
regurgitation I-DISEASE
cardiac O
catheterization O
recent O
admission O
demonstrate O
50 O
stenosis B-DISEASE
second O
diagonal O
artery O
mild O
diffuse O
disease O
coronary O
artery O
right O
ventricular O
endomyocardial O
biopsy O
rule O
myocarditis B-DISEASE
infiltrative O
cardiomyopathy O
heal O
ischemic O
microinfarct O
atheroemboli B-DISEASE
observe O
previous O
bp O
value O
low O
systolic B-SYMPTOMS
bp I-SYMPTOMS
60 O
mmhg O
65 O
mmhg O
diastolic B-SYMPTOMS
bp I-SYMPTOMS
40 O
mmhg O
45 O
mmhg O
follow O
intubation O
dopamine O
start O
hypotension O
management O
later O
replace O
noradrenaline O
patient O
develop O
atrial B-DISEASE
flutter I-DISEASE
successfully O
convert O
sinus B-SYMPTOMS
rhythm I-SYMPTOMS
direct O
current O
electric O
shock O
cardiology O
consultation O
result O
admission O
coronary O
care O
unit O
ccu O
admission O
ccu O
bp O
measure O
5636 O
mmhg O
left O
arm O
detectable O
right O
arm O
arterial O
line O
insert O
femoral O
artery O
bp O
measure O
19192 O
mmhg O
bp O
value O
consistently O
high O
femoral O
arterial O
line O
cuff O
arm O
high O
left O
arm O
right O
arm O
instance O
day O
postccu O
admission O
bp O
point O
measure O
17080 O
mmhg O
arterial O
line O
cuff O
reading O
arm O
8374 O
mmhg O
left O
6039 O
mmhg O
right O
arm O
investigate O
inconsistency O
brachial O
femoral O
bp O
value O
compute O
tomography O
ct O
scan O
thorax O
obtain O
125 O
mm O
slice O
intravenous O
contrast O
injection O
sagittal O
coronal O
planar O
reformatte O
maximumintensity O
projection O
image O
analysis O
initial O
unenhance O
ct O
image O
show O
densely O
calcify O
plaque B-SYMPTOMS
thrombus B-SYMPTOMS
origin O
subclavian O
artery O
right O
common O
carotid O
artery O
ct O
angiogram O
show O
absence O
flow B-SYMPTOMS
right O
subclavian O
artery O
tight O
stenosis O
origin O
left O
subclavian O
artery O
tight O
stenosis O
origin O
right O
common O
carotid O
artery O
vertebral O
artery O
show O
normal O
calibre B-SYMPTOMS
flow O
figure O
1 O
management O
follow O
insertion O
femoral O
arterial O
line O
base O
femoral O
bp O
reading O
diuretic O
bplowere O
agent O
patient O
eventually O
discharge O
stable O
condition O
remain O
stable O
month O
discharge O
time O
present O
report O
write O
exacerbation O
chf O
related O
er O
visit O

newborn B-AGE
boy B-SEX
healthy O
nonconsanguineous O
parent O
deliver O
37 O
week O
gestation O
cesarean O
section O
mother O
primipara O
32 O
year O
old O
admit O
hospital O
2 O
week O
previously O
reduce O
fetal O
intrauterine O
movement O
polyhydramnio O
child O
birthweight O
2330 O
g O
10th O
percentile O
length O
47 O
cm O
head O
circumference O
332 O
cm O
25th O
percentile O
lowset O
ear O
bilateral B-SYMPTOMS
clubfoot I-SYMPTOMS
apgar O
score O
2 O
6 O
7 O
1 O
5 O
10 O
minute O
child O
present O
severe O
hypotonia B-SYMPTOMS
generalized B-SYMPTOMS
muscle I-SYMPTOMS
weakness I-SYMPTOMS
require O
ventilatory O
assistance O
total O
parenteral O
nutrition O
weaning O
fail O
inadequate O
pulmonary O
ventilation O
respiratory B-DISEASE
acidosis I-DISEASE
hearing B-SYMPTOMS
loss I-SYMPTOMS
detect O
auditory O
evoke O
potential O
cranial O
mri O
show O
mildly O
enlarge O
ventricle O
liquor O
space O
day O
birth O
infant O
present O
severe O
abdominal B-SYMPTOMS
distension I-SYMPTOMS
hypoactive B-SYMPTOMS
bowel I-SYMPTOMS
mri O
reveal O
mark O
intestinal B-SYMPTOMS
dilation B-SYMPTOMS
mechanical B-SYMPTOMS
obstruction I-SYMPTOMS
laboratory O
investigation O
show O
hypoglycemia B-SYMPTOMS
27 O
mgdl O
hypomagnesemia B-SYMPTOMS
058 O
mmoll O
hypokalemia B-SYMPTOMS
24 O
mmoll O
blood O
lactate O
normal B-SYMPTOMS
13 O
mmoll O
normal O
range O
0522 O
mmoll O
liver O
enzyme O
unremarkable O
skeletal O
muscle O
biopsy O
perform O
show O
scatter O
hypertrophic O
cytochrome O
c O
oxidase O
coxdeficient O
succinate O
dehydrogenasepositive O
muscle O
fiber O
figure O
suggest O
mitochondrial B-DISEASE
disorder I-DISEASE
molecular O
genetic O
study O
reveal O
marked O
mtdna B-SYMPTOMS
depletion I-SYMPTOMS
muscle O
93 O
decrease O
compare O
agematched O
control O
screen O
mtdna O
rearrangement O
individual O
coxpositive O
coxdeficient O
fibers4 O
negative O
sequence O
entire O
code O
region O
intronexon O
boundary O
polg1 O
gene O
identify O
report O
heterozygous O
missense O
mutation O
compound O
c679ct O
predict O
pr227w O
c2542ga O
predict O
pg848s O
sequencing O
parental O
sample O
confirm O
recessive B-SYMPTOMS
inheritance I-SYMPTOMS
infant O
die O
20 O
day O
respiratory B-DISEASE
failure I-DISEASE
autopsy O
brain O
remarkable O
change O
gross O
examination O
histology O
informative O
poor O
preservation O
tissue O
evidence O
neuronal B-SYMPTOMS
damage I-SYMPTOMS
spinal O
cord O
liver O
show O
diffuse O
cholestasis B-SYMPTOMS
consistent O
total O
parenteral O
nutrition O
hepatocyte O
steatosis B-SYMPTOMS
necrosis B-SYMPTOMS
liver O
fibrosis B-SYMPTOMS
observe O
testicle O
undescended B-SYMPTOMS
remain O
visceral O
organ O
normal O
marked O
dilation O
thinning B-SYMPTOMS
bowel O
wall O
despite O
normal O
histology O
analysis O
stomach O
ileum O
colon O
homogenate O
reveal O
severe O
mtdna O
depletion O
94 O
decrease O
table O
e1 O
neurology O
web O
site O
wwwneurologyorg O
laser O
capture O
microdissection O
analysis5 O
reveal O
mtdna O
depletion O
confine O
muscularis O
propria O
prominent O
external O
layer O
figure O
ganglion O
cell O
myenteric O
plexus O
show O
milder O
mtdna O
depletion O
restrict O
small O
intestine O
figure O
mtdna O
depletion O
liver O
show O

46yearold O
woman B-SEX
present O
severe O
acute O
pain B-SYMPTOMS
right O
iliac O
fossa O
periumbilical O
region O
ultrasound O
compute O
tomography O
scan O
reveal O
mucocele B-SYMPTOMS
vermiform O
appendix O
define O
lesion B-SYMPTOMS
locate O
mid O
zone O
appendix O
patient O
underwent O
right O
hemicolectomy O
postoperative O
clinical O
course O
uneventful O
gross O
examination O
surgical O
speciman O
show O
enlarged O
appendix O
fill O
thick O
mucinous B-SYMPTOMS
material I-SYMPTOMS
distinct O
lesion O
involve O
appendiceal O
wall O
measure O
15 O
cm O
maximally O
identify O
midportion O
appendix O
evidence O
perforation B-SYMPTOMS
extravasation B-SYMPTOMS
mucin O
periappendiceal O
tissue O
pseudomyxoma B-DISEASE
peritonei I-DISEASE
surgery O
histopathological O
examination O
show O
combined O
gcc B-DISEASE
mca B-DISEASE
vermiform O
appendix O
figure O
1a O
appendiceal O
luman O
dilate O
line O
mucincontaine O
columnar O
epithelial O
cell O
figure O
1b O
significant O
cytologic B-SYMPTOMS
atypia I-SYMPTOMS
mitotic O
figure O
identify O
focal O
papillary O
configuration O
lining O
epithelium O
mild O
epithelial B-SYMPTOMS
pseudostratification I-SYMPTOMS
present O
addition O
appendiceal O
wall O
infiltrate O
glandular O
structure O
size O
arrange O
nest O
tubule O
glandular O
structure O
comprise O
2 O
distinct O
type O
cell O
1 O
small O
intermediate O
sized O
monotonous O
neuroendocrine O
cell O
small O
finely O
granular O
eosinophilic O
cytoplasm O
mild O
cytonuclear B-SYMPTOMS
atypia I-SYMPTOMS
figure O
figure1c1c O
2 O
mucinfille O
intermediate O
sized O
cell O
goblet O
cell O
peripherally O
locate O
small O
crescentlike O
hyperchromatic O
nucleus O
indistinct O
nucleolus O
figure O
figure1d1d O
scatter O
infiltrate O
single O
goblet O
neoplastic O
cell O
focally B-SYMPTOMS
present I-SYMPTOMS
previously O
described1 O
tumor O
nest O
appear O
arise O
basiglandular O
region O
intestinal O
crypt O
close O
proximity O
mca O
figure O
figure1e1e O
lymphovascular O
invasion B-SYMPTOMS
perineural O
intraneural O
invasion O
present O
tumor O
infiltrate O
thickness O
appendiceal O
wall O
extend O
mesoappendix O
lymph O
node O
histologically O
identify O
negative O
malignancy B-DISEASE
immunohistochemically O
table O
1 O
tumor O
cell O
gcc O
positive O
chromogranin O
synaptophysin O
serotonin O
neuroendocrine O
marker O
diffuse O
stain O
cytokeratin O
ck O
20 O
figure O
2 O
ck19 O
cd99 O
present O
ki67 O
proliferate O
index O
reveal O
nuclear B-SYMPTOMS
staining I-SYMPTOMS
approximately O
15 O
tumor O
cell O
staining O
ck7 O

60yearold O
man B-SEX
undergo O
colonoscopy O
find O
2 O
cm O
sessile B-SYMPTOMS
polyp I-SYMPTOMS
locate O
10 O
cm O
anal O
verge O
successfully O
remove O
polyp O
tubulovillous B-DISEASE
adenoma I-DISEASE
focal O
highgrade O
dysplasia B-SYMPTOMS
flexible O
sigmoidoscopy O
perform O
month O
later O
repeat O
colonoscopy O
year O
initial O
colonoscopy O
negative O
recurrence B-SYMPTOMS
colonoscopy O
perform O
year O
initial O
colonoscopy O
reveal O
sessile O
polyp O
3 O
cm O
size O
10 O
cm O
anal O
verge O
biopsy O
take O
report O
fragment O
villous B-DISEASE
adenoma I-DISEASE
lowgrade O
dysplasia O
previous O
highgrade O
dysplasia O
relatively O
rapid O
recurrence O
concern O
cancer B-DISEASE
miss O
sample O
error O
pelvic O
magnetic O
resonance O
imaging O
mri O
scan O
endoscopic O
ultrasound O
eus O
perform O
definitive O
excision O
mri O
reveal O
invasive O
rectal O
mass B-SYMPTOMS
involve O
muscularis O
propria O
breach B-SYMPTOMS
adventitia O
consistent O
t2 O
rectal B-DISEASE
carcinoma I-DISEASE
figure O
1 O
pelvic O
lymphadenopathy B-SYMPTOMS
detect O
eus O
reveal O
rectal O
mass O
involve O
mucosa O
submucosa O
involvement B-SYMPTOMS
muscularis O
propria O
figure O
2 O
result O
mri O
eus O
surgical O
versus O
endoscopic O
resection O
treatment O
option O
discuss O
patient O
opt O
surgical O
resection O
patient O
undergo O
low O
anterior O
resection O
endtoend O
anastomosis O
loop O
ileostomy O
pathology O
review O
resect O
rectosigmoid O
reveal O
villous O
adenoma O
lowgrade O
dyplasia O
evidence O
muscularis O
propria O
invasion B-SYMPTOMS
total O
pericolic O
mesorectal O
lymph O
node O
excise O
deem O
benign B-SYMPTOMS
patient O
underwent O
ileostomy O
reversal O
month O
later O
remain O
asymptomatic B-SYMPTOMS
recurrence O
tumour O

72yearold O
woman B-SEX
undergo O
rf O
ablation O
treatment O
metachronous O
solitary O
liver O
metastasis B-DISEASE
rectal O
adenocarcinoma B-DISEASE
treat O
18 O
mo O
preoperative O
chemoradiotherapy O
anterior O
resection O
lesion O
locate O
segment O
viii O
procedure O
go O
patient O
initially O
haemodynamically O
stable O
hour O
later O
condition O
suddenly O
worsen O
clinically O
dizzy B-SYMPTOMS
fatigue B-SYMPTOMS
pallor B-SYMPTOMS
detect O
hypotension B-SYMPTOMS
tachycardia B-SYMPTOMS
emergency O
blood O
test O
show O
haemoglobin O
level O
   O
7 O
gdl O
markedly O
elevate O
transaminase O
level O
compute O
tomography O
examination O
reveal O
accumulation O
intraperitoneal O
fluid O
pelvis O
liver O
haematoma O
image O
show O
liver O
laceration O
follow O
path O
needle O
figure O
figure1a1acc O
unexplained O
laceration O
lead O
away O
figure O
figure22 O
patient O
coughing B-SYMPTOMS
hiccup O
rf O
treatment O
complication O
cause O
increase O
abdominal O
pressure O
tumour O
rupture O
subsequently O
patient O
receive O
blood O
transfusion O
close O
monitoring O
haemodynamically O
stable O
second O
blood O
transfusion O
completely O
recover O
24 O
h O
later O
patient O
remain O
bed O
1 O
wk O
surgical O
intervention O
require O

70yearold O
man B-SEX
refer O
hospital O
gastric O
cancer B-DISEASE
detect O
screen O
esophagogastroduodenoscopy O
egd O
significant O
medical O
history O
identify O
dysuria B-SYMPTOMS
cause O
bladder O
contraction O
initial O
laboratory O
datum O
show O
serum O
level O
afp O
323 O
ngml O
normal O
range O
015 O
ngml O
abnormality O
include O
tumor O
marker O
carcinoembryonic O
antigen O
cea O
carbohydrate O
antigen O
199 O
ca199 O
egd O
reveal O
5 O
cm O
ulcerofungate O
mass B-SYMPTOMS
comprise O
septate O
ulcer O
great O
curvature O
gastric O
antrum O
pathological O
examination O
endoscopic O
biopsy O
tissue O
confirm O
presence O
moderately O
differentiate O
tubular O
adenocarcinoma B-DISEASE
subsequent O
abdominopelvic O
compute O
tomography O
visualize O
gastric O
mass O
deep O
ulceration O
gastric O
antrum O
perigastric O
lymph O
node O
enlargement O
metastatic O
lesion O
observe O
liver O
lung O
peritoneum O
chest O
radiography O
show O
significant O
finding O
radical O
subtotal O
gastrectomy O
d2 O
lymph O
node O
dissection O
billroth O
ii O
gastrojejunostomy O
perform O
grossly O
resect O
speciman O
contain O
double O
lesion O
58 O
cm O
   O
32 O
cm O
ulcerofungate O
mass O
antrum O
extensive O
hemorrhage O
light O
gray O
fibrosis O
second O
nearby O
25 O
cm O
   O
20 O
cm O
ulcerative O
lesion O
figure O
1 O
microscopically O
massive O
number O
pleomorphic O
bizarre O
tumor O
cell O
hemorrhage O
syncytiotrophoblast O
cytotrophoblast O
observe O
lesion O
hematoxylin O
eosin O
hestaine O
tissue O
reveal O
bubbly O
purple O
cytoplasm O
giant O
nucleus O
magnification O
40 O
   O
figure O
2a O
100 O
   O
figure O
2b O
tumor O
involve O
proper O
muscle O
layer O
t2a O
metastasis B-SYMPTOMS
find O
56 O
regional O
lymph O
node O
n1 O
immunohistochemical O
staining O
show O
positive O
immunoreactivity O
human O
chorionic O
gonadotropin O
hcg O
figure O
3a O
focal O
positivity O
afp O
figure O
3b O
finding O
confirm O
presence O
gastric O
choriocarcinoma B-DISEASE
contain O
small O
foci O
afpproducing O
adenocarcinoma O
second O
lesion O
moderately O
differentiate O
tubular O
adenocarcinoma O
extend O
submucosal O
layer O
t1b O
close O
distinct O
lesion O
negative O
immunohistochemical O
staining O
hcg O
afp O
patient O
uneventful O
postoperative O
course O
discharge O
postoperative O
day O
9 O
week O
later O
hcg O
level O
176 O
miuml O
normal O
range O
010 O
miuml O
afp O
level O
100 O
ngml O
cycle O
adjuvant O
chemotherapy O
capecitabine O
xeloda O
hoffmannla O
roche O
inc O
nutley O
nj O
usa O
start O
2500 O
mgm2 O
day O
14 O
dcycle O
cycle O
hcg O
level O
decline O
   O
3 O
miuml O
remain O
level O
recurrence B-SYMPTOMS
distant B-SYMPTOMS
metastasis I-SYMPTOMS
occur O
4year O
postoperative O
followup O

24yearold O
nonsmoking O
male B-SEX
patient O
present O
repeat O
hemoptysis B-SYMPTOMS
2008 O
4 O
day O
concomitant O
right O
thoracic O
pain B-SYMPTOMS
intensify O
breathing O
holiday O
home O
country O
cuban O
patient O
suffer O
cold B-SYMPTOMS
fever B-SYMPTOMS
strong O
cough B-SYMPTOMS
strong O
dry O
cough O
persist O
recovery O
cold O
patient O
report O
loss O
weight O
initial O
ct O
scan O
thorax O
show O
12 O
   O
4 O
cm O
solid O
mass B-SYMPTOMS
paravertebral O
right O
low O
thorax O
sign O
metastasis O
figure O
1 O
bronchoscopy O
figure O
2 O
nonbleede O
biopsy O
reveal O
mass O
low O
right O
bronchus O
histologically O
immunohistologically O
provide O
evidence O
granular O
cell O
abrikossoff B-DISEASE
tumor I-DISEASE
1 O
bronchial O
lavage O
follow O
negative O
malignant O
cell O
patient O
discharge O
surgical O
intervention O
plan O
day O
discharge O
spontaneous O
hemothorax B-SYMPTOMS
develop O
patient O
need O
readmitte O
hemothorax O
drain O
malignant O
cell O
detect O
cytological O
examination O
drain O
liquid O
uneventful O
course O
decrease O
hematoma B-SYMPTOMS
tumor O
excise O
perform O
low O
right O
lobectomy O
6 O
month O
initial O
admission O
final O
histological O
examination O
confirm O
peribronchial O
infiltrate O
s100 O
positive O
tumor O
support O
schwann O
cell O
origin O
theory O
low O
growth O
rate O
2 O
size O
15 O
mm O
figure O
3 O

54yearold O
woman B-SEX
stage O
iv O
nsclc B-DISEASE
treat O
carboplatin O
paclitaxel O
disease O
response O
molecular O
analysis O
tumor O
tissue O
unavailable O
time O
demographic O
profile O
asian O
minimal O
smoking O
history O
nonsmall O
cell O
histology O
predict O
disease O
harbor O
egfr O
tki O
sensitive O
cell O
2 O
initiate O
standard O
daily O
dosing O
erlotinib O
150 O
mg O
disease O
respond O
twentyeight O
month O
later O
acquire O
resistance O
erlotinib O
progression O
disease O
systemically O
follow O
progression O
experimental O
angiogenesis O
inhibitor O
initiate O
pemetrexed O
resume O
standard O
dose O
erlotinib O
initial O
response O
11 O
month O
later O
disease O
progress O
dna O
extract O
biopsy O
progressing O
lung O
lesion B-DISEASE
examine O
establish O
technique O
analysis O
egfr O
mutation O
5 O
direct O
sequencing O
exon O
1821 O
encode O
kinase O
domain O
egfr O
reveal O
l858r O
mutation O
associate O
egfr O
tki O
sensitivity O
fig1 O
2 O
demonstrate O
t790 O
m O
mutation O
associate O
acquire O
egfr O
tki O
resistance O
fig1 O
2 O
develop O
headache O
high O
clinical O
suspicion O
cns O
metastasis O
despite O
negative O
imaging O
show O
refuse O
lumbar O
puncture O
initiate O
empiric O
temozolomide O
plus O
standard O
dose O
erlotinib O
150 O
mg O
daily O
presume O
cns B-DISEASE
disease I-DISEASE
cycle O
headache O
worsen O
develop O
nausea B-SYMPTOMS
vomiting B-SYMPTOMS
concern O
cns O
metastasis O
associated O
raise O
intracranial O
pressure O
magnetic O
resonance O
imaging O
mri O
brain O
demonstrate O
lm B-DISEASE
fig2 O
confirm O
csf O
cytology O
show O
direct O
sequence O
dna O
csf O
cell O
harbor O
l858r O
predict O
egfr O
tki O
sensitivity O
fig3 O
leave O
panel O
t790 O
m O
resistance O
mutation O
datum O
show O
result O
t790 O
m O
negative O
sample O
perform O
sensitive O
fluorescence O
detection O
pcrbase O
assay O
take O
advantage O
pcr O
restriction O
fragment O
length O
polymorphism O
generate O
specific O
missense O
mutation O
fig3 O
right O
panel O
arrow O
positive O
control O
6 O
result O
negative O
wild O
type O
peak O
detect O
fig3 O
right O
panel O
hypothesize O
lm O
remain O
sensitive O
egfr O
tki O
sufficiently O
high O
concentration O
drug O
achieve O
csf O
erlotinib O
concentration O
require O
inhibit O
growth O
cell O
line O
harbor O
l858r O
50 O
ic50 O
100 O
nm O
nm O
2 O
standard O
dose O
erlotinib O
150 O
mg O
daily O
achieve O
3000 O
nm O
plasma O
7 O
csf O
concentration O
egfr O
tkis O
low O
1 O
plasma O
level O
ic50 O
3 O
8 O
increase O
daily O
dose O
gefitinib O
enhance O
csf O
penetration O
effective O
strategy O
3 O
gefitinib O
long O
available O
united O
states O
follow O
failure O
phase O
iii O
nsclc O
trial O
analogous O
increase O
daily O
erlotinib O
dose O
150200 O
mg O
daily O
induce O
unacceptable O
toxicity O
weekly O
highdose O
erlotinib O
2000 O
mg O
tolerable O
4 O
pharmacokinetic O
analysis O
csf O
patient O
nsclc O
lm O
show O
treat O
1500 O
mg O
erlotinib O
weekly O
demonstrate O
peak O
plasma O
concentration O
11300 O
nm O
concurrent O
csf O
concentration O
130 O
nm O
high O
dose O
weekly O
administration O
erlotinib O
achieve O
csf O
concentration O
exceed O
ic50 O
increase O
csf O
penetrance O
standard O
daily O
erlotinib O
dose O
patient O
initiate O
highdose O
weekly O
erlotinib O
1000 O
mg O
1200 O
mg O
persistent O
nausea O
preclude O
high O
dose O
pharmacokinetic O
analysis O
undertake O
patient O
1 O
month O
partial O
radiographic O
response O
lm O
brain O
mri O
fig2b O
2 O
month O
cauda O
equina O
show O
hydrocephalus B-DISEASE
persistent O
symptom O
referable O
increase O
intracranial O
pressure O
lead O
vp O
shunt O
wholebrain O
radiation O
therapy O
resume O
treatment O
1500 O
mg O
weekly O
erlotinib O
month O
later O
progressive O
intrathoracic O
disease O
lead O
initiation O
cetixumab O
erlotinib O
continue O
change O
low O
dose O
100 O
mg O
daily O
survive O
14 O
month O
follow O
diagnosis O
cns O
disease O

21yearold O
male B-SEX
present O
2year O
history O
progressive O
shortness O
breath O
exertion O
dry B-SYMPTOMS
cough I-SYMPTOMS
physical O
examination O
auscultation O
lung O
reveal O
random O
wheeze O
coarse O
crackle O
cardiac O
auscultation O
normal O
cyanosis B-SYMPTOMS
peripheral B-SYMPTOMS
edema I-SYMPTOMS
observe O
history O
smoking O
previous O
know O
pulmonary B-DISEASE
disease I-DISEASE
routine O
blood O
examination O
blood O
count O
serum O
chemistry O
find O
normal O
arterial O
blood O
gas O
analysis O
echocardiography O
show O
important O
abnormality O
pulmonary O
function O
test O
pft O
show O
mild O
restrictive B-SYMPTOMS
ventilatory I-SYMPTOMS
defect I-SYMPTOMS
reduce O
total O
lung O
capacity O
79 O
594 O
l O
force O
vital O
capacity O
80 O
418 O
l O
force O
expiratory O
volume O
second O
83 O
372 O
l O
sputum O
negative O
acidalcohol O
resistant O
bacillus O
human O
immunodeficiency O
virus O
testing O
negative O
chest O
plain O
film O
reveal O
diffuse O
symmetric O
dense O
bilateral O
micronodular B-SYMPTOMS
pattern I-SYMPTOMS
figure O
1 O
base O
finding O
hrct O
scan O
obtain O
reveal O
diffuse O
ground B-SYMPTOMS
glass I-SYMPTOMS
attenuation I-SYMPTOMS
septal B-SYMPTOMS
thickening I-SYMPTOMS
pronounced O
low O
pulmonary O
region O
calcification O
interlobar O
septum O
subpleural O
region O
subpleural O
cyst O
notice O
figure O
2 O
patient O
undergo O
fiberoptic O
bronchoscopy O
bronchoalveolar O
lavage O
transbronchial O
lung O
biopsy O
lavage O
fluid O
negative O
tuberculosis O
fungus O
microlith O
find O
histology O
reveal O
round O
concentrically O
laminate O
microlith O
alveoli O
associate O
slightly O
thicken O
interstitial O
septum O
consistent O
diagnosis O
pam B-DISEASE

48yearold O
man B-SEX
present O
hospital O
complaining O
intracranial O
bruit O
cranial O
nerve O
laboratory O
examination O
normal O
dvaf B-DISEASE
consider O
conventional O
digital O
subtraction O
angiography O
perform O
show O
cognard B-DISEASE
ii I-DISEASE
dvaf I-DISEASE
location O
right O
hypoglossal O
canal O
hc O
dvaf O
feed O
meningeal O
branch O
bilateral O
ascending O
pharyngeal O
artery O
right O
anterior O
condylar O
vein O
hypoglossal O
canal O
fistulous B-SYMPTOMS
point I-SYMPTOMS
mainly O
drain O
jugular O
vein O
endovascular O
treatment O
insist O
patient O
associated O
intolerable O
intracranial O
bruit O
treatment O
perform O
transarterial O
approach O
general O
anesthesia O
biplane O
angiographic O
unit O
standard O
coaxial O
technique O
guide O
catheter O
navigate O
left O
ascendingtrawt O
pharyngeal O
artery O
marathon O
flow O
direct O
catheter O
ev3 O
subsequently O
navigate O
mirage008 O
microwire O
ev3 O
reach O
near O
possible O
fistula B-SYMPTOMS
microcatheter O
flush O
10 O
ml O
normal O
saline O
dead O
space O
microcatheter O
subsequently O
fill O
dimethyl O
sulfoxide O
dmso O
onyx18 O
inject O
minute O
fill O
microcatheter O
replace O
dmso O
dead O
space O
injection O
stop O
unwanted O
flow O
branch O
right O
ascend O
pharyngeal O
artery O
observe O
followup O
angiogram O
show O
residual B-SYMPTOMS
shunt I-SYMPTOMS
figure O
1 O
intracranial O
bruit O
disappear O
immediately O
operation O
toxicity O
dmso O
10 O
mg O
dexamethasone O
intravenously O
inject O
day O
second O
day O
endovascular O
treatment O
patient O
complainte O
difficulty O
move O
tongue O
left O
cranial O
nerve O
examination O
significant O
right B-SYMPTOMS
hypoglossal I-SYMPTOMS
nerve I-SYMPTOMS
palsy I-SYMPTOMS
patient O
discharge O
hospital O
day O
treatment O
continuative O
pharmacotherapy O
month O
followup O
patient O
main O
complaint O
difficulty O
swallow O
dysphagia B-SYMPTOMS
slur O
speech O
dysarthria B-SYMPTOMS
addition O
tongue O
deviate O
right O
tongue O
protrusion O
mark O
rightside O
hemiatrophy B-SYMPTOMS
observe O
figure O
2 O
cranial O
nerve O
examation O
show O
right O
hypoglossal O
nerve O
palsy O
persist O
telephone O
patient O
month O
followup O
request O
vocal O
cord O
evaluation O
ent O
specialist O
local O
hospital O
vocal O
cord O
paralysis B-SYMPTOMS
find O
evidence O
vagus O
nerve O
dysfunction B-SYMPTOMS
oral O
vitamin O
b12 O
prognosis O
long O
followup O

41yearold O
man B-SEX
weight B-SYMPTOMS
loss I-SYMPTOMS
nausea B-SYMPTOMS
vomiting B-SYMPTOMS
abdominal O
pain B-SYMPTOMS
refer O
abdominal O
ct O
scan O
rule O
intraabdominal B-DISEASE
pathology I-DISEASE
dedicated O
ct O
abdoman O
perform O
institution O
accord O
standard O
venous O
phase O
protocol O
follow O
ingestion O
positive O
oral O
contrast O
material O
barium O
sulfate O
suspension O
21 O
wv O
mallinckrodt O
injection O
125 O
ml O
iopromide O
300 O
mg O
iml O
ultravist O
bayer O
healthcare O
helical O
ct O
obtain O
65 O
delay O
64slice O
ge O
lightspee O
vct O
scanner O
ge O
medical O
systems O
milwaukee O
wi O
axial O
section O
abdoman O
show O
large O
182222 O
cm O
heterogeneous O
retroperitoneal O
mass B-SYMPTOMS
probably O
arise O
left O
adrenal O
gland O
contain O
multiple O
area O
macroscopic O
fat O
fig1 O
patient O
document O
clinical O
laboratory O
evidence O
adrenal O
hormonal O
excess O
basis O
clinical O
history O
ct O
finding O
patient O
undergo O
surgical O
resection O
left O
adrenal O
mass O
find O
pathologic O
examination O
represent O
lowgrade O
adrenocortical B-DISEASE
carcinoma I-DISEASE

48 O
yearold O
female B-SEX
present O
vaginal O
bleeding B-SYMPTOMS
abnormal O
pap O
smear O
diagnosis O
invasive O
nonkeratinizing O
scc B-DISEASE
cervix O
undergo O
radical O
hysterectomy O
salpingooophorectomy O
demonstrate O
positive B-SYMPTOMS
spread I-SYMPTOMS
pelvic O
lymph O
node O
parametrium O
pathological O
examination O
reveal O
tumour O
extensively O
involve O
low O
uterine O
segment O
5 O
month O
surgery O
woman O
undergo O
external O
beam O
radiotherapy O
intracavitary O
brachytherapy O
year O
later O
patient O
present O
threemonth O
history O
productive O
cough B-SYMPTOMS
shortness O
breath O
23 O
week O
history O
progressive O
exertional O
dyspnea B-SYMPTOMS
xray O
chest O
demonstrate O
reticular O
nodular O
pattern O
ct O
scan O
reveal O
multiple O
bilateral O
patchy O
area O
ground O
glass O
opacity O
scar O
focal O
area O
subsegmental O
atelectasis B-SYMPTOMS
lung O
differential O
diagnosis O
include O
interstitial O
pneumonia B-DISEASE
versus O
noncardiogenic O
edema B-SYMPTOMS
woman O
undergo O
bronchoscopy O
leave O
thoracoscopy O
open O
wedge O
leave O
lung O
biopsy O
pathological O
examination O
left O
lung O
biopsy O
confirm O
presence O
neoplastic O
sheet O
cell O
classically O
distribute O
septal O
vessel O
perivascular O
peribronchial O
subpleural O
lymphatic O
subpleural O
nodule O
identify O
presence O
neoplastic O
cell O
distend O
subpleural O
lymphatic O
confirm O
lc B-DISEASE
figure O
1a O
1b O
1c O
immunohistochemical O
analysis O
lesional O
cell O
strongly O
positive O
p16 O
figure O
1d O
high O
low O
molecular O
weight O
keratin O
figure O
1e O
cytokeratin7 O
ck7 O
figure O
1f O
ck19 O
pan O
keratin O
negative O
ck20 O
p63 O
egfr O
base O
finding O
diagnose O
lymphangitic B-DISEASE
carcinomatosis I-DISEASE
lung O
metastatic B-SYMPTOMS
scc O
cervix O
start O
chemotherapy O
carbotaxol O
corticosteroid O
hospital O
discharge O
day O
later O
posttreatment O
improvement O
clinical O
symptom O
parallel O
radiographic O
imaging O
show O
marked O
interval O
improvement O
nodular O
opacification O
interstitial B-SYMPTOMS
thickening I-SYMPTOMS
previously O
note O
despite O
improvement O
subsequently O
die O
13 O
month O
initial O
diagnosis O

27 O
year O
old O
male B-SEX
right O
handed O
admit O
2 O
year O
history O
frequent O
gelastic O
seizure B-SYMPTOMS
patient O
describe O
auralike O
symptom O
especially O
warmth B-SYMPTOMS
face O
dizziness B-SYMPTOMS
precede O
seizure O
deny O
affective B-SYMPTOMS
connotation I-SYMPTOMS
seizure O
consist O
brief O
period O
laughter B-SYMPTOMS
motor B-SYMPTOMS
involvement I-SYMPTOMS
typical O
seizure O
consist O
sudden O
laughter O
accompany O
simple O
motor O
partial O
seizure O
arm O
involve O
left O
arm O
impairment O
consciousness O
state O
last O
1 O
minute O
previous O
past O
medical O
social O
history O
smoker O
1015 O
cigarette O
day O
frequency O
seizure O
initially O
low O
increase O
progressively O
time O
810 O
seizuresday O
despite O
antiepileptic O
treatment O
   O
time O
admission O
take O
keppra O
   O
levetiracetam O
3 O
x O
250 O
mgday O
phenytoin O
3 O
x O
100 O
mgday O
neurology O
electrophysiology O
department O
assistance O
able O
record O
couple O
seizure O
videoeeg O
neurological O
examination O
normal O
diagnosis O
native O
ct O
scan O
minimal O
hypodense O
frontal O
right O
paramedian O
lesion B-SYMPTOMS
figure O
1a O
cerebral O
mri O
figure O
1 O
bf O
show O
small O
right O
parenchymal O
homogeneous O
lesion O
162215 O
mm O
delimit O
involve O
gyrus O
cinguli O
perilesional O
edema B-SYMPTOMS
mass B-SYMPTOMS
effect I-SYMPTOMS
hyperintense O
t1 O
t2 O
mr O
sequences O
nonenhance O
gadolinium O
cerebral O
lesion O
document O
eeg O
videoeeg O
recording O
3 O
seizure O
mediofrontal O
origin O
rare O
interictal O
epileptiform O
element O
record O
figure O
1i O
interhemispheric O
microsurgical O
approach O
corpus O
callosum O
right O
pericallosal O
artery O
level O
gyrus O
cinguli O
yellowgray O
infiltrative O
tumour B-SYMPTOMS
have O
moderate O
vascularisation O
identify O
totally O
remove O
anatomopathological O
analysis O
reveal O
grade O
   O
astrocytoma B-DISEASE
patient O
recover O
deficit O
gelastic O
seizure O
epileptic O
manifestation O
month O
operation O
free O
seizure O
control O
postop O
ct O
reveal O
tumor B-SYMPTOMS
1 O
g O
h O

patient O
3yearold O
girl B-SEX
follow O
feature O
vacterl O
association O
absent O
c1 O
vertebra O
supernumerary O
lumbar O
vertebrae O
hypoplastic O
sacrumcoccyx O
fatty O
filum O
terminale O
tethered O
spinal O
cord O
fused O
rib O
anorectal B-DISEASE
malformation I-DISEASE
include O
cloaca O
consist O
common O
urogenital O
sinus O
duplex O
vagina O
midline O
septum O
type O
c O
te B-DISEASE
fistula I-DISEASE
right O
renal O
agenesis B-DISEASE
moderate O
left O
hydronephrosis B-DISEASE
vesicoureteral B-DISEASE
reflux I-DISEASE
cardiac O
limb O
malformation O
major O
organ O
anomaly O
father O
additionally O
clinically O
diagnose O
hypermobile O
type O
ehlersdanlos O
syndrome O
family O
history O
noncontributory O
diagnosis O
hypermobile O
type O
ehlersdanlos O
base O
patient O
hypermobility B-DISEASE
99 O
beighton O
hypermobility O
scale O
soft O
fragile O
skin O
unusual O
scarring O
poor O
skin O
heal O
skin O
biopsy O
perform O
test O
peripheral O
blood O
reveal O
mutation O
associate O
form O
ehlersdanlos O
syndrome O
microarray O
analysis O
initially O
show O
maternallyinherited O
deletion O
4q351 O
detect O
clone O
confirm O
fish O
rp11173m11 O
subsequent O
performance O
180k O
custom O
oligonucleotide O
microarray O
baylor O
college O
medicine O
medical O
genetic O
laboratory O
refine O
delete O
region O
deletion O
maximum O
size O
137 O
mb O
karyotype O
revise O
46xxarr O
cgh O
4q351q352 O
187321768188694589 O
3 O
1 O
gene O
delete O
region O
contain O
number O
small O
copy O
number O
variation O
cnvs O
identify O
normal O
control O
include O
cyp4v2 O
klkb2 O
f11 O
mtrnr1a O
fat1 O
clearly O
relate O
phenotype O
especially O
mother O
deletion O
inherit O
unaffected B-DISEASE
evidence O
mitochondrial B-DISEASE
dysfunction I-DISEASE
begin O
13 O
month O
age O
progressive O
muscle B-SYMPTOMS
weakness I-SYMPTOMS
autonomic B-DISEASE
dysregulation I-DISEASE
hypoglycemic O
episode O
exocrine B-DISEASE
pancreatic I-DISEASE
dysfunction I-DISEASE
decline O
gastrointestinal O
function O
eventually O
lead O
total O
parenteral O
nutrition B-DISEASE
dependency I-DISEASE
visceral O
hyperalgesia B-DISEASE
dysmotility B-DISEASE
malabsorption B-DISEASE
muscle O
biopsy O
show O
mild O
increase O
fiber O
size O
variability O
finding O
consistent O
mitochondrial O
disease O
include O
electron O
microscopy O
analysis O
electron O
transport O
chain O
etc O
activity O
show O
normal O
activity O
complex O
ii O
iii O
complex O
iv O
cytochrome O
c O
oxidase O
activity O
454 O
lmolme O
weight O
control O
range O
1489 O
   O
672 O
lmolming O
weight O
repeat O
etc O
analysis O
isolated O
mitochondria O
confirm O
profound O
reproducible O
complex B-DISEASE
iv I-DISEASE
deficiency I-DISEASE
citrate O
synthase O
activity O
content O
etc O
analysis O
normal O
confirm O
good O
sample O
quality O
normal O
mitochondrial O
content O
mitochondrial O
genome O
sequence O
sequence O
dna O
polymerase O
gamma O
1 O
2 O
polg1 O
polg2 O
thymidine O
phosphorylase O
reveal O
abnormality O

52yearold O
man B-SEX
body O
surface O
area O
13 O
m2 O
know O
dilate O
cardiomyopathy O
dcm B-DISEASE
admit O
worsen O
heart B-DISEASE
failure I-DISEASE
nyha O
class O
iv O
present O
5month O
history O
cough B-SYMPTOMS
progressive O
dyspnoea B-SYMPTOMS
orthopnea B-SYMPTOMS
recurrent O
upper O
abdominal O
pain B-SYMPTOMS
start O
2 O
month O
ago O
examination O
vital O
sign O
body O
temperature O
37c O
blood O
pressure O
8040 O
mmhg O
respiratory O
rate O
24 O
breath O
minute O
electrocardiogram O
show O
atrial B-DISEASE
fibrillation I-DISEASE
heart O
rate O
50 O
beat O
minute O
physical O
examination O
reveal O
jugular O
venous O
distension B-SYMPTOMS
significant O
tender O
hepatomegaly B-SYMPTOMS
bilateral O
pitting O
edema B-SYMPTOMS
low O
limb O
laboratory O
test O
show O
elevate O
pront O
brain O
natriuretic O
peptide O
22145 O
pgml O
normal O
0 O
227 O
pgml O
unremarkable O
ddimer O
xray O
compute O
tomography O
chest O
demonstrate O
consolidation B-SYMPTOMS
bilateral O
low O
lobe O
pleural B-SYMPTOMS
effusion I-SYMPTOMS
venous O
doppler O
low O
extremity O
normal O
base O
clinical O
condition O
echocardiography O
immediately O
insert O
severe O
dilate O
cardiac O
chamber O
especially O
enlargement B-SYMPTOMS
left O
ventricle O
lv O
58 O
mmm2 O
spherical B-SYMPTOMS
shape I-SYMPTOMS
decrease O
wall O
thickness O
impair O
ejection O
fraction O
22 O
severe O
mitral B-SYMPTOMS
regurgitation I-SYMPTOMS
twodimensional O
transthoracic O
echocardiography O
2dtte O
parasternal O
short O
axis O
subxyphoid O
view O
figure O
1 O
show O
mobile O
right O
atrial O
mass B-SYMPTOMS
highly O
suspicious O
thrombus B-DISEASE
traverse O
right O
atrial O
cavity O
cardiac O
cycle O
accompany O
freefloate O
small O
part O
thrombi B-DISEASE
realtime O
dimensional O
transthoracic O
echocardiography O
rt3dtte O
perform O
confirm O
nature O
mass O
show O
highly O
mobile O
thrombus O
irregular O
contour O
measure O
26 O
   O
10 O
cm O
float O
orifice O
inferior O
vena O
cava O
protruding O
right O
atrial O
cavity O
figure O
2 O
addition O
rt3dtte O
evaluate O
right O
ventricle O
rv O
systolic B-SYMPTOMS
dysfunction I-SYMPTOMS
ejection O
fraction O
157 O
figure O
3 O
maintain O
digoxin O
spironolactone O
furosemide O
sotalol O
dopamine O
time O
therapeutic O
anticoagulation O
start O
lowmolecularweight O
heparin O
warfarin O
patient O
uneventful O
hospital O
course O
week O
followup O
echocardiography O
confirm O
adequate O
removal O
thrombus O
figure O
4a O
4b O

75yearold O
female B-SEX
present O
emergency O
department O
ilfov O
clinical O
hospital O
bucharest O
romania O
dyspnea B-SYMPTOMS
orthopnea B-SYMPTOMS
low O
extremity O
swell O
palpitation O
3 O
year O
history O
atrial B-SYMPTOMS
fibrillation I-SYMPTOMS
diagnose O
family O
doctor O
oneyear O
history O
cardiac B-DISEASE
failure I-DISEASE
nyha O
new O
york O
heart O
association O
class O
   O
physical O
examination O
reveal O
irregular B-SYMPTOMS
pulse I-SYMPTOMS
80 O
beatsmin O
blood O
pressure O
10060 O
mmhg O
bibasal O
crackle O
chest O
auscultation O
low O
extremity O
swell O
heart O
sound O
examination O
reveal O
ivth O
degree O
pansystolic B-SYMPTOMS
murmur I-SYMPTOMS
left O
border O
stern O
jugular O
vein O
dilate O
patient O
complain O
pain B-SYMPTOMS
upper O
right O
abdominal O
region O
enhance O
palpation O
liver O
margin O
tender O
round O
6 O
cm O
costal O
rib O
smooth O
liver O
surface O
spleen O
feel O
ekg O
atrial O
fibrillation O
80min O
right B-SYMPTOMS
bundle I-SYMPTOMS
branch I-SYMPTOMS
block I-SYMPTOMS
inferolateral O
ischemia B-SYMPTOMS
transabdominal O
ultrasound O
show O
homogenous O
enlarged B-SYMPTOMS
liver I-SYMPTOMS
suprahepatic O
vein O
dilate O
inferior O
vena O
cava O
30 O
mm O
respiratory O
variation O
transthoracic O
echocardiography O
reveal O
dilate O
right O
atrium O
742 O
mm O
figure O
1 O
dilate O
left O
atrium O
552 O
mm O
dilate O
left O
ventricle O
64723 O
mm O
dilate O
right O
ventricle O
444 O
mm O
atrial B-DISEASE
septal I-DISEASE
defect I-DISEASE
ostium O
secundum O
type O
6 O
cm O
figure O
2 O
lefttoright O
shunt O
severe O
tricuspid B-DISEASE
insufficiency I-DISEASE
maximum O
gradient O
554 O
mm O
hg O
4th O
degree O
mitral B-DISEASE
insufficiency I-DISEASE
severe O
pulmonary O
hypertension B-SYMPTOMS
75 O
mm O
hg O
ejection O
fraction O
29 O
atrial O
fibrillation O
interventricular O
sept O
paradoxical B-SYMPTOMS
motion I-SYMPTOMS
flattening B-SYMPTOMS
interventricular O
septum O
figure O
3 O
diagnosis O
ivth O
degree O
chronic B-DISEASE
heart I-DISEASE
failure I-DISEASE
nyha O
atrial O
septal O
defect O
ostium O
secundum O
type O
lefttoright O
shunt O
severe O
tricuspid O
insufficiency O
4th O
degree O
mitral O
insufficiency O
severe O
pulmonary O
hypertension O
75 O
mm O
hg O
chronic O
atrial O
fibrillation O
right O
bundle O
branch O
block O

81yearold O
female B-SEX
hypertension B-SYMPTOMS
gout B-DISEASE
admit O
taichung O
veterans O
general O
hospital O
abdominal O
pain B-SYMPTOMS
hematemesis B-SYMPTOMS
begin O
suffer O
intermittent O
epigastralgia B-SYMPTOMS
10 O
year O
ago O
4 O
cm O
gastric O
tumor B-SYMPTOMS
find O
abdominal O
pain O
get O
bad O
2 O
year O
admission O
go O
local O
hospital O
abdominal O
ct O
scan O
reveal O
gastric O
tumor O
6 O
cm O
length O
wellcircumscribe O
calcificationfigure O
1 O
surgical O
intervention O
suggest O
decline O
10 O
day O
admission O
tarry B-SYMPTOMS
stool I-SYMPTOMS
passage O
note O
bloody B-SYMPTOMS
vomitus I-SYMPTOMS
find O
1 O
day O
later O
ugi O
scope O
reveal O
submucosal O
gastric O
tumor O
central O
ulceration O
transfer O
hospital O
physical O
examination O
show O
upper O
abdominal O
tenderness B-SYMPTOMS
mild O
muscle O
guard O
plain O
radiography O
show O
irregular O
shape O
calcification B-SYMPTOMS
upper O
abdomen O
ugi O
scope O
reveal O
deep O
gastric O
ulcer B-SYMPTOMS
foreign B-SYMPTOMS
body I-SYMPTOMS
ct O
scan O
show O
irregularly O
shape O
spaceoccupye O
lesion B-SYMPTOMS
stomach O
plate O
calcification O
localize O
free B-SYMPTOMS
air I-SYMPTOMS
figure O
2 O
3 O
impression O
perforate O
gastric O
tumor O
emergent O
laparotomy O
perform O
infiltrative O
mass B-SYMPTOMS
stomach O
transverse O
colon O
note O
operation O
sharp O
bonelike O
thick O
calcify O
plate O
penetrate O
gastric O
mucosa O
pericolic O
soft O
tissue O
observe O
submucosal O
tumor O
23 O
cm O
size O
adherent O
calcify O
plate O
note O
figure O
4 O
5 O
distal O
subtotal O
gastrectomy O
partial O
colectomy O
perform O
patient O
discharge O
13 O
day O
operation O
uneventfully O
microscopically O
spindleshape O
tumor O
cell O
low O
mitotic O
frequency O
450 O
hpf O
find O
immunohistochemical O
staining O
tumor O
demonstrate O
diffusely O
strong O
positive O
reactivity O
cd O
117 O
positive O
reactivity O
cd34 O
negative O
reactivity O
s100 O
protein O
desmin O
diagnosis O
tumor O
establish O
gist B-DISEASE
small O
size O
paucity O
mitotic O
figure O
tumor O
locate O
stomach O
classify O
low O
risk4 O
sporadic O
gist O
impressed O
family O
history O
gist O
gist O
present O
patient O

33 O
   O
year O
old O
woman B-SEX
present O
cardiology O
service O
sign O
symptom O
congestive B-DISEASE
heart I-DISEASE
failure I-DISEASE
medical O
history O
unremarkable O
year O
ago O
soon O
child O
delivery O
admit O
hospital O
acute B-DISEASE
pulmonary I-DISEASE
oedema I-DISEASE
labor O
cor B-DISEASE
triatriatum I-DISEASE
obstructive O
behavior O
cause O
pulmonary B-SYMPTOMS
hypertension I-SYMPTOMS
bee O
diagnose O
left O
ventricle O
structurally O
functionally O
intact O
patient O
time O
deny O
surgey O
discharge O
medical O
therapy O
present O
admission O
patient O
present O
nyha O
functional O
class O
iii O
symptom O
heart O
failure O
palpittion O
result O
persistent B-SYMPTOMS
atrial I-SYMPTOMS
flutter I-SYMPTOMS
physical O
examination O
loud O
pulmonary O
component O
2nd O
heart O
sound O
diastolic O
murmur B-SYMPTOMS
hear O
mitral O
area O
sign O
rightside O
heart O
failure O
absent O
transthoracic O
echocardiography O
reveal O
moderately O
dilate O
left O
ventricle O
lv O
globally O
hypokinetic B-DISEASE
severely O
impair O
systolic O
function O
ef O
estimate O
30 O
leave O
atrium O
la O
dilate O
mobile O
membranelike O
echogenic B-SYMPTOMS
structure I-SYMPTOMS
transesophageal O
echocardiogram O
tee O
document O
fibromuscular B-SYMPTOMS
membrane I-SYMPTOMS
la O
divide O
compartment O
proximal O
receive O
pulmonary O
venous O
flow O
distal O
contain O
left O
atrial O
appendage O
laa O
chamber O
communicate O
nonrestrictive O
orifice O
membrane O
prolapse O
mitral O
valve O
inflow O
cause O
severe O
obstruction B-SYMPTOMS
mitral O
valve O
appear O
normal O
mild O
regurgitation B-SYMPTOMS
patent O
foraman O
ovale O
pfo B-DISEASE
atrial B-DISEASE
septal I-DISEASE
defect I-DISEASE
asd B-DISEASE
anomalous B-SYMPTOMS
venous O
connection O
rule O
diagnosis O
cor O
triatriatum O
reconfirm O
magnetic O
resonance O
image O
   O
mri O
heart O
reveal O
fibromuscular B-SYMPTOMS
septum I-SYMPTOMS
left O
atrium O
low O
left O
ventricular O
ejection O
fraction O
lvef O
30 O
cardiac O
index O
16 O
lminm2 O
cardiac O
output O
27 O
lmin O
figure O
1 O
coronary O
angiography O
show O
normal O
coronary O
artery O
finding O
patient O
schedule O
surgery O
anesthetic O
induction O
achieve O
standard O
technique O
include O
administration O
sodium O
pentothal O
sevofluorane O
fentanyl O
muscle O
relaxant O
invasive O
monitoring O
include O
use O
right O
radial O
arterial O
line O
pulmonary O
artery O
catheter O
foley O
catheter O
temperature O
probe O
measure O
bladder O
temperature O
indicator O
core O
body O
temperature O
transesophageal O
echocardiography O
tee O
institute O
surgery O
perform O
median O
sternotomy O
connection O
cardiopulmonary O
bypass O
cpb O
achieve O
standard O
ascending O
aorta O
bicaval O
cannulation O
mildly O
hypothermic B-SYMPTOMS
32c O
cpb O
establish O
cold O
blood O
cardioplegia O
administer O
antegrade O
fashion O
aortic O
root O
clamp O
aorta O
interatrial O
groove O
develop O
common O
pulmonary O
venous O
chamber O
left O
atrium O
open O
vertical O
incision O
anterior O
right O
pulmonary O
vein O
exactly O
mitral O
valve O
surgery O
insertion O
selfretaine O
retractor O
facilitate O
exposure O
diaphragm O
expose O
central O
hole B-SYMPTOMS
identify O
preliminary O
incision O
hole O
improve O
exposure O
definitive O
excision O
orifice O
pulmonary O
vein O
side O
locate O
position O
atrial O
septum O
identify O
small O
opening O
right O
atrium O
insert O
curve O
clamp O
displace O
septum O
common O
pulmonary O
venous O
chamber O
left O
atrium O
atrial O
septal O
defect O
patent O
foraman O
ovale O
diaphragm O
easily O
completely O
excise O
expose O
mitral O
valve O
figure O
2 O
left O
atrial O
appendage O
close O
inside O
left O
atrium O
run O
30 O
polypropylene O
suture O
prevent O
future O
thrombus B-SYMPTOMS
formation I-SYMPTOMS
atriotomy O
incision O
close O
heart O
having O
fill O
blood O
suture O
place O
patient O
rewarme O
aortic O
crossclamp O
remove O
additional O
deairing O
carry O
usual O
manner O
cpb O
terminate O
minimal O
inotropic O
support O
involve O
milrinone O
levophe O
good O
hemodynamic O
postoperative O
course O
uneventful O
patient O
extubate O
12 O
hour O
discharge O
hospital O
fifth O
postoperative O
day O
3 O
month O
followup O
patient O
asymptomatic O
nyha O
class O
sinus O
rhythm O
tte O
mri O
reveal O
mildly O
dilate O
lv O
great O
improvement O
systolic O
function O
estimate O
lvef O
50 O

february O
2010 O
77yearold O
man B-SEX
history O
stroke B-DISEASE
peripheral B-DISEASE
vascular I-DISEASE
disease I-DISEASE
present O
emergency O
department O
florid O
pulmonary B-DISEASE
edema I-DISEASE
6month O
history O
worsen O
dyspnea B-SYMPTOMS
exertion O
paroxysmal O
nocturnal O
dyspnea O
leg O
edema O
physical O
examination O
diffuse O
rale O
murmur O
aortic O
stenosis O
2dimensional O
doppler O
transthoracic O
echocardiogram O
reveal O
severe O
aortic B-DISEASE
valve I-DISEASE
stenosis I-DISEASE
peak O
gradient O
70 O
mmhg O
mean O
gradient O
45 O
mmhg O
calculate O
aortic O
valve O
area O
07 O
cm2 O
severe O
mitral B-DISEASE
regurgitation I-DISEASE
severely O
dilate O
left O
ventricle O
lv O
ejection O
fraction O
020 O
pulmonary O
edema O
resolve O
cardiac O
catheterization O
confirm O
echocardiographic O
finding O
show O
nonobstructive O
coronary B-DISEASE
artery I-DISEASE
disease I-DISEASE
give O
finding O
patient O
comorbiditie O
decide O
minimally O
invasive O
surgical O
approach O
patient O
place O
supine O
position O
underwent O
anesthetic O
induction O
intubation O
singleluman O
endotracheal O
tube O
bronchial O
blocker O
intraoperative O
transesophageal O
echocardiography O
tee O
confirm O
previous O
finding O
show O
mitral O
valve O
leaflet O
free O
significant B-DISEASE
disease I-DISEASE
mitral O
regurgitation O
originate O
a2p2 O
portion O
mitral O
valve O
fig1 O
mitral O
regurgitation O
think O
functional O
cause O
mitral B-SYMPTOMS
annular I-SYMPTOMS
dilation I-SYMPTOMS
tethering B-SYMPTOMS
papillary O
muscle O
severely O
dilate O
lv O
decide O
perform O
edgetoedge O
repair O
mitral O
valve O
transaortic O
approach O
femoral O
platform O
establish O
cardiopulmonary O
bypass O
2 O
3 O
cm O
incision O
left O
inguinal O
crease O
50 O
prolene O
pursestre O
suture O
ethicon O
inc O
johnson O
   O
johnson O
company O
somerville O
nj O
place O
femoral O
artery O
vein O
left O
femoral O
artery O
cannulate O
16f18f O
arterial O
cannula O
left O
femoral O
vein O
cannulate O
25f O
biomedicus O
femoral O
venous O
cannula O
medtronic O
inc O
minneapolis O
minn O
place O
superior O
vena O
cava O
aid O
tee O
4 O
5 O
cm O
transverse O
parasternal O
incision O
3rd O
intercostal O
space O
transect O
4th O
costochondral O
cartilage O
enable O
adequate O
exposure O
aorta O
interspace O
choose O
event O
left O
atrium O
need O
enter O
pericardium O
open O
phrenic O
nerve O
aorta O
facilitate O
exposure O
retrograde O
coronary O
sinus O
catheter O
insert O
directly O
incision O
pursestre O
suture O
place O
right O
atrium O
lv O
vent O
insert O
pursestre O
suture O
right O
superior O
pulmonary O
vein O
transverse O
aortotomy O
perform O
expose O
aortic O
valve O
remove O
direct O
vision O
a2 O
p2 O
segment O
mitral O
valve O
identify O
edgetoedge O
repair O
carry O
50 O
prolene O
mattress O
suture O
reinforce O
pericardial O
pledget O
ventricular O
mitral O
valve O
fig2 O
27 O
mm O
hancock O
ii O
bioprosthetic O
aortic O
valve O
medtronic O
implant O
use O
standard O
technique O
aortotomy O
close O
2layer O
fashion O
patient O
wean O
cardiopulmonary O
bypass O
transect O
rib O
reattache O
sternum O
1 O
cm O
metal O
plate O
synthe O
inc O
west O
chester O
pa O
fiber O
wire O
place O
figure8 O
fashion O
single O
chest O
tube O
leave O
pleural O
space O
thoracotomy O
close O
routine O
fashion O
postoperative O
tee O
show O
mitral O
regurgitation O
fig3 O
elbowing B-SYMPTOMS
anterior O
leaflet O
middiastole O
tethering O
anterior O
leaflet O
posterior O
leaflet O
fig4 O
doubleorifice O
mitral O
valve O
result O
edgetoedge O
repair O
fig5 O
surgery O
patient O
shortness O
breath O
resolve O
discharge O
hospital O
postoperative O
day O
6 O
followup O
evaluation O
march O
2011 O
asymptomatic B-SYMPTOMS
echocardiography O
show O
grade O
1 O
mitral O
regurgitation O

59yearold O
man B-SEX
refer O
general O
surgery O
department O
hospital O
onemonth O
history O
progressive O
dysphagia B-SYMPTOMS
solid O
associate O
malnutrition B-DISEASE
significant O
weight B-SYMPTOMS
loss I-SYMPTOMS
patient O
recently O
undergo O
esophagogastroduodenoscopy O
hospital O
reveal O
bleed O
ulcerative O
lesion B-SYMPTOMS
middle O
esophagus O
biopsy O
collect O
medical O
past O
history O
include O
copd B-DISEASE
diagnose O
1999 O
myocardial B-DISEASE
infarction I-DISEASE
2002 O
patient O
smoke O
approximately O
25 O
cigarette O
day O
year O
physical O
examination O
unremarkable O
computed O
tomography O
ct O
chest O
abdomen O
reveal O
stenosis B-SYMPTOMS
involve O
5 O
cm O
segment O
middle O
esophagus O
lesion O
thoracic O
abdominal O
organ O
barium O
study O
disclose O
swelling B-SYMPTOMS
esophageal O
wall O
7 O
cm O
cardia O
ulcerative O
pattern O
reduce O
diameter O
luman O
5 O
mm O
endoscopic O
biopsy O
oesophageal O
mass B-SYMPTOMS
demonstrate O
poorly O
differentiate O
g3 O
squamous B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
middistal O
esophagectomy O
perform O
oesophagogastric O
anastomosis O
gastric O
tube O
reconstruction O
pathological O
examination O
surgical O
speciman O
confirm O
biopsy O
diagnosis O
poorly O
differentiate O
g3 O
scc B-DISEASE
tumor O
measure O
3 O
cm O
length O
infiltrate O
oesophageal O
wall O
surround O
paraesophageal O
fat O
surgical O
margin O
tumorfree O
seven O
perigastric O
limphnode O
dissect O
pt3 O
n0 O
postoperative O
period O
unremarkable O
contrast O
enhance O
xray O
obtain O
9th O
pod O
show O
normal O
esophageal O
gastric O
transit O
14th O
pod O
patient O
discharge O
oncology O
referral O
routine O
medical O
followup O
month O
operation O
ct O
esophagogastroduodenoscopy O
repeat O
imaging O
study O
reveal O
mild O
splenomegaly B-SYMPTOMS
multiple O
nonspecific O
nodule O
organ O
figure O
1 O
patient O
virtually O
asymptomatic B-SYMPTOMS
exception O
vague O
sensation O
mild O
discomfort B-SYMPTOMS
left O
upper O
quadrant O
abdomen O
fnac O
spleen O
reveal O
pattern O
numerous O
inflammatory O
cell O
admix O
large O
cell O
display O
immunohistochemical O
positivity O
cytokeratin O
figure O
2 O
speciman O
gram O
stainnegative O
bonemarrow O
biopsy O
negative O
metastatic O
involvement O
diagnosis O
isolate O
metastasis O
spleen O
inflammatory O
necrotic O
alteration O
patient O
refer O
centre O
splenectomy O
perform O
routine O
procedure O
role O
spontaneous O
rupture B-SYMPTOMS
spleen O
12th O
december O
2007 O
patient O
transabdominal O
total O
splenectomy O
splenic O
celiac O
artery O
lymph O
node O
dissection O
postoperative O
course O
uneventful O
7th O
postoperative O
day O
doppler O
ultrasonography O
reveal O
portaltree O
patency B-SYMPTOMS
sign O
thrombosis B-DISEASE
day O
later O
patient O
discharge O
stable O
platelet O
count O
780000mm3 O
hb O
109 O
gdl O
wbc O
count O
16500mm3 O
pathological O
examination O
spleen O
describe O
multiple O
nodule O
contain O
medium O
largesize O
cell O
keratinize O
nodule O
solid O
area O
central O
necrosis O
figure O
3 O
finding O
consistent O
metastasis O
scc O
patient O
refer O
oncology O
department O
hospital O
receive O
3day O
cycle O
separate O
3week O
interval O
systemic O
chemotherapy O
base O
5fluorouracil O
800 O
mgday O
iv O
cisplatin O
20 O
mgday O
month O
splenectomy O
multiple O
liver O
metastasis O
see O
ct O
scan O
cutaneous O
metastasis O
present O
patient O
die O
9 O
month O
later O

26yearold O
man B-SEX
portuguese O
descent O
significant O
past O
medical O
history O
present O
subacute O
onset O
rightside O
hemiparesis B-SYMPTOMS
aphasia B-DISEASE
marked O
expressive O
aphasia O
wordfinding O
difficulty O
rare O
paraphrasic O
error O
examination O
demonstrate O
right O
central O
facial O
weakness B-SYMPTOMS
235 O
strength O
right O
arm O
leg O
dysmetria B-SYMPTOMS
right O
upper O
low O
extremity O
reflex O
hyperactive O
right O
rightside O
babinski O
response O
mri O
brain O
show O
multiple O
bilateral O
concentric O
ringlike O
structure O
centrum O
semiovale O
corona O
radiata O
t2 O
imaging O
figurea O
consistent O
pattern O
balo B-DISEASE
concentric I-DISEASE
sclerosis I-DISEASE
associate O
restricted O
diffusion O
3 O
lesion B-SYMPTOMS
incomplete O
ring O
enhancement O
1 O
lesion O
csf O
analysis O
show O
30 O
leukocyte O
79 O
lymphocyte O
4 O
monocyte O
erythrocyte O
count O
850 O
oligoclonal O
band O
absent O
treat O
1 O
g O
iv O
methylprednisolone O
daily O
5 O
day O
little O
improvement O
undergo O
5 O
plasmapheresis O
exchange O
significant O
improvement O
motor O
sensory O
speech O
deficit O
gait O
fortyfive O
day O
discharge O
examination O
show O
45 O
strength O
right O
intrinsic O
muscle O
hand O
rightside O
positional B-SYMPTOMS
tremor I-SYMPTOMS
gait O
tandem O
gait O
normal O
place O
interferon1a O
44 O
g O
subcutaneously O
3 O
time O
week O
treatment O
presume O
clinically O
isolate O
syndrome O
good O
response O
year O
later O
neurologic O
examination O
essentially O
normal O
family O
history O
demyelinate O
autoimmune O
disorder O
mother O
significant O
history O
headache O
earlyonset O
stroke O
find O
carrier O
notch3 O
mutation O
consistent O
cerebral O
autosomal O
dominant O
arteriopathy O
subcortical O
infarct O
leukoencephalopathy O
cadasil O
sister O
stroke O
30 O
history O
migraine O
headache O
undergo O
medical O
evaluation O
testing O
cadasil O
patient O
show O
notch3 O
mutation O
associate O
cadasil O
transition O
ct O
nucleotide O
position O
1750 O
codon O
558 O
skin O
biopsy O
show O
electrondense O
extracellular O
material B-SYMPTOMS
close O
apposition O
smooth O
muscle O
vascular O
media1 O
figure O
b O

70yearold O
female B-SEX
present O
emergency O
department O
palpitation O
dyspnea B-SYMPTOMS
anterior O
epistaxis B-SYMPTOMS
3 O
year O
history O
atrial B-DISEASE
fibrillation I-DISEASE
chronic O
heart B-DISEASE
failure I-DISEASE
nyha O
class O
iii O
treat O
aspirin O
100 O
mgday O
physical O
examination O
reveal O
irregular O
pulse O
148 O
beatsmin O
blood O
pressure O
130100 O
mmhg O
pansystolic O
mitral O
murmur B-SYMPTOMS
26 O
grade O
murmur O
tricuspid O
regurgitation O
36 O
grade O
low O
extremity O
swell O
otorhinolaryngology O
exam O
conclusion O
anterior O
epistaxis O
12lead O
electrocardiogram O
reveal O
atrial O
fibrillation O
inferior O
ischemia B-SYMPTOMS
international O
normalize O
ratio O
inr O
124 O
twodimensional O
transthoracic O
echocardiography O
show O
thickening O
mitral O
valve O
moderate O
mitral B-SYMPTOMS
insufficiency I-SYMPTOMS
mobile O
round O
mass B-SYMPTOMS
left O
atrium O
heterogeneous O
inhomogeneous O
18 O
mm O
size O
attach O
narrow O
stalk O
interatrial O
septum O
show O
tumorlike O
movement O
cardiac O
cycle O
reach O
mitral O
annular O
plane O
figure O
1figure O
2 O
echocardiography O
show O
tricuspid B-SYMPTOMS
insufficiency I-SYMPTOMS
maximum O
gradient O
30 O
mmhg O
intact B-SYMPTOMS
interatrial I-SYMPTOMS
septum I-SYMPTOMS
akinesia B-SYMPTOMS
third O
basal O
inferior O
wall O
ejection O
fraction O
42 O
mass O
left O
atrial O
appendage O
twodimensional O
transesophageal O
echocardiography O
confirm O
presence O
intraatrial O
mass O
epistaxis O
consider O
heart O
failure O
increase O
venous B-SYMPTOMS
pressure I-SYMPTOMS
patient O
refer O
cardiovascular O
surgery O
clinic O
refuse O
surgery O
anticoagulation O
fraxiparine O
06 O
mlday O
start O
continue O
3 O
week O
cessation O
epistaxis O
nasal O
tamponament O
3 O
week O
echocardiography O
repeat O
remnant O
mass O
left O
atrium O
conclusion O
mass O
thrombus B-SYMPTOMS
melt O
away O
particular O
case O
left O
intraatrial O
thrombus O
presence O
atrial O
fibrillation O

53 B-AGE
year I-AGE
old I-AGE
female B-SEX
significant O
past O
medical O
history O
develop O
severe O
viral O
pneumonia B-DISEASE
rapid O
progressive O
deterioration O
respiratory O
status O
develop O
ard O
mechanical O
ventilatory O
management O
ard O
protocol O
unable O
maintain O
adequate O
oxygenation O
result O
bedside O
vvecmo O
plan O
transesophageal O
echocardiography O
tee O
perform O
visualize O
proper O
positioning O
guidewire O
cannula O
seldinger O
technique O
right O
internal O
jugular O
vein O
access O
guide O
wire O
place O
placement O
guidewire O
ivc O
prove O
difficult O
repeat O
migration O
guidewire O
right O
ventricle O
multiple O
attempt O
guidewire O
visualize O
course O
properly O
svc O
ivc O
bolus O
dose O
5000 O
unit O
intravenous O
heparin O
give O
right O
internal O
jugular O
venous O
access O
site O
dilate O
final O
dilatation O
complete O
dilator O
exchange O
simultaneous O
advancement O
23 O
french O
avalon O
cannula O
tee O
lose O
visualization O
guidewire O
multiple O
premature O
ventricular O
beat O
note O
immediately O
new O
rapidly O
enlarging O
pericardial B-DISEASE
effusion I-DISEASE
detect O
figure O
figure22 O
emergent O
preparation O
bedside O
surgical O
decompression O
pericardial O
space O
quickly O
patient O
lose O
blood O
pressure O
acute O
cardiac B-DISEASE
tamponade I-DISEASE
avalon O
cannula O
immediately O
clamp O
end O
remove O
emergent O
subxiphoid O
pericardial O
window O
perform O
result O
drainage B-SYMPTOMS
venous O
blood O
restoration O
blood O
pressure O
transfusion O
initiate O
patient O
emergently O
transport O
operating O
room O
surgical O
exploration O
avalon O
cannula O
find O
perforate O
apex O
right O
ventricle O
injury O
repair O
primarily O
avalon O
cannula O
reposition O
ivc O
tee O
additional O
direct O
manipulation O
vvecmo O
initiate O
oxygenation O
improve O
excessive O
coagulopathie O
sternum O
leave O
open O
close O
postoperative O
day O
2 O
point O
remain O
free O
cardiac O
infectious O
complication O
pulmonary O
condition O
slowly O
improve O
successfully O
wean O
vvecmo O
postoperative O
day O
9 O
discharge O
home O
postoperative O
day O
24 O
need O
home O
oxygen O
regain O
physical O
function O
home O
recover O
normal O
pulmonary O
function O
3 O
month O
follow O
discharge O
hospital O

60yearold O
male B-SEX
patient O
previously O
undergo O
radical O
resection O
t2bn0m0g3 O
stage O
iii O
retroperitoneal B-DISEASE
sarcoma I-DISEASE
include O
right O
nephrectomy O
cholecystectomy O
2002 O
pathologic O
evaluation O
demonstrate O
25 O
cm O
highgrade O
liposarcoma B-DISEASE
different O
histologic O
component O
include O
myxoid O
round O
cell O
welldifferentiate O
sclerose O
pleomorphic O
pattern O
surgical O
margin O
negative O
tumor B-SYMPTOMS
invade B-SYMPTOMS
kidney O
renal O
vein O
ureter O
free O
tumor O
patient O
undergo O
additional O
therapy O
surveillance O
magnetic O
resonance O
image O
2007 O
reveal O
isolated O
tumor B-SYMPTOMS
recurrence B-SYMPTOMS
retroperitoneum O
exploratory O
celiotomy O
reveal O
tumor B-SYMPTOMS
involvement B-SYMPTOMS
duodenum O
head O
pancreas O
superior O
mesenteric O
vein O
vena O
cava O
leave O
renal O
vein O
severe O
adhesive O
change O
lead O
intraoperative O
assessment O
unresectable B-DISEASE
disease I-DISEASE
subsequently O
patient O
undergo O
stereotactic O
body O
radiation O
retroperitoneal O
tumor O
fraction O
total O
dose O
30 O
gy O
complication B-SYMPTOMS
postradiation O
imaging O
reveal O
near O
complete O
resolution O
retroperitoneal O
mass B-SYMPTOMS
year O
later O
patient O
present O
weight B-SYMPTOMS
loss I-SYMPTOMS
postprandial O
abdominal O
pain B-SYMPTOMS
nausea B-SYMPTOMS
vomit O
crosssectional O
imaging O
reveal O
7 O
cm O
mass O
involvement O
portion O
duodenum O
figure O
1 O
obvious O
involvement O
pancreatic O
head O
structure O
note O
involve O
previous O
laparotomy O
elect O
perform O
resection O
attempt O
include O
possible O
pancreatoduodenectomy O
retroperitoneal O
vascular O
resection O
necessary O
exploration O
residual O
tumor O
entirely O
intraduodenal O
pedunculate O
mass O
posterior O
duodenal O
wall O
distal O
ampulla O
fill O
entire O
duodenal O
luman O
patient O
undergo O
duodenotomy O
stalk O
transection O
polypoid O
mass O
follow O
partial O
duodenal O
resection O
handsewn O
duodenojejunal O
anastomosis O
figure O
2 O
surgical O
pathology O
examination O
reveal O
95 O
cm O
recurrent O
highgrade O
liposarcoma O
polypoid O
intraluminal O
growth O
contain O
myxoid O
round O
cell O
welldifferentiate O
sclerose O
focally O
pleomorphic O
area O
surgical O
margin O
negative O
tumor O
come O
01 O
cm O
stalk O
margin O
evidence O
additional O
neoplastic O
component O
remain O
resect O
duodenum O
postoperative O
course O
uncomplicated O
patient O
demonstrate O
recurrence O
30 O
month O
resection O

5yearold O
caucasian O
male B-AGE
present O
children O
emergency O
department O
epistaxis B-SYMPTOMS
bleeding B-SYMPTOMS
dental O
extraction O
site O
widespread O
purpuric O
rash B-SYMPTOMS
secondary O
acute O
idiopathic O
thrombocytopenia B-SYMPTOMS
day O
prior O
develop O
generalised O
chickenpox B-SYMPTOMS
rash I-SYMPTOMS
department O
note O
heart O
rate O
range O
50 O
60 O
beat O
min O
haemodynamically O
stable O
normal O
blood O
pressure O
oxygen O
saturation O
air O
short O
systolic O
murmur B-SYMPTOMS
grade O
26 O
left O
sternal O
border O
clinical O
evidence O
myocarditis B-DISEASE
heart B-DISEASE
failure I-DISEASE
extensive O
generalised O
petechia O
purpuric O
rash O
figure O
1 O
secondary O
acute O
thrombocytopenia O
presume O
varicella B-DISEASE
infection I-DISEASE
apparently O
healthy B-SYMPTOMS
prior O
admission O
history O
maternal O
lupus O
ecg O
perform O
show O
complete O
heart B-DISEASE
block I-DISEASE
figure O
2 O
admit O
high O
dependency O
unit O
close O
overnight O
monitor O
presume O
diagnosis O
complete O
heart O
block O
secondary O
varicella O
infection1 O
2 O
initial O
investigation O
show O
normal O
electrolyte O
calcium O
phosphate O
glucose O
magnesium O
level O
blood O
count O
show O
normal O
haemoglobin O
white O
cell O
count O
platelet O
count O
low O
13109l O
platelet O
count O
normalise O
10 O
day O
intervention O
antinuclear O
antibody O
titre O
autoimmune O
screen O
negative O
maternal O
autoimmune O
screen O
negative O
echocardiogram O
show O
structurally B-SYMPTOMS
normal I-SYMPTOMS
heart O
followup O
24 O
h O
tape O
show O
persistence O
complete O
heart O
block O
follow O
investigation O
diagnosis O
congenital O
complete O
heart O
block O
followup O
6 O
month O
heart O
rate O
remain O
50 O
60 O
beat O
min O
remain O
asymptomatic B-SYMPTOMS
intervention O
need O
pacemaker O
consider O
followup O
incidental O
finding O
complete O
heart O
block O
congenital O
aetiology O
association O
varicella O
infection O
acute O
thrombocytopenia O
case O
highlight O
asymptomatic O
latepresente O
congenital O
complete O
heart O
block O
consider O
differential O
diagnosis O
child O
present O
asymptomatic O
bradycardia O
emergency O
department O

january O
2009 O
57yearold O
woman B-SEX
emergently O
present O
acute O
shortness O
breath O
1month O
history O
progressive O
shortness O
breath O
gradual O
decrease O
exercise O
capacity O
secondary O
mild O
dyspnea B-SYMPTOMS
report O
additional O
symptom O
age O
40 O
diagnose O
stage O
iia O
t1bn1 O
leftside O
breast B-DISEASE
cancer I-DISEASE
initial O
treatment O
include O
lumpectomy O
axillary O
node O
dissection O
subsequently O
undergo O
4 O
cycle O
dox O
therapy O
75 O
mgm2 O
follow O
8 O
cycle O
cyclophosphamide O
methotrexate O
5fluorouracil O
multigated O
acquisition O
scan O
chemotherapy O
show O
normal O
cardiac O
function O
chemotherapy O
undergo O
leave O
wholebreast O
radiation O
axillary O
boost O
tumor B-SYMPTOMS
estrogen O
receptorpositive O
subsequent O
medical O
regimen O
consist O
antiestrogen O
therapy O
take O
tamoxifen O
5 O
year O
aromatase O
inhibitor O
letrozole O
17 O
year O
chemotherapy O
active B-SYMPTOMS
relatively O
good O
health O
addition O
symptom O
present O
tachycardia B-SYMPTOMS
tachypnea B-SYMPTOMS
hypertension B-SYMPTOMS
mark O
jugular O
venous O
distention B-SYMPTOMS
s3 B-SYMPTOMS
pulmonary O
rale O
trace O
peripheral O
edema B-SYMPTOMS
initial O
laboratory O
value O
normal O
limit O
elevated O
level O
nterminal O
probrain O
natriuretic O
peptide O
2000 O
pgml O
result O
investigation O
newonset O
cardiomyopathy B-DISEASE
include O
normal O
cardiac O
enzyme O
level O
electrocardiogram O
ecg O
reveal O
ischemic O
change O
coronary O
angiogram O
normal O
appearance O
ecg O
show O
sinus O
tachycardia O
frequent O
premature O
ventricular O
complex O
leftaxis O
deviation O
leave O
atrial O
enlargement B-SYMPTOMS
lowvoltage O
qrs O
complex O
nonspecific O
st O
change O
fig1 O
2dimensional O
echocardiogram O
reveal O
left O
ventricular O
ejection O
fraction O
lvef O
020 O
severe O
diffuse O
leave O
ventricular O
lv O
hypokinesis B-SYMPTOMS
mildly O
dilate O
left O
atrium O
well O
define O
cause O
lv O
systolic O
dysfunction B-DISEASE
cardiovascular O
magnetic O
resonance O
cmr O
perform O
confirm O
lvef O
020 O
t2weighte O
sequence O
show O
slow O
flow O
secondary O
lv O
dysfunction O
myocardial O
edema O
fig2a O
late O
gadolinium O
enhancement O
disclose O
diffuse O
myocardial O
thinning B-SYMPTOMS
scar O
fig2b O
patient O
treat O
medically O
symptom O
progressively O
improve O
therapy O
consist O
blocker O
angiotensinconverte O
enzyme O
inhibitor O
digoxin O
diuretic O
therapy O
slowly O
taper O
lvef O
increase O
020 O
055 O
8month O
period O
medication O
lowdose O
metoprolol O
discontinue O
1 O
year O
remain O
asymptomatic B-SYMPTOMS

16yearold O
boy B-SEX
child O
nonconsanguineous O
parent O
parent O
young O
sibling O
healthy O
start O
school O
7 O
year O
age O
find O
short O
height O
slightly B-SYMPTOMS
myopic I-SYMPTOMS
astigmatic B-SYMPTOMS
subnormal B-SYMPTOMS
visual B-SYMPTOMS
acuity I-SYMPTOMS
endocrinological O
investigation O
perform O
initially O
reveal O
borderline O
value O
growth O
hormone O
gh O
deficiency O
treat O
period O
gh O
beneficiary O
effect O
growth O
age O
16 O
year O
height O
weight O
3 O
sd O
mean O
compare O
standardized O
swedish O
growth O
chart O
ophthalmological O
investigation O
10 O
year O
age O
show O
pigmentary B-SYMPTOMS
retinopathy I-SYMPTOMS
optic B-SYMPTOMS
atrophy I-SYMPTOMS
electroretinogram O
perform O
show O
severe O
rod B-SYMPTOMS
cone I-SYMPTOMS
dystrophy I-SYMPTOMS
decrease O
visual O
acuity O
visual O
field O
color B-SYMPTOMS
vision I-SYMPTOMS
dark B-SYMPTOMS
adaption I-SYMPTOMS
nystagmus B-SYMPTOMS
note O
14 O
year O
age O
year O
later O
photophobia B-SYMPTOMS
bilateral O
cataract O
develop O
cataract O
operate O
16 O
year O
age O
blind B-SYMPTOMS
14 O
year O
age O
refer O
neurological O
investigation O
clinical O
examination O
show O
mild O
ataxia O
tremor O
dysmetria B-SYMPTOMS
gait B-SYMPTOMS
instability I-SYMPTOMS
mild O
moderate O
muscle B-SYMPTOMS
weakness I-SYMPTOMS
weak O
absent O
tendon O
reflexe O
low O
extremity O
exercise B-SYMPTOMS
intolerance I-SYMPTOMS
audiometric O
investigation O
reveal O
mild O
bilateral O
sensorineural B-SYMPTOMS
hearing I-SYMPTOMS
impairment I-SYMPTOMS
15 O
year O
age O
unprovoked O
epileptic B-SYMPTOMS
seizure I-SYMPTOMS
treat O
levetiracetam O
decrease O
renal O
function O
identify O
15 O
year O
age O
increase O
serum O
creatinine O
145 O
moll O
reference O
interval O
3090 O
moll O
proteinuria B-SYMPTOMS
urine O
albumine O
244538 O
mgl O
reference O
interval20 O
mgl O
urine O
albuminecreatinine O
ratio O
4459 O
gmol O
reference O
interval O
3 O
gmol O
renal O
scintigraphy O
demonstrate O
reduce O
kidney O
size O
cr51edta O
clearance O
show O
decrease O
glomerular O
filtration O
rate O
42 O
normal O
filtration O
rate O
decrease O
time O
29 O
normal O
16 O
year O
age O
14 O
year O
age O
cardiac O
investigation O
demonstrate O
hypertrophy B-SYMPTOMS
wall O
left O
ventricle O
3 O
sd O
compare O
normal O
normal O
systolic O
diastolic O
function O
obstruction O
outflow O
mitochondrial O
investigation O
perform O
14 O
year O
age O
blood O
level O
lactate O
pyruvate O
16 O
0096 O
mmoll O
respectively O
lead O
ratio O
33 O
reference O
interval O
20 O
cerebrospinal O
fluid O
csf O
level O
lactate O
pyruvate O
36 O
0137 O
mmoll O
respectively O
lead O
lactate O
pyruvate O
ratio O
26 O
urinary O
lactate O
excretion O
normal O
csf O
albumin O
increase O
258 O
mgl O
reference O
level O
225 O
mgl O
increase O
csfplasma O
albumin O
ratio O
74 O
reference O
level O
5 O
serum O
acyl O
carnitine O
profile O
muscle O
carnitine O
level O
normal O
serum O
creatine O
kinase O
activity O
mildly O
increase O
54 O
katl O
reference O
interval O
35 O
katl O

51yearold O
man B-SEX
refer O
hospital O
severe O
congestive O
heart B-DISEASE
failure I-DISEASE
ventricular O
arrhythmia O
march O
2008 O
suffer O
heart O
failure O
ventricular O
tachycardia B-SYMPTOMS
year O
despite O
receive O
conventional O
treatment O
ie O
furosemide O
lisinopril O
hydrate O
pimobendan O
warfarin O
potassium O
carvedilol O
metildigoxin O
amiodarone O
hydrochloride O
height O
161 O
cm O
body O
weight O
83 O
kg O
blood O
pressure O
11060 O
mm O
hg O
fast O
blood O
glucose O
107 O
mgdl O
hba1c O
63 O
chest O
xray O
show O
cardiomegaly B-SYMPTOMS
cardiothoracic O
ratio O
067 O
figure O
1a O
ecg O
show O
video O
1 O
reveal O
diffused O
hypokinetic B-SYMPTOMS
left I-SYMPTOMS
ventricle I-SYMPTOMS
markedly O
dilate O
left O
ventricle O
dimension O
enddiastole O
95 O
mm O
reduce O
ef O
011 O
coronary O
angiogram O
normal O
myocardial O
biopsy O
reveal O
50 O
cardiomyocyte O
replace O
fibrosis B-SYMPTOMS
figure O
2 O
implantable O
cardioverterdefibrillator O
implant O
typical O
facial O
appearance O
thickening O
hand O
refer O
endocrinology O
department O
plasma O
level O
gh O
82 O
ngml O
igf1 O
504 O
ngml O
mri O
demonstrate O
macroadenoma B-DISEASE
pituitary O
diagnose O
acromegaly B-DISEASE
treat O
octreotide O
longactingrelease O
lar O
8 O
month O
undergo O
transsphenoidal O
surgery O
january O
2009 O
figure O
3 O
plasma O
level O
gh O
igf1 O
decrease O
octreotide O
lar O
basal O
plasma O
level O
gh O
4 O
ngml O
plasma O
igf1 O
level O
appropriate O
age O
range O
figure O
3 O
surgery O
plasma O
level O
gh O
igf1 O
decrease O
basal O
plasma O
level O
gh O
05 O
ngml O
igf1 O
level O
normal O
range O
figure O
3 O
treatment O
lar O
cardiac O
function O
improve O
partially O
cardiothoracic O
ratio058 O
ef020 O
september O
2008 O
surgery O
cardiac O
function O
improve O
drastically O
cardiothoracic O
ratio047 O
ef055 O
april O
2009 O
figure O
1b O
and2b2b O
frequency O
ventricular O
arrhythmias B-DISEASE
decrease O
pimobendan O
taper O

26yearold O
woman B-SEX
see O
emergency O
department O
ed O
chest O
pain B-SYMPTOMS
hypertension B-SYMPTOMS
find O
urinary O
tract O
infection B-DISEASE
send O
home O
antibiotic O
thiazide O
diuretic O
day O
later O
return O
epigastric O
pain O
nausea B-SYMPTOMS
emesis B-SYMPTOMS
myalgia O
patient O
significant O
medical O
history O
deny O
cardiorespiratory O
symptom O
complain O
low B-SYMPTOMS
exercise I-SYMPTOMS
tolerance I-SYMPTOMS
year O
family O
history O
cardiac O
pulmonary O
disease O
sudden O
cardiac O
death O
bear O
usa O
travel O
recently O
sick O
contact O
examination O
hypertensive B-SYMPTOMS
170105 O
mm O
hg O
tachycardic B-SYMPTOMS
125 O
bpm O
dry B-SYMPTOMS
mucous O
membrane O
appear O
ill O
look O
find O
elevated O
serum O
creatinine O
160 O
moll O
normal O
60110 O
moll O
receive O
15 O
l O
intravenous O
fluid O
presume O
volume B-DISEASE
depletion I-DISEASE
prerenal O
azotaemia B-SYMPTOMS
short O
breath O
crackle O
note O
auscultation O
chest O
portable O
chest O
film O
demonstrate O
hazy O
infiltrate O
likely O
represent O
pulmonary B-DISEASE
oedema I-DISEASE
develop O
hypotension B-SYMPTOMS
systolic O
pressure O
90 O
noninvasive O
positive O
pressure O
ventilation O
initiate O
ecg O
demonstrate O
sinus B-SYMPTOMS
tachycardia B-SYMPTOMS
rate O
130 O
bpm O
minimal O
st B-SYMPTOMS
depression I-SYMPTOMS
precordial O
lead O
consultation O
cardiologist O
patient O
receive O
40 O
mg O
intravenous O
furosemide O
echocardiogram O
demonstrate O
global O
hypokinesis B-SYMPTOMS
leftventricular O
ejection O
fraction O
10 O
figure O
1 O
patient O
transfer O
intensive O
care O
unit O
anxious B-SYMPTOMS
tachycardic O
170 O
bpm O
intubate O
sedate O
despite O
placement O
foley O
catheter O
administration O
intravenous O
loop O
diuretic O
remain O
anuric B-SYMPTOMS
12 O
h O
hospitalisation O
develop O
sign O
acute O
kidney B-DISEASE
injury I-DISEASE
creatinine O
increase O
350 O
moll O
24 O
h O
hospitalisation O
receive O
norepinephrine O
milrinone O
improve O
cardiac O
output O
second O
day O
hospitalisation O
evaluate O
cardiologist O
cardiothoracic O
surgeon O
emergent O
circulatory O
support O
develop O
sign O
poor B-SYMPTOMS
tissue I-SYMPTOMS
perfusion I-SYMPTOMS
lactic B-SYMPTOMS
acidosis I-SYMPTOMS
84 O
mmoll O
normal O
22 O
mmoll O
transaminitis B-SYMPTOMS
aspartate O
aminotransferasealanine O
transaminase O
150 O
iul O
normal O
40 O
ul O
take O
cardiac O
catheterisation O
laboratory O
emergent O
right O
heart O
catheterisation O
biopsy O
exclude O
acute O
myocarditis B-DISEASE
day O
gently O
fluid O
resuscitated O
guide O
bioreactance O
noninvasive O
cardiac O
output O
pressor O
gradually O
wean O
nonoliguric O
slowly O
regain O
renal O
function O
organ O
perfusion O
improve O
resolution O
lactic O
acidosis O
decrease O
liver O
transaminase O
hospital O
day O
5 O
transfer O
medical O
ward O
eventually O
discharge O
home O
nonselective O
   O
blockade O
ace O
inhibitor O
nitrate O
plan O
followup O
heartfailure O
clinic O
patient O
return O
ed O
4 O
day O
later O
elevated O
blood O
pressure O
nausea O
abdominal O
pain O
contrast O
scan O
abdomen O
reveal O
pancreatitis B-DISEASE
adrenal O
mass B-SYMPTOMS
treatment O
pancreatitis O
begin O
paroxysm O
headache O
nausea O
emesis O
abdominal O
pain O
corresponding O
hypertension O
220s O
systolic O
tachycardia O
120s O
baseline O
systolic O
pressure O
90110 O
mm O
hg O
figure O
2 O
urinary O
plasma O
catecholamine O
elevate O
confirm O
repeat O
testing O
give O
aggressive O
fluid O
rehydration O
     O
blockade O
plan O
adrenalectomy O
prior O
surgery O
leftventricular O
ejection O
fraction O
improve O
55 O
medical O
management O
figure O
1 O
pathology O
adrenal O
gland O
consistent O
nonmalignant O
pheochromocytoma B-DISEASE
figure O
3 O

31yearold O
white O
primipara O
twin O
pregnancy O
admit O
hospital O
38th O
week O
gestation O
elevated B-SYMPTOMS
blood I-SYMPTOMS
pressure I-SYMPTOMS
150100 O
mmhg O
receive O
antihypertensive O
treatment O
blood O
pressure O
12080 O
laboratory O
variable O
include O
plasma O
protein O
respective O
reference O
interval O
hour O
admission O
hospital O
contraction O
start O
caesarean O
section O
perform O
vertextransverse O
presentation O
twin O
liveborn O
female O
male O
deliver O
postoperative O
course O
initially O
inconspicuous B-SYMPTOMS
hour O
postpartum O
experience O
sudden O
epigastric B-SYMPTOMS
pain I-SYMPTOMS
blood O
pressure O
rise O
190130 O
laboratory O
finding O
show O
haemolysis B-SYMPTOMS
thrombocytopenia B-SYMPTOMS
increase O
serum O
creatinine O
aminotransferase O
table O
intravenous O
magnesium O
sulphate O
administer O
abdominal O
ultrasound O
disclose O
uterine O
cavity O
placenta B-SYMPTOMS
residue I-SYMPTOMS
hour O
postpartum O
patient O
transfer O
intensive O
care O
unit O
poor B-SYMPTOMS
urine I-SYMPTOMS
output I-SYMPTOMS
drowsiness B-SYMPTOMS
suspicion O
dic B-DISEASE
examination O
sleepy B-SYMPTOMS
disorient O
combination O
haemolysis O
thrombocytopenia O
elevated O
liver O
enzyme O
suggest O
postpartum B-DISEASE
hellp B-DISEASE
syndrome I-DISEASE
complicate O
dic O
patient O
rehydrate O
treatment O
institute O
fresh O
frozen O
plasma O
red O
cell O
transfusion O
fresh O
platelet O
kybernin O
p O
antithrombin O
iii O
high O
serum O
urea O
creatinine O
persistent O
anuria B-SYMPTOMS
compatible O
acute O
renal B-DISEASE
failure I-DISEASE
high O
dose O
furosemide O
fail O
increase O
diuresis O
sixteen O
hour O
postpartum O
blood O
pressure O
6040 O
oxygen O
saturation O
70 O
minute O
later O
patient O
acute O
cardiac B-DISEASE
arrest I-DISEASE
resuscitation O
start O
resuscitation O
successful O
normal B-SYMPTOMS
heart I-SYMPTOMS
action I-SYMPTOMS
reestablish O
blood O
pressure O
rise O
150110 O
oxygen O
saturation O
90 O
laboratory O
finding O
deteriorate O
development O
acute O
renal O
failure O
indicate O
necessity O
urgent O
dialysis O
follow O
dialysis O
patient O
stable B-SYMPTOMS
oxygen O
saturation O
98 O
hour O
postpartum O
patient O
develop O
cardiopulmonary B-DISEASE
arrest I-DISEASE
despite O
resuscitation O
attempt O
outcome O
lethal O
fact O
death O
occur O
hospital O
short O
time O
surgical O
intervention O
medicolegal O
autopsy O
order O
autopsy O
reveal O
oedema B-SYMPTOMS
brain O
lung O
dilatation B-SYMPTOMS
right O
leave O
ventricle O
hydrothorax B-SYMPTOMS
900 O
ml O
hydroperitoneum B-SYMPTOMS
2500 O
ml O
hydropericardium B-SYMPTOMS
200 O
ml O
present O
field O
operation O
caesarean O
section O
unremarkable B-SYMPTOMS
petechial O
suffusional O
haemorrhage O
observe O
pleura O
endocardium O
mucosa O
renal O
pelvis O
peritoneum O
small O
large O
bowel O
histology O
reveal O
periportal O
hepatocellular O
necrosis B-SYMPTOMS
bloodless O
glomerulus O
swollen O
vacuolated O
intracapillary O
cell O
confluent O
haemorrhage O
kidney O
liver O
spleen O
death O
attribute O
multiple O
organ B-DISEASE
failure I-DISEASE
dic O
consequence O
hellp O
syndrome O

37yearold O
caucasian O
man B-SEX
refer O
department O
external O
hospital O
severe O
abdominal O
pain B-SYMPTOMS
unclear O
aetiology O
patient O
suffer O
friedreichs O
ataxia1 O
2 O
recent O
transthoracic O
echocardiography O
perform O
day O
admission O
show O
dilated O
cardiomyopathy B-DISEASE
impair O
leave O
ventricular O
function O
ejection O
fraction O
30 O
pulmonary O
artery O
pressure O
55 O
mm O
hg O
finding O
unchanged O
previous O
examination O
time O
live O
residential O
home O
mobile O
wheelchair O
arrival O
emergency O
department O
patient O
somnolent B-SYMPTOMS
disorient O
axillary O
body O
temperature O
357 O
c O
arterial O
blood O
pressure O
12589 O
mm O
hg O
pulse O
rate O
84 O
rhythmic O
beatsmin O
complain O
increase O
diffuse O
abdominal O
pain O
day O
combine O
absence O
appetite O
vomit O
single O
occasion O
daily O
medication O
perindopril O
25 O
mg O
torasemide O
75 O
mg O
esomeprazole O
40 O
mg O
physical O
examination O
find O
tender B-SYMPTOMS
abdomen O
painful B-SYMPTOMS
epigastric O
palpation O
normal O
bowel O
sound O
auscultate O
upper O
right O
low O
left O
quadrant O
renal O
bed O
free O
pain O
palpation O
cardiac O
auscultation O
26 O
systolic O
murmur B-SYMPTOMS
audible O
lung O
auscultation O
show O
normal O
respiration O
laboratory O
finding O
slightly O
elevate O
c O
reactive O
protein O
crp O
16 O
mgl O
normal O
5 O
mgl O
elevated O
troponinth O
0070 O
gl O
normal O
0014 O
gl O
highly O
elevated O
probtype O
natriuretic O
peptide O
7382 O
pgml O
normal O
63 O
pgml O
kidney O
function O
parameter O
upper O
normal O
range O
creatinine O
100 O
moll O
calculate O
glomerular O
filtration O
rate O
73 O
mlmin O
blood O
count O
reveal O
leucocytosis B-SYMPTOMS
156109litre O
thyroid O
function O
thyroidstimulate O
hormone O
ft3 O
ft4 O
reference O
range O
urine O
analysis O
show O
pathology B-DISEASE
abdominal O
sonography O
organ O
normal O
especially O
kidney O
free B-SYMPTOMS
fluid I-SYMPTOMS
detect O
figure O
1 O
severe O
pain O
persist O
night O
despite O
analgesia O
paracetamol O
1 O
g O
metamizole O
1 O
g O
pethidine O
75 O
g O
contrastenhance O
abdominal O
ct O
perform O
reveal O
infarction B-DISEASE
right O
kidney O
appear O
hypodense B-SYMPTOMS
area I-SYMPTOMS
kidney O
artery O
vein O
assess O
open B-SYMPTOMS
figure O
2 O
3 O
cardiac B-DISEASE
dysfunction I-DISEASE
frequent O
cause O
death O
patient O
affect O
friedreichs O
ataxia O
commonly O
congestive O
heart B-DISEASE
failure I-DISEASE
arrhythmia B-DISEASE
renal O
artery O
embolism B-DISEASE
rare O
event O
patient O
nonabdominal O
viscous O
cause O
severe O
diffuse O
abdominal O
pain O
porphyria B-DISEASE
familial O
mediterranean B-DISEASE
fever I-DISEASE
diabetic B-DISEASE
ketoacidosis I-DISEASE
tocopherol B-DISEASE
deficiency I-DISEASE
exclude O
negative O
cardiolipin O
test O
exclude O
tabetic O
crisis O
evidence O
preexist O
porphyria O
encounter O
example O
quantitative O
determination O
aminolevulinic O
acid O
porphobilinogen O
porphyrin O
24h O
urine O
negative O
genetic O
diagnosis O
example O
clotting B-DISEASE
disorder I-DISEASE
conclusive O
hypovitaminosis B-DISEASE
present O
patient O
endocrinopathie O
example O
diabetes B-DISEASE
evidence O
hypothyreosis B-DISEASE
hyperthyreosis B-DISEASE
patient O
hospitalise O
delay O
department O
nephrology O
immediate O
anticoagulation O
heparin O
initiate O
later O
replace O
lifelong O
oral O
anticoagulation O
phenprocoumon O
11 O
day O
hospitalisation O
complication O
occur O
kidney O
function O
parameter O
remain O
normal O
transoesophageal O
echocardiography O
fifth O
day O
show O
cardiac O
thrombus B-DISEASE
patent O
foraman O
ovale O
deep B-DISEASE
vein I-DISEASE
thrombosis I-DISEASE
exclude O
duplex O
sonography O
anticardiolipin O
antibody O
testing O
genetic O
testing O
clot O
disorder O
negative O
urine O
test O
reveal O
evidence O
porphyria O
hospitalisation O
patient O
remain O
stable O
cardiological O
function O
diuretic O
adjust O
accord O
fluid O
balance O
patient O
treat O
levofloxacin O
pneumonic O
infection B-DISEASE
prior O
hospitalisation O
antibiotic O
treatment O
continue O
increase O
inflammatory O
parameter O
course O
disease O
crp O
increase O
200 O
mgl O
interpret O
inflammatory O
response O
renal O
infarction O
discharge O
laboratory O
parameter O
significantly O
decrease O

45yearold O
lady B-SEX
seek O
dermatology O
consultation O
severely O
tender O
erythematous O
vesicle O
bullae B-SYMPTOMS
chest O
arm O
sudden O
onset O
associate O
fever B-SYMPTOMS
nausea B-SYMPTOMS
malaise B-SYMPTOMS
complain O
pain B-SYMPTOMS
upper O
abdomen O
history O
receive O
drug O
prior O
onset O
lesion O
report O
significant O
weight B-SYMPTOMS
loss I-SYMPTOMS
loss O
appetite O
physical O
examination O
temperature O
38c O
pulse O
rate O
100min O
blood O
pressure O
12672 O
mm O
hg O
multiple O
coalescing O
vesicle O
bullae O
upper O
chest O
arm O
distribute O
symmetrically O
show O
area O
pustulation B-SYMPTOMS
necrosis B-SYMPTOMS
surround O
multiple O
pseudovesicular O
satellite O
papule B-SYMPTOMS
figure O
1ab O
abdominal O
examination O
mild O
tenderness B-SYMPTOMS
present O
right O
hypochondrium O
patient O
initial O
laboratory O
investigation O
show O
total O
leucocyte O
count O
12 O
000 O
cellsmm3 O
75 O
neutrophil O
haemoglobin O
level O
143 O
gm O
erythrocyte O
sedimentation O
rate O
30 O
mmh O
liver O
function O
test O
kidney O
function O
test O
c O
reactive O
protein O
level O
normal O
limit O
gram O
stain O
purulent O
exudate O
show O
neutrophil O
organism O
culture O
growth B-SYMPTOMS
72 O
h O
incubation O
lesional O
skin O
biopsy O
take O
satellite O
papule O
show O
neutrophilic B-SYMPTOMS
infiltration I-SYMPTOMS
dermis O
papillary B-SYMPTOMS
dermal I-SYMPTOMS
oedema I-SYMPTOMS
spongiosis B-SYMPTOMS
figure O
2ab O
abdominal O
ultrasonography O
reveal O
intraluminal O
gall O
bladder O
mass B-SYMPTOMS
suggestive O
malignancy B-SYMPTOMS
basis O
finding O
final O
diagnosis O
ss B-DISEASE
associate O
gall O
bladder O
malignancy O
start O
oral O
prednisolone O
dose O
40 O
mg O
daily O
symptomatic O
treatment O
cutaneous O
lesion O
respond O
dramatically O
subside O
completely O
1 O
week O
treatment O
figure O
3ab O
dose O
prednisolone O
taper O
open O
cholecystectomy O
perform O
histopathology O
excise O
tissue O
confirm O
welldifferentiate O
gall O
bladder O
adenocarcinoma B-DISEASE
form O
gland O
papillae O
infiltrate O
muscularis O
propria O
superficially O
cystic O
duct O
cut O
margin O
free O
tumour B-SYMPTOMS
figure O
2cd O
patient O
postoperative O
period O
uneventful B-SYMPTOMS
discharge O
taper O
dose O
prednisolone O
advice O
followup O
periodically O

76year O
old O
woman B-SEX
present O
24month O
history O
enlarge O
mass B-SYMPTOMS
involve O
history O
trauma B-DISEASE
physical O
examination O
show O
mass O
3x4 O
cm O
diameter O
localize O
right O
interscapular O
region O
mass O
ulcerative O
helophytic O
grayish O
colour O
hard O
consistency O
easily O
bleed O
manipulation O
remainder O
examination O
unremarkable O
lymphadenopathy B-SYMPTOMS
abdominal O
masse O
feel O
resection O
histological O
examination O
specimen O
conclude O
basal B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
local O
recurrence B-SYMPTOMS
observe O
18 O
month O
later O
patient O
admit O
institution O
lumpectomy O
figure O
1 O
histopathological O
examination O
reveal O
syringomatous B-SYMPTOMS
pattern I-SYMPTOMS
infiltrate O
dermis O
figure O
2 O
figure O
3 O
subcutis O
skeletal O
muscle O
neoplastic O
epithelial O
cell O
arrange O
interconnect O
cord O
microcystic O
area O
nest O
cord O
tubule O
tumour B-SYMPTOMS
extend O
dermis O
adjacent O
muscle O
lobule O
show O
squamous O
differentiation O
sclerosis B-SYMPTOMS
stroma O
cord O
present O
tumour O
cell O
connect O
epidermis O
immunohistochemical O
analysis O
show O
positivity O
antick7 O
figure O
4 O
ae1ae3 O
negativity O
anti O
cea O
anti O
ck20 O
base O
histological O
immunohistochemical O
presentation O
diagnosis O
syringomatous B-DISEASE
eccrine I-DISEASE
carcinoma I-DISEASE
establish O
radiotherapy O
involved O
area O
perform O
70 O
gy O
35 O
session O

patient O
4yearold O
boy B-SEX
diagnose O
have O
blau B-DISEASE
syndrome I-DISEASE
base O
manifestation O
typical O
clinical O
feature O
ankle O
wrist O
arthritistenosynovitis O
diffuse O
eczematous O
rash B-SYMPTOMS
uveitis B-DISEASE
histologic O
evidence O
noncaseate O
granuloma O
heterozygous O
nod2 O
mutation O
pr334w O
ocular B-DISEASE
involvement I-DISEASE
initially O
control O
topical O
oral O
corticosteroid O
year O
visual B-DISEASE
impairment I-DISEASE
progress O
manifestation O
blau O
syndrome O
arthritis B-DISEASE
rash O
subside O
time O
bilateral O
panuveitis B-DISEASE
progress O
age O
5 O
year O
initially O
treat O
methotrexate O
ocular O
inflammation B-DISEASE
persist O
despite O
addition O
local O
steroid O
injection O
repeat O
intravenous O
iv O
bolus O
methylprednisolone O
treatment O
patient O
age O
10 O
year O
infliximab O
initially O
5 O
mgkg O
increase O
10 O
mgkg O
iv O
4 O
6 O
week O
initiate O
initial O
improvement O
1 O
year O
treatment O
start O
uveitis O
worsen O
age O
12 O
year O
infliximab O
discontinue O
adalimumab O
24 O
mgm2 O
2 O
week O
initiate O
dosage O
methotrexate O
15 O
mgm2weekly O
increase O
ocular B-DISEASE
disease I-DISEASE
remain O
active O
mycophenolate O
mofetil O
750 O
mgm2 O
abatacept O
10 O
mgkgmonth O
iv O
sequentially O
administer O
significant O
improvement O
age O
16 O
year O
patient O
granulomatous B-DISEASE
retinal O
lesion O
anterior O
chamber O
inflammation O
macular O
edema B-SYMPTOMS
develop O
lead O
retinal B-DISEASE
detachment I-DISEASE
addition O
steroid O
therapy O
corticosteroid O
pulse O
therapy O
necessary O
control O
disease O
flare O
average O
3 O
bolusesmonth O
6 O
consecutive O
month O
suppose O
autoinflammatory O
nature O
blau O
syndrome O
initiate O
trial O
il1 O
antibody O
administration O
2 O
mgkgmonth O
canakinumab O
6 O
month O
follow O
ocular B-DISEASE
flare I-DISEASE
occur O
steroid O
pulse O
therapy O
necessary O
concomitant O
treatment O
oral O
methotrexate O
lowdose O
prednisone O
02 O
mgkgday O
remain O
unchanged O
figure O
1 O
show O
fluorangiogram O
treatment O
6 O
injection O
drug O
tolerate O
effect O
finding O
laboratory O
test O
perform O
monthly O
normal O

57yearold O
jewish O
man B-SEX
crohns O
disease O
cd B-DISEASE
ileum O
diagnose O
age O
thirteen O
present O
multiple O
nonmelanoma O
skin O
cancer O
nmsc B-DISEASE
develop O
past O
16 O
year O
coincide O
initiation O
prolong O
course O
thiopurine O
6mercaptopurine O
mercaptopurine O
6mp O
diagnose O
total O
84 O
nmsc O
72 O
nmsc O
clinic O
12 O
clinic O
await O
biopsy O
removal O
additional O
lesion O
cd O
initially O
treat O
sulfasalazine O
intermittent O
steroid O
diagnosis O
past O
20 O
year O
take O
6mp O
daily O
year O
begin O
6mp O
develop O
30 O
nmsc O
14 O
squamous B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
scc B-DISEASE
16 O
basal B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
bcc B-DISEASE
patient O
treat O
subsequent O
year O
past O
year O
return O
clinic O
100 O
new O
lesion O
suggestive O
malignancy B-DISEASE
torso O
extremity O
subsequent O
exam O
42 O
biopsyproven O
lesion O
nmcs B-DISEASE
20 O
scc O
22 O
bcc O
addition O
sccs B-DISEASE
moderately O
differentiate O
poorly O
differentiate O
large O
skin O
cancer O
necessitate O
mohs O
surgery O
xenografte O
large O
lesion O
pretibial O
measure O
64x53 O
mm O
figure O
1 O
await O
biopsy O
suspicious O
lesion O
patient O
fitzpatrick O
ii O
skin O
type O
admit O
excessive O
sun O
exposure O
25 O
year O
hawaii O
early O
use O
sunscreen O
sail O
catamaran O
peak O
sun O
hour O
reveal O
mother O
skin O
cancer O
lesion O
remove O
deny O
having O
smoker O
past O
year O
discontinue O
6mp O
begin O
mesalamine O
pentasa O
later O
adalimumab O
humira O
hope O
attenuate O
progression O
nmsc O
continue O
monthly O
skin O
exam O
overall O
hospitalize O
16 O
time O
cd O
require O
intestinal O
resection O
unfortunately O
recent O
hospitalization O
diagnose O
metastatic O
adenocarcinoma B-DISEASE
small O
bowel O
pass O
away O
shortly O

18yearold O
lady B-SEX
present O
history O
progressive O
swaying B-SYMPTOMS
walk O
bad O
night O
5 O
year O
speech O
normal O
tremulousness B-SYMPTOMS
upper O
limb O
history O
weakness B-SYMPTOMS
numbness B-SYMPTOMS
family O
history O
significant O
eld O
sister O
similar O
difficulty O
walk O
7year O
duration O
die O
poorly O
control O
diabetes B-DISEASE
mellitus I-DISEASE
age O
20 O
year O
member O
kin O
affect O
history O
consanguinity O
parent O
cognitive O
function O
normal O
mini O
mental O
status O
score O
3030 O
visual O
acuity O
fundus O
examination O
normal O
extraocular O
movement O
include O
saccade O
pursuit O
normal O
saccadic O
intrusion O
nystagmus B-DISEASE
notice O
tone O
power O
normal O
limb O
generalised O
exaggeration O
myotatic O
reflex O
bilateral B-SYMPTOMS
extensor I-SYMPTOMS
plantar I-SYMPTOMS
response I-SYMPTOMS
vibration O
joint O
position O
sense O
intact O
rombergs O
positive O
patient O
sway O
perform O
tandem O
walk O
fasting O
postprandial O
blood O
glucose O
level O
normal O
haemogram O
renal O
liver O
thyroid O
function O
test O
normal O
serum O
vitamin O
b12 O
folic O
acid O
level O
normal O
limit O
nerve O
conduction O
study O
show O
absent O
sensory O
nerve O
action O
potential O
normal O
distal O
latency O
conduction O
velocity O
amplitude O
compound O
muscle O
action O
potential O
cmap O
nerve O
trunk O
mri O
show O
marked O
atrophy B-SYMPTOMS
cervical O
cord O
compare O
cerebellum O
normal O
figure O
1 O
genetic O
testing O
pcr O
disclose O
expansion O
gaa O
repeat O
allele O
254 O
298 O
fxn O
gene O
variety O
cause O
autosomal O
recessive O
ataxia O
need O
consider O
differential O
diagnosis O
frda B-DISEASE
systemically O
exclude O
ataxia O
vitamin O
e O
deficiency O
ave O
phenotype O
similar O
frda O
titubation B-SYMPTOMS
hyperkinesia B-SYMPTOMS
common O
aved4 O
strong O
family O
history O
ataxia O
diabete O
mellitus O
eld O
sister O
favour O
frda O
ataxia O
oculomotor O
apraxia O
aoa B-DISEASE
type O
1 O
2 O
consider O
owe O
lack O
apraxia O
ocular O
movement O
distal B-SYMPTOMS
amyotrophy I-SYMPTOMS
severe O
axonal B-SYMPTOMS
sensorimotor I-SYMPTOMS
polyneuropathy B-DISEASE
atrophy O
cerebellum O
involuntary O
movements5 O
ataxia B-DISEASE
telengiectesia I-DISEASE
presentation O
similar O
aoa O
type O
1 O
2 O
mucocutaneous O
marker O
sinopulmonary O
infection O
hypogammaglobulinaemia B-SYMPTOMS
radiosensitivity B-SYMPTOMS
predisposition O
development O
variety O
neoplasm O
feature O
ataxia O
telengiectasia O
see O
aoas O
frda O
important O
cause O
autosomal B-DISEASE
recessive I-DISEASE
spastic I-DISEASE
ataxia I-DISEASE
apart O
frda O
autosomal O
recessive O
spastic O
ataxia O
charlevoixsaguenay O
marinescosjgren O
syndrome O
charcotmarietooth O
disease O
inherited O
polyneuropathy O
gait B-SYMPTOMS
ataxia I-SYMPTOMS
common O
frda O
case O
cmt B-DISEASE
improbable O
follow O
feature O
case O
lack O
motor B-SYMPTOMS
weakness I-SYMPTOMS
retain O
reflex O
bilaterally B-SYMPTOMS
extensor I-SYMPTOMS
plantar I-SYMPTOMS
pure B-SYMPTOMS
sensory I-SYMPTOMS
neuropathy I-SYMPTOMS
nerve O
conduction O
study O
idebenone O
start O
dose O
450 O
mg O
twice O
day O
antioxidant O
property O
gait O
ataxia O
physiotherapyfrenkels O
exercisewas O
initiate O
blood O
glucose O
monitor O
regularly O
4 O
month O
significant O
change O
gait O
difficulty O

54 O
yearold O
diabetic O
woman B-SEX
complain O
blurred B-SYMPTOMS
vision I-SYMPTOMS
left O
eye O
5 O
day O
scalp O
tenderness B-SYMPTOMS
headache B-SYMPTOMS
visual O
acuity O
va O
2020 O
right O
eye O
2030 O
leave O
eye O
intraocular O
pressure O
normal O
funduscopic O
examination O
reveal O
leave O
optic O
nerve O
edema B-SYMPTOMS
small O
disc O
margin O
hemorrhage B-SYMPTOMS
wbc O
count O
12700 O
esr O
7 O
normal O
020 O
mmhr O
crp O
24 O
normal O
010 O
mgdl O
day O
later O
note O
new O
left O
eye O
pain B-SYMPTOMS
vision O
decline O
count O
finger O
pain O
eye O
movement O
right O
pupil O
4 O
mm O
react O
light O
left O
pupil O
4 O
mm O
relative O
left O
afferent O
pupillary O
defect B-SYMPTOMS
left O
optic O
nerve O
swollen B-SYMPTOMS
peripapillary O
nerve O
fiber O
layer O
hemorrhage O
cherry O
red O
spot B-SYMPTOMS
mild O
macular O
edema O
consistent O
central B-DISEASE
retinal I-DISEASE
artery I-DISEASE
occlusion I-DISEASE
posterior O
pole O
peripheral O
retinal O
hemorrhage O
trace O
cell O
see O
anterior O
chamber O
vitreous O
fluid O
repeat O
wbc O
esr O
crp O
normal O
treponemal O
bartonella O
antibodie O
quantiferontb O
test O
blood O
culture O
ekg O
carotid O
doppler O
ultrasound O
unremarkable O
brain O
contrast O
mri O
demonstrate O
optic O
nerve O
enhancement O
day O
later O
leave O
eye O
pain O
vision O
worsen O
patient O
complain O
jaw O
claudication B-SYMPTOMS
scalp O
pain O
va O
decline O
light O
perception O
left O
eye O
1 O
cell O
flare O
anterior O
chamber O
2 O
vitreous O
cell O
haze O
funduscopic O
examination O
reveal O
extensive O
retinal O
necrosis B-SYMPTOMS
diffuse O
hemorrhage O
multiple O
area O
focal O
venous B-SYMPTOMS
beading I-SYMPTOMS
fig1 O
consistent O
acute B-DISEASE
retinal I-DISEASE
necrosis I-DISEASE
vitreous O
fluid O
examine O
pcr O
amplifiable O
hsv O
vzv O
cmv O
toxoplasma O
sequence O
return O
positive O
vzv O
dna O
treat O
onetime O
intravitreal O
injection O
ganciclovir O
2000 O
mcg05 O
ml O
left O
eye O
oral O
acyclovir O
800 O
mg O
5 O
time O
daily O
14 O
day O
oral O
prednisone O
60 O
mg O
daily O
7 O
day O
follow O
20 O
mg O
7 O
day O
day O
start O
treatment O
recently O
develop O
jaw O
claudication O
intermittent O
scalp O
pain O
temporal O
artery O
biopsy O
perform O
histological O
examination O
normal O
fig2 O
immunohistochemical O
analysis O
demonstrate O
vzv O
antigen O
arterial O
adventitia O
evaluation O
adjacent O
section O
hsv1 O
antigen O
infiltrating O
leukocyte O
cd45 O
show O
negative O
fig3 O
antiviral O
therapy O
alter O
intravenous O
acyclovir O
10 O
mgkg O
8 O
h O
14 O
day O
steroid O
discontinue O

23yearold O
woman B-SEX
history O
carnitine B-DISEASE
deficiency I-DISEASE
present O
exertional O
dyspnea B-SYMPTOMS
fatigue B-SYMPTOMS
diagnose O
nonischemic O
cardiomyopathy B-DISEASE
age O
10 O
year O
present O
symptom O
congestive O
heart B-DISEASE
failure I-DISEASE
transthoracic O
echocardiography O
tte O
reveal O
severe O
left O
ventricular O
lv B-DISEASE
dysfunction I-DISEASE
time O
total O
carnitine O
level O
3 O
moll O
normal O
range O
2569 O
moll O
free O
carnitine O
level O
3 O
moll O
normal O
range O
1660 O
moll O
cardiomyopathy O
attribute O
carnitine O
deficiency O
5 O
month O
therapy O
carnitine O
supplement O
total O
carnitine O
free O
carnitine O
level O
increase O
86 O
moll O
48 O
moll O
respectively O
left O
ventricular O
systolic O
function O
normalize O
fractional O
shortening O
347 O
current O
admission O
patient O
report O
past O
10 O
year O
intermittently O
compliant O
carnitine O
supplement O
regiman O
approximately O
6 O
month O
presentation O
total O
carnitine O
free O
carnitine O
level O
drop O
18 O
moll O
17 O
moll O
respectively O
undergo O
tte O
follow O
cardiac O
magnetic O
resonance O
cmr O
gadolinium O
enhancement O
tte O
show O
normal O
lv O
function O
mild O
concentric O
lv B-DISEASE
hypertrophy I-DISEASE
fig1 O
result O
cmr O
confirm O
normal O
lv O
size O
function O
show O
focal O
increase O
wall O
thickness O
basal O
mid O
lateral O
wall O
enddiastolic O
thickness O
16 O
cm O
fig2 O
patchy O
delay O
gadolinium O
enhancement O
fig3 O
basis O
patient O
family O
history O
sudden B-DISEASE
cardiac I-DISEASE
death I-DISEASE
abnormal O
myocardial O
structure O
underlying O
disease O
process O
dualchamber O
implantable O
cardioverterdefibrillator O
place O
primary O
prevention O
sudden O
cardiac O
death O
bradyarrhythmia O
tachyarrhythmia O

14monthold O
boy B-SEX
refer O
hospital O
hospital O
dilate O
hypertrophy O
left O
ventricle O
lv O
neutropenia B-SYMPTOMS
developmental B-DISEASE
delay I-DISEASE
27 O
october O
2011 O
bear O
term O
body O
weight O
32 O
kg O
sixteen O
day O
birth O
hospitalize O
owe O
persistent O
irritability B-SYMPTOMS
chest O
radiograph O
show O
cardiomegaly B-SYMPTOMS
echocardiogram O
reveal O
decrease O
lv O
contractility O
ejection O
fraction O
24 O
impression O
myocarditis B-DISEASE
manage O
1 O
yr O
presentation O
hospital O
patient O
show O
feeding B-SYMPTOMS
difficulty I-SYMPTOMS
developmental O
delay O
birth O
referral O
admit O
hospital O
7 O
time O
infection B-DISEASE
episode O
take O
furosemide O
spironolactone O
enalapril O
carvedilol O
referral O
refer O
hospital O
14 O
month O
old O
body O
weight O
6 O
kg O
3rd O
percentile O
height O
71 O
cm O
3rd O
percentile O
overall O
motor O
development O
delay O
sit O
mama O
papa O
recorded O
blood O
pressure O
heart O
rate O
9430 O
mmhg O
132 O
beat O
minute O
respectively O
physical O
examination O
definite O
heart B-SYMPTOMS
murmur I-SYMPTOMS
audible O
liver O
palpable B-SYMPTOMS
show O
persistent O
neutropenia O
start O
stay O
previous O
hospital O
wbc O
neutrophil O
count O
8800l O
2 O
176l O
respectively O
bnatriuretic O
peptide O
level O
1045 O
pgml O
chest O
radiograph O
show O
mild O
cardiomegaly O
cardiothoracic O
ratio O
628 O
fig1a O
electrocardiogram O
show O
low O
qrs O
voltage O
limb O
lead O
echocardiogram O
reveal O
dilate O
hypertrophy O
globular B-SYMPTOMS
lv O
hypertrophy O
papillary O
muscle O
hypertrabeculation O
meet O
criterion O
lv O
noncompaction O
echocardiographic O
parameter O
follow O
lv O
internal O
diameter O
diastole O
377 O
mm O
z O
   O
102 O
ejection O
fraction O
366 O
lv O
mass O
index O
756 O
g O
z O
   O
63 O
fig1b O
rule O
systemic O
cause O
dilate O
hypertrophy O
lv O
perform O
thoracoabdominal O
compute O
tomographic O
ct O
angiography O
contrast O
dye O
ct O
finding O
show O
abnormality B-SYMPTOMS
kidney O
organ O
vessel O
undergo O
ct O
angiography O
patient O
show O
abrupt O
highgrade O
spike O
fever B-SYMPTOMS
fig2 O
develop O
secretory O
diarrhea B-SYMPTOMS
800 O
cc O
day O
associate O
metabolic B-DISEASE
acidosis I-DISEASE
time O
wbc O
neutrophil O
count O
decrease O
3290l O
1 O
33l O
respectively O
bnatriuretic O
peptide O
level O
great O
4901 O
pgml O
associate O
respiratory O
symptom O
result O
respiratory O
gastrointestinal O
viral O
study O
negative O
blood O
stool O
culture O
negative O
pathogen O
creactive O
protein O
level O
708 O
mgdl O
despite O
supportive O
care O
include O
intravenous O
fluid O
resuscitation O
empirical O
antibiotic O
patient O
condition O
worsen O
aggravate O
metabolic O
acidosi O
respiratory B-SYMPTOMS
difficulty I-SYMPTOMS
require O
transfer O
intensive O
care O
unit O
icu O
icu O
transfer O
serum O
ph O
6881 O
bicarbonate O
level O
78 O
mmoll O
total O
co2 O
414 O
mm O
hg O
patient O
treat O
intensive O
ventilator O
care O
inotropic O
agent O
supportive O
care O
measure O
eventually O
die O
aggravate O
metabolic O
acidosi O
acutely O
decompensate O
heart B-DISEASE
failure I-DISEASE
7 O
day O
icu O
care O
stay O
icu O
perform O
genetic O
analysis O
barth B-DISEASE
syndrome I-DISEASE
evidence O
display O
cardiomyopathy B-DISEASE
neutropenia O
developmental O
delay O
gene O
sequence O
analysis O
reveal O
taz O
gene O
harbor O
novel O
hemizygous O
frameshift O
mutation O
c227delc O
ppro76leufsx7 O
inherit O
mother O
fig3 O

84yearold O
male B-SEX
patient O
history O
coronary B-DISEASE
artery I-DISEASE
disease I-DISEASE
right O
coronary O
artery O
rca O
stenting O
admit O
university O
hospital O
february O
2012 O
progressive O
dyspnoea B-SYMPTOMS
recur O
syncope O
cardiological O
workup O
reveal O
grade O
iii O
severe O
symptomatic O
aortic B-DISEASE
stenosis I-DISEASE
relevant O
comorbiditie O
logistic O
euroscore O
19 O
point O
severe O
femoral O
arteriopathy B-DISEASE
schedule O
transsubclavian O
tavi O
successful O
implantation O
corevalve O
prosthesis O
medtronic O
medtronic O
world O
headquarters O
medtronic O
parkway O
minneapolis O
minnesota O
usa O
diameter O
31 O
mm O
initial O
discharge O
refer O
hospital O
dyspnoea O
bilateral O
pleural B-DISEASE
effusions I-DISEASE
transoesophageal O
echocardiography O
tee O
show O
severe O
mitral B-SYMPTOMS
regurgitation I-SYMPTOMS
mr B-SYMPTOMS
subsequently O
treat O
interventional O
mitral O
valve O
repair O
mitraclip O
abbott O
vascular O
abbott O
laboratories O
abbott O
park O
illinois O
usa O
procedurally O
dependent O
atrial O
septal B-SYMPTOMS
defect I-SYMPTOMS
asd O
closure O
amplatzer O
pfo O
occluder O
st O
jude O
medical O
gmbh O
helfmannpark O
7 O
eschborn O
germany O
week O
secondary O
discharge O
patient O
develop O
progressive O
heart B-DISEASE
failure I-DISEASE
combination O
acute O
renal B-DISEASE
failure I-DISEASE
immediate O
echocardiography O
reveal O
moderatetosevere O
aortic B-SYMPTOMS
regurgitation I-SYMPTOMS
recurrent O
severe O
mr O
valvular O
defect O
result O
slight O
significant O
aortic B-SYMPTOMS
valve I-SYMPTOMS
prosthesis I-SYMPTOMS
migration I-SYMPTOMS
left O
ventricular O
outflow O
tract O
cause O
aortic B-SYMPTOMS
paravalvular I-SYMPTOMS
leakage I-SYMPTOMS
partial O
posterior O
mitral B-SYMPTOMS
leaflet I-SYMPTOMS
detachment I-SYMPTOMS
fig1 O
consequence O
finding O
patient O
transfer O
cardiac O
surgery O
department O
preoperative O
coronary O
angiography O
reveal O
progression O
coronary O
artery O
disease O
consequently O
patient O
schedule O
conventional O
aortic O
mitral O
valve O
replacement O
coronary O
artery O
bypass O
surgery O
operation O
perform O
median O
sternotomy O
initialization O
cardiopulmonary O
bypass O
ascending O
aorta O
open O
exploration O
aortic O
valve O
fig2a O
careful O
removal O
corevalve O
prosthesis O
edwards O
perimount O
aortic O
valve O
prosthesis O
diameter O
25 O
mm O
implant O
veingrafte O
circumflex O
coronary O
artery O
mitral O
valve O
explore O
left O
atrium O
excise O
attached O
clip O
edwards O
perimount O
mitral O
valve O
prosthesis O
diameter O
31 O
mm O
implant O
recently O
atrial O
septal O
occluder O
remove O
prior O
direct O
closure O
result O
septal O
defect O
singlesuture O
line O
fig2b O
intraoperative O
echocardiography O
reveal O
adequate O
function O
prosthesis O
operation O
complete O
usual O
manner O
postoperative O
phase O
patient O
recover O
surgery O
hospitalization O
prolong O
transient O
renal O
failure O
recur O
pleural O
effusion O
month O
postoperative O
care O
patient O
discharge O
hospital O
rehabilitation O
good O
condition O
sign O
heart O
failure O
followup O
month O
surgery O
patient O
cardiopulmonary O
stable O
condition O
undergo O
additional O
physiotherapy O

60yearold O
caucasian O
woman B-SEX
significant O
medical O
history O
develop O
exercise B-SYMPTOMS
intolerance I-SYMPTOMS
fatigue B-SYMPTOMS
shortness O
breath O
exertion O
month O
prior O
presentation O
outpatient O
clinic O
time O
presentation O
report O
dry O
cough B-SYMPTOMS
orthopnea B-SYMPTOMS
paroxysmal O
nocturnal O
dyspnoea B-SYMPTOMS
generalise O
weakness B-SYMPTOMS
intermittent O
numbness B-SYMPTOMS
hand O
foot O
social O
history O
negative O
smoke O
alcohol O
illicit O
drug O
physical O
examination O
unremarkable O
jugular O
venous O
distension B-SYMPTOMS
audible O
s1 O
s2 O
sound O
bilateral O
crackle O
lung O
auscultation O
bilateral O
pitting O
oedema B-SYMPTOMS
chest O
xray O
show O
cardiomegaly B-SYMPTOMS
pulmonary B-SYMPTOMS
oedema I-SYMPTOMS
smallsized O
bilateral O
pleural O
effusion O
12lead O
ecg O
demonstrate O
normal O
sinus O
rhythm O
lowvoltage O
complex O
extreme O
rightaxis O
deviation O
figure O
1 O
transthoracic O
echocardiogram O
tte O
demonstrate O
asymmetric O
biventricular O
hypertrophy B-SYMPTOMS
preserve O
ejection O
fraction O
60 O
elevate O
rightventricular O
systolic O
pressure O
36 O
mm B-DISEASE
hg O
abnormal O
myocardial O
texture O
describe O
granular O
sparkling O
figure O
2 O
coronary O
ct O
angiogram O
demonstrate O
normal O
coronary O
artery O
subsequently O
cardiac O
mri O
demonstrate O
early O
diffuse O
subendocardial O
delay O
enhancement O
concern O
infiltrative B-DISEASE
myocardial I-DISEASE
disease I-DISEASE
diffuse O
biventricular O
hypertrophy O
normal O
ejection O
fraction O
figure O
3 O
patient O
undergo O
right O
heart O
catheterisation O
endomyocardial O
biopsy O
reveal O
diffuse O
amyloidosis B-DISEASE
amorphous O
proteinaceous B-SYMPTOMS
material I-SYMPTOMS
cardiac O
myocyte O
blood O
vessel O
positive O
congo O
red O
stain O
figure O
4 O
subsequent O
laboratory O
evaluation O
register O
elevate O
free O
   O
light O
chain O
863 O
mgl O
normal O
57263 O
mgl O
positive O
bencejone O
protein O
037 O
g24 O
h O
urine O
bone O
marrow O
biopsy O
reveal O
great O
10 O
infiltration O
cd19 O
cd56 O
cd138 O
plasma O
cell O
reversal O
marrow O
   O
ratio O
12 O
normal O
21 O
consistent O
mm O
patient O
eventually O
diagnose O
systemic O
al O
amyloidosis O
advanced O
stage O
iii O
cardiac O
amyloidosis O
underlie O
mm O
give O
advanced O
cardiac O
amyloidosis O
patient O
deem O
poor O
candidate O
autologous O
stemcell O
transplantation O
patient O
start O
systemic O
chemotherapy O
melphalan O
dexamethasone O
despite O
receive O
standard O
therapy O
heart O
failureincluding O
diuretic O
blocker O
ace O
inhibitorsthe O
patient O
condition O
continue O
worsen O
succumb O
sudden B-DISEASE
cardiac I-DISEASE
death I-DISEASE

24yearold O
malay O
male B-SEX
patient O
refer O
respiratory O
clinic O
abnormal O
preemployment O
chest O
radiograph O
smoke O
10 O
cigarette O
day O
21 O
year O
age O
stop O
smoke O
10 O
month O
ago O
notice O
have O
reduce O
effort O
tolerance O
past O
year O
office O
worker O
history O
exposure O
organic O
inorganic O
dust O
sibling O
asymptomatic B-SYMPTOMS
examination O
patient O
tachypnoeic B-SYMPTOMS
sign O
finger O
club O
pulmonary O
hypertension B-DISEASE
oxygen O
saturation O
room O
air O
rest O
94 O
drop O
92 O
climb O
flight O
stairs O
spirometry O
testing O
reveal O
restrictive O
pattern O
lung B-DISEASE
disease I-DISEASE
force O
expiratory O
volume O
1 O
second O
fev1 O
force O
vital O
capacity O
fvc O
27 O
l O
69 O
predict O
32 O
l O
68 O
predict O
respectively O
fev1fvc O
ratio O
85 O
haemoglobin O
168 O
gl O
serum O
parathyroid O
hormone O
29 O
pmoll O
normal O
1173 O
calcium O
234 O
mmoll O
level O
normal O
24hour O
urine O
calcium O
normal O
69 O
mmol O
24hour O
urine O
volume O
28 O
l O
chest O
radiograph O
fig1a O
reveal O
dense O
micronodular O
opacity O
distribute O
symmetrically O
predominantly O
middle O
low O
zone O
lung O
give O
classical O
sandstorm O
appearance O
cardiac O
border O
obscure O
sandlike O
opacitie O
highresolution O
compute O
tomography O
hrct O
scan O
lung O
fig1b O
show O
widespread O
tiny O
microcalcification O
lung O
preponderance O
microlith O
low O
lobe O
associate O
area O
interlobular O
septal B-SYMPTOMS
thickening I-SYMPTOMS
groundglass O
change O
subpleural O
cystic O
change O
see O
low O
lobe O
give O
rise O
black B-SYMPTOMS
pleura I-SYMPTOMS
sign I-SYMPTOMS
fig1c O
2 O
pneumothorax B-DISEASE
pleural B-DISEASE
effusion I-DISEASE
present O
bronchial O
system O
include O
small O
bronchiole O
size O
pulmonary O
vessel O
normal O
diffuse B-DISEASE
parenchymal I-DISEASE
lung I-DISEASE
disease I-DISEASE
videoassiste O
thoracic O
surgical O
vat O
lung O
biopsy O
plan O
procedure O
convert O
minithoracotomy O
difficulty O
manoeuver O
endostapler O
moderate O
pneumothorax O
postminithoracotomy O
patient O
fully O
recover O
5 O
day O
ward O
lung O
biopsy O
speciman O
reveal O
feature O
consistent O
pam B-DISEASE
numerous O
calcospherite O
alveolar O
space O
fig1d O
intervene O
alveolar O
septae O
congest O
show O
mild O
fibrosis B-SYMPTOMS
infiltrate O
mainly O
lymphoplasmacytic O
cell O

young B-AGE
boy B-SEX
child O
healthy O
nonconsanguineous O
white O
british O
parent O
bear O
term O
follow O
uneventful O
pregnancy O
weigh O
3132 O
g O
9th25th O
centile O
early O
development O
think O
normal O
approximately O
6 O
month O
age O
develop O
tonic O
upward O
eye B-SYMPTOMS
deviation I-SYMPTOMS
associate O
flexion B-SYMPTOMS
arm O
neck O
consistent O
infantile O
spasm O
electroencephalograph O
eeg O
time O
grossly O
abnormal O
hypsarrhythmia B-SYMPTOMS
strongly O
support O
diagnosis O
west B-DISEASE
syndrome I-DISEASE
cranial O
mri O
report O
normal O
prednisolone O
prescribe O
treat O
seizure B-SYMPTOMS
effectively O
steroid O
wean O
6 O
week O
remain O
seizure O
free O
6 O
month O
age O
1 O
year O
apparent O
early O
developmental O
progress O
maintain O
function O
68 O
month O
developmental O
stage O
seizure O
return O
shortly O
birthday O
prolong O
frequent O
occasion O
focal O
involve O
right O
arm O
leg O
right O
face O
clonazepam O
briefly O
improve O
seizure O
frequency O
subsequently O
epilepsy B-DISEASE
prove O
refractory O
combination O
anticonvulsant O
therapy O
prolong O
seizure O
60 O
min O
associate O
stepwise O
regression O
neurodevelopment O
seizure O
semiology O
predominantly O
epilepsia O
partialis O
continuum O
involve O
right O
face O
right O
arm O
right O
leg O
development O
focal O
seizure O
progressive O
nature O
condition O
prompt O
second O
cranial O
mri O
age O
2 O
year O
6 O
month O
contrast O
previous O
scan O
mri O
reveal O
symmetrical O
subcortical O
white O
matter O
lesion O
fig1a O
thinning B-SYMPTOMS
anterior O
genu O
corpus O
callosum O
fig1b O
examination O
patient O
small O
round O
anteriorly O
rotate O
ear O
broad O
nasal O
root O
demonstrate O
visual O
awareness O
startle O
loud O
noise O
tone O
increase O
4 O
limb O
internal B-SYMPTOMS
rotation I-SYMPTOMS
leg O
hip O
reflex O
pathologically O
brisk O
brief O
myoclonic O
jerk O
evident O
examination O

67yearold O
japanese O
female B-SEX
present O
left O
buttock O
tumor B-SYMPTOMS
detect O
approximately O
1 O
year O
early O
recently O
gradually O
enlarge O
physical O
examination O
reveal O
relatively O
wellcircumscribe O
skincolore O
tumor O
hyperkeratosis O
measure O
43 O
x O
38 O
mm O
diameter O
left O
buttock O
biopsy O
speciman O
reveal O
bowen O
disease O
squamous O
cell O
carcinoma O
situ O
subsequently O
total O
resection O
tumor O
perform O
histopathological O
study O
resect O
speciman O
reveal O
proliferation B-SYMPTOMS
atypical O
squamous O
cell O
entire O
layer O
acanthotic B-SYMPTOMS
epidermis O
accompany O
hyperparakeratosis B-SYMPTOMS
figure O
1a O
atypical O
squamous O
cell O
enlarge O
hyperchromatic O
nucleus O
figure O
1b O
multinucleate O
atypical O
squamous O
cell O
present O
mitotic O
figure O
scatter O
present O
upper O
portion O
epidermis O
atypical O
mitotic O
figure O
observe O
figure O
1b O
invasive O
neoplastic B-SYMPTOMS
growth I-SYMPTOMS
note O
figure O
1a O
approximately O
95 O
lesion B-SYMPTOMS
compose O
abovementione O
bowen O
disease O
squamous O
cell O
carcinoma O
situ O
superficial O
sebaceous B-DISEASE
carcinoma I-DISEASE
present O
central O
area O
lesion O
component O
compose O
proliferation O
nest O
atypical O
cell O
vacuolated O
clear O
cytoplasm O
large O
nucleus O
contain O
conspicuous O
nucleolus O
figure O
1c O
1d1d O
sebaceous O
carcinoma O
invade O
superficial O
reticular O
dermis O
figure O
1c O
atypical O
cell O
contain O
vacuolated O
cytoplasm O
present O
lesion O
bowen O
disease O
adjacent O
sebaceous O
carcinoma O
figure O
1e O
immunohistochemical O
study O
perform O
autostainer O
ventana O
method O
previously O
report O
912 O
epithelial O
membrane O
antigen O
ema O
cytokeratin O
7 O
adipophilin O
express O
sebaceous O
carcinoma O
component O
bowen O
disease O
figure O
2a O
androgen O
receptor O
express O
tumor O
cell O
sebaceous O
carcinoma O
bowen O
disease O
atypical O
vacuolated O
cell O
lesion O
bowen O
disease O
positive O
adipophilin O
figure O
2b O
overexpression O
p53 O
protein O
observe O
sebaceous O
carcinoma O
bowen O
disease O
accordingly O
ultimate O
diagnosis O
sebaceous O
carcinoma O
associate O
bowen O
disease O

44yearold O
chinese O
man B-SEX
7 O
packyear O
smoking O
history O
refer O
shanghai O
pulmonary O
hospital O
february O
2013 O
left O
upper O
lobe O
lung O
mass B-SYMPTOMS
multiple O
bilateral O
intrapulmonary O
metastasis O
leave O
pleural B-DISEASE
effusion I-DISEASE
2r4r10l11l O
lymphadenopathy B-DISEASE
pleural O
fluid O
cytology O
reveal O
adenocarcinoma B-DISEASE
scorpion O
amplification O
refractory O
mutation O
system O
amoydx O
co O
xiamen O
china O
show O
detectable O
epidermal B-SYMPTOMS
growth I-SYMPTOMS
factor I-SYMPTOMS
receptor I-SYMPTOMS
mutation I-SYMPTOMS
commence O
chemotherapy O
gemcitabine O
cisplatin O
single O
cycle O
symptom O
worsen O
image O
confirm O
progressive O
disease B-DISEASE
second O
opinion O
request O
university O
colorado O
compute O
tomographyguided O
biopsy O
left O
upper O
lobe O
lesion B-SYMPTOMS
perform O
permit O
additional O
molecular O
testing O
interim O
patient O
commence O
pemetrexed O
nedaplatin O
unfortunately O
cycle O
shortness O
breath O
worsen O
evidence O
progression B-SYMPTOMS
scan O
fig1a O
molecular O
testing O
repeat O
biopsy O
speciman O
reveal O
mutation O
snapshot O
multiplex O
pcr O
testing O
life O
technology O
carlsbad O
technically O
negative O
alk O
breakapart O
fish O
test O
show O
atypical O
negative O
pattern O
specifically O
68 O
cell O
demonstrate O
single O
copy O
5 O
alk O
signal O
numerous O
cell O
doublet O
5 O
alk O
signal O
combine O
3 O
alk O
signal O
fig2a O
subsequently O
confirmatory O
diagnostic O
assay O
demonstrate O
alk O
protein O
expression O
ihc O
d5f3 O
antibody O
cell O
signal O
technology O
inc O
danver O
ma O
h O
score O
   O
150 O
fig2b O
presence O
echinoderm O
microtubuleassociate O
proteinlike O
4 O
eml4alk O
transcript O
e13 O
a20 O
rtpcr O
fig2c O
patient O
receive O
crizotinib O
250 O
mg O
twice O
daily O
thirdline O
therapy O
2013 O
impressive O
symptomatic B-SYMPTOMS
improvement I-SYMPTOMS
ct O
response O
1 O
month O
therapy O
fig1b O
remain O
treatment O
crizotinib O
evidence O
progression O
september O
2013 O

35yearold O
woman B-SEX
present O
medical O
emergency O
department O
lowgrade O
fever B-SYMPTOMS
3 O
week O
vomit O
1 O
week O
anuria B-SYMPTOMS
3 O
day O
report O
dysuria B-SYMPTOMS
breathlessness B-SYMPTOMS
1 O
week O
history O
decrease O
urine O
output O
dialysis O
effort B-SYMPTOMS
intolerance I-SYMPTOMS
chest O
pain B-SYMPTOMS
palpitation B-SYMPTOMS
dyspnoea B-SYMPTOMS
weight B-SYMPTOMS
loss I-SYMPTOMS
menstrual O
history O
normal O
limit O
report O
gradually O
progressive O
loss O
appetite O
family O
history O
include O
smoky O
urine O
young O
brother O
childhood O
die O
accident O
general O
survey O
patient O
conscious B-SYMPTOMS
alert B-SYMPTOMS
dyspnoeic B-SYMPTOMS
febrile B-SYMPTOMS
severe O
pallor B-SYMPTOMS
present O
mild O
pedal O
oedema B-SYMPTOMS
blood O
pressure O
180100 O
mm O
hg O
pulse O
rate O
116min O
regular O
evidence O
jaundice B-SYMPTOMS
club O
cyanosis B-SYMPTOMS
lymphadenopathy B-DISEASE
find O
physical O
examination O
reveal O
bibasilar O
endinspiratory O
crepitation O
lung O
suprapubic O
tenderness B-SYMPTOMS
hepatosplenomegaly B-SYMPTOMS
ascite O
cardiac O
examination O
normal O
find O
severe O
bilateral O
hearing B-SYMPTOMS
loss I-SYMPTOMS
gradually O
progressive O
5 O
year O
fundus O
bilaterally O
pale B-SYMPTOMS
patient O
refer O
department O
ophthalmology O
comprehensive O
eye O
examination O
visual O
acuity O
document O
618 O
eye O
obvious O
lenticular B-SYMPTOMS
opacity I-SYMPTOMS
slitlamp O
examination O
show O
bilateral O
anterior B-SYMPTOMS
lentiglobus I-SYMPTOMS
figure O
1 O
posterior B-SYMPTOMS
lenticonus B-SYMPTOMS
figure O
2 O
distant O
direct O
ophthalmoscopy O
reveal O
oil B-SYMPTOMS
droplet I-SYMPTOMS
sign I-SYMPTOMS
suggestive O
confirmation O
presence O
lenticonus O
peripheral O
retina O
reveal O
multiple O
yellowish O
white O
lesionlike O
fleck O
midperiphery O
blot O
haemorrhage O
indicative O
hypertensive O
change O
figure O
3 O
4 O

30yearold O
woman B-SEX
history O
hiv B-DISEASE
hcv B-DISEASE
present O
emergency O
department O
4month O
history O
gradual O
progressive O
swelling B-SYMPTOMS
low O
limb O
abdoman O
deny O
chest O
pain B-SYMPTOMS
dyspnoea B-SYMPTOMS
paroxysmal O
nocturnal O
dyspnoea O
orthopnoea B-SYMPTOMS
vital O
stable O
cardiovascular O
examination O
remarkable O
elevated O
jugular O
venous O
pressure O
jvp O
12 O
cm O
pronounced O
y O
descent O
prominent O
pericardial B-SYMPTOMS
knock I-SYMPTOMS
sound I-SYMPTOMS
hear O
praecordium O
pericardial B-SYMPTOMS
rub I-SYMPTOMS
murmur B-SYMPTOMS
lung O
clear O
auscultation O
patient O
markedly O
oedematous B-SYMPTOMS
abdoman O
low O
limb O
admit O
diagnostic O
workup O
management O
diagnose O
hiv O
2010 O
antiretroviral O
therapy O
illicit O
drug O
approximately O
56 O
year O
renal O
hepatic O
disease O
rule O
blood O
test O
image O
peritoneal O
fluid O
negative O
malignancy B-DISEASE
echocardiogram O
show O
thicken O
bright O
pericardium O
adjacent O
right O
heart O
border O
figure O
1 O
parallel O
separation O
epicardial O
pericardial O
echo O
railroad O
track O
sign O
septal O
bounce O
lack O
pericardial O
slide O
annulus B-SYMPTOMS
paradoxus I-SYMPTOMS
demonstrate O
tissue O
doppler O
figure O
2 O
leave O
ventricular O
ejection O
fraction O
64 O
right O
ventricle O
normal O
size O
function O
moderate O
tricuspid B-SYMPTOMS
regurgitation I-SYMPTOMS
pericardial B-SYMPTOMS
effusion I-SYMPTOMS
pericardial O
space O
remarkable O
debris B-SYMPTOMS
constrictive B-DISEASE
physiology I-DISEASE
demonstrate O
doppler O
study O
tricuspid O
mitral O
inflow O
figure O
3 O
inspiration O
expiration O
diastolic B-SYMPTOMS
flow I-SYMPTOMS
reversal I-SYMPTOMS
demonstrate O
hepatic O
vein O
expiration O
mark O
dilatation B-SYMPTOMS
inferior O
vena O
cava O
change O
inspiration O
expiration O
ct O
chest O
reveal O
thickening B-SYMPTOMS
pericardium O
evidence O
calcification B-SYMPTOMS
lung O
nodule O
bilateral O
pleural O
effusion O
interstitial O
thickening O
present O
lung O
basis O
cardiac O
mri O
confirm O
presence O
diffusely O
thicken O
pericardium O
5 O
mm O
inferior O
vena O
cava O
hepatic O
vein O
appear O
plethoric B-SYMPTOMS
rapid O
early O
diastolic O
filling O
associate O
diastolic B-SYMPTOMS
septal I-SYMPTOMS
bounce I-SYMPTOMS
secondary O
hinder O
late O
diastolic O
filling O
figure O
4 O
patient O
show O
good O
response O
diuresis O
undergo O
right O
leave O
heart O
catheterisation O
confirm O
constrictive O
physiology O

affected O
individual O
male B-SEX
fourth O
child O
bear O
arab O
muslim O
family O
palestinian O
origin O
parent O
cousin O
sible O
girl O
die O
age O
1 O
month O
sid O
accord O
parent O
investigation O
inform O
consent O
muscle O
skin O
biopsy O
exome O
sequence O
obtain O
parent O
study O
approve O
local O
institutional O
review O
board O
pregnancy O
patient O
suspect O
iugr B-DISEASE
deliver O
cesarian O
section O
362 O
gestational O
week O
apgar O
score O
9 O
10 O
birth O
weight O
23 O
kg O
10th O
percentile O
head O
circumference O
32 O
cm O
10th O
percentile O
physical O
exam O
birth O
detect O
systolic B-SYMPTOMS
murmur I-SYMPTOMS
36 O
day O
life O
patient O
develop O
metabolic O
acidosi O
lactate O
level O
27 O
mm O
normal O
range O
0524 O
mm O
elevated O
ammonia O
level O
277 O
m O
normal O
range O
1060 O
m O
metabolic O
work O
show O
normal O
acylcarnitine O
elevate O
alanine O
level O
1400 O
m O
normal O
700 O
m O
urine O
organic O
acid O
show O
increase O
lactic O
acidosi O
ketone O
chest O
xray O
reveal O
cardiomegaly B-SYMPTOMS
cardiac O
echo O
reveal O
symmetrical O
left B-SYMPTOMS
ventricular I-SYMPTOMS
hypertrophy I-SYMPTOMS
tricuspid B-SYMPTOMS
regurge I-SYMPTOMS
pulmonary B-SYMPTOMS
hypertension I-SYMPTOMS
patient O
transport O
nicu O
treat O
bicarbonate O
acetate O
diuretic O
age O
4 O
day O
quadricep O
muscle O
biopsy O
perform O
pathology O
show O
decrease O
cytochrome O
c O
oxidase O
stain O
brain O
ultrasound O
perform O
age O
5 O
day O
normal O
subsequently O
head O
circumference O
grew O
rapidly O
add O
13 O
centimeter O
age O
35 O
day O
repeat O
brain O
reveal O
dilated B-SYMPTOMS
ventricle O
confirm O
head O
ct O
show O
subcortical O
white O
matter O
cortical O
hemorrhage B-SYMPTOMS
occipital O
region O
15 O
week O
ventriculoperitoneal O
vp O
shunt O
insert O
head O
ct O
perform O
age O
2 O
year O
show O
prominent O
dilatation B-SYMPTOMS
ventricle O
figure O
1 O
hypotonia B-DISEASE
feed O
difficulty O
recurrent O
aspiration O
percutaneous O
endoscopic O
gastrostomy O
peg O
feeding O
tube O
insert O
age O
10 O
week O
eye O
examination O
age O
15 O
week O
reveal O
cortical O
blindness B-DISEASE
hear O
test O
abr O
normal O
repeat O
cardiac O
echo O
continue O
mild O
tricuspid O
regurge O
mild O
left O
ventricular O
hypertrophy O
lvh B-SYMPTOMS
pulmonary O
hypertension O
phtn B-SYMPTOMS
month O
life O
age O
4 O
month O
start O
develop O
hypertrophic O
obstructive O
cardiomyopathy B-DISEASE
start O
diuretic O
beta O
blocker O
late O
calcium O
channel O
blocker O
add O
followup O
echo O
age O
2 O
year O
reveal O
improvement O
lvh O
phtn O
coenzyme O
q10 O
supplementation O
60 O
mg O
twice O
daily O
initiate O
4 O
month O
discontinue O
parent O
following O
month O
patient O
admit O
time O
hospital O
mainly O
chest O
infection B-DISEASE
shunt O
malfunction O
fever O
die O
age O
30 O
month O
severe O
hypoxemia B-SYMPTOMS
febrile B-DISEASE
illness I-DISEASE
chest O
infection O
pulmonary O
edema B-SYMPTOMS
parent O
refuse O
mechanical O
ventilation O
refuse O
reanimation O

woman B-SEX
60 O
find O
screen O
detect O
invasive O
lobular O
breast B-DISEASE
carcinoma I-DISEASE
right O
breast O
invasive O
ductal B-DISEASE
carcinoma I-DISEASE
special O
type O
left O
breast O
stage O
ct O
image O
prior O
mastectomy O
show O
12 O
cm O
pelvic O
mass B-SYMPTOMS
initial O
impression O
think O
fibroid B-SYMPTOMS
uterus O
associate O
postmenopausal O
bleeding B-SYMPTOMS
lead O
pelvic O
ultrasound O
hysteroscopy O
biopsy O
biopsy O
show O
undifferentiated O
sarcoma B-DISEASE
unclassifiable O
immunohistochemistry O
follow O
discussion O
multidisciplinary O
team O
meet O
feel O
uterine O
tumour B-SYMPTOMS
separate O
primary O
malignancy O
metastasis B-DISEASE
breast O
hysterectomy O
bilateral O
salpingooophorectomy O
perform O
treatment O
purpose O
fully O
categorise O
malignancy O
guide O
adjuvant O
therapy O
histological O
examination O
resection O
speciman O
show O
partially O
necrotic O
tumour O
discrete O
outline O
locate O
extend O
myometrium O
tumour O
compose O
malignant O
spindle O
cell O
figure O
1a O
intermittent O
component O
pleomorphic O
cell O
abundant O
eosinophilic O
cytoplasm O
plentiful O
osteoclastlike O
giant O
cell O
present O
figure O
1b O
mitose O
numerous O
structurally O
abnormal O
form O
common O
neoplastic O
cell O
surround O
hyaline O
osteoid O
matrix O
foci O
coarse O
neoplastic O
weave O
bone O
figure O
1c O
generous O
sampling O
tumour O
show O
admixed O
neoplastic O
epithelial O
element O
rule O
common O
carcinosarcoma O
malignant O
mixed O
mllerian O
tumour O
tumour O
cell O
show O
immunohistochemical O
expression O
vimentin O
smooth O
muscle O
actin O
sma O
desmin O
focally O
cd99 O
epithelial O
marker O
express O
morphological O
immunohistochemical O
appearance O
keep O
primary O
uterine O
osteoblastic O
variant O
osteosarcoma B-DISEASE
unfortunately O
despite O
treatment O
ct O
imaging O
show O
development O
multiple O
peritoneal O
pulmonary O
deposit O
confirm O
biopsy O
metastatic O
osteosarcoma O
patient O
receive O
palliative O
chemotherapy O
die O
month O
later O

56yearold O
african O
american O
man B-SEX
initially O
present O
diarrhea B-SYMPTOMS
weight B-SYMPTOMS
loss I-SYMPTOMS
painless O
jaundice B-SYMPTOMS
subsequently O
find O
adenocarcinoma B-DISEASE
head O
pancrea O
initial O
workup O
reveal O
localize O
cancer B-DISEASE
evidence O
distant O
metastasis O
undergo O
pancreaticoduodenectomy O
complete O
surgical O
resection O
5 O
cm O
moderately O
differentiate O
pancreatic O
adenocarcinoma O
patient O
underwent O
complete O
surgical O
resection O
pathological O
examination O
reveal O
neoplastic B-SYMPTOMS
invasion I-SYMPTOMS
resect O
adjacent O
organ O
seven O
resect O
lymph O
node O
contain O
cancer O
t3n1m0 O
point O
oncology O
department O
recommend O
proceed O
adjuvant O
chemotherapy O
gemcitabine O
1000mgm2 O
iv O
day O
1 O
8 O
15 O
28day O
cycle O
cycle O
try O
reduce O
likelihood O
recurrence B-SYMPTOMS
complete O
cycle O
total O
dose O
chemotherapy O
present O
emergency O
department O
worsen O
exertional O
dyspnea B-SYMPTOMS
threepillow O
orthopnea B-SYMPTOMS
paroxysmal O
nocturnal O
dyspnea O
fatigue B-SYMPTOMS
physical O
examination O
reveal O
elevated O
jugular O
venous O
pressure O
jvp O
10 O
cm O
sternal O
angle O
bibasilar O
rale O
2 O
pitting O
edema B-SYMPTOMS
low O
extremity O
cardiac O
auscultation O
reveal O
gallop B-SYMPTOMS
rhythm I-SYMPTOMS
s3 O
grade O
3 O
holosystolic O
murmur B-SYMPTOMS
precordium O
chest O
xray O
show O
cardiomegaly B-SYMPTOMS
mild O
moderatesize O
rightside O
pleural B-DISEASE
effusion I-DISEASE
think O
presentation O
consistent O
fluid B-SYMPTOMS
overload I-SYMPTOMS
secondary O
congestive B-DISEASE
heart I-DISEASE
failure I-DISEASE
chf B-DISEASE
start O
intravenous O
iv O
furosemide O
partial O
improvement O
symptom O
day O
twodimensional O
echocardiography O
2d O
echo O
perform O
show O
leave O
ventricular O
ejection O
fraction O
lvef O
15 O
20 O
percent O
global O
hypokinesia B-SYMPTOMS
moderate O
mitral B-SYMPTOMS
regurgitation I-SYMPTOMS
give O
finding O
2d O
echo O
absence O
significant O
risk O
factor O
coronary B-DISEASE
artery I-DISEASE
disease I-DISEASE
cad B-DISEASE
ischemic O
cardiomyopathy B-DISEASE
cmp B-DISEASE
conclude O
patient O
cmp O
relate O
recent O
use O
gemcitabine O
patient O
start O
carvedilol O
angiotensinconverte O
enzyme O
inhibitor O
addition O
diuretics O
discharge O
hospital O
day O
later O
euvolemic B-SYMPTOMS
state O
point O
cardiology O
department O
recommend O
stop O
chemotherapy O
gemcitabine O
oncology O
department O
advise O
testing O
rule O
ischemia B-SYMPTOMS
cause O
cmp O
opinion O
chemotherapy O
gemcitabine O
option O
reduce O
risk O
recurrence O
patient O
week O
later O
patient O
underwent O
myocardial O
perfusion O
imaging O
mpi O
show O
fix O
small O
moderatesize O
inferior O
wall O
defect B-SYMPTOMS
evidence O
active O
ischemia O
ejection O
fraction O
ef O
mpi O
calculate O
17 O
20 O
percent O
severe O
global O
hypokinesia O
patient O
continue O
standard O
heart O
failure O
therapy O
admission O
hospital O
chf O
exacerbation O
month O
later O
respond O
iv O
furosemide O
adjustment O
heart O
failure O
therapy O
2d O
echo O
repeat O
month O
later O
show O
improvement O
systolic O
function O
lvef O
40 O
percent O
poor O
functional O
status O
underlie O
cmp O
gemcitabine O
chemotherapy O
stop O
later O
patient O
develop O
recurrence O
pancreatic B-DISEASE
cancer I-DISEASE
refuse O
chemotherapy O
decide O
proceed O
palliative O
care O
exact O
etiology O
patient O
dilate O
cardiomyopathy O
remain O
unclear O
gemcitabine O
remain O
likely O
culprit O
temporal O
relationship O
symptom O
initiation O
gemcitabine O
chemotherapy O
lack O
risk O
factor O
ischemic O
cmp O
prior O
history O
cad O
finding O
global O
hypokinesia O
2d O
echo O
absence O
ischemia O
mpi O
improvement O
systolic O
function O
discontinuation O
gemcitabine O
consistent O
gemcitabineinduce O
cardiomyopathy O

66yearold O
caucasian O
woman B-SEX
history O
hypertension B-SYMPTOMS
admit O
hospital O
recent O
diagnosis O
burkitt B-DISEASE
lymphoma I-DISEASE
lactate O
dehydrogenase O
level O
high O
diameter O
mediastinal O
mass B-SYMPTOMS
10 O
cm O
physical O
examination O
normal O
basal O
electrocardiography O
ecg O
show O
sinus B-SYMPTOMS
rhythm I-SYMPTOMS
heart O
rate O
72 O
beatsminute O
twodimensional O
transthoracic O
echocardiography O
tte O
siemens O
acuson O
sequoia O
c512 O
reveal O
normal O
biventricular O
function O
lv O
ejection O
fraction O
lvef O
60 O
mild O
mitral O
tricuspid O
regurgitation B-SYMPTOMS
moderate O
pericardial B-SYMPTOMS
effusion I-SYMPTOMS
risk O
assessment O
patient O
highrisk O
category O
undergo O
rituximabhyperfractionatedcyclophosphamidevincristinedoxorubicindexamethasone O
rhypercvad O
chemotherapy O
protocol O
laboratory O
value O
summarize O
table O
1 O
receive O
highdose O
cyclophosphamide O
300mgm2 O
twice O
daily O
3 O
day O
doxorubicin O
25mgm2day O
2 O
day O
rituximab O
375mgm2day O
1 O
day O
dexamethasone O
40mgday O
4 O
day O
vincristine O
2mgday O
2 O
day O
total O
treatment O
dose O
cyclophosphamide O
doxorubicin O
receive O
1800mgm2 O
50mgm2 O
respectively O
give O
allopurinol O
300mgday O
perorally O
sodium O
bicarbonate O
84 O
10 O
flaconday O
infusion O
24 O
hour O
chemotherapy O
mesna O
600mgm2day O
2 O
day O
prophylaxis O
tumor B-DISEASE
lysis I-DISEASE
syndrome I-DISEASE
hemorrhagic B-DISEASE
cystitis I-DISEASE
respectively O
receive O
granisetron O
2mgday O
lansoprazole O
30mgday O
antiemetogenic O
gastric O
prophylaxis O
respectively O
patient O
develop O
dyspnea B-SYMPTOMS
seventh O
day O
therapy O
physical O
examination O
reveal O
blood O
pressure O
10060mmhg O
heart O
rate O
110 O
beatsminute O
chest O
auscultation O
inspiratory O
sound O
hear O
low O
zone O
inspiratory O
crackle O
hear O
middle O
zone O
cardiac O
murmur O
s3 B-SYMPTOMS
hear O
ecg O
show O
low O
voltage O
limb O
precordial O
lead O
tte O
show O
diffusely O
increase O
myocardial O
echogenicity O
mild O
pericardial O
effusion O
generally O
impair O
biventricular O
systolic O
function O
lvef O
31 O
right O
ventricular O
midapical O
akinesis B-SYMPTOMS
manifest O
pleural B-SYMPTOMS
effusion I-SYMPTOMS
detect O
druginduced O
cardiotoxicity O
myocarditis B-DISEASE
suspect O
furosemide O
ramipril O
start O
betablocker O
therapy O
patient O
take O
hypertension O
continue O
12 O
day O
tte O
show O
lvef O
37 O
normal O
right O
ventricular O
function O
dyspnea O
decrease O
discharge O
day O
20 O
1 O
month O
tte O
show O
normal O
biventricular O
function O
lvef O
60 O
course O
rhypercvad O
chemotherapy O
protocol O
undergo O
highdose O
methotrexate O
cytarabine O
cycle O
severe O
neutropenia B-SYMPTOMS
pneumonia B-DISEASE
cardiac O
failure O
symptom O
chemotherapy O
course O
decline O
course O
chemotherapy O
remission B-SYMPTOMS
despite O
abbreviate O
course O
chemotherapy O

29yearold O
primipara B-SEX
present O
complaint O
persistent O
severe O
right O
side O
upper O
abdominal O
pain B-SYMPTOMS
deep O
inspiration O
physical O
exercise O
local O
pressure O
complaint O
develop O
gradually O
give O
birth O
year O
early O
pregnancy O
complicate O
hellp B-DISEASE
syndrome I-DISEASE
subcapsular O
liver O
hematoma B-SYMPTOMS
size O
20 O
cm O
   O
5 O
cm O
resolve O
spontaneously O
current O
presentation O
liver O
function O
test O
normal O
assure O
having O
experience O
sign O
suggestive O
sexually O
transmit O
disease O
pelvic B-DISEASE
inflammatory I-DISEASE
disease I-DISEASE
pid O
undergo O
intraabdominal O
intervention O
upperabdominal O
magnetic O
resonance O
imaging O
reveal O
density B-SYMPTOMS
liver O
diaphragm O
site O
subcapsular O
hematoma O
suspect O
perihepatic O
adhesion B-SYMPTOMS
figure O
1 O
refer O
hepatobiliary O
surgeon O
perform O
laparoscopy O
confirm O
presence O
thick O
adhesion O
liver O
segment O
vviii O
diaphragm O
figure O
2 O
adhesiolysis O
perform O
session O
monopolar O
diathermia O
sharp O
dissection O
follow O
instillation O
15 O
l O
adept O
4 O
icodextrin O
solution O
peritoneal O
cavity O
prevent O
formation O
new O
adhesion O
followup O
year O
postsurgery O
free O
symptom O

45yearold O
woman B-SEX
present O
general O
practitioner O
leftsided O
neck O
shoulder O
pain B-SYMPTOMS
pain O
mild O
nonspecific O
patient O
history O
unremarkable O
deny O
history O
smoke O
excessive O
alcohol O
use O
radiation O
exposure O
physical O
examination O
demonstrate O
mild O
left O
side O
cervical O
lymphadenopathy B-SYMPTOMS
routine O
blood O
test O
reveal O
borderline O
elevate O
calcium O
105 O
mgdl O
subsequent O
work O
exhibit O
markedly O
elevate O
parathyroid O
hormone O
level O
286 O
pgml O
patient O
refer O
otolaryngology O
evaluation O
thyroid O
ultrasound O
show O
hypoechoic O
nodule B-SYMPTOMS
left O
low O
lobe O
thyroid O
ct O
scan O
neck O
reveal O
2 O
cm O
hypodense O
nodule O
posterior O
inferior O
aspect O
left O
low O
thyroid O
sestamibi O
scan O
show O
increase O
uptake O
low O
pole O
left O
thyroid O
lobe O
elevated O
pth O
aberrant B-SYMPTOMS
parathyroid O
gland O
imaging O
suggest O
primary O
hyperparathyroidism B-DISEASE
historically O
hyperparathyroidism O
associate O
bone B-DISEASE
disease I-DISEASE
renal O
stone O
neuromuscular B-DISEASE
dysfunction I-DISEASE
current O
screening O
modalitie O
patient O
catch O
early O
asymptomatic3 O
primary O
hyperparathyroidism O
commonly O
cause O
parathyroid O
adenoma B-DISEASE
infrequent O
cause O
include O
parathyroid O
hyperplasia B-DISEASE
affect O
gland O
rarely O
cause O
parathyroid B-DISEASE
carcinoma I-DISEASE
markedly O
elevate O
serum O
pth O
calcium O
level O
lead O
severe O
renal O
bone O
manifestation O
helpful O
diagnosis O
cancer B-DISEASE
usually O
discover O
operatively O
base O
local O
invasion B-SYMPTOMS
metastases3 O
primary O
indication O
parathyroidectomy O
historically O
symptomatic O
patient O
currently O
patient O
catch O
early O
new O
indication O
surgery O
include O
asymptomatic B-SYMPTOMS
patient O
follow O
glomerular O
filtration O
rate O
60 O
mlmin O
bone O
density O
tscore O
25 O
site O
andor O
previous O
fracture O
age O
50 O
serum O
calcium O
10 O
ngdl O
upper O
limit O
normal3 O
patient O
present O
pain O
markedly O
elevated O
pth O
young O
50 O
year O
old O
decide O
surgery O
good O
choice O
management O
patient O
bring O
operating O
room O
undergo O
parathyroidectomy O
surgeon O
find O
parathyroid O
gland O
firm B-SYMPTOMS
densely O
adherent B-SYMPTOMS
thyroid O
capsule O
overlying O
strap O
muscle O
make O
difficult O
dissect O
visible O
invasion O
capsule O
surround O
muscle O
regional O
lymph O
nod O
resect O
speciman O
note O
brownish O
grey O
colour O
scatter O
necrotic B-SYMPTOMS
foci I-SYMPTOMS
irregular O
texture O
postoperative O
pathology O
speciman O
confirm O
positive O
parathyroid O
carcinoma O
capsular O
invasion O
focal O
tumour B-SYMPTOMS
necrosis I-SYMPTOMS
reactive O
fibrosis B-SYMPTOMS
local O
skeletal O
muscle O
invasion O
figure O
1 O
2 O
margin O
resect O
immunohistochemical O
stain O
show O
increase O
ki67 O
reactivity O
strong O
bcl1 O
cyclin O
d1 O
reactivity O
support O
diagnosis O
parathyroid O
carcinoma O
figure O
3 O
additionally O
p57 O
staining O
negative O
report O
parathyroid B-DISEASE
carcinomas I-DISEASE
associate O
marked O
hypercalcaemia B-SYMPTOMS
nonfunctione O
cancer O
patient O
tend O
behave O
aggressively1 O
owe O
severity O
uncertainty O
lesion O
patient O
follow O
postoperatively O
repeat O
image O
determine O
residual O
tumour O
remain O
repeat O
sestamibi O
positron O
emission O
tomography O
pet O
scan O
reveal O
residual O
activity O
surgical O
area O
patient O
subsequently O
undergo O
second O
operation O
radical O
left O
neck O
dissection O
leave O
hemithyroidectomy O
patient O
recover O
postoperatively O
3 O
year O
second O
surgery O
patient O
continue O
follow O
3 O
month O
monitor O
serum O
pth O
calcium O
level O
long O
report O
neck O
shoulder O
pain O
patient O
blood O
test O
marginally O
elevated O
pth O
level O
remain O
eucalcaemic B-SYMPTOMS
followup O
nuclear O
scan O
pet O
scan O
continue O
negative O
patient O
continue O
monitor O
3 O
month O
indefinitely O

20yearold O
male B-SEX
cystic O
fibrosis O
transfer O
houston O
methodist O
hospital O
january O
2013 O
evaluate O
lung O
kidney O
transplant O
patient O
cystic O
fibrosis O
know O
develop O
chronic O
lung O
infection O
adapt O
time O
unique O
anatomic O
niche O
14 O
15 O
complicated O
medical O
history O
include O
pancreatic B-DISEASE
insufficiency I-DISEASE
liver O
transplantation O
2004 O
steroidinduced O
diabetes B-DISEASE
endstage O
renal O
disease O
testicular B-DISEASE
cancer I-DISEASE
long O
history O
respiratory O
infection O
multidrugresistant O
bacteria O
include O
mrsa B-DISEASE
treat O
ceftaroline O
outside O
hospital O
immediately O
prior O
transfer O
houston O
methodist O
hospital O
patient O
periodically O
hospitalize O
january O
july O
2013 O
treat O
recurrent O
respiratory O
catheterrelate O
infection O
cause O
mrsa O
multidrugresistant O
pseudomonas O
aeruginosa O
antibiotic O
exposure O
include O
long O
treatment O
course O
agent O
include O
meropenem O
ceftazidime O
doxycycline O
vancomycin O
linezolid O
cefepime O
ciprofloxacin O
inhaled O
systemic O
colistin O
tobramycin O
shortly O
readmitte O
hospital O
june O
2013 O
mrsa O
grow O
culture O
blood O
respiratory O
specimen O
isolate O
resistant O
clindamycin O
linezolid O
oxacillin O
trimethoprimsulfamethoxazole O
susceptible O
minocycline O
rifampin O
vancomycin O
blood O
isolate O
grow O
confluently O
ceftaroline O
et O
strip O
yield O
mic O
32 O
mgliter O
additional O
s O
aureus O
respiratory O
tract O
isolate O
available O
study O
mrsa O
isolate O
patient O
smallcolonyvariant O
scv O
phenotype O

7yearold O
boy B-SEX
goldenhar B-DISEASE
syndrome I-DISEASE
postnatal O
genetic O
diagnosis O
refer O
department O
radiology O
imaging O
study O
temporal O
bone O
patient O
undergo O
3dct O
scan O
brilliance O
ct64channel O
philips O
medical O
system O
amsterdam O
netherlands O
employ O
protocol O
generate O
120 O
kv O
current O
150 O
ma O
slice O
thickness O
image O
1 O
mm O
05 O
mm O
increment O
image O
dicom O
format O
process O
pc O
commercial O
software O
obtain O
threedimensional O
reconstruction O
skeletal O
structure O
3dimensional O
reconstruction O
skin O
plan O
show O
hypoplasia B-DISEASE
auricle O
right O
consist O
simple O
dysmorphic B-SYMPTOMS
rough I-SYMPTOMS
left O
auricle O
regular O
dimension O
morphology O
atresia B-DISEASE
right O
auditory O
conduit O
normal O
left O
auditory O
conduit O
observe O
upper O
image O
show O
partial O
ossification O
cranium O
typical O
paediatric O
age O
description O
profile O
typical O
ii O
class O
convex O
profile O
interposition O
inferior O
lip O
reduce O
neckchin O
anglefig1 O
skeletal O
study O
mandibular O
condyle O
ramus O
corpus O
short O
affected O
tilting O
oral O
rhyme O
occlusal O
plane O
mandibular O
plane O
evident O
number O
form O
abnormality O
find O
mixed O
dentition O
mandibular O
condyle O
temporomandibular O
joint O
asymmetric O
particular O
right O
condyle O
deform O
short O
wide O
mandibular O
condyle O
dimension O
11 O
   O
7 O
mm O
right O
14 O
   O
7 O
mm O
leave O
3dimensional O
reconstruction O
skeleton O
plane O
show O
different O
morphology O
right O
leave O
hemimandibula O
mandibular O
3dimensional O
reconstruction O
show O
detail O
shift O
medial O
axis O
hypoplastic B-DISEASE
right O
asymmetry O
right O
mandibular O
condyle O
appear O
dysmorphic O
short O
wide O
axial O
coronal O
scansion O
figs2 O
3 O
study O
temporal O
bone O
show O
right O
external O
auditory O
canal O
atresia O
hypoplasia O
tympanic O
cavity O
pneumatize O
occupy O
dense O
material O
soft O
part O
pneumatization B-DISEASE
present O
right O
mastoid O
cell O
leave O
external O
auditory O
canal O
dimension O
morphology O
normal O
left O
tympanic O
cavity O
normally O
form O
totally O
occupy O
dense O
material O
soft O
tissue O
right O
leave O
ear O
present O
minor O
hypoplasia O
auricle O
bone O
right O
agreement O
resolution O
instrument O
normal O
representation O
malleus O
head O
articulate O
dysmorphic O
rough O
deform O
incus O
observe O
impossible O
staple O
left O
malleus O
incus O
visible O
appear O
articulate O
abnormal O
manner O
reduce O
contact O
surface O
staple O
difficult O
observe O
regular O
morphology O
dimension O
morphology O
cochlea O
semicircular O
canal O
vestibulum O
utriculum O
unaltered O
figs47 O
conclusion O
3dct O
valuation O
young O
patient O
observe O
asymmetry O
condyle O
particular O
right O
condyle O
dysmorphic O
short O
wide O
auricle O
right O
external O
ear O
hypoplastic O
dysmorphic O
rough O
present O
right O
middle O
ear O
hypoplastic O
tympanic O
cavity O
right O
internal O
ear O
atresic B-DISEASE
auditory O
conduit O

19yearold O
woman B-SEX
present O
lump B-SYMPTOMS
right O
breast O
macrocephaly B-DISEASE
milimetric O
papule O
tongue O
give O
cobble O
stone O
appearance O
breast O
ultrasonography O
show O
circumscribe O
oval O
masse O
breast O
usguided O
core O
biopsy O
perform O
palpable O
masse O
confirm O
juvenile O
fibroadenoma B-DISEASE
biopsy O
breast O
followup O
6 O
12 O
month O
3 O
year O
surveillance O
period O
core O
biopsy O
perform O
time O
follow O
usguided O
vacuumassisted O
core O
needle O
excision O
surgical O
excision O
lesion O
increase O
size O
pathologic O
result O
fibroadenoma O
tubular B-DISEASE
adenoma I-DISEASE
atypical B-DISEASE
ductal I-DISEASE
hyperplasia I-DISEASE
adh B-DISEASE
involve O
fibroadenoma O
age O
19 O
year O
patient O
undergo O
neck O
palpable O
mass B-DISEASE
left O
neck O
indeterminate O
nodule O
reveal O
thyroid O
gland O
followup O
reveal O
nodule O
increase O
size O
patient O
undergo O
total O
thyroidectomy O
pathologic O
result O
reveal O
invasive O
follicular B-DISEASE
carcinoma B-DISEASE
left O
thyroid O
follicular B-DISEASE
adenoma I-DISEASE
right O
thyroid O
fig1a O
age O
21 O
year O
visit O
hospital O
swelling B-SYMPTOMS
left O
cheek O
head O
neck O
ct O
scan O
reveal O
vascular O
mass O
left O
parotid O
gland O
extend O
left O
forehead O
external O
carotid O
angiography O
confirm O
diagnosis O
avm B-DISEASE
feeder O
vessel O
arise O
left O
internal O
maxillary O
artery O
fig1b O
partial O
embolization O
decrease O
blood O
flow O
avm O
alleviate O
patient O
symptom O
refer O
genetic O
counseling O
suggestion O
cowden B-DISEASE
syndrome I-DISEASE
pten O
dna O
sequence O
test O
blood O
sample O
reveal O
frameshift O
mutation O
c301dupa O
pi101nfsx6 O
age O
22 O
year O
patient O
present O
mass O
increase O
size O
increase O
vascularity O
left O
breast O
usguided O
vacuumassisted O
core O
needle O
excision O
reveal O
ductal O
carcinoma O
situ O
dcis B-DISEASE
noncomedo O
type O
low O
grade O
involve O
fibroadenoma O
fig1c O
contrastenhanced O
breast O
mri O
preoperative O
evaluation O
demonstrate O
multiple O
wellcircumscribe O
enhance O
masse O
breast O
fig1d O
masse O
show O
high O
intermediate O
signal O
intensity O
t2weighte O
image O
fig1e O
masse O
show O
early O
rapid O
enhancement O
washout O
kinetic O
pattern O
timesignal O
intensity O
curve O
evaluation O
tend O
associate O
malignancy B-DISEASE
fig1f O
bilateral O
prophylactic O
mastectomy O
immediate O
breast O
reconstruction O
perform O
view O
multiple O
bilateral O
breast O
masse O
suspicious O
kinetic O
feature O
breast O
mri O
high O
risk O
breast B-DISEASE
cancer I-DISEASE
cowden O
syndrome O
surgical O
histopathology O
reveal O
adh O
involve O
tubular O
adenoma O
residual O
carcinoma O
left O
breast O
multiple O
tubular O
adenoma O
fibroadenoma O
intraductal O
papilloma O
breast O
patient O
family O
history O
breast O
cancer O
cowden O
syndrome O

patient O
d O
73387 O
female B-SEX
child B-AGE
bear O
emergency O
caesarean O
section O
34 O
week O
gestation O
consanguineous O
firstcousin O
british O
pakistani O
parent O
antenatal O
scan O
show O
small O
gestation O
weigh O
119 O
kg O
birth O
head O
circumference O
267 O
cm O
considerably O
04th O
centile O
induction O
labour O
attempt O
growth B-SYMPTOMS
retardation I-SYMPTOMS
fail O
lead O
emergency O
caesarean O
section O
apgar O
score O
4 O
1 O
min O
7 O
5 O
min O
9 O
10 O
min O
admit O
neonatal O
intensive O
care O
unit O
continuous O
positive O
airway O
pressure O
ventilation O
hour O
age O
develop O
severe O
lactic B-SYMPTOMS
acidosis B-SYMPTOMS
initial O
lactic O
acid O
concentration O
22 O
mmoll O
subsequently O
increase O
63 O
mmoll O
normal O
range O
0721 O
mmoll O
treat O
intravenous O
infusion O
sodium O
bicarbonate O
trishydroxymethyl O
aminomethane O
tham O
possible O
correct O
metabolic B-SYMPTOMS
acidosis I-SYMPTOMS
develop O
hypoglycaemia B-SYMPTOMS
hour O
birth O
correct O
intravenous O
infusion O
15 O
glucose O
78 O
mgkgmin O
ammonia O
concentration O
normal O
urine O
organic O
acid O
profile O
show O
massive O
excretion O
lactic O
acid O
increase O
phenolic O
acid O
especially O
hydroxyphenyllactate O
plasma O
amino O
acid O
show O
raise O
concentration O
alanine O
glutamine O
1567 O
1369 O
moll O
respectively O
consistent O
lactic O
acidosis O
amino O
acid O
mildly O
increase O
gross O
generalised O
aminoaciduria B-SYMPTOMS
blood O
acylcarnitine O
analysis O
normal O
echocardiography O
show O
structurally O
normal O
heart O
good O
ventricular O
function O
cranial O
ultrasound O
show O
bilateral O
intraventricular O
cyst B-SYMPTOMS
frontal O
horn O
anterior O
portion O
lateral O
ventricle O
leftsided O
cyst O
large O
15 O
mm O
diameter O
large O
cyst O
right O
8 O
mm O
diameter O
choroid O
plexus O
hyperechoic B-SYMPTOMS
irregular B-SYMPTOMS
suggest O
previous O
intraventricular B-DISEASE
haemorrhage I-DISEASE
abdominal O
ultrasound O
show O
distended B-SYMPTOMS
urinary O
bladder O
unremarkable O
severe O
coagulopathy B-DISEASE
extended O
prothrombin O
time O
477 O
s O
normal O
123166 O
s O
low O
plasma O
albumin O
7 O
gl O
normal O
3550 O
gl O
normal O
liver O
function O
test O
raise O
creatine O
kinase O
2700 O
ul O
normal O
300 O
ul O
transfer O
tertiary O
centre O
worsen O
metabolic O
acidosis O
start O
have O
seizure O
48 O
h O
age O
despite O
infusion O
bicarbonate O
tham O
acidosis O
continue O
worsen O
muscle O
skin O
biopsy O
perform O
family O
agree O
withdrawal O
intensive O
care O
treatment O
die O
aged O
55 O
h O
document O
study O
approve O
perform O
ethical O
guideline O
issue O
institution O
clinical O
study O
write O
inform O
consent O
obtain O
family O

patient O
57yearold O
woman B-SEX
note O
rapidly O
enlarging O
mass B-SYMPTOMS
left O
neck O
2010 O
undergo O
total O
thyroidectomy O
central O
neck O
dissection O
reveal O
38 O
cm O
anaplastic O
thyroid B-DISEASE
cancer I-DISEASE
arise O
background O
oncocytic O
variant O
poorly O
differentiate O
thyroid O
cancer O
fig1a O
figs1 O
supplementary O
appendix O
1 O
available O
text O
article O
nejmorg O
resection O
margin O
positive O
3 O
12 O
lymph O
node O
involve O
3 O
week O
surgery O
serum O
thyroglobulin O
level O
172 O
ng O
milliliter O
undetectable O
thyroglobulin O
antibodie O
patient O
receive O
concurrent O
radiation O
therapy O
weekly O
carboplatin O
paclitaxel O
chemotherapy O
serum O
thyroglobulin O
level O
4 O
week O
completion O
chemotherapy O
radiation O
therapy O
120 O
ng O
milliliter O
restage O
scan O
obtain O
3 O
month O
later O
reveal O
new O
rightside O
hilar O
mass O
fig1c O
patient O
enrol O
phase O
2 O
clinical O
trial O
everolimus O
administer O
dose O
10 O
mg O
daily O
6 O
month O
followup O
scan O
show O
lesion O
greatly O
diminish O
size O
30 O
26 O
cm O
11 O
08 O
cm O
fig1d O
18 O
month O
sustain O
response B-SYMPTOMS
everolimus O
scan O
reveal O
progressive B-DISEASE
disease I-DISEASE
fig1e O
patient O
undergo O
mediastinoscopy O
removal O
enlarged B-SYMPTOMS
lymph O
node O
contain O
metastatic O
anaplastic O
thyroid O
cancer O
fig1b O
figs1 O
supplementary O
appendix O
1 O
wholeexome O
sequence O
perform O
biopsy O
sample O
pretreatment O
resistant O
tumor O
blood O
sample O

46yearold O
caucasian O
woman B-SEX
ashkenazi O
jewish O
descent O
present O
chief O
complaint O
severe O
constant O
throbbing O
pain B-SYMPTOMS
left O
posterior O
mandible O
report O
pain O
aggravate O
chew O
start O
month O
initial O
consultation O
visit O
visual O
analog O
scale O
pain O
report O
710 O
day O
visit O
past O
medical O
history O
remarkable O
gaucher B-DISEASE
disease I-DISEASE
leave O
hip O
replacement O
gall O
bladder O
removal O
herniorrhaphy O
spleen O
abscess B-SYMPTOMS
drainage O
hepatitis B-DISEASE
c I-DISEASE
infection I-DISEASE
asthma B-DISEASE
social O
history O
significant O
20 O
packyear O
cigarette O
smoke O
family O
history O
unremarkable O
hereditary O
systemic O
disease O
medication O
include O
oral O
antiresorptive O
drug O
alendronate O
early O
osteoporosis B-DISEASE
associate O
gaucher O
disease O
70 O
mg O
weekly O
2 O
year O
calcium O
supplement O
loratadine O
hydromorphone O
esomeprazole O
promethazine O
levalbuterol O
carisoprodol O
fluticasone O
ibuprofen O
report O
enzyme O
replacement O
therapy O
ert O
intermittently O
year O
treat O
gaucher O
disease O
diagnose O
20 O
year O
prior O
receive O
intravenous O
injection O
twice O
month O
ert O
recount O
fatigue B-SYMPTOMS
infusion O
report O
receive O
antibiotic O
analgesic O
medication O
pain O
month O
ago O
helpfulhead O
neck O
examination O
cranial O
nerve O
examination O
vital O
sign O
normal O
limit O
intraoral O
examination O
complete O
percussion O
testing O
vitality O
testing O
probe O
evaluation O
mandibular O
posterior O
tooth O
region O
chief O
complaint O
leave O
mandibular O
molar O
endodontically O
treat O
3 O
year O
prior O
test O
nonvital O
remain O
mandibular O
tooth O
normal O
vitality O
testing O
evaluation O
opposing O
nonrestored O
noncarious O
tooth O
internal O
control O
gingival O
tissue O
jaw O
noninflame O
gross O
evidence O
plaque B-SYMPTOMS
calculus B-SYMPTOMS
periodontal O
pocket O
mandible O
range O
4 O
6 O
mm O
significant O
bony O
defect O
mouth O
dental O
xray O
panoramic O
radiograph O
take O
show O
relatively O
welldefine O
radiolucent O
lesion B-SYMPTOMS
multiple O
region O
mandible O
bilaterally O
pseudocystic O
multilocular O
appearance O
conebeam O
compute O
tomography O
confirm O
finding O
reveal O
large O
lytic O
lesion O
left O
posterior O
mandible O
region O
chief O
complaint O
figure O
1our O
clinical O
radiographic O
differential O
diagnosis O
chief O
complaint O
include O
chronic O
apical B-DISEASE
periodontitis I-DISEASE
radicular B-DISEASE
cyst I-DISEASE
central B-DISEASE
giant I-DISEASE
cell I-DISEASE
granuloma B-DISEASE
keratocystic O
odontogenic B-DISEASE
tumor I-DISEASE
ameloblastoma B-DISEASE
odontogenic B-DISEASE
fibroma I-DISEASE
neuralgianeuropathy O
mandibular O
involvement O
gaucher O
disease O
give O
medical O
history O
finding O
discuss O
patient O
write O
consent O
obtain O
surgical O
biopsy O
left O
mandible O
local O
anesthesia O
definitive O
diagnosis O
fourcorner O
gingival O
flap O
buccally O
reflect O
posterior O
leave O
mandible O
extend O
canine O
second O
molar O
cortical O
bone O
remove O
surgical O
bur O
create O
window O
access O
lesion O
pathologic B-SYMPTOMS
soft O
tissue O
evident O
access O
window O
entire O
pathologic O
soft O
tissue O
bone O
access O
window O
submit O
pathology O
laboratory O
histological O
evaluation O
histopathological O
finding O
reveal O
infiltration B-SYMPTOMS
jawbone O
marrow O
fibrous O
connective O
tissue O
contain O
abundant O
gaucher O
cell O
figure O
2 O
evidence O
abscess O
neutrophil O
granuloma O
malignancy B-SYMPTOMS
postoperative O
healing O
uneventful O
patient O
report O
resolution O
chief O
complaint O
symptomatology O
1month O
followup O
refer O
physician O
consultation O
evaluation O
relate O
gaucher O
disease O
status O
follow O
finding O
treat O
ert O
1year O
reevaluation O
symptom B-SYMPTOMS
free O
oral O
cavity O

21yearold O
man B-SEX
present O
emergency O
department O
rash B-SYMPTOMS
arm O
neck O
figure O
1 O
develop O
course O
36 O
h O
discrete O
pin O
prick O
area O
erythema B-SYMPTOMS
maculopapular O
rash O
vesicle O
figure O
2 O
cover O
forearm O
dorsal O
aspect O
hand O
flexor O
surface O
elbow O
begin O
develop O
neck O
figure O
3 O
describe O
rash O
itchy O
painful O
feel O
weather O
patient O
previous O
dermatological O
medical O
history O
note O
take O
medication O
work O
supermarket O
handle O
food O
item O
history O
occupational O
chemical O
exposure O
recently O
change O
washing O
powder O
personal O
hygiene O
product O
physiological O
observation O
entirely O
normal O
systemic O
examination O
unremarkable O
close O
examination O
rash O
reveal O
present O
skin O
expose O
sun O
wear O
shortsleeve O
shirt O
striking O
feature O
v O
shape O
patient O
chest O
keep O
neck O
line O
polo O
shirt O
question O
patient O
describe O
period O
time O
48 O
h O
prior O
presentation O
12 O
h O
prior O
development O
rash O
spend O
strimme O
grass O
hedge O
garden O
blood O
test O
include O
blood O
count O
urea O
electrolyte O
liver O
function O
test O
creactive O
protein O
normal O
reference O
range O
list O
potential O
differential O
diagnosis O
maculopapular O
rash O
long O
give O
distribution O
rash O
history O
plant O
material O
exposure O
diagnosis O
phytophotodermatitis B-DISEASE
patient O
discharge O
chlorphenamine O
simple O
analgesia O
advice O
wear O
longsleeve O
tshirt O
sunscreen O
garden O
future O
rash O
resolve O
period O
3 O
week O
remain O
pruritic O
healing O
associated O
pain B-SYMPTOMS
settle O
day O
residual O
scarring B-SYMPTOMS
begin O
fade O
2 O
month O
presentation O

77yearold O
woman B-SEX
dysphagia B-SYMPTOMS
present O
twoweek O
history O
rash B-SYMPTOMS
characterize O
brown O
plaque O
erythematous O
border O
overlie O
thick O
scale O
involve O
face O
prior O
percutaneous O
endoscopic O
gastrostomy O
peg O
tube O
site O
fig1a O
c O
oral O
conjunctival O
involvement B-SYMPTOMS
present O
receive O
parenteral O
nutrition O
month O
follow O
removal O
peg O
tube O
infection B-DISEASE
differential O
diagnosis O
include O
drug B-DISEASE
hypersensitivity I-DISEASE
autoimmune O
disorder O
nutritional B-DISEASE
deficiency I-DISEASE
rash O
appearance O
consistent O
acrodermatitis O
enteropathicalike O
eruption B-SYMPTOMS
secondary O
zinc B-DISEASE
deficiency I-DISEASE
serum O
zinc O
level O
12 O
mcgdl O
normal O
55150 O
mcgdl O
rash O
resolve O
week O
parenteral O
zinc O
supplementation O
fig1b O
d O
zinc O
essential O
protein O
synthesis O
wound O
heal O
acrodermatitis B-DISEASE
enteropathica I-DISEASE
present O
infancy O
periorificial O
desquamative O
dermatitis O
result O
autosomal O
recessive O
mutation O
impair O
zinc O
absorption O
similar O
syndrome O
occur O
nutritional O
zinc O
deficiency O
report O
setting O
parenteral O
nutrition O
fail O
include O
zinc O
supplementation O
prompt O
response O
supplementation O
help O
confirm O
diagnosis O
recent O
national O
shortage O
parenteral O
zinc O
united O
states O
likely O
contribute O
patient O
presentation O

42 O
yearold O
man B-SEX
chronic O
lymphocytic B-DISEASE
leukemia I-DISEASE
underwent O
allogeneic O
bone O
marrow O
transplant O
september O
2013 O
graft O
mismatch O
single O
human O
leukocyte O
antigen O
allele O
dqb1 O
tcell O
deplete O
vivo O
alemtuzumab O
engraft O
day O
12 O
transplant O
aside O
persistent O
lymphopenia B-SYMPTOMS
diarrhea B-SYMPTOMS
noroviru O
infection O
posttransplant O
course O
unremarkable O
midoctober O
develop O
tinnitus B-SYMPTOMS
rapidly O
progressive O
sensorineural B-DISEASE
deafness I-DISEASE
result O
subtotal O
hearing B-SYMPTOMS
loss I-SYMPTOMS
bilaterally O
95 O
db O
23 O
week O
brain O
magnetic O
resonance O
imaging O
mri O
unremarkable O
cerebrospinal O
fluid O
csf O
analysis O
4 O
leukocytesl O
50 O
neutrophil O
50 O
lymphocyte O
6 O
red O
blood O
cellsl O
glucose O
24 O
mmoll O
normal O
range O
2247 O
mmoll O
protein O
61 O
mgdl O
normal O
range O
1545 O
mgl O
absence O
oligoclonal O
band O
viral B-DISEASE
polymerase O
chain O
reaction O
pcr O
testing O
csf O
negative O
enterovirus B-DISEASE
herpesvirus B-DISEASE
infection O
patient O
treat O
empirically O
highdose O
valacyclovir O
broadspectrum O
antibiotic O
2 O
gkg O
intravenous O
immunoglobulin O
ivig O
despite O
intervention O
develop O
new O
symptom B-SYMPTOMS
central O
dyspnea B-SYMPTOMS
postural O
hypotension B-SYMPTOMS
nausea B-SYMPTOMS
gradually O
worsen O
balance O
repeat O
neurological O
assessment O
confirm O
persistent O
vestibulocochlear B-DISEASE
dysfunction I-DISEASE
6 O
week O
symptom O
onset O
middecember O
patient O
increasingly O
withdraw O
irritable B-SYMPTOMS
intermittently O
agitate O
remain O
lymphopenic B-SYMPTOMS
lymphocyte O
054 O
   O
106l O
normal O
range O
1236 O
   O
106l O
mri O
scan O
brain O
unremarkable O
serum O
testing O
antineuronal O
antibody O
electroencephalogram O
reveal O
diffuse O
encephalopathy B-DISEASE
give O
continue O
suspicion O
viral O
etiology O
patient O
treat O
highdose O
glucocorticoid O
ivig O
begin O
refuse O
fluid O
food O
medication O
detain O
uk O
mental O
health O
act O
repeat O
mri O
scanning O
show O
interval O
development O
new O
nonenhancing O
signal O
abnormality O
thalami O
midbrain O
cranial O
nerve O
involvement O
meningeal O
enhancement B-SYMPTOMS
figure O
1a O
near O
end O
december O
frontal O
lobe O
biopsy O
perform O
histology O
reveal O
reactive O
gliosis B-SYMPTOMS
diffuse O
infiltration B-SYMPTOMS
cd38 O
lymphocyte O
figure O
1b O
extensive O
microbiological O
testing O
biopsy O
tissue O
infectious O
etiology O
negative O
supplementary O
table O
1 O
give O
absence O
diagnosis O
patient O
progressive O
neurological B-DISEASE
deterioration I-DISEASE
csf O
brain O
biopsy O
tissue O
analyze O
january O
2014 O
metagenomic O
nextgeneration O
sequence O
ng O
2 O
ng O
analysis O
brain O
biopsy O
genome O
assembly O
situ O
hybridization O
reveal O
finding O
neuroinvasive O
astrovirus B-DISEASE
astv B-DISEASE
infection O
despite O
lack O
approve O
therapy O
patient O
treat O
ribavirin O
ivig O
respond O
intervention O
remain O
minimally B-SYMPTOMS
conscious I-SYMPTOMS
state I-SYMPTOMS
follow O
withdrawal O
sedation O
march O
2014 O
eventually O
die O
end O
4 O
month O
ngs O
diagnosis O
approximately O
75 O
month O
onset O
symptom O

68yearold O
man B-SEX
refer O
optometrist O
s O
suspect O
ltg B-DISEASE
repeatedly O
irregular O
visual O
field O
test O
result O
advanced O
optic O
disc O
cup O
normal O
intraocular O
pressure O
iop O
family O
history O
glaucoma B-DISEASE
patient O
subjectively O
feel O
vision B-SYMPTOMS
good O
left O
eye O
le O
normally O
visual O
acuity O
66 O
n5 O
start O
deteriorate O
6 O
month O
early O
point O
referral O
well O
correct O
675 O
n6 O
right O
eye O
know O
amblyopic B-DISEASE
visual O
acuity O
618 O
n12 O
medical O
history O
include O
considerable O
risk O
factor O
systemic O
vasculopathy B-DISEASE
hypertension B-DISEASE
hypercholesterolaemia B-DISEASE
50 O
packyear O
smoking O
type B-DISEASE
2 I-DISEASE
diabetes I-DISEASE
diabetic B-DISEASE
retinopathy I-DISEASE
despite O
detailed O
questioning O
deny O
new O
systemic O
symptom O
apart O
experience O
increase O
lethargy B-SYMPTOMS
clinical O
examination O
s O
reveal O
advanced O
bilateral O
cupped O
optic O
disc O
cuptodisc O
ratio O
right O
09 O
90 O
leave O
08 O
80 O
figure O
1 O
furthermore O
finding O
refer O
optometrist O
equal O
reactive O
pupil O
normal O
eye O
movement O
iop O
midteen O
confirm O
computerised O
perimetry O
show O
constricted O
visual O
field O
eye O
albeit O
considerably O
raise O
falsenegative O
error O
rate O
excess O
30 O
figure O
2a O
result O
poor O
concentration B-SYMPTOMS
attention B-SYMPTOMS
span I-SYMPTOMS
testing O
compound O
especially O
amblyopic O
field O
test O
repeat O
4 O
week O
later O
similar O
result O
figure O
2b O
visit O
patient O
experience O
deterioration O
good O
le O
visual O
acuity O
measure O
624 O
loss O
snellen O
line O
n36 O
amblyopic O
618 O
loss O
snellen O
line O
n36 O
le O
show O
depressed O
colour O
vision O
urgent O
scan O
patient O
head O
orbit O
request O
rule O
compressive O
lesion B-DISEASE
blood O
analysis O
carry O
screen O
cause O
optic B-DISEASE
neuropathy I-DISEASE
include O
vitamin O
b12 O
folate O
level O
inflammatory O
marker O
mri O
reveal O
large O
mass B-DISEASE
centre O
pituitary O
fossa O
measure O
approximately O
45 O
cm51 O
cm O
48 O
cm O
figure O
3ac O
extend O
suprasellar O
cistern O
infrasellar O
sphenoid O
sinuse O
optic O
chiasm O
optic O
nerve O
displace O
superiorly O
compress O
side O
mass O
show O
heterogeneous O
t1 O
t2 O
signal O
multiple O
fluid O
level O
likely O
previous O
haemorrhage B-DISEASE
lowsignal O
component O
suggest O
calcification O
appearance O
probably O
craniopharyngioma B-DISEASE
haemorrhagic O
pituitary B-DISEASE
adenoma I-DISEASE
patient O
refer O
urgently O
neurosurgery O
unit O
find O
markedly O
raise O
prolactin O
level O
great O
200 O
000 O
miul O
confirm O
diagnosis O
giant O
prolactinoma B-DISEASE
cooperation O
local O
endocrinology O
service O
start O
cabergoline O
500 O
g O
dexamethasone O
8 O
mg O
week O
lead O
dramatic O
improvement O
patient O
visual O
field O
acuity O
618 O
69 O
le O
prolactin O
level O
show O
similar O
dramatic O
response O
level O
come O
336 O
miul O
month O
later O
visual O
acuity O
le O
618 O
65 O
respectively O
visual O
field O
examination O
show O
strike O
recovery O
normal O
result O
figure O
2c O

8yearold O
boy B-SEX
refer O
evaluation O
fatigue B-SYMPTOMS
bear O
term O
weigh O
4 O
kg O
nonconsanguineous O
parent O
attain O
normal O
early O
developmental O
milestone O
height O
weight O
10th O
50th O
centile O
respectively O
preliminary O
examination O
remarkable O
hepatomegaly B-SYMPTOMS
extend O
35 O
cm O
right O
costal O
margin O
initial O
laboratory O
evaluation O
reveal O
normochromic O
normocytic O
anaemia B-SYMPTOMS
haemoglobin O
78 O
gdl O
11516 O
mean O
corpuscular O
volume O
mcv O
858 O
fl O
7587 O
mean O
corpuscular O
haemoglobin O
mch O
254 O
pg O
2535 O
marked O
anisocytosis B-SYMPTOMS
redcell O
distribution O
width O
rdw O
29 O
11145 O
hypochromia B-SYMPTOMS
teardrop O
evident O
blood O
film O
leucopoenia B-SYMPTOMS
feature O
white O
cell O
count O
29109l O
45135 O
neutrophil O
17109l O
275 O
lymphocyte O
08109l O
154 O
bone O
marrow O
aspirate O
biopsy O
reveal O
hypercellular B-SYMPTOMS
marrow O
erythroid B-SYMPTOMS
hyperplasia I-SYMPTOMS
iron O
stain O
reveal O
approximately O
50 O
erythroblast O
ring O
sideroblast O
marrow O
cytogenetic O
normal O
include O
fluorescence O
situ O
hybridisation O
study O
chromosome O
5q O
7 O
8 O
flow O
cytometry O
detect O
blast O
population O
serum O
copper O
lead O
normal O
blood O
smear O
proband O
parent O
sister O
analysis O
gene O
responsible O
hereditary O
sa O
alas2 O
abc7 O
fech O
pus1 O
reveal O
report O
pathogenic O
variant O
fast O
lactate O
elevate O
38 O
mmoll O
neurological O
examination O
identify O
upper O
motor O
neuron O
sign O
low O
limb O
bilaterally O
cerebellar O
sign O
negative O
mri O
brain O
demonstrate O
volume B-SYMPTOMS
loss I-SYMPTOMS
slight O
prominence B-SYMPTOMS
cerebellar O
folia O
urine O
organic O
acid O
reveal O
elevate O
3methylglutaconate O
3methylglutarate O
lactatepyruvate O
ratio O
elevate O
301 O
muscle O
biopsy O
reveal O
structurally O
normal O
muscle O
biochemical O
assay O
respiratory O
chain O
component O
result O
diagnosis O
partial O
complex B-DISEASE
iv I-DISEASE
deficiency I-DISEASE
subsequently O
commence O
highfat O
diet O
coenzyme O
q O
resultant O
improvement O
energy O
analysis O
mtdna O
leucocyte O
muscle O
utilise O
pcr O
reveal O
deletion B-SYMPTOMS
carnitine O
vitamin O
thiamine O
pyridoxine O
folate O
uridine O
supplement O
improvement O
anaemia O
haemoglobin O
level O
fall O
44 O
gdl O
lead O
occasional O
regular O
threeweekly O
red O
cell O
transfusion O
repeat O
transfusion O
ferritin O
rise O
1700 O
gl O
necessitating O
iron O
chelation O
peak O
growth O
hormone O
cortisol O
insulininduced O
hypoglycaemia B-SYMPTOMS
309 O
mul O
normal O
20 O
447 O
nmoll O
normal O
500 O
respectively O
age O
13 O
year O
thyroid O
function O
normal O
repeat O
peak O
cortisol O
384 O
nmoll O
follow O
adrenocorticotropic O
hormone O
acth O
stimulation O
plasma O
renin O
activity O
elevate O
15 O
ngmlh O
adrenal O
androgen O
low O
limit O
assay O
detection O
urinary O
steroid O
profile O
qualitatively O
normal O
abdominal O
ultrasound O
hydrocortisone O
5 O
mg O
twice O
daily O
fludrocortisone O
100 O
g O
daily O
initiate O
adrenal O
autoantibody O
21hydroxylase O
negative O
verylongchain O
fatty O
acid O
normal O
patient O
recently O
develop O
renal O
tubular O
fanconi B-DISEASE
syndrome I-DISEASE
include O
glycosuria B-SYMPTOMS
hypokalaemia B-SYMPTOMS
hypophosphataemia B-SYMPTOMS
low O
maximal O
tubular O
reabsorption O
phosphate O
generalised O
aminoaciduria B-SYMPTOMS
addition O
incidentally O
note O
hyperglycaemia B-SYMPTOMS
admission O
percutaneous O
endoscopic O
gastrostomy O
insertion O
glycate O
haemoglobin O
elevate O
62 O
mmolmol O
78 O
despite O
rapid O
red O
cell O
turnover O
pancreatic O
autoantibody O
negative O
glutamic O
acid O
decarboxylase O
antiinsulin O
antiislet O
antigen O
2 O
pancreatic O
islet O
cell O
antibodie O
maintain O
twice O
daily O
insulin O
detemir O
satisfactory O
glycaemic O
control O
fructosamine O
161 O
moll O
205285 O

71yearold O
africanamerican O
woman B-SEX
present O
hospital O
worsen O
exertional O
dyspnoea B-SYMPTOMS
associate O
orthopnoea B-SYMPTOMS
low O
extremity O
oedema B-SYMPTOMS
3 O
week O
longstanding O
history O
hypertension B-SYMPTOMS
document O
g6pd B-DISEASE
deficiency I-DISEASE
prior O
episode O
haemolysis B-SYMPTOMS
cigarette O
smoker O
family O
member O
g6pd O
deficiency O
hypertension O
diabete O
mellitus O
vital O
sign O
measurement O
reveal O
blood O
pressure O
15073 O
mm O
hg O
pulse O
rate O
70 O
bpm O
respiratory O
rate O
24 O
breathsmin O
temperature O
366c O
97 O
saturation O
room O
air O
comfortable B-SYMPTOMS
rest O
physical O
examination O
show O
distend O
jugular O
vein O
inspiratory O
crackle O
bilateral O
lung O
basis O
laterally O
displace O
apical O
impulse O
bipedal O
oedema O
ecg O
show O
leave O
ventricular O
hypertrophy B-SYMPTOMS
inferolateral O
twave O
inversion O
chest O
radiography O
reveal O
cardiomegaly B-SYMPTOMS
mild O
pulmonary O
oedema O
metabolic O
panel O
troponin O
level O
normal O
btype O
natriuretic O
peptide O
increase O
8265 O
pgml O
echocardiography O
show O
dilate O
left O
ventricle O
ejection O
fraction O
ef O
30 O
mild O
right O
ventricular O
systolic B-DISEASE
dysfunction I-DISEASE
coronary O
artery O
catheterisation O
reveal O
normal O
coronary O
circulation O
ethacrynic O
acid O
50 O
mg O
daily O
choose O
diuresis O
improve O
day O
dyspnoea O
add O
spironolactone O
subsequently O
metoprolol O
succinate O
losartan O
include O
regimen O
repeat O
chest O
radiography O
show O
resolution O
pulmonary O
oedema O
patient O
laboratory O
result O
hospital O
stay O
sign O
haemolysis O
worsen O
kidney O
function O
develop O
ototoxicity B-SYMPTOMS
discharge O
home O
asymptomatic B-SYMPTOMS

65yearold O
woman B-SEX
present O
complaint O
right O
upper O
quadrant O
pain B-SYMPTOMS
year O
prior O
patient O
incidentally O
diagnose O
idiopathic O
bcs B-DISEASE
health O
checkup O
doppler O
ultrasound O
examination O
show O
obstruction B-SYMPTOMS
middle O
leave O
hepatic O
vein O
investigation O
underlying O
thrombophilia B-DISEASE
unremarkable O
treat O
warfarin O
maintain O
international O
normalize O
ratio O
2 O
3 O
discontinue O
1 O
year O
noncompliance O
patient O
consult O
doctor O
2 O
year O
remain O
asymptomatic B-SYMPTOMS
past O
3 O
year O
recently O
start O
experience O
steadily O
worsen O
intermittent O
pain O
right O
upper O
quadrant O
abdomen O
associated O
alleviate O
factor O
physical O
examination O
notable O
mild O
right O
upper O
quadrant O
tenderness B-SYMPTOMS
laboratory O
test O
reveal O
mildly O
elevate O
bilirubin O
22 O
mgdl O
albumin O
deficit O
238 O
gdl O
childpugh O
cp O
score O
8 O
model O
endstage O
liver O
disease O
meld O
score O
11 O
rotterdam O
score O
015 O
bcstips O
prognostic O
index O
bcstips O
pi O
score O
63 O
contrastenhanced O
compute O
tomography O
ct O
scan O
show O
nonvisualized O
middle O
leave O
hepatic O
vein O
hepatomegaly B-SYMPTOMS
hypertrophy B-SYMPTOMS
caudate O
lobe O
splenomegaly B-SYMPTOMS
hepatic O
venous O
collateral O
saccular O
aneurysm B-SYMPTOMS
locate O
extrahepatic O
portal O
vein O
main O
branch O
measure O
32 O
cm O
height O
25 O
cm O
   O
24 O
cm O
diameter O
figure O
1a O
aneurysm O
think O
associate O
bcs O
precede O
history O
trauma B-DISEASE
present O
doppler O
examination O
perform O
3 O
year O
previously O
patient O
ascite O
variceal O
bleed O
decision O
create O
tip O
relieve O
hepatic O
venous O
outflow O
obstruction O
increase O
pain O
concern O
complication O
aneurysm O
size O
direct O
approach O
aneurysm O
consider O
risk O
associate O
complication O
setting O
portal O
hypertension B-SYMPTOMS
stentgrafting O
consider O
concern O
patency O
setting O
hepatic O
venous O
outflow O
obstruction O
underlie O
thrombophilia O
inform O
consent O
obtain O
patient O
bring O
interventional O
radiology O
suite O
procedure O
perform O
patient O
conscious O
sedation O
portal O
vein O
access O
obtain O
right O
hepatic O
vein O
fluoroscopy O
portography O
show O
saccular O
aneurysm O
locate O
main O
portal O
vein O
extensive O
intrahepatic O
portal O
vein O
thrombosis B-SYMPTOMS
small O
splenorenal O
varix O
figure O
2a O
10 O
mm O
diameter O
expand O
polytetrafluoroethylene O
eptfe O
cover O
stentgraft O
fluency O
plus O
bard O
peripheral O
vascular O
tempe O
arizona O
united O
states O
deploy O
liver O
parenchymal O
tract O
deploy O
stentgraft O
main O
portal O
vein O
trunk O
cover O
aneurysm O
neck O
consider O
obstruct B-SYMPTOMS
blood O
flow O
portal O
vein O
branch O
completion O
portography O
show O
widely O
patent B-SYMPTOMS
shunt I-SYMPTOMS
markedly O
decrease O
aneurysm O
filling O
figure O
2b O
portosystemic O
pressure O
gradient O
ppg O
decrease O
19 O
mmhg O
8 O
mmhg O
patient O
recover O
uneventfully O
complete O
resolution O
abdominal O
pain O
2 O
d O
discharge O
longterm O
warfarin O
remain O
asymptomatic O
1 O
year O
followup O
recent O
laboratory O
test O
reveal O
normal O
liver O
function O
doppler O
examination O
perform O
1 O
3 O
6 O
12 O
mo O
postprocedure O
confirm O
patent O
shunt O
cp O
score O
5 O
meld O
score O
8 O
rotterdam O
score O
012 O
tipsbc O
pi O
score O
61 O
ct O
scan O
show O
aneurysm O
decrease O
size O
24 O
cm O
height O
20 O
cm O
   O
19 O
cm O
diameter O
3 O
mo O
tip O
figure O
1b O
decrease O
19 O
cm O
height O
16 O
cm O
   O
15 O
cm O
diameter O
1 O
year O
figure O
1c O

present O
case O
66yearold O
female B-SEX
patient O
significant O
past O
medical O
history O
present O
chest O
pain B-SYMPTOMS
treat O
antacid O
primary O
care O
physician O
day O
present O
emergency O
room O
electrocardiogram O
reveal O
posterolateral O
st O
elevation O
myocardial B-DISEASE
infarction I-DISEASE
patient O
immediately O
take O
catheterization O
lab O
successful O
percutaneous O
intervention O
perform O
acutely O
occlude O
large O
ramus O
intermedius O
vessel O
supply O
large O
portion O
lateral O
wall O
figure O
1 O
patient O
initially O
hour O
later O
suddenly O
go O
cardiogenic B-DISEASE
shock I-DISEASE
intraaortic O
balloon O
pump O
place O
echocardiogram O
demonstrate O
severe O
mitral B-DISEASE
regurgitation I-DISEASE
ruptured B-DISEASE
papillary O
muscle O
figure O
2 O
patient O
maximal O
support O
deteriorate O
rapidly O
progressive O
acidosis B-SYMPTOMS
oliguria B-SYMPTOMS
florid O
pulmonary O
edema B-SYMPTOMS
spite O
high O
risk O
decide O
intervene O
surgically O
operating O
room O
transesophageal O
echocardiography O
confirm O
severe O
mitral O
regurgitation O
ruptured O
anterolateral O
papillary O
muscle O
small B-SYMPTOMS
left O
atrium O
shortly O
patient O
cardiopulmonary O
bypass O
acidosis O
resolve O
begin O
urine O
excellent O
visualization O
mitral O
valve O
obtain O
vertical O
transseptal O
approach O
right O
atrium O
valve O
carefully O
inspect O
necrotic B-SYMPTOMS
rupture O
anterolateral O
papillary O
muscle O
see O
figure O
3 O
large O
chunk O
muscle O
attach O
a1 O
chordal O
apparatus O
anterior O
leaflet O
mitral O
valve O
excise O
keep O
posterior O
leaflet O
intact B-SYMPTOMS
27 O
mm O
st O
jude O
epic O
bioprosthesis O
insert O
figure O
4 O
place O
extracorporeal O
membrane O
oxygenation O
successfully O
wean O
3 O
day O
later O
follow O
remarkable O
early O
recovery B-SYMPTOMS
month O
later O
prior O
discharge O
expire O
develop O
pneumonia B-DISEASE
progress O
sepsis B-DISEASE
multiorgan B-DISEASE
failure I-DISEASE

patient O
68yearold O
woman B-SEX
chronic O
obstructive O
pulmonary O
disease O
history O
gastroesophageal O
reflux O
disease O
esophageal O
disorder O
find O
progressive O
solitary O
pulmonary O
nodule B-SYMPTOMS
113 O
cm O
right O
low O
wedge O
resection O
perform O
december O
2011 O
university O
iowa O
pathology O
department O
identify O
tumor O
lcnec B-DISEASE
approximately O
month O
operation O
patient O
start O
having O
slowly O
progress O
dysphagia B-SYMPTOMS
solid O
liquid O
positron O
emission O
tomography O
pet O
scan O
perform O
2012 O
year O
post O
surgery O
unremarkable O
recurrence B-SYMPTOMS
metastasis B-SYMPTOMS
repeat O
compute O
tomography O
ct O
june O
2013 O
18 O
month O
post O
surgery O
recurrence O
figure O
1 O
patient O
esophagogastroduodenoscopy O
egd O
barium O
swallow O
reveal O
stricture B-SYMPTOMS
esophagus O
failure B-SYMPTOMS
primary O
secondary O
peristaltic O
wave O
reflux O
july O
2013 O
esophageal O
manometry O
find O
failure O
low O
esophageal O
sphincter O
relax O
residual O
pressure O
32mmhg O
patient O
treat O
calcium O
channel O
blocker O
partial O
relief B-SYMPTOMS
far O
18 O
month O
post O
resection O
patient O
able O
maintain O
weight O
basic O
laboratory O
parameter O
include O
hemoglobin O
albumin O
cholesterol O
level O
january O
2014 O
report O
worsen O
dysphagia O
weight B-SYMPTOMS
loss I-SYMPTOMS
10 O
lb O
period O
month O
refer O
center O
treatment O
achalasia B-DISEASE
repeat O
esophageal O
manometry O
show O
elevated O
low O
esophageal O
sphincter O
pressure O
50mmhg O
nonpropagative O
nonperistaltic O
contraction O
esophageal O
musculature O
figure O
2 O
repeat O
egd O
intention O
perform O
therapeutic O
pneumatic O
dilation O
show O
nearly O
circumferential O
ulcerated O
fungating O
mass B-SYMPTOMS
approximately O
36 O
cm O
extend O
gastroesophageal O
junction O
39 O
cm O
biopsy O
reveal O
lcnec O
similar O
feature O
primary O
tumor O
resect O
2011 O
conclude O
metastasis O
subsequently O
repeat O
ct O
scan O
reveal O
progressive O
diffuse O
metastatic B-DISEASE
disease I-DISEASE
patient O
undergo O
course O
chemotherapy O
die O
disease O
month O

woman B-SEX
early O
70 O
present O
emergency O
room O
30 O
min O
husband O
expire O
810 O
substernal O
chest O
pain B-SYMPTOMS
concurrent O
diaphoresis B-SYMPTOMS
dyspnoea B-SYMPTOMS
patient O
husband O
outofhospital O
cardiac O
arrest O
early O
day O
bring O
emergency O
room O
subsequently O
admit O
coronary O
care O
unit O
recurrent O
ventricular O
fibrillation O
successfully O
resuscitate O
patient O
medical O
history O
include O
hypertension O
hypothyroidism O
deny O
having O
similar O
episode O
pain O
regular O
appointment O
primary O
care O
physician O
medication O
include O
oral O
furosemide O
20 O
mg O
levothyroxine O
100 O
g O
daily O
deny O
allergy O
presentation O
patient O
afebrile B-SYMPTOMS
blood O
pressure O
10555 O
heart O
rate O
93 O
bpm O
respiratory O
rate O
20min O
oxygen O
saturation O
98 O
room O
air O
physical O
examination O
significant O
distress B-SYMPTOMS
pain O
skin O
warm O
moist O
minimal O
crackle O
bilateral O
basis O
regular O
rate O
rhythm O
26 O
systolic O
murmur B-SYMPTOMS
apex O
radiation O
rub O
elevate O
jugular O
vein O
distention B-SYMPTOMS
8 O
cm O
strong O
peripheral O
pulse O
peripheral O
oedema B-SYMPTOMS
abdoman O
soft O
nontender O
nondistende O
bowel O
sound O
patient O
alert B-SYMPTOMS
orient O
focal O
neurological O
deficit O
complete O
blood O
count O
basic O
metabolic O
panel O
coagulation O
test O
normal O
limit O
cardiac O
enzyme O
increase O
troponin O
259 O
ngml O
normal O
range O
00150045 O
ngml O
creatine O
phosphokinase O
84 O
ul O
normal O
range O
26192 O
ul O
ecg O
admission O
reveal O
normal O
sinus O
rhythm O
23 O
mm O
st O
segment O
elevation O
lead O
v2v3 O
q O
wave O
lead O
v1v3 O
suggestive O
anterior O
wall O
infarct B-DISEASE
figure O
2 O
echocardiogram O
reveal O
leave O
ventricular O
ejection O
fraction O
3035 O
mild O
concentric O
leave O
ventricular O
hypertrophy B-SYMPTOMS
akinesis B-SYMPTOMS
apex O
23 O
inferoseptum O
apical O
inferioranterior O
wall O
segment O
suggest O
ischaemic B-SYMPTOMS
damage I-SYMPTOMS
left O
anterior O
descend O
artery O
distribution O
versus O
takotsubo B-DISEASE
cardiomyopathy B-DISEASE
figure O
3 O
4 O
patient O
receive O
aspirin O
162 O
mg O
prasugrel O
60 O
mg O
take O
cardiac O
catheterisation O
laboratory O
angiogram O
show O
nonobstructive O
coronary B-DISEASE
artery I-DISEASE
disease I-DISEASE
luminal O
irregularity O
figure O
5 O
6 O
left O
ventriculography O
show O
ejection O
fraction O
35 O
akinesis O
apical O
wall O
hyperkinesis B-SYMPTOMS
basal O
segment O
figure O
7 O
8 O
patient O
remain O
haemodynamically O
stable O
start O
oral O
heart O
failure O
medication O
include O
lisinopril O
25 O
mg O
daily O
metoprolol O
tartrate O
125 O
mg O
time O
day O
pain O
shortness O
breath O
resolve O
discharge O
home O
48 O
h O
hospitalisation O
stable O
condition O
repeat O
echocardiogram O
2 O
month O
later O
show O
resolution O
cardiomyopathy O
ejection O
fraction O
6570 O
normal O
left O
ventricular O
motion O

36yrold O
previously O
healthy O
sri O
lankan O
male B-SEX
take O
care O
horse O
present O
medical O
casualty O
ward O
fever B-SYMPTOMS
arthralgia B-SYMPTOMS
myalgia B-SYMPTOMS
day O
complain O
mild O
dysuria B-SYMPTOMS
normal O
urine O
output O
chest O
pain B-SYMPTOMS
shortness O
breath O
inquiry O
reveal O
treat O
leptospirosis B-DISEASE
febrile O
illness O
past O
examination O
patient O
afebrile B-SYMPTOMS
anicteric B-SYMPTOMS
blood O
pressure O
9060 O
mmhg O
pulse O
rate O
76 O
bpm O
rest O
examination O
unremarkable O
initial O
investigation O
perform O
day O
admission O
reveal O
neutrophil O
leukocytosis B-SYMPTOMS
mild O
thrombocytopaenia B-SYMPTOMS
microscopic O
haematuria B-SYMPTOMS
table O
1 O
renal O
function O
liver O
enzyme O
normal O
limit O
urine O
analysis O
reveal O
pus O
cell O
05 O
   O
06 O
hpf O
red O
cell O
30 O
   O
35 O
hpf O
crp O
creactive O
protein O
75 O
mgdl O
clinical O
diagnosis O
leptospirosis O
start O
intravenous O
penicillin O
addition O
adequate O
hydration O
second O
day O
illness O
develop O
hypotension B-SYMPTOMS
tachycardia B-SYMPTOMS
dyspnoea B-SYMPTOMS
ecg O
reveal O
sinus O
tachycardia O
st O
depression O
lead O
v4 O
   O
v6 O
figure O
1 O
cxr O
chest O
x O
ray O
show O
gross O
cardiomegaly B-DISEASE
bilateral O
pulmonary O
shadow O
figure O
2 O
cvp O
central O
venous O
pressure O
16 O
cmh2o O
2d O
echocardiogram O
reveal O
dilatation B-SYMPTOMS
chamber O
severe O
global O
hypokinesia B-DISEASE
ejection O
fraction O
20 O
troponin O
1277 O
ngml O
normal O
range O
   O
040 O
diagnose O
early O
severe O
myocarditis B-DISEASE
patient O
transfer O
icu O
intensive O
care O
unit O
need O
inotropic O
support O
intravenous O
antibiotic O
include O
penicillin O
meropenem O
levofloxacin O
continue O
patient O
electively O
ventilate O
3rd O
day O
illness O
severe O
respiratory B-DISEASE
distress I-DISEASE
day O
develop O
rapid O
atrial B-DISEASE
fibrillation I-DISEASE
figure O
3 O
unresponsive O
digoxin O
intravenous O
amiodarone O
platelet O
count O
drop O
10 O
   O
103 O
l O
give O
platelet O
transfusion O
prevent O
bleeding O
table O
1 O
start O
intravenous O
methylprednisolone O
base O
previous O
study O
show O
mortality O
benefit O
severe O
leptospirosis O
complicate O
myocarditis O
11 O
serum O
creatinine O
increase O
362 O
   O
moll O
5th O
day O
illness O
alt O
alanine O
transaminase O
ast O
aspartate O
transaminase O
markedly O
elevate O
2726 O
ul O
7438 O
ul O
respectively O
dengue O
mycoplasma O
infection O
exclude O
blood O
culture O
negative O
leptospira O
igm O
antibody O
perform O
5th O
day O
illness O
positive O
igg O
negative O
patient O
develop O
refractory B-DISEASE
shock I-DISEASE
die O
persistent O
ventricular O
tachycardia O
despite O
optimal O
treatment O
icu O

35yearold O
woman B-SEX
present O
ear O
nose O
throat O
outpatient O
department O
headache B-SYMPTOMS
block O
leftsided O
nasal O
canal O
epistaxis B-SYMPTOMS
2 O
year O
medical O
history O
reveal O
secondary O
amenorrhoea B-SYMPTOMS
past O
19 O
year O
regression O
secondary O
sexual O
characteristic O
galactorrhoea B-SYMPTOMS
physical O
ophthalmological O
examination O
normal O
limit O
nasal O
examination O
reveal O
leftsided O
choanal O
mass B-SYMPTOMS
mass O
bleed O
palpation O
imaging O
advise O
prior O
perform O
biopsy O
mri O
head O
show O
sellar O
infrasellar O
mass O
extend O
nasopharynx O
figure O
1 O
patient O
refer O
endocrinologist O
hormonal O
investigation O
serum O
prolactin O
high7443 O
gl O
n20 O
pituitary O
hormone O
normal O
limit O
final O
diagnosis O
giant B-DISEASE
prolactinoma I-DISEASE
patient O
prescribe O
cabergoline O
025 O
mg O
twice O
week O
associate O
risk O
explain O
advance O

38yearold O
woman B-SEX
present O
emergency O
department O
severe O
abdominal O
pain B-SYMPTOMS
history O
drug O
use O
constipation O
say O
intermittent O
bloody O
diarrhea B-SYMPTOMS
physical O
examination O
reveal O
rebound O
tenderness B-SYMPTOMS
guard O
abdomen O
stool O
microscopy O
negative O
amoeba O
trophozoite O
parasite O
fecal O
occult O
blood O
find O
sedimentation O
27 O
mms O
crp O
nephelometry O
656 O
mgl O
normal O
range O
05 O
antinuclear O
antibody O
04 O
008 O
negative O
antid O
dna O
10 O
20 O
negative O
white O
blood O
cell O
count O
1498 O
normal O
range O
410 O
hemoglobin O
level O
109 O
neutrophil O
count O
1314 O
platelet O
count O
473 O
100300 O
urea O
level O
17 O
mgdl O
bun O
level O
794 O
mgdl O
creatinine O
level O
056 O
mgdl O
ast O
20 O
ul O
alt O
24 O
ul O
hiv O
negative O
abdominal O
ultrasound O
scanning O
show O
free B-SYMPTOMS
fluid I-SYMPTOMS
right O
paracolic O
perihepatic O
left O
paracolic O
gutter O
pelvis O
detection O
airfluid O
level O
free B-SYMPTOMS
air I-SYMPTOMS
diaphragm O
erect O
abdominal O
xray O
emergency O
laparotomy O
perform O
operation O
multiple O
perforation B-DISEASE
area O
find O
sigmoid O
colon O
descend O
colon O
transverse O
colon O
wide O
resection O
transverse O
colon O
descend O
sigmoid O
colon O
resection O
undertake O
figure O
1 O
pathergy O
test O
positive O
patient O
recurrent O
oral O
genital O
aphthous O
ulcer O
45 O
time O
past O
year O
eye O
examination O
result O
normal O
computed O
tomography O
reveal O
extensive O
thrombus B-DISEASE
inferior O
vena O
cava O
extend O
right O
middle O
hepatic O
vein O
figure O
2 O
patient O
receive O
corticosteroid O
anticoagulant O
immunosuppressive O
therapy O
patient O
alive B-SYMPTOMS
healthy B-SYMPTOMS
53 O
week O
later O
figure O
3 O
macroscopy O
transverse O
colon O
50 O
cm O
sigmoid O
descend O
colon O
specimen O
27 O
cm O
length O
specimen O
colon O
segment O
4 O
cm O
diameter O
perforation O
area O
evident O
serosal O
surface O
colonic O
wall O
bowel O
mucosa O
edematous B-SYMPTOMS
hyperemic B-SYMPTOMS
plicae O
regular O
course O
3 O
roundish O
punchedout O
perforation O
transverse O
colon O
4 O
descending O
sigmoid O
colon O
somewhat O
separate O
colonic O
wall O
large O
2 O
cm O
diameter O
figure O
4 O
multiple O
ulcer O
large O
1 O
cm O
diameter O
different O
location O
merge O
somewhat O
separate O
surround O
mucosa O
certain O
limit O
cover O
exudate O
surround O
hyperemic B-SYMPTOMS
region I-SYMPTOMS
macroscopic O
lymph O
node O
serosa O
numerous O
sample O
take O
ulcerated O
perforate O
region O
normal O
mucosa O
sample O
submit O
routine O
microscopic O
tissue O
followup O
hematoxylineosin O
tissue O
giemsa O
passtaine O
slide O
prepare O
examination O
microscopic O
examination O
neutrophil O
leukocyte O
lymphocyte O
reaction B-SYMPTOMS
wall O
lumen O
arteriole O
venule O
perforated O
ulcerated O
lesion O
figure O
5 O
and66 O
wellorganize O
thrombi B-SYMPTOMS
intimal B-SYMPTOMS
proliferation I-SYMPTOMS
vessel O
figure O
7 O
and88 O
mark O
acute O
peritonitis B-DISEASE
surface O
epithelium O
colonic O
crypt O
regular O
colonic O
mucosa O
apart O
ulcerated O
perforate O
lesion O
sample O
free O
parasite O
egg O

patient O
38yearold O
caucasian O
man B-SEX
spanish O
origin O
height O
165 O
cm O
parent O
cousin O
parent O
normal O
height O
show O
minor O
anomaly O
evc O
syndrome O
spectrum O
patient O
healthy O
sister O
morphological O
feature O
normal B-SYMPTOMS
mouth I-SYMPTOMS
opening I-SYMPTOMS
miss O
low O
incisor O
fig1 O
b O
small B-SYMPTOMS
chest I-SYMPTOMS
determine O
cardiothoracic O
examination O
c O
disproportionately O
short O
extremity O
additional B-SYMPTOMS
postaxial I-SYMPTOMS
digit I-SYMPTOMS
hand O
fig2 O
sensorymotor O
deficit O
note O
patient O
present O
mild O
mental B-DISEASE
retardation I-DISEASE
genetic O
analysis O
early O
infancy O
show O
previously O
report O
homozygous O
nonsense O
mutation B-SYMPTOMS
c1195 O
c1 O
t O
parg399x O
evc2 O
result O
loss O
function O
protein5 O
parent O
heterozygous O
carrier O
mutation O
1998 O
patient O
undergo O
successful O
ostium O
primum O
atrial O
septal O
defect O
closure O
midsternotomy O
represent O
embolic O
cerebral O
ictus B-SYMPTOMS
2007 O
cavotricuspid O
isthmus O
ablation O
common O
atrial B-DISEASE
flutter I-DISEASE
perform O
successfully O
aftereffect O
routine O
examination O
2012 O
highpitche O
systolic O
murmur B-SYMPTOMS
discover O
electrocardiography O
show O
sinus O
rhythm O
hemiblock B-DISEASE
right B-DISEASE
bundle I-DISEASE
branch I-DISEASE
block I-DISEASE
echocardiography O
reveal O
dilated B-SYMPTOMS
hypertrophic B-SYMPTOMS
left O
ventricle O
abnormality O
produce O
flow B-SYMPTOMS
direct O
left O
atrial O
appendage O
lead O
severe O
mitral B-SYMPTOMS
valve I-SYMPTOMS
regurgitation I-SYMPTOMS
patient O
systolic O
pulmonary O
artery O
pressure O
50 O
mmhg O
aortic O
valve O
normal O
medical O
treatment O
include O
ramipril O
duloxetine O
alprazolam O
acenocumarol O
patient O
schedule O
mitral O
valve O
surgery O
operating O
theatre O
patient O
right O
femoral O
artery O
cannulate O
right O
thoracotomy O
perform O
fourth O
intercostal O
space O
bicaval O
cannulation O
establish O
vein O
exclude O
operation O
normothermic O
cardiopulmonary O
bypass O
crossclampe O
aorta O
beat O
heart O
avoid O
air O
embolisms O
continuous O
carbon O
dioxide O
co2 O
field O
flooding O
apply O
carbonaid O
co2 O
diffuser O
cardia O
innovation O
ab O
stockholm O
sweden O
attempt O
perform O
mitral O
valve O
repair O
unsuccessful O
bileaflet O
mechanical O
valve O
no29 O
implant O
complication O
associate O
anaesthesia O
occur O
patient O
postoperative O
recovery O
uneventful O
discharge O
postoperative O
day O
10 O
year O
followup O
echocardiography O
reveal O
optimal O
function O
mitral O
valve O
decrease O
systolic O
pulmonary O
artery O
pressure O
30 O
mmhg O

march O
2009 O
21yearold O
man B-SEX
admit O
institution O
symptom O
intermittent O
fever B-SYMPTOMS
headache B-SYMPTOMS
polyarthralgias B-SYMPTOMS
skin O
rash B-SYMPTOMS
trunk O
petechia O
finger O
palm O
patient O
previously O
healthy B-SYMPTOMS
history O
drug O
abuse O
take O
regular O
medication O
pet O
travel O
recently O
usual O
state O
health O
month O
admission O
intermittent O
high O
fever O
develop O
maximum O
axillary O
temperature O
39 O
c O
addition O
report O
headache O
bilateral O
symmetric O
arthralgia B-SYMPTOMS
wrist O
hand O
inflammatory O
pattern O
petechia O
palm O
finger O
salmoncolore O
rash O
trunk O
nausea B-SYMPTOMS
vomit O
evanescent O
salmoncolore O
rash O
observe O
chest O
abdoman O
2 O
mm O
petechia O
cover O
palm O
finger O
sign O
suggest O
arthritis B-DISEASE
lymphadenopathy B-SYMPTOMS
hepatosplenomegaly B-SYMPTOMS
blood O
testing O
show O
elevated O
inflammatory O
marker O
table O
ii O
electrocardiographic O
ecg O
chest O
radiographic O
result O
normal O
ibuprofen O
1200 O
mgd O
acetaminophen O
need O
begin O
provide O
symptomatic B-SYMPTOMS
relief O
extensive O
evaluation O
perform O
include O
blood O
culture O
viral O
bacterial O
serologic O
study O
immunologic O
screen O
rheumatoid O
factor O
antinuclear O
antibody O
compute O
tomographic O
ct O
study O
chest O
abdomen O
pelvis O
cranium O
significant O
change O
find O
transthoracic O
echocardiogram O
tte O
show O
circumferential O
mild O
pericardial B-SYMPTOMS
effusion B-SYMPTOMS
maximal O
diameter O
8 O
mm O
sign O
tamponade B-SYMPTOMS
relevant O
finding O
day O
later O
dyspnea B-SYMPTOMS
diffuse O
chest O
pain B-SYMPTOMS
develop O
pain O
relieve O
chest O
anteflexion O
aggravate O
deep O
inspiration O
lie O
supine O
patient O
hypotensive B-SYMPTOMS
tachycardic B-SYMPTOMS
hyperpneic B-SYMPTOMS
manifest O
jugular O
venous O
distention B-SYMPTOMS
ecg O
show O
sinus O
tachycardia B-SYMPTOMS
diffuse O
stsegment O
elevation O
fig1 O
chest O
radiograph O
reveal O
enlarged B-SYMPTOMS
cardiac O
silhouette O
fig2 O
inflammatory O
marker O
elevate O
table O
ii O
repeat O
tte O
show O
increase O
pericardial O
effusion O
maximal O
diameter O
12 O
mm O
fig3 O
collapse B-SYMPTOMS
right O
heart O
chamber O
emergency O
pericardiocentesis O
drain O
60 O
ml O
serosanguineous B-SYMPTOMS
fluid I-SYMPTOMS
repeat O
ct O
chest O
abdomen O
reveal O
mild O
right O
severe O
left O
pleural B-SYMPTOMS
effusion I-SYMPTOMS
mild O
ascite O
thoracocentesis O
perform O
350 O
ml O
serosanguineous B-SYMPTOMS
pleural I-SYMPTOMS
fluid I-SYMPTOMS
drain O
heart O
lung O
fluid O
exudate O
yield O
negative O
microbiologic O
examination O
unremarkable O
histologic O
analysis O
diagnosis O
aosd B-DISEASE
establish O
patient O
medicate O
prednisone O
05 O
mgkgd O
major O
clinical O
laboratory O
improvement B-SYMPTOMS
table O
ii O
stsegment O
normalization O
followup O
echocardiogram O
show O
mild O
pericardial O
effusion O
23 O
mm O
hemodynamic B-DISEASE
compromise I-DISEASE
screen O
autoimmune O
infectious O
disorder O
repeat O
significant O
change O
find O
patient O
discharge O
hospital O
regimen O
prednisone O
recurrence O
pericardial O
pleural O
effusion O
2 O
month O
discharge O
corticosteroid O
weaning O
withdrawal O
resolve O
resume O
prednisone O
therapy O
month O
discharge O
patient O
present O
institution O
followup O
visit O
asymptomatic O
maintain O
corticosteroid O
therapy O
followup O
ecg O
tte O
show O
significant O
change O
figs4 O
5 O

11yearold O
boy B-SEX
present O
history O
headache O
vomiting B-SYMPTOMS
present O
month O
physical O
examination O
show O
papilledema B-DISEASE
presence O
neurological O
deficit O
magnetic O
resonance O
imaging O
mri O
reveal O
large O
prepontine O
mass B-SYMPTOMS
dorsal O
displacement B-SYMPTOMS
brainstem O
secondary O
obstructive O
hydrocephalus B-DISEASE
compression B-SYMPTOMS
aqueduct O
lesion O
inhomogeneous O
hypointense B-SYMPTOMS
aspect I-SYMPTOMS
t1weighte O
image O
t1wi O
inhomogeneous O
hyperintense B-SYMPTOMS
aspect I-SYMPTOMS
t2weighte O
image O
t2wi O
administration O
iv O
gadolinium O
inhomogeneous O
enhancement B-SYMPTOMS
fig1 O
compute O
tomography O
ct O
imaging O
show O
bone B-SYMPTOMS
involvement I-SYMPTOMS
operation O
ventriculoperitoneal O
shunt O
insert O
right O
lateral O
ventricle O
treat O
hydrocephalus O
careful O
study O
mri O
suggest O
infra O
supratentorially O
locate O
tumour B-SYMPTOMS
resect O
single O
approach O
left O
frontotemporal O
transsylvian O
approach O
perform O
gain O
access O
tumour O
tumour O
welldefine O
margin O
entirely O
locate O
intradural O
plane O
attachment O
cranial O
nerve O
brainstem O
macroscopic O
complete O
resection O
perform O
postoperatively O
patient O
develop O
left O
oculomotor O
nerve B-DISEASE
palsy I-DISEASE
completely O
recover O
4 O
week O
postoperative O
mri O
show O
complete O
removal O
tumour O
fig2 O
careful O
consideration O
multidisciplinary O
team O
decide O
indication O
postoperative O
radiation O
therapy O
followup O
half O
year O
later O
patient O
find O
remain O
asymptomatic B-SYMPTOMS
sign O
tumour B-SYMPTOMS
recurrence I-SYMPTOMS
mri O
scan O
followup O
6 O
year O
treatment O
sign O
tumour O
recurrence O
mri O
scan O
histological O
examination O
show O
slightly O
lobulate O
tumour O
consist O
chondromyxoid O
matrix O
tumour O
cell O
show O
vacuolated O
pale O
cytoplasm O
moderate O
nuclear B-SYMPTOMS
polymorphism I-SYMPTOMS
observe O
obvious O
mitotic B-SYMPTOMS
activity I-SYMPTOMS
fig3 O
calcification O
see O
tumour O
cell O
stain O
positive O
pankeratin O
s100 O
epithelial O
membrane O
antigen O
ema O
finding O
suggest O
histopathological O
diagnosis O
chordoma B-DISEASE

25yearold O
female B-SEX
patient O
notice O
leftsided O
visual B-DISEASE
loss I-DISEASE
amenorrhea B-DISEASE
2 O
year O
prior O
see O
right O
hemiparesis B-DISEASE
develop O
6 O
month O
aggravate O
symptom O
droop O
corner O
right O
lip O
bilateral O
temporal O
hemianopia B-DISEASE
finally O
prompt O
hospitalization O
time O
massive O
5 O
cm O
tumor B-SYMPTOMS
intra O
suprasellar O
location O
exclude O
mesencephalon O
backward O
see O
computerized O
tomography O
ct O
head O
fig1a O
testing O
reveal O
exceedingly O
highserum O
level O
prolactin O
prl O
4408 O
ngml O
level O
pituitary O
hormone O
reference O
range O
growth O
hormone O
gh O
050 O
ngml O
luteinize O
hormone O
lh O
260 O
miuml O
folliclestimulating O
hormone O
fsh O
457 O
miuml O
adrenocorticotropic O
hormone O
acth O
374 O
pgml O
thyroidstimulate O
hormone O
tsh O
268 O
iuml O
t1weighte O
magnetic O
resonance O
mr O
image O
contrast O
gadolinium O
show O
homogeneous O
tumor O
enhancement O
adjacent O
tissue O
edematous B-SYMPTOMS
t2weighte O
view O
mass B-SYMPTOMS
regress B-SYMPTOMS
despite O
4week O
course O
dopamine O
analog O
cabergoline O
1 O
mgweek O
serum O
prl O
level O
2207 O
ngml O
remain O
elevated O
relative O
status O
admission O
right O
lateral O
ventricle O
enlarge O
somewhat O
obstruction B-SYMPTOMS
foraman O
monro O
fig1b O
light O
intransigence O
surgical O
debulking O
tumor O
elect O
craniotomy O
transsphenoidal O
approach O
harden O
elastic O
quality O
tumor O
strong O
attachment O
neighboring O
structure O
prevent O
complete O
removal O
related O
mass B-SYMPTOMS
effect I-SYMPTOMS
significantly O
reduce O
serum O
prl O
level O
decline O
250 O
ngml O
step O
procedural O
stage O
normalization O
prl O
level O
achieve O
administration O
cabergoline O
increase O
05 O
mgday O
residual O
tumor O
show O
evidence O
regrowth B-SYMPTOMS
distant O
metastasis B-SYMPTOMS
1 O
year O
surgery O
histopathologically O
hematoxylin O
eosin O
hestaine O
section O
specimen O
second O
surgical O
procedure O
similarly O
compose O
polygonal O
spindle O
cell O
round O
oval O
elongate O
nucleus O
eosinophilic O
cytoplasm O
fig2ac O
cell O
form O
irregular O
nest O
short O
fascicle O
accompany O
frequent O
hyaline O
change O
vessel O
wall O
vacuolation O
fig2d O
nuclear B-SYMPTOMS
pleomorphism I-SYMPTOMS
prominent O
hand O
high B-SYMPTOMS
mitotic I-SYMPTOMS
rate I-SYMPTOMS
necrosis B-SYMPTOMS
evident O
fig2b O
c O
conspicuous O
fibrous B-SYMPTOMS
change I-SYMPTOMS
tumor O
stroma O
note O
focally O
fig3a O
chromophobic O
nature O
tumor O
cell O
confirm O
pearse O
periodic O
acid O
schiff O
pas O
stain O
fig3b O
immunostain O
show O
strong O
diffuse O
positivity O
prl O
fig3c O
chromogranina O
synaptophysin O
hormone O
gh O
tsh O
acth O
lh O
fsh O
express O
tumor O
cell O
marker O
include O
s100 O
protein O
fig3d O
glial O
fibrillary O
acidic O
protein O
gfap O
epithelial O
membrane O
antigen O
ema O
cytokeratin O
ae1ae3 O
ck O
ae1ae3 O
vimentin O
p53 O
bcl2 O
negative O
immunostaine O
ki67 O
labeling O
index O
approximately O
2 O
   O
final O
diagnosis O
prlproduce O
pituitary B-DISEASE
adenoma I-DISEASE
reach O
consider O
immunohistochemical O
profile O
suprasellar O
location O
prolactin O
production O
tumor O
absence O
metastatic O
foci O
invasion O
surround O
tissue O

62yearold O
male B-SEX
present O
15day O
history O
dyspnea B-SYMPTOMS
exertion O
associate O
low O
extremity O
edema B-SYMPTOMS
admission O
suffer O
abdominal O
bloating B-SYMPTOMS
tasteless B-SYMPTOMS
year O
noticeable O
body O
weight B-SYMPTOMS
loss I-SYMPTOMS
time O
20 O
kg O
past O
6 O
month O
develop O
multiple B-DISEASE
system I-DISEASE
disorder I-DISEASE
include O
painless O
paresthesia O
low O
limb O
erectile B-DISEASE
dysfunction I-DISEASE
chronic B-DISEASE
diarrhea I-DISEASE
average O
stool O
frequency O
time O
day O
obvious O
blood O
mucus O
abdominal O
pain B-SYMPTOMS
tenesmus B-SYMPTOMS
unfortunately O
previous O
stomach O
rectum O
biopsy O
examine O
accumulation O
amyloid O
fibril O
protein O
family O
history O
unremarkable O
physical O
examination O
blood O
pressure O
8256 O
mmhg O
heart O
rate O
52 O
bpm O
significant O
jugular O
venous O
distention B-SYMPTOMS
moderate O
hepatomegaly B-SYMPTOMS
low O
extremity O
edema O
note O
neurological O
examination O
reveal O
weakness B-SYMPTOMS
muscular O
atrophy B-SYMPTOMS
bilateral O
tibialis O
anterior O
gastrocnemius O
hyporeflexia B-SYMPTOMS
note O
knee O
ankle O
sensory O
examination O
reveal O
diminish O
tactile O
pain O
sensation O
stocking O
glove O
pattern O
vibratory O
sensation O
distally O
reduce O
low O
limb O
motor O
sensory O
function O
upper O
extremity O
relatively O
spare O
initial O
laboratory O
datum O
include O
blood O
count O
transaminase O
creatinine O
electrolyte O
cardiac O
troponin O
thyroid O
function O
normal O
negative O
nterminal O
fragment O
probrain O
natriuretic O
peptide O
ntprobnp O
3996 O
pgml O
nerve O
conduction O
study O
confirm O
bilateral O
sensorymotor O
neuropathy O
table O
1 O
electromyography O
study O
demonstrate O
active O
denervation B-SYMPTOMS
chronic O
reinnervation O
change O
tibialis O
anterior O
gastrocnemius O
electrocardiogram O
ecg O
reveal O
sinus O
rhythm O
low O
voltage O
limb O
lead O
qs O
wave O
precordial O
inferior O
lead O
firstdegree O
atrioventricular B-SYMPTOMS
block I-SYMPTOMS
prolong O
qtc O
figure O
1 O
twodimensional O
echocardiography O
reveal O
mark O
concentrically O
thicken O
speckle O
appearance O
ventricular O
wall O
biatrial O
dilatation B-SYMPTOMS
leave O
ventricular O
ejection O
fraction O
70 O
figure O
2 O
doppler O
reveal O
severe O
restrictive B-SYMPTOMS
mitral I-SYMPTOMS
filling I-SYMPTOMS
pattern I-SYMPTOMS
ea O
ratio O
21 O
coronary O
angiography O
finding O
normal O
combine O
occurrence O
low O
qrs O
voltage O
ecg O
ventricular O
thickening B-SYMPTOMS
sign O
diastolic B-SYMPTOMS
dysfunction I-SYMPTOMS
strongly O
suggestive O
cardiac O
amyloidosis B-DISEASE
follow O
serum O
   O
lightchain O
concentration O
1763 O
normal O
range O
5981329 O
mgdl O
   O
lightchain O
concentration O
normal O
rectum O
biopsy O
confirm O
amyloid O
infiltrate B-SYMPTOMS
figure O
3 O
diagnosis O
al B-DISEASE
amyloidosis I-DISEASE
establish O
despite O
chemotherapy O
administration O
melphalan O
dexamethasone O
immunomodulator O
lenalidomide O
supportive O
therapy O
include O
montmorillonite O
decrease O
diarrhea O
lowdose O
furosemide O
alleviate O
fluid B-SYMPTOMS
retention I-SYMPTOMS
patient O
continue O
deteriorate B-SYMPTOMS
die O
home O
3 O
month O
initial O
diagnosis O

56yearold O
man B-SEX
present O
2year O
history O
dysphagia B-SYMPTOMS
diagnose O
middle O
thoracic O
oesophageal O
squamous B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
gastroscopy O
biopsy O
chest O
compute O
tomography O
ct O
scan O
show O
enlarged B-SYMPTOMS
azygos O
vein O
diameter O
25 O
cm O
continuation B-SYMPTOMS
ivc O
fig1a O
b O
ct O
scan O
abdoman O
show O
defect B-SYMPTOMS
suprarenal O
segment O
inferior O
vena O
cava O
direct O
drainage B-SYMPTOMS
hepatic O
vein O
right O
atrium O
consultation O
thoracic O
surgery O
department O
clinician O
anaesthesiology O
department O
decide O
perform O
mckeown O
oesophagectomy O
patient O
anaesthetise O
doubleluman O
tube O
undergo O
standard O
posterolateral O
thoracotomy O
traditional O
open O
surgery O
perform O
jugular O
femoral O
vein O
percutaneous O
puncture O
create O
venovenous O
bypass O
connect O
pressure O
sensor O
system O
monitor O
monitor O
display O
realtime O
pressure O
value O
jugular O
vein O
femoral O
vein O
macroscopically O
diameter O
azygo O
arch O
approximately O
25 O
cm O
fig1c O
superior O
edge O
tumour B-SYMPTOMS
adhere O
tightly O
arch O
azygos O
vein O
arch O
azygo O
vein O
pull O
rubber O
hose O
dissociate O
carcinoma O
monitor O
show O
femoral O
vein O
pressure O
increase O
52 O
mmh2o O
pressure O
return O
normal O
value O
open O
bypass O
femoral O
vein O
jugular O
vein O
fig2 O
surgery O
perform O
smoothly O
injury B-DISEASE
azygo O
vein O
postoperative O
recovery O
uneventful O
pathology O
resect O
speciman O
show O
poorly O
differentiate O
squamous O
cell O
carcinoma O
evidence O
malignancy B-SYMPTOMS
15 O
lymph O
node O
5 O
month O
followup O
patient O
asymptomatic B-SYMPTOMS
evidence O
recurrent B-DISEASE
disease I-DISEASE
clinically O
ct O

55yearold O
woman B-SEX
refer O
hospital O
suspicion O
mediastinal O
tumor B-SYMPTOMS
incidentally O
find O
medicalcheckup O
plain O
xray O
photography O
xp O
figure O
figure1a1a O
chest O
mri O
reveal O
3 O
cm O
diameter O
tumor O
connect O
right O
lobe O
thyroid O
project O
mediastinum O
figure O
1b O
123iri O
unusual O
accumulation O
detect O
figure O
1c O
fine O
needle O
aspiration O
biopsy O
view O
gold O
standard O
diagnosis O
case O
try O
reach O
conclusive O
diagnosis O
18ffdgpet O
perform O
high O
accumulation O
reveal O
standardized O
uptake O
value O
suv O
38 O
figure O
1d O
possibility O
malignancy B-DISEASE
exclude O
right O
lobe O
excision O
procedure O
thyroid O
gland O
enforce O
obtain O
tumor O
continuous O
right O
lobe O
expect O
surface O
flat O
smooth O
exfoliation O
circumference O
organization O
easy O
figure O
2a O
microscopically O
encapsulate O
tumor O
consist O
atypical B-SYMPTOMS
largesize O
follicle O
malignant O
characteristic O
background O
thyroid O
tissue O
show O
remarkable O
change B-SYMPTOMS
figure O
2b O
histological O
diagnosis O
follicular B-DISEASE
thyroid I-DISEASE
adenoma I-DISEASE
ethical O
approval O
think O
necessary O
clinical O
course O
case O
completely O
usual O
medical O
care O
informed O
consent O
give O
case O
occasion O
diagnostic O
examination O
therapeutic O
procedure O

65year O
old O
female B-SEX
admit O
progressive O
dysphagia B-SYMPTOMS
2 O
month O
5 O
kg O
weight B-SYMPTOMS
loss I-SYMPTOMS
past O
medical O
history O
significant O
osteoporosis B-DISEASE
treat O
calcium O
lactate O
tablet O
daily O
5 O
year O
upper O
gastrointestinal O
endoscopy O
describe O
4 O
cm O
whitish O
firm O
mass B-SYMPTOMS
middle O
esophagus O
fig1 O
semicircumferential O
deep O
ulcer B-SYMPTOMS
irregular O
border O
opposite O
mucosa O
fig2 O
endoscopy O
pedicle B-SYMPTOMS
identify O
handle O
polipectomy O
snare O
esophageal O
mass O
upper O
gastrointestinal O
series O
gastrografin O
fig3 O
reveal O
ovoid O
lacunar O
image B-SYMPTOMS
distal O
esophagus O
esophageal O
inhomogeneous O
calcification B-SYMPTOMS
smooth O
contour O
peristalsis O
image O
mobile O
pedicle O
identify O
esophageal O
luman O
enlarge O
diverticula B-SYMPTOMS
development O
posterior O
wall O
computer O
tomography O
thorax O
exclude O
pedunculated O
tumor B-SYMPTOMS
describe O
intraluminal O
calcify O
esophageal O
mass O
fig4 O
biopsy O
obtain O
esophageal O
ulcerated B-SYMPTOMS
mucosa O
reveal O
inflammatory O
cell O
malignancy B-SYMPTOMS
base O
endoscopic O
imagistic O
result O
bezoar B-SYMPTOMS
suppose O
develop O
esophageal O
diverticula O
subsequently O
ulcerated O
mucosa O
esophageal O
mass O
remove O
endoscopic O
snare O
piece O
fragmentation O
physically O
possible O
macroscopic O
appearance O
reveal O
4 O
cm O
globular O
mass O
heterogeneous O
dense O
whitish O
place O
harsh O
yellow O
foci O
likely O
dystrophic O
calcification O
macroscopic O
examination O
cross O
section O
reveal O
light O
gray O
aspect B-SYMPTOMS
fibrous O
appearance O
include O
multiple O
harsh O
yelloworange O
structure O
difficult O
section O
fig5 O
mass O
immerse O
trichloracetic O
acid O
decalcification O
microscopic O
examination O
reveal O
hyaline B-SYMPTOMS
fibrous I-SYMPTOMS
tissue I-SYMPTOMS
fig6a O
stain O
green O
tricrom O
mason O
fig6b O
numerous O
crystalline O
basophil O
deposit O
mineral O
rare O
fibrocyte O
vessel O
presence O
capillary O
structure O
rare O
fibroblast O
collagen O
fiber O
bring O
discussion O
mesenchymal O
originate O
mass O
likely O
fibrovascular B-DISEASE
polyp I-DISEASE
definitive O
histological O
diagnosis O
possible O
pedicle O
identify O
presence O
connective O
tissue O
suggest O
previous O
presence O
pedicle O
lesion O
long O
term O
calcium O
tablet O
intake O
explain O
calcification O
process O
develop O
vascularconnective O
tissue O
reveal O
histology O
numerous O
crystalline O
basophil O
deposit O
mineral O
month O
later O
patient O
asymptomatic B-SYMPTOMS
endoscopy O
reveal O
enlarged B-SYMPTOMS
esophagus O
appearance O
esophageal O
mucosa O
normal O
ulceration O
diverticula O
identify O
motility O
disturbance O
find O
esophageal O
manometry O
base O
clinical O
course O
history O
calcium O
lactate O
intake O
histological O
appearance O
diagnosis O
esophageal O
benign O
mesenchymal O
originate O
mass O
probably O
fibrovascular O
polyp O
autoamputate O
calcify O
formulate O

58yearold O
man B-SEX
past O
medical O
history O
poorly O
control O
hypertension B-DISEASE
type O
2 O
diabete O
present O
icu O
cardiogenic B-DISEASE
shock I-DISEASE
complicate O
acute O
myocardial B-DISEASE
infarction I-DISEASE
physical O
examination O
reveal O
reduce O
level O
consciousness O
glasgow O
coma O
scale O
1015 O
weak O
vital O
sign O
blood O
pressure O
8050 O
mmhg O
80 O
oxygen O
saturation O
capillary O
blood O
glucose O
226 O
gl O
heart O
rate O
125 O
bpm O
crackling B-SYMPTOMS
pulmonary O
auscultation O
cardiovascular O
examination O
show O
cardiac B-SYMPTOMS
murmur I-SYMPTOMS
sign O
right O
heart O
failure O
ecg O
admission O
show O
normal O
sinus O
rhythm O
heart O
rate O
125 O
bpm O
extended O
stelevation O
anterior O
territory O
laboratory O
result O
demonstrate O
troponin O
level O
641 O
ngml O
creatinine O
kinase O
ckmb O
67 O
uil O
lactate O
deshydrogenase O
281 O
uil O
glucose O
level O
270 O
gl O
urea O
040 O
gl O
creatinine O
186 O
mg O
   O
l O
patient O
intubate O
sedated O
inotropic O
agent O
start O
norepinephrine O
04gkgmin O
dobutamine O
20gkgmin O
chest O
xray O
show O
diffuse O
alveolar B-DISEASE
syndrome I-DISEASE
transthoracic O
echocardiography O
reveal O
wall O
motion O
abnormality O
extensive O
akinesis B-SYMPTOMS
anteroseptal O
anterior O
lateral O
inferior O
wall O
severe O
left B-SYMPTOMS
ventricular I-SYMPTOMS
systolic I-SYMPTOMS
dysfunction I-SYMPTOMS
ejection O
fraction O
29 O
medical O
management O
initiate O
anticoagulant O
therapy O
acute B-DISEASE
coronary I-DISEASE
syndrome I-DISEASE
start O
500 O
mg O
acetylsalicylic O
acid O
subcutaneous O
lowmolecularweight O
heparin O
06ml O
enoxaparin O
patient O
prepare O
myocardial O
revascularization O
coronary O
angioplasty O
nonimprovement O
neurological O
status O
occurrence O
seizure O
brain O
ct O
indicate O
reveal O
infratentorial O
diffuse O
hemorrhage B-SYMPTOMS
fisher O
grade O
iii O
figure O
1 O
cerebral O
angiography O
confirm O
dissecting B-DISEASE
aneurysm B-DISEASE
anastomotic O
branch O
leave O
pica O
v4 O
segment O
leave O
vertebral O
artery O
figure O
2 O
successfully O
embolize O
24 O
hour O
patient O
improve O
withdrawal O
vasoactive O
drug O
24 O
hour O
leave O
hemicorporeal O
seizure O
persist O
despite O
anticonvulsant O
treatment O
control O
brain O
ct O
report O
rebleeding B-SYMPTOMS
angiography O
show O
complete O
exclusion O
aneurysm O
eeg O
reveal O
diffuse O
brain B-DISEASE
damage I-DISEASE
10 O
day O
admission O
patient O
discharge O
stable O
condition O
suffer O
amnesia B-DISEASE

53yearold O
male B-SEX
patient O
go O
hospital O
chief O
complaint O
massive O
gum O
bleed O
1 O
day O
patient O
history O
chronic O
hepatitis B-DISEASE
c I-DISEASE
pegifn2a O
180 O
g O
plus O
ribavirin O
1200 O
mgday O
prescribe O
patient O
march O
17 O
2014 O
deny O
autoimmune O
condition O
treatment O
baseline O
virological O
datum O
reveal O
high O
virus O
load O
hcv O
rna O
21 O
   O
106 O
iuml O
genotype O
1b O
rapid O
virological B-SYMPTOMS
response I-SYMPTOMS
achieve O
fourth O
week O
hcv O
rna O
212 O
   O
106 O
iuml O
partial O
early O
virological O
response O
hcv O
rna O
103 O
iuml O
week O
12 O
delay O
virological O
response O
hcv O
rna O
15 O
iuml O
week O
24 O
note O
fatigue B-SYMPTOMS
anemia B-SYMPTOMS
depression B-SYMPTOMS
syndrome I-SYMPTOMS
progress O
30th O
week O
patient O
request O
stop O
treatment O
week O
36 O
viral O
load O
endoftreatment O
eot O
undetectable O
platelet O
count O
eot O
92 O
   O
103 O
cellsl O
elevate O
159 O
   O
103 O
cellsl O
1 O
week O
later O
week O
follow O
eot O
patient O
develop O
massive O
gum O
bleed O
physical O
examination O
show O
multiple O
petechia O
extremity O
sign O
intracerebral O
hemorrhage B-SYMPTOMS
gastrointestinal O
bleeding B-SYMPTOMS
internal O
bleeding O
initial O
platelet O
count O
4 O
   O
103cellsl O
coagulation O
profile O
show O
normal O
prothrombin O
time O
activate O
partial O
thromboplastin O
time O
fibrinogen O
ddimer O
fibrin O
degradation O
product O
peripheral O
blood O
smear O
show O
fragmented O
red O
blood O
cell O
helmet O
cell O
abnormal B-SYMPTOMS
platelet I-SYMPTOMS
aggregation I-SYMPTOMS
concomitant O
autoimmune O
connective O
tissue O
disease O
systemic B-DISEASE
lupus I-DISEASE
erythematosus I-DISEASE
cryoglobulinemia B-DISEASE
exclude O
negative O
antinuclear O
antibody O
cryoglobulin O
positive O
anticardiolipin O
igg O
116 O
gpl O
normal O
range O
20 O
gpl O
antiphospholipid O
igg O
165 O
u O
normal O
range O
15 O
u O
antiphospholipid O
syndrome O
exclude O
previous O
thromboembolic O
event O
accord O
2006 O
sapporo O
criteria12 O
bone O
marrow O
biopsy O
perform O
reveal O
hypocellular B-SYMPTOMS
marrow O
cellular O
distribution O
evidence O
lymphoid B-DISEASE
neoplasia I-DISEASE
potential O
drug O
cause O
platelet O
lysis O
rule O
blood O
transfusion O
platelet O
perform O
poor O
response O
rapid O
decline O
platelet O
count O
day O
transfusion O
diagnosis O
immune B-DISEASE
thrombocytopenic I-DISEASE
purpura I-DISEASE
start O
intravenous O
methylprednisolone O
therapy O
40 O
mg O
3 O
time O
daily O
november O
27 O
combine O
platelet O
transfusion O
treatment O
show O
significant O
improvement B-SYMPTOMS
azathioprine O
100 O
mg O
oral O
daily O
add O
december O
3 O
hydroxychloroquine O
400 O
mg O
oral O
daily O
prescribe O
positive O
antiphospholipid O
antibodie O
platelet O
count O
gradually O
increase O
93 O
   O
103 O
cellsl O
17 O
day O
admission O
methylprednisolone O
change O
oral O
form O
slowly O
taper O
december O
15 O
patient O
discharge O
stable B-SYMPTOMS
condition I-SYMPTOMS
platelet O
count O
elevate O
117 O
   O
103 O
cellsl O
figure O
1 O
follow O
laboratory O
datum O
5 O
month O
reveal O
sustained O
virologic B-SYMPTOMS
response I-SYMPTOMS
platelet O
count O
150 O
   O
103 O
cellsl O
decrease O
anticardiolipin O
igg O
305gpl O
antiphospholipid O
igg O
7321 O
u O
level O

66 B-AGE
year I-AGE
old I-AGE
patient O
history O
uc O
treat O
mesalazine O
5 O
year O
consult O
july O
2012 O
painful O
erythematous O
swelling B-SYMPTOMS
right O
hand O
bacteriological O
sample O
negative O
lesion O
consider O
abscess O
patient O
treat O
antibiotic O
local O
antiseptic O
improvement B-SYMPTOMS
evolution O
characterize O
appearance O
erythematous O
vesiculobullous O
centrifugal B-SYMPTOMS
expansion I-SYMPTOMS
take O
right O
hand O
treat O
time O
antibiotic O
unsuccessfully O
biopsy O
lesion O
initially O
specific O
october O
2012 O
patient O
hospitalize O
fever B-SYMPTOMS
polyarthralgia B-SYMPTOMS
context O
impaired B-SYMPTOMS
general I-SYMPTOMS
condition I-SYMPTOMS
quiescent O
uc B-DISEASE
disease I-DISEASE
skin O
examination O
find O
erythematous O
plaque B-SYMPTOMS
10 O
cm O
diameter O
raise O
border O
vesicule O
take O
right O
hand O
wrist O
figure O
1 O
infiltrate O
erythematous O
plaque O
right O
leg O
figure O
2 O
top O
large O
pustule O
left O
ankle O
figure O
3 O
biology O
biological B-DISEASE
inflammatory I-DISEASE
syndrome I-DISEASE
high O
leukocytosis B-SYMPTOMS
neutrophil O
hepatic O
renal O
function O
normal O
skin O
biopsy O
show O
edge O
closet O
right O
hand O
ulcerated B-SYMPTOMS
epidermis I-SYMPTOMS
dermis O
infiltrate O
rich O
neutrophil O
leukocytoclastic O
vasculitis B-SYMPTOMS
find O
pg B-DISEASE
figure O
4 O
biopsy O
take O
infiltrate O
erythematous O
plaque O
ankle O
show O
normal O
appearance O
skin O
edema B-SYMPTOMS
superficial O
dermis O
base O
infiltrate O
rich O
neutrophil O
vasculitis O
confirm O
diagnosis O
ss B-DISEASE
figure O
5 O
corticosteroid O
treatment O
start O
prednisolone O
dose O
1mgkgj O
evolution O
mark O
day O
7 O
treatment O
desinfiltration O
plaque O
figure O
6 O
recovery O
general O
condition O
disappearance O
biological O
inflammatory O
syndrome O

35yearold O
woman B-SEX
admit O
5day O
history O
increase O
drowsiness B-SYMPTOMS
fatigue B-SYMPTOMS
personality O
change O
generalised O
weakness B-SYMPTOMS
deteriorate O
mobility O
medical O
history O
include O
10year O
history O
schizoaffective O
disorder O
lithiuminduce O
diabetes B-DISEASE
insipidus I-DISEASE
hypothyroidism B-DISEASE
medication O
include O
sodium O
valproate O
1 O
g O
twice O
daily O
carbamazepine O
quetiapine O
lithium O
admission O
patient O
drowsy B-SYMPTOMS
difficult O
rouse O
sleep O
night O
afternoon O
glasgow O
coma O
scale O
gcs O
1415 O
abbreviate O
minimental O
test O
score O
610 O
note O
slow O
response O
neurological O
examination O
show O
reduce O
power O
low O
limb O
345 O
pyramidal O
distribution O
brisk O
reflex O
intact O
sensation O
modality O
cardiovascular O
respiratory O
gastrointestinal O
examination O
unremarkable O
demonstrable O
feature O
hepatic B-DISEASE
disease I-DISEASE
routine O
biochemistry O
unremarkable O
patient O
alanine O
transaminase O
7 O
ul O
115 O
alkaline O
phosphatase O
61 O
ul O
30130 O
glutamyl O
transferase O
17 O
ul O
45 O
bilirubin O
6 O
moll O
21 O
normal O
serum O
b12 O
folate O
level O
normal O
thyroid O
function O
test O
serum O
lithium O
level O
therapeutic O
range O
serum O
ammonia O
47 O
moll O
112354 O
valproate O
concentration O
elevate O
140 O
mgl O
50100 O
brain O
imaging O
include O
ct O
mri O
haemorrhage B-SYMPTOMS
intracranial O
mass B-SYMPTOMS
lumbar O
puncture O
demonstrate O
clear O
cerebrospinal O
fluid O
white O
cell O
count O
1106l O
protein O
025 O
gl O
0204 O
eeg O
demonstrate O
mild O
variable O
slowing B-SYMPTOMS
irregularity O
background O
activity O
likely O
medication O
differential O
diagnosis O
include O
encephalitis B-DISEASE
guillainbarr O
syndrome O
acute O
disseminate O
encephalomyelitis O
adem B-DISEASE
exclude O
investigation O
view O
raise O
valproate O
ammonia O
level O
diagnosis O
valproate B-DISEASE
hyperammonaemic I-DISEASE
encephalopathy I-DISEASE
vhe B-DISEASE
point O
dose O
sodium O
valproate O
reduce O
half O
completely O
withdraw O
complex O
challenging O
nature O
manage O
patient O
schizoaffective O
disorder O
3 O
day O
evident O
clinical O
improvement O
mental O
status O
patient O
able O
sit O
communicate O
team O
abbreviate O
mental O
test O
score O
improve O
1010the O
serum O
ammonia O
normalise O
valproate O
level O
decrease O
therapeutic O
range O
4 O
day O
discharge O
home O
result O
investigation O
urea O
cycle O
await O
week O
postdischarge O
patient O
clinically O
stable O
term O
mental O
functioning O
having O
episode O
confusion B-SYMPTOMS
drowsiness O
continue O
fatigue O
walk O
difficulty O
residual O
leg O
weakness O
result O
serum O
amino O
acid O
reveal O
patient O
carnitine B-DISEASE
deficiency I-DISEASE
evident O
low O
acylcarnitine O
low O
free O
serum O
carnitine O
142 O
moll O
normal O
range O
2352 O
low O
total O
serum O
carnitine O
199 O
moll O
normal O
range O
2763 O
start O
oral O
carnitine O
1 O
g O
twice O
daily O
2 O
week O
symptom O
resolve O
completely O
normalisation O
serum O
carnitine O
level O
free O
carnitine O
252 O
moll O
total O
carnitine O
413 O
moll O
sodium O
valproate O
initially O
stop O
completely O
relapse O
patient O
schizoaffective O
disorder O
restart O
valproate O
1 O
g O
daily O
longterm O
carnitine O
supplement O

50yearold O
male B-SEX
patient O
admit O
department O
thyroid O
nodule B-SYMPTOMS
right O
neck O
incidentally O
detect O
carotid O
doppler O
ultrasound O
scan O
fineneedle O
aspiration O
cytology O
fnac O
show O
follicular O
lesion B-SYMPTOMS
time O
evaluation O
patient O
good O
health O
medical O
history O
reveal O
hypertension B-SYMPTOMS
vitiligo B-DISEASE
celiac B-DISEASE
disease B-DISEASE
physical O
examination O
small O
nodule O
1 O
cm O
palpable B-SYMPTOMS
right O
thyroid O
lobe O
enlarged B-SYMPTOMS
neck O
lymph O
node O
palpable O
neck O
ultrasound O
show O
13 O
cm O
hypoechoic O
nodule O
irregular O
margin O
right O
thyroid O
lobe O
bilateral O
small O
thyroid O
nodule O
45 O
mm O
absence O
enlarged O
cervical O
bilateral O
lymph O
nodes O
thyroid O
function O
test O
normal O
absence O
thyroid O
autoantibody O
serum O
calcium O
normal O
97 O
mgdl O
normal O
range O
84104 O
mgdl O
pth O
routinely O
measure O
serum O
calcium O
center O
patient O
undergo O
thyroid O
surgery O
slightly O
elevate O
68 O
pgml O
intact O
pth O
2nd O
generation O
assay O
normal O
range O
1065 O
pgml O
rereview O
original O
slide O
fnac O
confirm O
follicular O
lesion O
particular O
cytology O
nodule O
show O
epithelial O
cell O
hyperchromatic O
nucleus O
organize O
small O
cohesive O
cluster O
resemble O
microfollicle O
typically O
observe O
thyroid O
follicular O
lesion O
evident O
fig1a O
patient O
undergo O
right O
lobectomy O
neck O
exploration O
macroscopic O
sign O
local O
invasion B-SYMPTOMS
intraoperative O
frozensection O
pathological O
examination O
raise O
suspicion O
pc B-DISEASE
definitive O
histology O
show O
markedly O
irregular O
infiltrative B-SYMPTOMS
growth I-SYMPTOMS
tumor B-SYMPTOMS
invasion O
thyroid O
tissue O
cervical O
soft O
tissue O
fig1b O
c O
immunostaine O
thyroglobulin O
negative O
stain O
chromogranin O
pth O
show O
strong O
reactivity O
fig1df O
base O
light O
microscopic O
finding O
immunohistochemical O
profile O
tumor O
diagnose O
pc O
postoperative O
serum O
calcium O
87 O
mgdl O
phosphate O
3 O
mgdl O
level O
normal O
range O
month O
surgery O
serum O
calcium O
plasma O
pth O
96 O
mgdl O
47 O
pgml O
respectively O
neck O
ultrasound O
total O
body O
compute O
tomography O
scan O
negative O
local O
metastatic O
disease O
month O
later O
serum O
calcium O
plasma O
pth O
level O
9192 O
mgdl O
3844 O
pgml O
184 O
pth O
3rd O
generation O
assay O
normal O
range O
840 O
pgml O
respectively O
neck O
ultrasound O
pathological O
lesion O
order O
exclude O
familiar O
form O
phpt B-DISEASE
pc O
rarely O
occur O
nonfunctione O
tumor O
11 O
screening O
serum O
calcium O
neck O
ultrasound O
firstdegree O
relative O
normal O

60yearold O
male B-SEX
visit O
outpatient O
clinic O
mass B-SYMPTOMS
left O
hip O
diabete O
alcoholic B-DISEASE
hepatitis I-DISEASE
physical O
examination O
large O
mass O
measure O
10 O
cm O
diameter O
observe O
hip O
approximate O
5 O
cm O
leave O
inguinal O
lymph O
node O
palpable B-SYMPTOMS
figure O
1 O
serum O
tumor B-SYMPTOMS
marker O
include O
cea O
199 O
normal O
limit O
serum O
amylase O
227 O
iul O
normal O
range O
43116 O
iul O
lipase O
378 O
iul O
normal O
range O
760 O
fast O
blood O
sugar O
144 O
mgdl O
normal O
range O
70100 O
mgdl O
liver O
function O
test O
level O
include O
aspartate O
aminotransferase O
178 O
iul O
normal O
range O
738 O
iul O
alanine O
aminotransferase O
225 O
iul O
normal O
range O
443 O
iul O
serum O
alkaline O
phosphatase O
370 O
iul O
normal O
range O
103335 O
iul O
normal O
range O
abdominal O
computerized O
tomography O
ct O
scan O
demonstrate O
left O
hip O
mass O
enlarged B-SYMPTOMS
leave O
inguinal O
lymph O
node O
huge O
heterogeneous O
enhance O
mass O
body O
pancreas O
figure O
2 O
pet O
scan O
additional O
metastasis O
find O
plan O
stage O
surgery O
perform O
hip O
inguinal O
mass O
excision O
december O
19 O
2014 O
histopathological O
report O
reveal O
metastatic O
small O
cell O
neuroendocrine B-DISEASE
carcinoma I-DISEASE
maximal O
diameter O
105 O
cm O
buttock O
mass O
7 O
cm O
growth B-SYMPTOMS
inguinal O
lymph O
node O
mitotic O
index O
50 O
mitose O
50 O
hpf O
ki67 O
index O
measure O
50 O
january O
21 O
2015 O
perform O
total O
pancreatectomy O
total O
gastrectomy O
finding O
reveal O
tumor O
body O
pancrea O
9 O
cm O
   O
6 O
cm O
diameter O
involve O
left O
gastric O
artery O
splenic O
artery O
splenic O
vein O
histopathological O
report O
metastatic O
lesion B-SYMPTOMS
additionally O
tumor O
spread O
8 O
32 O
lymph O
node O
figure O
3 O
7th O
postoperative O
day O
patient O
develop O
high O
fever B-SYMPTOMS
leukocytosis B-SYMPTOMS
administer O
abdominal O
ct O
scan O
reveal O
infected O
fluid B-SYMPTOMS
collection I-SYMPTOMS
less O
sac O
47 O
cmsize O
recur O
mass O
detect O
operative O
bed O
left O
hip O
figure O
figure44 O
infection B-DISEASE
abdominal O
cavity O
treat O
antibiotic O
remove O
left O
hip O
recur O
mass O
february O
3 O
2015 O
histopathology O
previous O
report O
maximum O
diameter O
75 O
cm O
patient O
discharge O
complication O
february O
9 O
2015 O
currently O
receive O
chemotherapy O
base O
etoposide O
cisplatin O
treatment O

68yearold O
female B-SEX
nonsmoker O
nondrinker O
medical O
history O
hypertension B-DISEASE
present O
newonset O
painless O
jaundice B-SYMPTOMS
pruritus B-SYMPTOMS
threemonth O
history O
99 O
kg O
weight B-SYMPTOMS
loss I-SYMPTOMS
chronic O
diarrhea B-SYMPTOMS
loose O
bowel O
movement O
day O
medication O
include O
vitamin O
d O
amlodipine O
eprosartan O
physical O
examination O
normal O
jaundice O
muscle O
waste O
recent O
colonoscopy O
normal O
total O
direct O
bilirubin O
level O
684 O
mgdl O
11696 O
moll O
918 O
mgdl O
15698 O
moll O
respectively O
result O
include O
international O
normalize O
ratio O
10 O
alanine O
aminotransferase O
level O
247 O
ul O
normal O
33 O
ul O
aspartate O
aminotransferase O
level O
139 O
ul O
normal O
32 O
ul O
alkaline O
phosphatase O
level O
524 O
ul O
normal O
35 O
104 O
ul O
viral O
hepatitis O
serology O
antimitochondrial O
antibody O
antismooth O
muscle O
antibody O
test O
negative O
alphafetoprotein O
level O
24 O
ngml O
normal O
5 O
ngml O
total O
immunoglobulin O
ig O
g O
1880 O
mgdl O
normal O
640 O
mgdl O
carbohydrate O
antigen O
199 O
856 O
uml O
normal O
33 O
uml O
igg4 O
890 O
gl O
normal O
3 O
gl O
doppler O
ultrasound O
magnetic O
resonance O
cholangiopancreatography O
magnetic O
resonance O
imaging O
liver O
suspicious O
subtly O
enhance O
mass B-SYMPTOMS
28 O
cm O
42 O
cm O
diameter O
region O
hilum O
porta O
hepatis O
obstruct O
right O
leave O
hepatic O
duct O
endoscopic O
retrograde O
cholangiopancreatography O
identify O
stricture O
central O
portion O
right O
leave O
hepatic O
duct O
concern O
cholangiocarcinoma B-DISEASE
figure O
1 O
biliary O
brushing O
negative O
malignancy O
esophagogastroduodenoscopy O
normal O
biopsy O
ampulla O
vater O
reveal O
chronic O
active O
duodenitis B-DISEASE
figure O
2 O
and33 O
ancillary O
test O
confirm O
diagnosis O
figure O
4 O
treatment O
corticosteroid O
normalize O
patient O
biochemical O
radiological O
abnormality O
month O

report O
case O
previously O
healthy O
28yearold O
woman B-SEX
afrobrazilian O
pregnancy O
patient O
medical O
record O
36th O
pregnancy O
week O
report O
allergy O
diclofenac O
present O
emergency O
department O
acute O
onset O
abdominal O
pain B-SYMPTOMS
jaundice B-SYMPTOMS
nausea B-SYMPTOMS
vomit O
sign O
encephalopathy B-DISEASE
arterial O
blood O
pressure O
11060mmhg O
heart O
rate O
98bpm O
axillary O
temperature O
35c O
severely O
dehydrate O
decrease O
peripheral O
perfusion O
laboratory O
examination O
reveal O
hemoglobin O
123gdl O
leukocyte O
13 O
   O
109ml O
platelet O
97 O
   O
103mm3 O
international O
nationalize O
ratio O
inr O
69 O
fibrinogen O
98mgdl O
total O
bilirubin O
142mgdl O
serum O
creatinine O
34mgdl O
serum O
aspartate O
aminotransferase O
ast O
306ul O
serum O
alanine O
aminotransferase O
alp O
302ul O
arterial O
bicarbonate O
11meql O
arterial O
ph O
721 O
blood O
glucose O
65mgdl O
ionic O
calcium O
102mmoll O
abdominal O
ultrasound O
depict O
fatty B-SYMPTOMS
infiltration I-SYMPTOMS
liver O
confirm O
fetal O
viability O
patient O
receive O
initial O
fluid O
load O
crystalloid O
calcium O
glucose O
hypothermia B-DISEASE
reverse O
diagnosis O
aflp B-DISEASE
confirm O
follow O
swanseas O
criterion O
9 O
cesarean O
section O
indicate O
thromboelastometry O
rotem O
pentapharm O
co O
munich O
germany O
perform O
beginning O
surgery O
thromboelastometry O
analysis O
show O
intense O
kinetic O
structural O
hypocoagulable B-SYMPTOMS
state I-SYMPTOMS
fig1 O
table O
1 O
fibtem O
reveal O
impairment O
fibrinogen O
function O
quality O
extem O
depict O
coagulation B-DISEASE
factor I-DISEASE
deficiency I-DISEASE
fig1ac O
table O
1 O
base O
respectively O
fibtem O
maximum O
clot O
firmness O
mcf O
0 O
mm O
table O
1 O
extem O
clotting O
time O
ct O
228s O
table O
1 O
40 O
g O
fibrinogen O
concentrate O
haemocomplettan O
p O
csl O
behre O
marburg O
germany O
1000ui O
prothrombin O
complex O
concentrate O
beriplex O
pn O
500ui O
csl O
behring O
marburg O
germany O
administer O
beginning O
cesarean O
section O
fluid O
input O
crystalloid O
output O
caesarian O
section O
respectively O
2000ml O
200ml O
cesarean O
section O
succeed O
major O
bleeding B-SYMPTOMS
hemostatic O
therapy O
additional O
hemocomponent O
transfusion O
fresh O
frozen O
plasma O
ffp O
cryoprecipitate O
platelet O
blood O
concentrate O
necessary O
second O
thromboelastometry O
analysis O
perform O
end O
surgery O
fig1de O
table O
1 O
show O
mild O
hypocoagulation B-SYMPTOMS
state I-SYMPTOMS
patient O
admit O
intensive O
care O
unit O
icu O
remain O
stable B-SYMPTOMS
bleeding O
recovery O
phase O
discharge O
icu O
3 O
day O
admission O
3 O
day O
later O
discharge O
hospital O

woman B-SEX
age O
31 O
year O
g2p2 O
pathological O
past O
history O
good O
prenatal O
care O
normal O
prenatal O
analysis O
blood O
pressure O
followup O
normal O
admit O
elective O
caesarian O
section O
38 O
week O
amenorrhea B-SYMPTOMS
realization O
spinal O
anesthesia O
patient O
present O
peak O
hypertensive B-SYMPTOMS
180100 O
mm O
hg O
normalize O
minute O
treatment O
postpartum O
12 O
hour O
caesarian O
section O
lady O
present O
severe O
headache B-SYMPTOMS
apyrexia B-SYMPTOMS
develop O
episode O
generalized O
tonicoclonic O
convulsion B-SYMPTOMS
1st O
convulsion O
cease O
1 O
min O
measure O
resuscitation O
injection O
diazepam O
iv O
postcritical O
clinical O
examination O
find O
afebrile B-SYMPTOMS
patient O
blood O
pressure O
14090 O
mmhg O
glasgow O
coma O
scale O
14 O
neurological B-SYMPTOMS
deficit I-SYMPTOMS
neck O
rigidity B-SYMPTOMS
diuresis B-SYMPTOMS
preserve O
examination O
urine O
urinary O
strip O
positive O
     O
2nd O
3th O
convulsive B-SYMPTOMS
crisis I-SYMPTOMS
stop O
spontaneously O
second O
laboratory O
finding O
hellp B-DISEASE
syndrome I-DISEASE
include O
raise O
liver O
enzyme O
asat O
525 O
iul O
alat O
214 O
iul O
hemolysis B-SYMPTOMS
hemoglobinemia B-SYMPTOMS
7 O
mgdl O
low O
platelet O
count O
44 O
000 O
plateletml O
investigation O
include O
renal O
function O
test O
inflammatory O
marker O
thyroid O
hormone O
normal O
viral O
serology O
negative O
patient O
transfer O
intensive O
care O
unit O
treat O
immediately O
magnesium O
sulfate O
associate O
calcium O
channel O
blocker O
nicardipine O
antiepileptic O
phenobarbital O
preventive O
dose O
low O
molecular O
weight O
heparin O
anemia B-SYMPTOMS
thrombopenia B-SYMPTOMS
correct O
transfusion O
pack O
red O
blood O
cell O
platelet O
respectively O
magnetic O
resonance O
imaging O
mri O
realize O
hour O
episode O
convulsion O
show O
zone O
hyposignal O
t1 O
hypersignal O
t2 O
flair O
sequence O
interesting O
cerebral O
cortex O
parietal O
occipital O
subcortical O
white O
matter O
intracranial O
venous O
sinus O
permeable B-SYMPTOMS
diagnosis O
pre O
syndrome O
secondary O
severe O
preeclampsia B-DISEASE
immediate O
postpartum O
retain O
figure O
1 O
electroencephalogram O
eeg O
realize O
second O
day O
show O
anomaly B-SYMPTOMS
evolution O
mark O
normalization O
blood O
pressure O
normalization O
neurological O
state O
biological O
analysis O
patient O
discharge O
good O
condition O
day O
5 O
betablocker O
sodium O
valproate O
maintain O
month O
mri O
controle O
month O
later O
show O
complete O
resolution O
cerebral O
edema B-SYMPTOMS
figure O
2 O

58yearold O
man B-SEX
suffer O
general B-SYMPTOMS
fatigue I-SYMPTOMS
severe O
anemia B-SYMPTOMS
month O
hemoglobin O
level O
66 O
gdl O
normal O
range O
1216 O
gdl O
medical O
history O
medicine O
esophagogastroduodenoscopy O
colonoscopy O
reveal O
significant O
bleed O
abdominal O
computer O
tomography O
reveal O
2 O
cm O
hypervascular O
tumor B-SYMPTOMS
small O
intestine O
fig1 O
oral O
dbe O
detect O
2cmdiameter O
reddish O
submucosal O
tumorlike O
lesion B-SYMPTOMS
surface O
ulceration O
jejunum O
approximately O
20 O
cm O
away O
treitz O
ligament O
fig2 O
perform O
biopsy O
difficult O
stop O
bleed O
case O
hypervascular O
lesion O
diagnosis O
small B-DISEASE
bowel I-DISEASE
tumor I-DISEASE
gastrointestinal B-DISEASE
stromal I-DISEASE
tumor I-DISEASE
gist B-DISEASE
malignant B-DISEASE
lymphoma I-DISEASE
cancer B-DISEASE
perform O
laparoscopicassiste O
segmental O
resection O
jejunum O
dissection O
lymph O
node O
examination O
resected O
tumor O
show O
measure O
19 O
   O
16 O
mm O
diameter O
fig3 O
histology O
reveal O
proliferation O
blood O
capillary O
granulation B-SYMPTOMS
tissue I-SYMPTOMS
consistent O
pg B-DISEASE
fig4 O
patient O
discharge O
postoperative O
day O
9 O
complication B-SYMPTOMS
anemia O
improve O
gradually O
need O
oral O
iron O
surgery O

33yearold O
man B-SEX
present O
left O
flank O
dull O
ache B-SYMPTOMS
abdominal O
compute O
tomography O
solid O
renal O
mass B-SYMPTOMS
upper O
portion O
left O
kidney O
identify O
mass O
measure O
28 O
cm O
   O
28 O
cm O
   O
25 O
cm O
size O
welldefine O
patient O
abnormal O
finding O
suspect O
distant O
metastasis B-SYMPTOMS
lymph O
node O
metastasis O
radical O
nephrectomy O
perform O
1492005 O
gross O
examination O
nephrectomy O
speciman O
measure O
115 O
cm O
   O
65 O
cm O
   O
45 O
cm O
tumor O
solid O
grayishbrown O
mass O
measure O
35 O
cm O
   O
25 O
cm O
   O
22 O
cm O
size O
histologic O
examination O
demonstrate O
trabecular O
ribbonlike O
pattern O
minimal O
fibrotic O
stroma O
cytoplasm O
granular O
eosinophilic O
uniform O
round O
oval O
nucleus O
finely O
stippled O
chromatin O
inconspicuous O
nucleolus O
mitose O
find O
0 O
10 O
highpower O
field O
stain O
final O
pathologic O
examination O
reveal O
welldifferentiate O
neuroendocrine O
carcinoid B-DISEASE
tumor I-DISEASE
confine O
kidney O
fig1 O
immunohistochemical O
stain O
demonstrate O
label O
chromogranin O
neuronspecific O
enolase O
synaptophysin O
fig2 O
proliferation O
index O
2 O
   O
measure O
immunohistochemistry O
ki67 O
radiation O
chemotherapy O
receive O
year O
radical O
nephrectomy O
compute O
tomography O
abdoman O
demonstrate O
2 O
cm O
   O
18 O
cm O
cyst O
mass O
right O
liver O
multiple O
high B-SYMPTOMS
density I-SYMPTOMS
shadow I-SYMPTOMS
gallbladder O
enlarged B-SYMPTOMS
lymph O
node O
find O
abdominal O
cavity O
cholecystectomy O
extirpation O
hepatic B-DISEASE
cyst I-DISEASE
perform O
laparoscopy O
surgery O
histologic O
examination O
demonstrate O
trabecular O
glandlike O
growth O
fig3 O
moderate O
uniform O
nucleus O
mitose O
not O
find O
0 O
10 O
highpower O
field O
advanced O
immunohistochemistry O
reveal O
lesion O
positive O
synaptophysin O
fig4 O
cd56 O
negative O
chromogranin O
neuronspecific O
enolase O
feature O
support O
neuroendocrine B-DISEASE
tumor I-DISEASE
similar O
pathologic O
characteristic O
primary O
renal O
carcinoid O
tumor O
liver O
tumor O
final O
pathology O
report O
indicate O
carcinoid O
tumor O
left O
kidney O
liver O
metastasis O

patient O
9 O
yearold O
caucasian O
female B-SEX
diagnose O
medulloblastoma B-DISEASE
age O
3 O
year O
treatment O
include O
surgical O
resection O
tumor B-SYMPTOMS
follow O
systemic O
chemotherapy O
vincristine O
lomustine O
cisplatin O
carboplatin O
cyclophosphamide O
etoposide O
craniospinal O
radiation O
2340 O
cgy O
boost O
posterior O
fossa O
total O
dose O
5900 O
cgy O
cisra O
subsequently O
administer O
14day O
cycle O
180mgm2 O
day O
13month O
period O
cumulative O
dose O
17360 O
mg O
24640 O
mgm2 O
complete O
medulloblastoma O
therapy O
age O
56 O
year O
age O
6 O
year O
diagnose O
radiationinduce O
central O
hypothyroidism B-DISEASE
growth B-DISEASE
hormone I-DISEASE
deficiency I-DISEASE
ghd B-DISEASE
treat O
levothyroxine O
subsequent O
biochemical O
euthyroidism B-SYMPTOMS
give O
tumor B-SYMPTOMS
remission I-SYMPTOMS
status O
abnormal O
height O
velocity O
094 O
cmyear O
growth O
hormone O
gh O
therapy O
initiate O
age O
7 O
year O
03 O
mgkgweek O
subsequent O
increase O
height O
velocity O
36 O
cm O
growthseven O
month O
seven O
month O
initiation O
gh O
increase O
bony B-SYMPTOMS
prominence I-SYMPTOMS
note O
wrist O
knee O
concomitant O
decline O
height O
velocity O
16 O
cm O
growthfive O
month O
physical O
examination O
radiograph O
significant O
leg O
length O
discrepancy O
right O
low O
extremity O
measure O
175 O
cm O
short O
left O
right O
femur O
249 O
cm O
right O
tibia O
196 O
cm O
right O
low O
extremity O
445 O
cm O
leave O
femur O
2525 O
cm O
leave O
tibia O
21 O
cm O
leave O
low O
extremity O
4625 O
cm O
prior O
initiation O
gh O
height O
102 O
cm O
figure O
1 O
armspan O
102 O
cm O
similar O
upper O
segmentlower O
segment O
ratio O
seven O
month O
gh O
height O
increase O
minimally O
1056 O
cm O
compare O
significant O
increase O
armspan O
1092 O
cm O
upper O
segmentlower O
segment O
ratio O
remain O
radiograph O
reveal O
poorly O
visualize O
growth O
plate O
distal O
proximal O
femur O
tibia O
figure O
2ab O
raise O
concern O
premature O
closure O
physe O
low O
limb O
growth O
plate O
closure O
normally O
observe O
time O
latestage O
puberty O
contrast O
bone O
age O
left O
hand O
wrist O
radiograph O
precede O
year O
display O
open O
growth O
plate O
figure O
2cd O

73yearold O
woman B-SEX
initially O
refer O
19 O
month O
prior O
current O
presentation O
time O
fluorescein O
indocyanine O
green O
angiography O
show O
mediumsize O
subfoveal O
classic O
cnv B-DISEASE
left O
eye O
previously O
treat O
return O
treatment O
current O
presentation O
note O
decrease O
vision O
left O
eye O
bestcorrected O
visual O
acuity O
bcva O
20100 O
slit O
lamp O
examination O
show O
small O
yellowish O
patch B-SYMPTOMS
perifoveal O
region O
retinal B-SYMPTOMS
edema I-SYMPTOMS
structural O
oct O
reveal O
retinal B-SYMPTOMS
elevation I-SYMPTOMS
subretinal B-SYMPTOMS
fluid I-SYMPTOMS
hyperreflective O
elongate O
area O
rpe O
indicate O
type O
ii O
cnv O
antiangiogenic O
treatment O
intravitreal O
aflibercept O
injection O
administer O
treatandextend O
regimen O
oct O
angiograms O
fig1 O
show O
noticeable O
reduction O
cnv O
flow O
area O
12 O
day O
post O
injection O
continue O
reduction O
1 O
week O
2 O
week O
cnv O
flow O
area O
vessel O
density O
reduce O
probably O
decrease O
flow O
temporary O
closure O
small O
anastomose O
significant O
reappearance O
cnv O
noticeable O
4 O
week O
injection O
6 O
week O
second O
injection O
vascular O
pattern O
reenlarge O
cnv O
fig1a O
similar O
initial O
pretreatment O
cnv O
suggest O
recurrence O
reopen O
original O
channel O
growth O
new O
vessel O
compare O
cnv O
network O
prior O
3rd O
injection O
baseline O
notable O
few O
small O
channel O
large O
caliber O
channel O
remain O
quantitative O
measurement O
oct O
angiography O
fig2a O
show O
reduction O
cnv O
flow O
area O
flow O
index O
2 O
week O
subsequent O
return O
retinal B-SYMPTOMS
thickness I-SYMPTOMS
fig2b O
show O
fluid O
resorption O
4 O
week O
treatment O
cycle O
continue O
2 O
week O
second O
treatment O
cycle O
time O
fluid O
remain O
fig1b O
fluid O
reaccumulate O
retina O
6 O
week O
2nd O
injection O
visual O
acuity O
fig2b O
continue O
improve O
3 O
treatment O
cycle O

8yearold O
boy B-SEX
s549r17171 O
g O
   O
genotype O
start O
ivacaftor O
150 O
mg O
bid O
compassionate O
use O
age O
9 O
month O
diagnose O
cf B-DISEASE
failure O
thrive O
previous O
history O
remarkable O
recur O
nasal O
polyposis O
require O
endoscopic O
surgery O
exocrine O
pancreatic O
insufficiency O
necessitating O
enzyme O
replacement O
therapy O
grow O
body O
weight O
height O
10th O
percentile O
suffer O
mild O
respiratory O
symptom O
primarily O
intermittent O
productive O
cough B-SYMPTOMS
close O
normal O
lung O
function O
parameter O
previous O
year O
measure O
body O
plethysmography O
spirometry O
minimal O
zscore O
fev1 O
12 O
sputum O
culture O
grew O
haemophilus O
influenzae O
staphylococcus O
aureus O
occasion O
6 O
week O
ivacaftor O
treatment O
patient O
report O
clinical O
improvement O
cough O
frequency O
sputum B-SYMPTOMS
production I-SYMPTOMS
physical O
performance O
salt O
craving O
gain O
14 O
kg O
body O
weight O
change O
dose O
pancreatic O
enzyme O
replacement O
therapy O
sweat O
chloride O
level O
macroduct O
decrease O
115 O
mmoll O
ivacaftor O
40 O
mmoll O
6 O
week O
52 O
mmoll O
41 O
week O
normal O
   O
30 O
mmoll O
11 O
treatment O
fev1 O
increase O
125 O
l O
12 O
zscore O
165 O
l O
05 O
zscore O
41 O
week O
ivacaftor O
therapy O
lci O
normal O
   O
8 O
measure O
n2mbw O
decrease O
145 O
83 O
6 O
week O
78 O
41 O
week O
ivacaftor O
treatment O
table O
1 O
fig1 O

36yearold O
female B-SEX
present O
emergency O
department O
aggravate O
right O
upper O
abdominal O
pain B-SYMPTOMS
2 O
hour O
patient O
diagnose O
hepatitis O
b O
virus O
hbv O
carrier O
year O
nonalcoholic O
specific O
personal O
familial O
medical O
history O
note O
initial O
blood O
pressure O
10060 O
mmhg O
pulse O
rate O
70min O
respiration O
rate O
20min O
body O
temperature O
375 O
laboratory O
finding O
white O
blood O
cell O
12000mm3 O
poly O
70 O
hemoglobin O
128 O
gdl O
platelet O
198000mm3 O
prothrombin O
time O
143 O
second O
international O
normalize O
ratio O
111 O
aspartate O
aminotransferase O
22 O
iul O
alanine O
aminotransferase O
12 O
iul O
total O
bilirubin O
05 O
mgdl O
alkaline O
phosphatase O
134 O
iul O
lactate O
dehydrogenase O
295 O
iul O
gammaglutamyl O
transpeptidase O
26 O
iul O
proteinalbumin O
6440 O
gdl O
uric O
acid O
50 O
mgdl O
blood O
urea O
nitrogencreatinine O
16607 O
mgdl O
serum O
viral O
marker O
hbsag O
   O
antihbs O
   O
antihbc O
   O
hbeag O
   O
antihbe O
   O
hbvdna O
20 O
iuml O
antihcv O
   O
antihiv O
   O
patient O
serum O
fetoprotein O
afp O
6765 O
ngml O
carbohydrate O
antigen O
199 O
ca199 O
06 O
uml O
take O
abdominal O
ct O
scan O
show O
9 O
cm O
sized O
necrotic O
mass B-SYMPTOMS
internal O
hemorrhage O
right O
hepatic O
lobe O
rupture O
peritoneum O
fig1a O
emergency O
hepatic O
central O
bisectionectomy O
fig2a O
initial O
histological O
diagnosis O
chcccc O
spindle O
cell O
metaplasia O
cholangiocarcinoma O
element O
fig2b O
serum O
afp O
decrease O
767 O
ngml O
time O
discharge O
chcccc O
postoperative O
adjuvant O
chemotherapy O
tegafururacil O
uft O
administrate O
3 O
month O
3 O
month O
later O
followup O
abdominal O
ct O
scanning O
show O
previously O
unseen O
55 O
cm O
sized O
leave O
subphrenic O
mass O
mild O
enhancement B-SYMPTOMS
delay O
image O
fig3a O
b O
afp O
increase O
31206 O
ngml O
undergo O
laparoscopic O
splenectomy O
mass O
excision O
histologic O
examination O
mesenchymal O
element O
consist O
proliferation O
primitiveappeare O
mesenchymal O
spindleshape O
cell O
intimately O
admixed O
epithelial O
element O
highly O
cellular O
pattern O
cytoplasm O
abundant O
mature O
fibroblast O
nucleus O
elongate O
plump O
cell O
blend O
progressively O
area O
intense O
cellular O
mesenchymal O
proliferation O
relatively O
acellular O
fibrous O
septum O
osteoid O
present O
primitive O
mesenchyme O
near O
fibrous O
septum O
pseudocapsule O
admix O
epithelial O
element O
osteoid O
foci O
contain O
cell O
morphologically O
identical O
osteoblast O
fig4a O
immunohistochemistry O
stain O
show O
expression O
hepatocyte O
hcg O
afp O
vimentin O
ck7 O
ck19 O
cd56 O
catenin O
negativity O
ceafig4b O
c O
d O
e O
f O
g O
metastatic O
hepatoblastoma B-DISEASE
confirm O
histologic O
examination O
immunohistochemistry O
stain O
immunohistochemistrically O
reexamination O
previous O
surgical O
specimen O
confirm O
hepatoblastoma O
followup O
abdominal O
ct O
scan O
perform O
1 O
month O
reoperation O
show O
newly O
onset O
17 O
cm O
sized O
subtle O
enhance O
soft O
tissue O
mass O
splenic O
bed O
positron O
emission O
tomography O
pet O
show O
multiple O
fdg O
uptakemax O
suv O
   O
380 O
leave O
upper O
low O
quadrant O
area O
abdomen O
paralumbar O
area O
include O
right O
subphrenic O
area O
fig5a O
b O
c O
followup O
afp O
16269 O
ngml O
systemic O
chemotherapy O
start O
cisplatin O
60 O
mgm2 O
5fluorourasil O
5fu O
600 O
mgm2 O
vincristine O
15 O
mgm2 O
total O
3 O
cycle O
chemotherapy O
4 O
week O
entecavir O
05 O
mg O
start O
chemoprophylaxis O
chb B-DISEASE
3rd O
chemotherapy O
cycle O
followup O
abdominal O
ct O
pet O
scan O
show O
progression O
multiple O
intraperitoneal O
metastasis B-SYMPTOMS
large O
intraperitoneal O
fluid B-SYMPTOMS
fig6a O
b O
followup O
afp O
increase O
254 O
ngml O
chemotherapy O
regiman O
change O
carboplatin O
350 O
mgm2 O
doxorubicin O
30 O
mgm2 O
3 O
week O
patient O
experience O
neutropenia B-SYMPTOMS
new O
regimen O
recover O
shortly O
treatment O
granulocyte O
colonystimulating O
factor O
gcsf O
second O
carboplatin O
doxorubicin O
chemotherapy O
followup O
afp O
increase O
151019 O
ngml O
abdominal O
ct O
scan O
show O
ascite O
decrease O
fig7 O
radiologic O
improvement O
fourth O
chemotherapy O
perform O
4th O
chemotherapy O
followup O
abdominal O
ct O
reveal O
progression O
multiple O
intraperitoneal O
metastatic O
masse O
newly O
develop O
hepatic O
metastasis O
large O
intraperitoneal O
fluid O
fig8 O
diagnostic O
paracentesis O
perform O
show O
white O
blood O
cell O
310mm3 O
poly O
20 O
lymph O
80 O
protein O
36 O
gdl O
albumin O
23 O
gdl O
ascitic O
fluid O
analysis O
serum O
albumin O
31 O
gdl O
serumascite O
albumin O
gradient O
saag O
08 O
gdl O
afb O
stain O
culture O
negative O
ascitic O
fluid O
afp O
688193 O
ngml O
serum O
regard O
peritoneal O
carcinomatosis B-DISEASE
patient O
underwent O
conservative O
treatment O
include O
use O
repeat O
therapeutic O
paracentesis O
1 O
month O
death O

42yearold O
woman B-SEX
present O
right O
breast O
lump B-SYMPTOMS
low O
pain B-SYMPTOMS
loss O
height O
mark O
kyphosis B-SYMPTOMS
hepatomegaly B-SYMPTOMS
core O
biopsy O
breast O
lump O
show O
ductal B-DISEASE
carcinoma I-DISEASE
situ O
sample O
label O
p11 O
supplementary O
fig1 O
supplementary O
table O
1 O
additional O
biopsy O
ipsilateral O
axillary O
lymph O
node O
p12 O
reveal O
metastatic O
ductal B-DISEASE
adenocarcinoma I-DISEASE
er O
88 O
her2 O
3 O
compute O
tomography O
scan O
reveal O
widespread O
metastatic B-DISEASE
disease I-DISEASE
bone O
pleura O
liver O
supplementary O
fig2 O
supplementary O
table O
2 O
patient O
start O
treatment O
trastuzumab O
taxanebase O
chemotherapy O
significant O
partial O
response B-SYMPTOMS
supplementary O
fig3 O
induction O
chemotherapy O
maintain O
tamoxifen O
trastuzumab O
19 O
month O
treatment O
present O
seizure O
head O
compute O
tomography O
reveal O
large O
metastasis B-DISEASE
left O
frontal O
lobe O
supplementary O
fig4 O
resect O
m21 O
therapy O
tamoxifen O
trastuzumab O
continue O
collection O
plasma O
sample O
initiate O
sample O
t1t9 O
month O
surgery O
enlarge O
liver O
lesion O
new O
metastatic B-SYMPTOMS
deposit I-SYMPTOMS
left O
ovary O
supplementary O
fig5 O
treatment O
switch O
combination O
lapatinib O
capecitabine O
result O
stable B-SYMPTOMS
disease I-SYMPTOMS
12 O
month O
supplementary O
fig6 O
general B-SYMPTOMS
deterioration I-SYMPTOMS
occur O
disease B-SYMPTOMS
progression I-SYMPTOMS
chest O
new O
pulmonary O
nodule O
bilateral O
pleural O
effusion O
posterior O
chest O
wall O
mass B-SYMPTOMS
supplementary O
fig7 O
eastern O
cooperative O
oncology O
group O
performance O
status O
23 O
treatment O
stop O
patient O
die O
4 O
month O
later O
tumour B-SYMPTOMS
sample O
obtain O
diagnosis O
primary O
breast O
site O
p11 O
axillary O
lymph O
node O
p12 O
19 O
month O
brain O
metastasis O
area O
m21 O
autopsy O
3 O
year O
treatment O
primary O
breast O
site O
metastatic O
deposit O
chest O
liver O
ovary O
vertebrae O
label O
p31 O
m31m34 O
respectively O
serial O
plasma O
sample O
obtain O
500 O
day O
clinical O
followup O
t1t9 O
tumour O
plasma O
sample O
collect O
clinical O
course O
summarize O
fig1ab O

present O
case O
22yearold O
woman B-SEX
diagnose O
childhood O
type O
iib O
vhl O
know O
multiple O
retinal O
angiomas O
pancreatic O
cyst O
spinal O
cerebellar O
hemangioblastomas O
admit O
hospital O
complaining O
progressive O
dyspnea B-SYMPTOMS
palpitation O
examination O
blood O
pressure O
159119 O
mm O
hg O
pulse O
123 O
bpm O
physical O
examination O
reveal O
systolic O
murmur B-SYMPTOMS
mitral O
focus O
irradiation O
axilla O
pulmonary O
rale O
electrocardiography O
reveal O
remarkable O
finding O
sinus O
tachycardia B-SYMPTOMS
laboratory O
test O
show O
elevated O
nterminal O
probrain O
natriuretic O
peptide O
chest O
xray O
show O
sign O
pulmonary B-SYMPTOMS
interstitial I-SYMPTOMS
edema I-SYMPTOMS
patient O
admit O
department O
cardiology O
diagnosis O
acute O
decompensate O
heart B-DISEASE
failure I-DISEASE
transthoracic O
echocardiography O
show O
dilate O
left O
ventricle O
severely O
depressed O
ejection O
fraction O
generalized O
hypokinesia B-SYMPTOMS
mild O
mitral B-SYMPTOMS
regurgitation I-SYMPTOMS
fig1a O
admission O
patient O
episode O
paroxysmal O
dyspnea O
despite O
treatment O
blocker O
diuretic O
clinical O
suspicion O
adrenal B-DISEASE
gland I-DISEASE
disease I-DISEASE
24hour O
urinary O
catecholamine O
metanephrine O
test O
request O
cardiac O
mri O
perform O
order O
complete O
cardiomyopathy O
study O
confirm O
echocardiographic O
finding O
reveal O
incidental O
finding O
great O
left O
renal O
mass B-SYMPTOMS
24hour O
urine O
laboratory O
test O
show O
markedly O
elevate O
level O
norepinephrine O
total O
catecholamine O
normetanephrine O
metanephrine O
normal O
epinephrine O
value O
24hour O
norepinephrine O
468 O
g O
normal O
range O
23105 O
24hour O
epinephrine O
13 O
g O
normal O
range O
420 O
24hour O
total O
catecholamine O
658 O
g O
normal O
range O
217575 O
24hour O
normetanephrine O
2988 O
g O
normal O
range O
105354 O
24hour O
total O
metanephrine O
3013 O
g O
normal O
range O
01000 O
abdominal O
mri O
perform O
show O
presence O
cystic O
masse O
fig2 O
locate O
left O
hypochondrium O
surgical O
resection O
masse O
perform O
blockade O
phenoxybenzamine O
blockade O
propranolol O
laparoscopic O
approach O
confirm O
diagnosis O
pheochromocytoma B-DISEASE
clear O
cell O
renal O
carcinoma O
histology O
followup O
blood O
pressure O
heart O
rate O
value O
normalize O
12477 O
mm O
hg O
78 O
bpm O
24hour O
urinary O
catecholamine O
value O
return O
normal O
range O
norepinephrine O
69 O
g24 O
h O
total O
catecholamine O
221 O
g24 O
h O
normetanephrine O
202 O
g24 O
h O
total O
metanephrine O
259 O
g24 O
h O
patient O
new O
episode O
palpitation O
dyspnea O
month O
surgical O
resection O
echocardiography O
repeat O
show O
left O
ventricle O
normal O
diameter O
preserve O
ejection O
fraction O
fig1b O
genetic O
analysis O
reveal O
germline B-SYMPTOMS
mutation I-SYMPTOMS
exon O
3 O
deletion O
vhl O
tumor O
suppressor O
gene O
short O
arm O
chromosome O
3 O
patient O
family O
history O
vhl O
conclude O
de O
novo O
mutation O

13 O
yearold O
boy B-SEX
present O
1 O
month O
history O
intermittent O
episode O
small O
volume O
epistaxis B-SYMPTOMS
significant O
past O
medical O
surgical O
family O
history O
physical O
examination O
reveal O
left O
palatal O
fleshy O
mass B-SYMPTOMS
center O
left O
posterior O
molar O
nasoendoscopic O
examination O
demonstrate O
large O
swelling B-SYMPTOMS
floor O
leave O
anterior O
nasal O
space O
involve O
left O
inferior O
meatus O
abut O
inferior O
turbinate O
compute O
tomography O
ct O
paranasal O
sinus O
show O
lobulated O
expansile O
lytic O
lesion B-SYMPTOMS
left O
maxilla O
fig O
1 O
lucent O
center O
peripheral O
calcification O
lesion O
associate O
large O
soft O
tissue O
component O
demonstrate O
mild O
heterogeneous O
contrast B-SYMPTOMS
enhancement I-SYMPTOMS
lesion O
center O
left O
maxillary O
alveolus O
involve O
left O
hard O
palate O
inferior O
anterior O
leave O
maxillary O
wall O
medial O
left O
maxillary O
wall O
lesion O
involve O
root O
left O
maxillary O
molar O
premolar O
abut O
left O
orbital O
floor O
gross O
orbital O
invasion B-SYMPTOMS
patient O
subsequently O
undergo O
18fdg O
petct O
study O
mass O
center O
left O
maxilla O
hypermetabolic O
index O
suvmax O
97 O
fig O
2 O
fdgavid O
metastatic B-DISEASE
disease I-DISEASE
transoral O
incisional O
biopsy O
left O
palatal O
mass O
perform O
suggestive O
preliminary O
diagnosis O
mesenchymal B-DISEASE
chondrosarcoma I-DISEASE
evidence O
biphasic O
pattern O
feature O
sheet O
small O
round O
cell O
hemangiopericytomalike O
vascular O
pattern O
mature O
cartilaginous O
island O
patient O
underwent O
leave O
subtotal O
maxillectomy O
lateral O
rhinotomy O
translabial O
approach O
final O
histology O
conclusive O
5 O
cm O
highgrade O
grade O
3 O
mesenchymal O
chondrosarcoma O
resection O
margin O
positive O
tumor B-SYMPTOMS
involvement I-SYMPTOMS
patient O
plan O
adjuvant O
chemotherapy O

case O
report O
approve O
review O
board O
shandong O
power O
central O
hospital O
patient O
parent O
sign O
informed O
consent O
publication O
case O
report O
accompany O
image O
4yearold O
female B-SEX
child O
present O
outpatient O
department O
slowly O
enlarge O
painless O
symmetrical O
swelling B-SYMPTOMS
cheek O
girl O
approximately O
2 O
year O
old O
parent O
notice O
change O
facial O
symmetry O
later O
obvious O
palpation O
swelling O
bony O
hard O
consistency O
skin O
swelling O
smooth O
freely O
movable O
increase O
temperature O
fig1 O
history O
trauma O
pain O
pus O
discharge O
blood O
discharge O
fever O
paresthesia O
anorexia O
weight O
loss O
significant O
family O
history O
report O
panoramic O
radiography O
reveal O
involvement B-SYMPTOMS
mandible O
maxilla O
show O
soap O
bubblelike O
multilocular O
radiolucency B-SYMPTOMS
thin O
expand O
cortex O
unerupted O
tooth O
include O
15 O
25 O
35 O
37 O
45 O
47 O
impact O
fig2 O
multislice O
compute O
tomography O
show O
presence O
multilocular O
cystic O
lesion O
fill O
softtissue O
density O
material O
dental O
anomaly O
affect O
body O
side O
mandible O
similar O
lesion O
observe O
maxilla O
fig3 O
biopsy O
obtain O
central O
area O
left O
rami O
histologic O
examination O
show O
large O
multinucleated O
giant O
cell O
loose O
delicate O
fibrillar O
connective O
tissue O
stroma O
contain O
large O
number O
fibroblast O
small O
blood O
vessel O
fig4 O
child O
grow O
old O
lesion O
static O
regression O
puberty O
current O
case O
surgical O
intervention O
take O
patient O
follow O
regular O
interval O

49yearold O
man B-SEX
history O
cardiac O
disease O
present O
progressive O
dyspnea B-SYMPTOMS
month O
duration O
medical O
history O
medical O
history O
include O
blunt O
chest O
trauma B-DISEASE
result O
accidental O
fall O
scaffold O
15 O
month O
early O
fall O
approximately O
8 O
foot O
land O
right O
right O
shoulder O
patient O
sustain O
bilateral O
pneumothorax B-SYMPTOMS
right O
iliopsoas O
muscle O
hematoma B-SYMPTOMS
multiple O
right O
costal O
fracture B-SYMPTOMS
fracture O
l3 O
vertebral O
body O
transverse O
process O
displace O
fracture O
right O
clavicle O
hospitalization O
last O
40 O
day O
time O
clinician O
detect O
murmur B-SYMPTOMS
request O
cardiac O
evaluation O
patient O
return O
normal O
activity O
4 O
week O
discharge O
hospital O
remain O
asymptomatic B-SYMPTOMS
year O
arrival O
department O
auscultation O
reveal O
bibasilar O
rale O
pansystolic O
murmur O
chest O
radiography O
show O
mild O
lung O
congestion B-SYMPTOMS
transthoracic O
echocardiography O
limit O
suboptimal O
acoustic O
window O
reveal O
severe O
eccentric O
mitral B-SYMPTOMS
regurgitation I-SYMPTOMS
valvular O
subvalvular O
apparatus O
appear O
structurally B-SYMPTOMS
normal I-SYMPTOMS
left O
atrium O
mildly O
dilate O
patient O
treat O
intravenous O
diuretic O
sign O
symptom O
congestion O
relieve O
coronary O
angiography O
reveal O
absence O
substantial O
coronary B-DISEASE
disease I-DISEASE
plan O
elective O
surgical O
procedure O
mitral O
valve O
repair O
surgical O
procedure O
intraoperative O
transesophageal O
echocardiography O
tee O
observe O
trivial O
central O
mitral B-SYMPTOMS
regurgitant I-SYMPTOMS
jet I-SYMPTOMS
severe O
perivalvular B-SYMPTOMS
regurgitant I-SYMPTOMS
jet I-SYMPTOMS
originate O
ventriculoatrial O
fistulous B-SYMPTOMS
communication I-SYMPTOMS
p1 O
scallop O
fig1 O
examination O
confirm O
absence O
structural B-DISEASE
disease I-DISEASE
involve O
mitral O
leaflet O
subvalvular O
apparatus O
surgical O
exposure O
mitral O
valve O
small O
tear B-SYMPTOMS
length O
67 O
mm O
see O
posterior O
leaflet O
lateral O
position O
involve O
annulus O
left O
atrial O
wall O
absence O
leaflet O
abnormality O
vegetation O
suggest O
posttraumatic O
origin O
perivalvular B-SYMPTOMS
leak I-SYMPTOMS
valvular O
repair O
successfully O
achieve O
direct O
suture O
tear O
50 O
prolene O
stitch O
subsequent O
insertion O
30 O
mm O
mitral O
annuloplasty O
ring O
patient O
extubate O
day O
postsurgical O
course O
uncomplicated O
year O
later O
asymptomatic O
oneyear O
followup O
transthoracic O
echocardiogram O
confirm O
excellent O
result O
surgical O
treatment O

60yearold O
white O
brazilian O
man B-SEX
control O
hypertension O
stage O
2 O
obesity O
present O
institution O
complaint O
progressive O
fatigue B-SYMPTOMS
moderate O
light O
exertion O
approximately O
1 O
year O
duration O
period O
undergo O
myocardial O
perfusion O
scintigraphy O
evidence O
obstructive B-DISEASE
ischemic I-DISEASE
disease I-DISEASE
clinical O
evidence O
systolic O
heart B-DISEASE
failure I-DISEASE
undergo O
biological O
mitral O
valve O
replacement O
3 O
year O
previously O
mitral B-DISEASE
valve I-DISEASE
stenosis I-DISEASE
undergone O
ablation O
atrioventricular O
nodal O
reentry O
tachycardia B-SYMPTOMS
18 O
month O
previously O
time O
valve O
replacement O
reported O
evidence O
pulmonary B-DISEASE
arterial I-DISEASE
hypertension I-DISEASE
patient O
medication O
list O
include O
aspirin O
100 O
mgday O
carvedilol O
50 O
mgday O
atorvastatin O
10 O
mgday O
losartan O
25 O
mgday O
echocardiogram O
show O
normal O
function O
mitral O
prosthesis O
global O
leave O
ventricular O
systolic O
function O
normal O
limit O
leave O
ventricular O
ejection O
fraction O
62 O
   O
measure O
teichholz O
method O
stage O
diastolic B-DISEASE
dysfunction I-DISEASE
mean O
pulmonary O
arterial O
systolic O
blood O
pressure O
50 O
mmhg O
6minute O
walk O
test O
patient O
walk O
104 O
meter O
table O
1 O
catheterization O
right O
heart O
chamber O
pulmonary O
artery O
confirm O
diagnosis O
pulmonary B-DISEASE
hypertension I-DISEASE
table O
2 O
followup O
period O
therapy O
nifedipine O
sildenafil O
tolerate O
secondary O
orthostatic O
hypotension B-SYMPTOMS
patient O
refer O
radiofrequency O
ablation O
pulmonary O
artery O
trunk O
treatment O
refractory O
pulmonary O
hypertension O
procedure O
perform O
catheterization O
laboratory O
direct O
visualization O
fluoroscopy O
radiopaque O
contrast O
dye O
patient O
remain O
unconscious O
sedation O
catheterization O
right O
femoral O
artery O
standard O
seldinger O
technique O
perform O
8french O
valve O
short O
sheath O
subcutaneous O
injection O
local O
anesthetic O
subsequently O
sheath O
replace O
steerable O
long O
sheath O
agilis O
st O
jude O
medical O
st O
paul O
mn O
usa O
standard O
overthewire O
technique O
unfractionated O
heparin O
administer O
intravenously O
target O
activate O
coagulation O
time O
250 O
350 O
second O
electroanatomic O
reconstruction O
right O
ventricular O
outflow O
tract O
pulmonary O
artery O
perform O
ensite O
velocity O
cardiac O
mapping O
system O
stjude O
medical O
direct O
fluoroscopic O
visualization O
merger O
format O
image O
obtain O
perform O
cardiac O
compute O
tomography O
angiography O
fig1 O
agilis O
sheath O
advance O
right O
ventricular O
outflow O
tract O
reach O
pulmonary O
valve O
long O
sheath O
introduce O
ablation O
catheter O
open O
irrigate O
tip O
stjude O
medical O
parameter O
application O
accord O
protocol O
follow O
power O
5 O
w O
maximum O
temperature O
48 O
c O
60second O
duration O
spot O
maximum O
impedance O
variation O
10 O
   O
baseline O
value O
irrigation O
flow O
rate O
17 O
mlminute O
create O
circle O
pulmonary O
artery O
trunk O
patient O
discharge O
morning O
noteworthy O
change O
procedure O
discharge O
patient O
radiographic O
echocardiographic O
laboratory O
parameter O
see O
patient O
blood O
pressure O
right O
heart O
chamber O
pulmonary O
artery O
determine O
catheterization O
3 O
6 O
month O
procedure O
result O
show O
table O
2 O
patient O
3month O
followup O
examination O
show O
improvement O
functional O
class O
fatigue O
major O
exertion O
demonstrate O
increase O
distance O
walk O
6minute O
walk O
test O
reduction O
pressure O
right O
cavity O
pulmonary O
artery O
currently O
6 O
month O
clinical O
followup O
maintain O
improvement O
functional O
classification O
pedal O
bicycle O

patient O
50year O
old O
man B-SEX
bicuspid O
aortic B-SYMPTOMS
valve I-SYMPTOMS
insufficiency I-SYMPTOMS
ascend O
aorta B-SYMPTOMS
dilatation I-SYMPTOMS
undergo O
freehand O
aortic O
homograft O
implantation O
replacement O
noncoronary O
sinus O
24 O
mm O
homograft O
2006 O
age O
41 O
followup O
evaluation O
perform O
6 O
month O
show O
mild O
aortic O
valve O
insufficiency O
8 O
year O
followup O
patient O
present O
hospital O
fever B-SYMPTOMS
echocardiography O
show O
severe O
aortic B-SYMPTOMS
insufficiency I-SYMPTOMS
rupture B-SYMPTOMS
cusp O
homograft O
worsening O
cardiac O
contractility O
left O
ventricular O
ejection O
fraction O
lvef O
depression O
4045 O
dilatation O
left O
ventricle O
telediastolictelesystolic O
diameter O
6042 O
mm O
respectively O
patient O
present O
orthopnoea B-SYMPTOMS
hypotension B-SYMPTOMS
need O
infusion O
dopamine O
diuretic O
compute O
tomography O
scan O
show O
calcification B-SYMPTOMS
homograft O
pleural O
effusion O
sign O
pericardial B-SYMPTOMS
effusion I-SYMPTOMS
fig1 O
duke O
criterion O
endocarditis B-DISEASE
satisfied O
final O
diagnosis O
early O
structural B-DISEASE
deterioration I-DISEASE
homograft O
severe O
calcification O
process O
operation O
perform O
median O
resternotomy O
standard O
aortaright O
atrium O
central O
cannulation O
extracorporeal O
circulation O
leaflet O
annulus O
homograft O
present O
severe O
calcification O
sign O
endocarditis O
find O
edwards O
intuity O
bioprosthesis O
21 O
mm O
implant O
fig2 O
crossclampe O
time O
41 O
min O
cardiopulmonary O
bypass O
time O
64 O
min O
patient O
require O
dopamine O
adrenaline O
low O
dose O
bypass O
wean O
complication O
occur O
postoperative O
period O
echocardiography O
discharge O
show O
absence O
paravalvular O
leak O
peakmean O
aortic O
gradient O
3420 O
mmhg O
lvef O
33 O
followup O
echocardiography O
3 O
month O
operation O
show O
leak O
malfunction O
edwards O
intuity O
prosthesis O
peakmean O
gradient O
3822 O
mmhg O
initial O
recovery O
lvef O
value O
47 O
patient O
asymptomatic B-SYMPTOMS

69yearold O
woman B-SEX
history O
hypertension B-DISEASE
present O
generalized O
petechial O
rash B-SYMPTOMS
shortness O
breath O
3 O
day O
duration O
rash O
nonpruritic O
painless O
start O
thigh O
rapidly O
disseminate O
rest O
body O
progressive O
dyspnea B-SYMPTOMS
exertion O
significant O
decrease O
exercise O
tolerance O
deny O
fever B-SYMPTOMS
headache B-SYMPTOMS
dizziness B-SYMPTOMS
hemoptysis B-SYMPTOMS
bleed O
history O
new O
drug O
use O
unusual O
food O
intake O
contact O
sick O
person O
recent O
travel O
medication O
enalapril O
take O
year O
patient O
deny O
use O
recreational O
drug O
tobacco O
alcohol O
admission O
afebrile B-SYMPTOMS
normotensive B-SYMPTOMS
mild O
tachypnea B-SYMPTOMS
respiratory O
rate O
22 O
breath O
minute O
physical O
examination O
reveal O
scatter O
petechial O
rash O
prominent O
low O
extremity O
nonpalpable O
nonblanche O
chest O
auscultation O
reveal O
coarse O
crackle O
bilaterally O
cardiovascular O
abdominal O
neurological O
examination O
normal O
palpable O
lymphadenopathy B-SYMPTOMS
visceromegaly B-SYMPTOMS
laboratory O
examination O
reveal O
thrombocytopenia B-SYMPTOMS
platelet O
7000l O
anemia B-SYMPTOMS
hemoglobin O
108 O
mgdl O
hematocrit O
34 O
leukocytosis B-SYMPTOMS
white O
blood O
cell O
wbc O
11600l O
coagulation O
profile O
normal O
exclude O
disseminate O
intravascular O
coagulation O
arterial O
blood O
gas O
ambient O
air O
reveal O
partial O
pressure O
oxygen O
pao2 O
64 O
torr O
partial O
pressure O
carbon O
dioxide O
paco2 O
37 O
torr O
ph O
745 O
increase O
alveolararterial O
gradient O
44 O
torr O
diffuse O
airspace B-SYMPTOMS
consolidation I-SYMPTOMS
find O
chest O
roentgenogram O
fig1a O
compute O
tomography O
ct O
chest O
show O
diffuse O
ground O
glass O
alveolar O
opacity O
patchy O
infiltrate O
fig1b O
c O
start O
broadspectrum O
antibiotic O
receive O
intravenous O
steroid O
peripheral O
smear O
show O
giant O
platelet O
occasional O
small O
platelet O
clump O
schistocyte O
flexible O
fiberoptic O
bronchoscopy O
ffb O
show O
normal O
mucosa O
endobronchial O
lesion O
fig2a O
serial O
aliquot O
bal O
fluid O
balf O
turn O
hemorrhagic B-SYMPTOMS
confirm O
bronchoscopic O
diagnosis O
dah B-DISEASE
fig2b O
cytology O
balf O
show O
substantial O
hemosiderinladen O
macrophage O
support O
diagnosis O
balf O
culture O
gram O
stain O
negative O
patient O
remain O
severe O
thrombocytopenia O
hypoxia B-SYMPTOMS
despite O
steroid O
platelet O
transfusion O
high O
dose O
pulse O
steroid O
intravenous O
immunoglobulin O
ivig O
add O
clinicoradiological O
improvement B-SYMPTOMS
bone O
marrow O
aspirate O
morphologically O
normal O
additional O
laboratory O
study O
fail O
reveal O
etiology O
secondary O
thrombocytopenia O
table O
1 O
support O
diagnosis O
itp B-DISEASE
steroid O
gradually O
taper O
repeat O
chest O
radiograph O
show O
complete O
resolution O
bilateral O
infiltrate O
fig3 O
platelet O
count O
return O
normal O
week O
10 O
admission O
additional O
therapy O
fig4 O

24yearold O
azeri O
male B-SEX
present O
chief O
complaint O
blurred B-SYMPTOMS
vision I-SYMPTOMS
eye O
diagnose O
achondroplasia O
early O
childhood O
bear O
term O
normal O
birth O
weight O
history O
hereditary O
ocular O
systemic O
disease O
patient O
characteristic O
feature O
achondroplasia O
ie O
short O
stature O
lumbar O
lordosis O
short O
proximal O
long O
bone O
large O
hand O
frontal O
bossing O
flat O
nasal O
bridge O
figure O
1 O
height O
108 O
cm O
well O
correct O
visual O
acuity O
2070 O
right O
eye O
075 O
   O
125 O
   O
60 O
2070 O
left O
eye O
os O
025 O
   O
050 O
   O
130 O
pupil O
equal O
size O
round O
reactive O
light O
reverse B-SYMPTOMS
afferent I-SYMPTOMS
pupillary I-SYMPTOMS
defect I-SYMPTOMS
ocular O
motility O
normal O
eye O
slit O
lamp O
examination O
unremarkable O
intraocular O
pressure O
12 O
mm O
hg O
goldmann O
applanation O
tonometry O
central O
corneal O
thickness O
value O
right O
leave O
eye O
561 O
557 O
   O
respectively O
dilate O
fundus O
examination O
reveal O
welldemarcate O
circular O
macular O
lesion B-SYMPTOMS
eye O
right O
eye O
lesion O
approximately O
25 O
disc O
diameter O
dd O
width O
27 O
dd O
length O
left O
eye O
lesion O
approximately O
25 O
dd O
width O
28 O
dd O
length O
border O
lesion O
pigment O
underlie O
choroidal O
overlying O
retinal O
vasculature O
appear O
normal O
addition O
stalk O
tissue O
emanate O
optic O
disc O
course O
vitreous O
figure O
2 O
fluorescein O
angiography O
posterior O
segment O
optical O
coherence O
tomography O
optic O
nerve O
head O
stratus O
carl O
zeiss O
gmbh O
jena O
germany O
perform O
figure O
figures3 O
4 O
background O
maculopathy O
patient O
appropriately O
fixate O
target O
image O
acquisition O
result O
slightly O
decentered O
fluorescein O
angiography O
image O
figure O
3 O

64 B-AGE
year I-AGE
old I-AGE
female B-SEX
know O
hht B-DISEASE
refer O
clinic O
recurrent O
epistaxis B-SYMPTOMS
nearly O
50 O
year O
recurrent O
symptom O
age O
16 O
condition O
diagnose O
sibling O
diagnose O
hht O
mother O
pass O
away O
intracranial O
hemorrhage B-SYMPTOMS
year O
prior O
presentation O
undergo O
leftsided O
septodermoplasty O
lateral O
rhinotomy O
approach O
operation O
significantly O
reduce O
frequency O
symptom O
year O
epistaxis O
control O
use O
low O
dose O
thalidomide O
refer O
clinic O
increase O
epistaxis O
severity O
frequency O
prior O
12 O
month O
necessitate O
frequent O
transfusion O
time O
consultation O
patient O
concern O
daily O
severe O
left O
side O
epistaxis O
despite O
month O
use O
topical O
bevacizumab O
oral O
tranexamic O
acid O
require O
intravenous O
iron O
blood O
transfusion O
month O
baseline O
hemoglobin O
time O
consultation O
75 O
gl O
normal O
   O
120 O
   O
160 O
gl O
hht O
epistaxis O
severity O
score O
17 O
severe O
normalize O
score O
949 O
examination O
multiple O
telangiectasia B-SYMPTOMS
finger O
face O
lip O
palate O
endoscopic O
examination O
reveal O
bilateral O
telangiectasia O
nasal O
septum O
extensive O
crust O
entire O
left O
nasal O
cavity O
manipulation O
result O
immediate O
profuse O
epistaxis O
give O
severity O
patient O
epistaxis O
despite O
medical O
therapy O
offer O
endoscopic O
leftsided O
septodermoplasty O
surgical O
goal O
improve O
quality O
life O
reduce O
number O
severity O
epistaxis O
episode O
diminish O
need O
blood O
transfusion O
patient O
content O
treatment O
plan O
agree O
undergo O
surgical O
intervention O
endoscopic O
procedure O
perform O
general O
anesthesia O
endotracheal O
intubation O
nasal O
cavity O
prepare O
insert O
pledget O
soak O
topical O
adrenaline O
11000 O
place O
nostril O
decongestion O
zero O
degree O
endoscope O
residual O
stsg O
mucosa O
left O
septum O
dissect O
supraperichondrial O
plane O
result O
expect O
significant O
diffuse O
hemorrhage O
immediate O
hemostasis O
attain O
topical O
gelatinthrombin O
matrix O
floseal O
floseal O
hemostatic O
matrix O
baxter O
healthcare O
corporation O
deerfield O
il O
usa O
fig1 O
mucosal B-SYMPTOMS
defect I-SYMPTOMS
fig2 O
measure O
approximately O
3 O
cm O
anteriorposterior O
dimension O
4 O
x O
2 O
cm O
split O
thickness O
skin O
graft O
harvest O
right O
thigh O
piecruste O
15 O
blade O
place O
endoscopically O
length O
septal O
defect O
see O
fig3 O
graft O
place O
overlap O
mucosa O
nasal O
floor O
residual O
superior O
septal O
mucosa O
finally O
2 O
ml O
fibrin O
sealant O
tisseel O
fibrin O
sealant O
baxter O
healthcare O
corporation O
deerfield O
il O
usa O
apply O
edge O
central O
portion O
stsg O
fig4 O
packing O
postoperatively O
patient O
discharge O
home O
day O
surgery O
clinical O
followup O
week O
surgery O
fig5 O
show O
entire O
graft O
take O
leftsided O
epistaxis O
dramatically O
diminish O
patient O
content O
result O
procedure O
6 O
month O
followup O
baseline O
hemoglobin O
improve O
102 O
gl O
require O
transfusion O
4 O
month O
hematologist O
intent O
stop O
transfusion O
hemoglobin O
remain O
great O
100 O
gl O
epistaxis O
severity O
score O
6 O
month O
follow O
mild O
normalize O
score O
305 O

65yearold O
man B-SEX
admit O
chinajapan O
friendship O
hospital O
chief O
complaint O
progressive O
dysphagia B-SYMPTOMS
3 O
mo O
complain O
drastic O
weight B-SYMPTOMS
loss I-SYMPTOMS
8 O
kg O
past O
2 O
mo O
deny O
history O
smoke O
alcohol O
intake O
substance O
abuse O
chronic O
atrophic O
gastritis B-DISEASE
nearly O
10 O
year O
family O
history O
genetic O
defect O
malignancy O
physical O
examination O
show O
palpable O
finding O
admission O
blood O
test O
show O
slight O
decrease O
hemoglobin O
106 O
gl O
upper O
gastrointestinal O
gi O
examination O
barium O
contrast O
show O
large O
tumor B-SYMPTOMS
block O
esophagogastric O
junction O
figure O
1 O
compute O
tomography O
ct O
scan O
reveal O
soft O
mass B-SYMPTOMS
esophagogastric O
junction O
lymph O
node O
metastasis B-SYMPTOMS
less O
curvature O
stomach O
figure O
2 O
endoscopic O
examination O
show O
black O
spot B-SYMPTOMS
low O
esophagus O
bulky O
black O
mass O
block O
esophagogastric O
junction O
black O
craterlike O
ulcer O
fundus O
stomach O
figure O
3 O
biopsy O
specimen O
take O
tumor O
identify O
poorly O
differentiate O
adenocarcinoma B-DISEASE
preoperative O
nutrition O
status O
case O
score O
2 O
base O
nutrition O
risk O
screen O
2002 O
nrs O
20026 O
obstructive O
symptom O
cause O
tumor O
debulking O
surgery O
distal O
esophagectomy O
proximal O
gastrectomy O
perform O
esophagogastric O
anastomosis O
reconstruction O
complete O
staple O
device O
intraoperatively O
tumor O
find O
locate O
esophagogastric O
junction O
tumor O
infiltrate O
layer O
lymph O
node O
metastasis O
station O
ascite O
dissemination O
tumor O
observe O
peritoneal O
cavity O
tumor O
measure O
3 O
cm O
   O
6 O
cm O
size O
black O
pigmentation O
figure O
4 O
pigment O
satellite O
nodule O
main O
tumor O
lesion O
large O
1 O
cm O
   O
1 O
cm O
diameter O
ulceration O
lesion O
find O
fundus O
stomach O
microscopically O
excise O
tumor O
tissue O
compose O
nonorganized O
pleomorphic O
cell O
exhibit O
atypical O
nucleus O
abundant O
melanin O
granule O
figure O
5 O
pathological O
examination O
identify O
case O
stage O
iva O
t4an1m0 O
immunohistochemical O
staining O
show O
tumor O
positive O
s100 O
hmb45 O
mcleana O
vimentin O
negative O
cytokeratin O
7 O
cytokeratin O
20 O
figure O
6 O
base O
result O
diagnosis O
primary O
advanced O
esophagogastric O
melanoma B-DISEASE
establish O
postoperative O
course O
smooth O
complication O
patient O
gradually O
recover O
discharge O
14 O
d O
surgery O
patient O
deny O
postoperative O
adjuvant O
therapy O
abdominal O
recurrence B-SYMPTOMS
hepatic O
metastasis O
find O
month O
postoperative O
followup O
ct O
effective O
treatment O
administer O
patient O
die O
diffuse O
metastatic B-DISEASE
disease I-DISEASE
2 O
mo O
later O

65yearold O
man B-SEX
refer O
hospital O
evaluation O
stutter O
chest O
pain B-SYMPTOMS
10 O
day O
common O
worker O
positive O
finding O
relevant O
physical O
examination O
medical O
family O
psychosocial O
history O
include O
comorbiditie O
relevant O
genetic O
information O
electrocardiogram O
show O
twave O
inversion B-SYMPTOMS
lead O
v1 O
v4 O
figure O
1 O
coronary O
angiography O
show O
90 O
stenosis B-SYMPTOMS
midleft O
anterior O
descend O
coronary O
artery O
lad O
stente O
figure O
2 O
twave O
inversion O
lead O
v1 O
v4 O
percutaneous O
coronary O
intervention O
pci O
figure O
3 O
patient O
discharge O
pci O
5 O
day O
recharge O
hospital O
palpation B-SYMPTOMS
electrocardiogram O
demonstrate O
ventricular B-DISEASE
tachycardia I-DISEASE
figure O
4 O
severe O
hypertension B-SYMPTOMS
remarkable O
blood B-SYMPTOMS
pressure I-SYMPTOMS
fluctuation I-SYMPTOMS
22476 O
7050 O
mm O
hg O
antihypertensive O
drug O
ventricular O
tachycardia O
occur O
2 O
time O
precede O
period O
blood O
pressure O
fluctuation O
burst O
concomitantly O
peak O
hypertension B-DISEASE
crisis I-DISEASE
patient O
feel O
abdominal O
pain O
abdominal O
ultrasound O
show O
suspicious O
right O
adrenal O
gland O
tumor B-SYMPTOMS
enhance O
computed O
tomography O
adrenal O
gland O
conform O
tumor O
right O
adrenal O
gland O
accompany O
upset O
level O
aldosterone O
figure O
5 O
tumor O
remove O
laparoscope O
pathological O
examination O
show O
pheochromocytoma B-DISEASE
figure O
6 O
surgery O
blood O
pressure O
turn O
normal O
gradually O
twave O
inversion O
lead O
v1v4 O
figure O
7 O

50yearold O
lady B-SEX
present O
complaint O
pain B-SYMPTOMS
abdoman O
jaundice B-SYMPTOMS
half O
month O
complain O
intermittent O
type O
fever B-SYMPTOMS
1 O
week O
physical O
examination O
reveal O
presence O
icterus B-SYMPTOMS
palpable O
tender O
globular O
mass B-SYMPTOMS
right O
hypochondrium O
measure O
3 O
   O
3 O
cm O
clinical O
diagnosis O
obstructive O
jaundice O
secondary O
periampullary B-DISEASE
carcinoma I-DISEASE
ultrasonographic O
examination O
abdomen O
pelvis O
reveal O
dilatation O
intrahepatic O
biliary O
radicle O
ihbr O
multiple O
freely O
mobile O
gall O
stone O
dilated B-SYMPTOMS
common I-SYMPTOMS
bile I-SYMPTOMS
duct I-SYMPTOMS
cbd O
measure O
18 O
cm O
sudden O
narrowing O
distal O
end O
ct O
scan O
show O
moderate O
dilatation O
extra O
intrahepatic O
biliary O
radicle O
cholelithiasis B-SYMPTOMS
suspicious O
thickening O
gall O
bladder O
wall O
fundus O
distal O
cbd O
stricture B-SYMPTOMS
evidence O
distant O
metastasis B-SYMPTOMS
fig1 O
preoperative O
diagnosis O
periampullary O
carcinoma O
chronic B-DISEASE
cholecystitis I-DISEASE
patient O
plan O
pancreaticoduodenectomy O
whipples O
procedure O
optimization O
patient O
undergo O
classical O
whipples O
procedure O
table O
examination O
resect O
speciman O
reveal O
multiple O
gall O
stone O
gall O
bladder O
area O
mucosal B-SYMPTOMS
thickening I-SYMPTOMS
fundus O
irregular O
circumferential O
growth B-SYMPTOMS
involve O
intrapancreatic O
portion O
cbd O
postoperative O
period O
uneventful O
patient O
recover O
satisfactorily O
histopathological O
examination O
resect O
speciman O
figs2 O
3 O
reveal O
thickening O
gall O
bladder O
wall O
fundus O
multiple O
small O
calculi B-SYMPTOMS
large O
measure O
14 O
cm O
fig3 O
section O
study O
area O
thickening O
show O
feature O
suggestive O
adenocarcinoma B-DISEASE
limit O
mucosa O
microscopic O
section O
obtain O
distal O
cbd O
region O
show O
adenocarcinoma O
common O
bile O
duct O
invasion O
muscular O
wall O
duodenum O
section O
study O
resected O
lymph O
node O
free O
tumor O
cell O
pathological O
staging O
pt1an0m0 O
adenocarcinoma O
gall O
bladder O
pt2n0m0 O
adenocarcinoma O
distal O
cbd O
patient O
subject O
adjuvant O
therapy O
patient O
diseasefree O
2 O
year O
surgery O

53yearold O
man B-SEX
come O
hospital O
sign O
symptom O
acute O
heart B-DISEASE
failure I-DISEASE
2week O
history O
progressive O
breathlessness B-SYMPTOMS
history O
recurrent O
skin O
abscess O
atopic O
dermatitis B-DISEASE
regularly O
visit O
dermatologist O
hospital O
arrive O
hospital O
extremity O
warm B-SYMPTOMS
dry B-SYMPTOMS
accord O
new O
york O
heart O
association O
criterion O
class O
iii O
congestive B-DISEASE
heart I-DISEASE
failure I-DISEASE
chf B-DISEASE
electrocardiogram O
reveal O
diffuse O
nonspecific O
twave O
change O
low O
voltage O
5 O
mm O
extremity O
lead O
poor O
rwave O
progression O
anterior O
chest O
lead O
multiple O
sporadic O
ventricular O
premature O
beat O
see O
figure O
1 O
chest O
xray O
film O
confirm O
right O
pleural B-DISEASE
effusion I-DISEASE
mild O
cardiomegaly B-SYMPTOMS
pulmonary B-DISEASE
congestion I-DISEASE
figure O
2 O
blood O
test O
show O
severely O
elevate O
btype O
natriuretic O
peptide O
901 O
pgml O
markedly O
raise O
ige O
12 O
000 O
iuml O
eosinophilia B-SYMPTOMS
eosinophil O
count O
162108l O
biochemical O
analysis O
reveal O
significant O
finding O
blood O
urea O
nitrogen O
143 O
mgdl O
reference O
value O
rv O
7002200 O
creatinine O
090 O
mgdl O
rv O
060100 O
creactive O
protein O
crp O
02 O
mgdl O
rv O
000050 O
serum O
amyloid O
saa O
70 O
gml O
rv O
080 O
troponin O
t O
007 O
ngml O
rv O
001 O
immunology O
testing O
reveal O
negative O
perinuclear O
antineutrophil O
cytoplasmic O
antibody O
elevation O
myeloperoxidase O
antibodie O
distribution O
albumin O
globulin O
serum O
normal O
serum O
protein O
immunoelectrophoresis O
reveal O
mprotein O
urinalysis O
reveal O
bencejone O
protein O
transthoracic O
echocardiography O
figure O
3 O
show O
concentric O
mild O
left O
ventricular O
lv O
hypertrophy B-SYMPTOMS
12 O
mm O
characteristic O
granular B-SYMPTOMS
sparkling I-SYMPTOMS
appearance I-SYMPTOMS
pericardial B-DISEASE
effusion I-DISEASE
preserve O
ejection O
fraction O
60 O
biatrial O
enlargement B-SYMPTOMS
normal O
ventricular O
chamber O
dopplerderive O
lv O
diastolic O
filling O
demonstrate O
restrictive O
pattern O
transmitral O
early O
filling O
wave O
deceleration O
time O
160 O
m O
elevated O
ea O
ratio O
28 O
markedly O
elevation O
ee O
ratio O
273 O
indicate O
elevate O
lv O
fill O
pressure O
day O
1 O
hospitalization O
prescribe O
angiotensinconverte O
enzyme O
ace O
inhibitor O
lowdose O
diuretic O
day O
3 O
hospitalization O
initiate O
ace O
inhibitor O
diuretic O
therapy O
patient O
symptom O
resolve O
dermatologist O
perform O
biopsy O
blue O
macula B-SYMPTOMS
forehead O
skin O
day O
4 O
introduce O
lowdose O
blocker O
perform O
endomyocardial O
biopsy O
emb O
obtain O
3 O
fragment O
right O
ventricular O
septum O
diagnostic O
confirmation O
cardiac O
amyloidosis B-DISEASE
require O
demonstration O
amyloid O
deposit O
addition O
perform O
right O
heart O
catheterization O
rhc O
coronary O
angiography O
exclude O
obstructive B-DISEASE
coronary I-DISEASE
artery I-DISEASE
disease I-DISEASE
datum O
obtain O
rhc O
indicate O
subset O
type O
iv O
accord O
forrester O
classification O
right O
ventricular O
pressure O
curve O
dipandplateau O
configuration O
skin O
biopsy O
reveal O
hyperkeratosis B-SYMPTOMS
epidermis O
mild O
inflammatory O
change O
dermis O
infiltration B-SYMPTOMS
lymphocyte O
speciman O
exhibit O
applegreen O
birefringence O
polarize O
light O
congo O
red O
staining O
figure O
4 O
histological O
examination O
myocardial O
speciman O
show O
sign O
suggest O
myocarditis B-DISEASE
eosinophilic O
granulomas B-DISEASE
cardiomyopathy B-DISEASE
iron O
deposition O
congo O
red O
staining O
reveal O
amyloid O
deposit O
figure O
5 O
addition O
strongly O
positive O
immunohistochemical O
reaction O
immunoglobulin O
chain O
myocardial O
interstitium O
lead O
diagnose O
patient O
systemic O
amyloidosis O
al B-DISEASE
amyloidosis I-DISEASE
patient O
generally O
tolerate O
lowdose O
blocker O
discharge O
day O
10 O
complication O
patient O
currently O
followedup O
6month O
interval O
outpatient O
exacerbation O
chf O
far O

institutional O
review O
board O
chengdu O
military O
general O
hospital O
approve O
work O
waive O
need O
inform O
consent O
2013 O
66yearold O
farmer O
history O
ventricular O
tachycardia O
vt B-DISEASE
hypertension B-DISEASE
present O
emergency O
department O
continuous O
palpitation B-SYMPTOMS
chest B-SYMPTOMS
tightness B-SYMPTOMS
profuse O
sweating B-SYMPTOMS
nausea B-SYMPTOMS
obvious O
predisposing O
cause O
patient O
experience O
sudden O
drop O
blood O
pressure O
acute O
confusion B-SYMPTOMS
immediate O
electrical O
conversion O
consciousness B-SYMPTOMS
gradually O
restore O
symptom O
relieve O
patient O
transfer O
department O
cardiology O
evaluation O
treatment O
patient O
blood O
pressure O
10575 O
mm O
hg O
admission O
heart O
rate O
75 O
beatsmin O
body O
temperature O
366c O
respiration O
rate O
18 O
timesmin O
heart O
border O
extend O
left O
apical O
impulse O
locate O
left O
5th O
intercostal O
space O
10 O
cm O
lateral O
midclavicular O
line O
patient O
history O
hypertension O
30 O
year O
regular O
antihypertensive O
medication O
high O
blood O
pressure O
170110 O
mm O
hg O
family O
history O
early O
coronary O
artery O
disease O
sudden O
cardiac O
death O
smoke O
cigarette O
use O
illicit O
drug O
rarely O
consume O
alcohol O
report O
known O
contact O
sick O
person O
recent O
travel O
twelvelead O
surface O
electrocardiogram O
ecg O
vt O
indicate O
origin O
vt O
boundary O
right O
ventricular O
outflow O
tract O
rvot O
tricuspid O
valve O
vt O
increase O
150 O
beatsmin O
high O
epsilon O
wave O
find O
precordial O
lead O
figure1a O
b O
contrast O
vt O
decrease O
120 O
beatsmin O
low O
epsilon O
wave O
appear O
lead O
v1v2 O
figure1c O
notably O
epsilon O
wave O
precede O
qrs O
wave O
lead O
v1v2 O
endocardiac O
tracing O
confirm O
correspond O
local O
potential O
originating O
rvot O
appear O
prior O
ventricular O
rhythm O
figure O
figure1d1d O
sinus O
ecg O
year O
2013 O
suggest O
slight O
left O
deviation O
electric O
axis O
heart O
rate O
87 O
beatsmin O
flat O
t O
wave O
lead O
ii O
t O
wave O
inversion O
find O
lead O
iii O
avf O
v1v3 O
epsilon O
wave O
find O
follow O
qrs O
complex O
lead O
v1v3 O
figure O
figure2b2b O
lead O
avr O
amplify O
epsilon O
wave O
find O
qrs O
wave O
figure O
2c O
atrial O
premature O
beat O
appear O
occasionally O
ventricular O
premature O
beat O
find O
originate O
right O
ventricular O
apex O
epsilon O
wave O
appear O
qrs O
wave O
figure O
figure2b2b O
contrast O
sinus O
ecg O
obtain O
year O
1999 O
reveal O
similar O
left O
deviation O
electric O
axis O
flat O
t O
wave O
t O
wave O
inversion O
absence O
epsilon O
wave O
figure O
figure2a2a O
datum O
biochemical O
assay O
follow O
cardiac O
troponin O
level O
0714 O
gl O
normal O
range O
0006 O
gl O
serum O
btype O
natriuretic O
peptide O
level O
466530 O
pgml O
normal O
range O
0100 O
pgml O
serum O
ddimer O
level O
814 O
mgl O
normal O
range O
0055 O
mgl O
blood O
urea O
level O
1169 O
mmoll O
normal O
range O
290720 O
mmoll O
serum O
creatinine O
level O
14400 O
moll O
normal O
range O
44133 O
moll O
serum O
uric O
acid O
level O
61140 O
moll O
normal O
range O
100432 O
moll O
endogenous O
creatinine O
clearing O
value O
5790 O
mlmin O
normal O
range O
80 O
mlmin O
echo O
datum O
reveal O
remarkably O
enlarge O
right O
atrium O
right O
ventricle O
widen O
rovt O
uncoordinated O
motion O
left O
right O
ventricular O
wall O
detect O
find O
aortic O
valve O
degradation B-SYMPTOMS
slight O
regurgitation B-SYMPTOMS
slight O
mitral O
regurgitation O
moderate O
severe O
tricuspid O
regurgitation O
left O
ventricular O
diastolic O
function O
reduce O
55 O
figure O
3a O
b O
coronary O
angiogram O
reveal O
vascular B-DISEASE
stenosis I-DISEASE
figure O
3ce O
base O
abovementione O
examination O
patient O
meet O
2 O
major O
criterion O
bilateral O
ventricular O
dilation O
existence O
epsilon O
wave O
provide O
diagnostic O
support O
arvc B-DISEASE
diet O
low O
salt O
low O
fat O
suggest O
patient O
treat O
metoprolol O
succinate O
sustainedrelease O
tablet O
2375 O
mg O
daily O
po O
amiodarone O
200 O
mg O
daily O
po O
furosemide O
20 O
mg O
daily O
iv O
compound O
ketoacid O
tablet O
252 O
g O
daily O
po O
vts O
different O
morphology O
cycle O
length O
find O
radiofrequency O
ablation O
figure O
4 O
substrate O
voltage O
mapping O
reveal O
anterior O
wall O
rvot O
wrap O
circular O
scar B-SYMPTOMS
figure O
5a O
consider O
association O
vt O
scar O
area O
substrate O
ablation O
choose O
patient O
residual O
potential O
scar O
area O
search O
linear O
focal O
ablation O
perform O
figure O
5b O
program O
stimulation O
induce O
stimulation O
induce O
vt O
procedure O
complete O
indicate O
success O
operation O
ecg O
radiofrequency O
ablation O
show O
sinus B-SYMPTOMS
rhythm I-SYMPTOMS
heart O
rate O
61 O
beatsmin O
t O
wave O
inversion O
lead O
iii O
avf O
epsilon O
wave O
t O
wave O
inversion O
lead O
v1v3 O
figure O
2d O
patient O
discharge O
hospital O
day O
9 O
regimen O
metoprolol O
succinate O
sustainedrelease O
tablet O
2375 O
mg O
daily O
po O
amiodarone O
hydrochloride O
tablet O
200 O
mg O
daily O
po O
spironolactone O
tablet O
40 O
mg O
daily O
po O
fosinopril O
sodium O
tablet O
10 O
mg O
daily O
po O
patient O
follow O
3 O
month O
discharge O
recurrent O
palpitation O
chest O
tightness O
profuse O
sweating O
nausea O
arvc O
main O
diagnosis O
time O
patient O
initial O
presentation O
essential O
case O
perform O
reassessment O
presence O
structural O
heart O
disease O
evolve O
time O

36 O
year O
old O
white O
woman B-SEX
40 O
week O
gestation O
admit O
local O
obstetric O
clinic O
elective O
repeat O
cesarean O
delivery O
slant O
position O
fetus O
previous O
current O
pregnancy O
uncomplicated O
past O
medical O
history O
unremarkable O
family O
history O
cardiac O
disease O
report O
caesarean O
delivery O
perform O
follow O
administration O
standard O
spinal O
anesthesia O
surgery O
patient O
hypotensive B-SYMPTOMS
ephedrine O
inject O
maintain O
blood O
pressure O
normal O
range O
hour O
delivery O
healthy O
male O
infant O
patient O
complain O
nausea B-SYMPTOMS
increase O
dyspnoea B-SYMPTOMS
palpitation O
physical O
examination O
tachycardia B-SYMPTOMS
ventricular O
extra O
systole O
pulmonary O
rale O
detect O
blood O
pressure O
8040 O
mmhg O
demand O
administration O
inotropic O
agent O
initially O
continuous O
infusion O
norepinephrine O
05 O
mgh O
follow O
dobutamine O
7 O
gkgmin O
owe O
worsening O
oxygen O
saturation O
70 O
   O
gradual O
deterioration O
consciousness O
mechanical O
ventilation O
apply O
patient O
transfer O
intensive O
care O
unit O
chest O
x O
ray O
indicate O
pulmonary B-DISEASE
congestion I-DISEASE
emergency O
computer O
tomography O
exclude O
pulmonary B-DISEASE
thromboembolism I-DISEASE
pe B-DISEASE
confirm O
severe O
pulmonary B-DISEASE
oedema I-DISEASE
fig1 O
patient O
receive O
loop O
diuretic O
furosemide O
initial O
daily O
dose O
80 O
mg O
progressively O
reduce O
diuretic O
discontinue O
12 O
day O
treatment O
electrocardiogram O
disclose O
sinus B-SYMPTOMS
tachycardia I-SYMPTOMS
st O
segment O
elevation O
15 O
mm O
negative O
t O
wave O
avl O
st O
segment O
depression O
1 O
mm O
ii O
iii O
avf O
v5v6 O
fig2 O
laboratory O
test O
show O
elevated O
troponin O
908 O
pgml O
normal O
value O
14 O
pgml O
not O
pro O
bnp O
6236 O
pgml O
normal O
value O
125 O
pgml O
bedside O
transthoracic O
echocardiography O
tte O
reveal O
severe O
left O
ventricular O
lv O
systolic B-DISEASE
dysfunction I-DISEASE
patient O
transfer O
intensive O
cardiac O
therapy O
clinic O
repeat O
tte O
show O
lv O
ejection O
fraction O
30 O
   O
hypokinesis B-SYMPTOMS
mid O
basal O
segment O
posterior O
anterior O
lateral O
wall O
preserve O
contractility O
apical O
segment O
urgent O
coronary O
angiography O
present O
normal O
coronary O
artery O
diagnosis O
invert O
stress O
induce O
cardiomyopathy B-DISEASE
set O
overall O
clinical O
datum O
3 O
day O
patient O
wean O
respirator O
extubate O
follow O
hemodynamic O
improvement O
inotropic O
agent O
taper O
gradually O
tte O
magnetic O
resonance O
image O
figs3 O
4 O
perform O
fifth O
day O
show O
complete O
recovery O
myocardial O
function O
patient O
discharge O
15 O
day O
good O
overall O
condition O
12 O
month O
follow O
remain O
asymptomatic B-SYMPTOMS
echocardiographic O
abnormality O

66yearold O
man B-SEX
admit O
hospital O
november O
2008 O
splenomegaly B-SYMPTOMS
high O
red O
cell O
count O
subnormal O
serum O
erythropoietin O
level O
cytogenetic O
analysis O
show O
normal O
male O
karyotype O
molecular O
study O
negative O
bcrabl1 O
rearrangement O
reveal O
jak2v617f B-SYMPTOMS
mutation I-SYMPTOMS
allele O
burden O
449 O
diagnosis O
pv B-DISEASE
basis O
morphological O
bone O
marrow O
analysis O
accord O
2008 O
criterion O
patient O
start O
aspirin O
hydroxyurea O
phlebotomy O
tolerate O
year O
later O
abdominal O
ultrasound O
scan O
reveal O
presence O
dense O
bilateral O
perinephric O
infiltration B-SYMPTOMS
confirm O
wholebody O
compute O
tomography O
ct O
scan O
fluotine18 O
fluordeoxyglucose O
positron O
emission O
tomography O
ffdgpet O
scan O
demonstrate O
increase O
glucose O
uptake B-SYMPTOMS
medullary O
channel O
humeri O
femur O
morphological O
bone O
marrow O
analysis O
confirm O
previous O
diagnosis O
pv O
show O
evident O
change O
grading O
bone O
marrow O
fibrosis B-DISEASE
mf0 O
accord O
eumnet O
consensus13 O
cytogenetic O
analysis O
reveal O
follow O
complex O
male O
karyotype O
47xy922047xyadd6p25922046xy1620 O
histological O
nature O
perinephric O
infiltration O
identify O
mean O
ctguided O
core O
biopsy O
lesion B-SYMPTOMS
morphological O
analysis O
demonstrate O
accumulation O
foamy O
histiocyte O
positive O
cd68 O
negative O
dendritic O
cell O
marker O
cd1a O
s100 O
surround O
fibrosis O
scanty O
lymphomonocytic O
infiltrate B-SYMPTOMS
figure O
figure11 O
detection O
brafv600e B-SYMPTOMS
mutation I-SYMPTOMS
lead O
diagnosis O
ecd B-DISEASE
cardiac O
magnetic O
resonance O
imaging O
mri O
reveal O
pseudotumoral O
infiltration O
atrioventricular O
wall14 O
bone O
scan O
show O
symmetrically O
irregular O
radiotracer O
uptake O
long O
bone O
limb O
consistent O
ecd O
figure O
figure222 O
finding O
cerebral O
pulmonary O
imaging O
negative O
accordance O
recent O
guideline O
treatment O
ecd1 O
patient O
start O
therapy O
pegylate O
interferon O
ifnalpha O
3 O
month O
treatment O
new O
abdominal O
ultrasound O
scan O
reveal O
complete O
resolution O
dense O
bilateral O
perinephric O
infiltration O
normalization O
blood O
cell O
count O
achieve O

50year O
old O
man B-SEX
history O
metastatic O
mucinous O
appendiceal B-DISEASE
adenocarcinoma I-DISEASE
present O
evaluation O
desquamate O
rash B-SYMPTOMS
face O
spread O
scalp O
inguinal O
region O
perineum O
past O
4 O
month O
figure O
1 O
rash O
accompany O
diffuse O
alopecia B-DISEASE
face O
scalp O
axilla O
groin O
improvement O
rash O
despite O
multiple O
round O
oral O
fluconazole O
topical O
antibiotic O
ointment O
intravenous O
antibiotic O
prior O
development O
rash O
complete O
neoadjuvant O
chemotherapy O
follow O
surgical O
resection O
undergo O
colostomy O
fail O
surgical O
correction O
enterocutaneous B-DISEASE
fistula I-DISEASE
require O
total O
parenteral O
nutrition O
tpn O
past O
year O
notice O
significant O
change O
ostomy O
output O
time O
dermatological O
examination O
reveal O
widespread O
erythematous O
plaque O
face O
scalp O
medial O
aspect O
thigh O
bilaterally O
scatter O
papule O
scale O
face O
scalp O
chest O
diffuse O
nonscarre O
alopecia O
present O
face O
scalp O
axillae O
groin O
patient O
acquire O
ae B-DISEASE
rare O
dermatologic O
condition O
cause O
zinc B-DISEASE
deficiency I-DISEASE
patient O
develop O
acquire O
zinc O
deficiency O
setting O
inadequate O
zinc O
supplementation O
tpn O
patient O
receive O
trace O
element O
approximately O
year O
national O
shortage O
key O
correct O
diagnosis O
acquire O
ae O
combination O
desquamate O
rash O
couple O
alopecia O
setting O
chronic O
supplemental O
alimentation O
reasonable O
consider O
skin O
biopsy O
skin O
biopsy O
definitively O
establish O
diagnosis O
paraneoplastic O
panel O
consider O
delay O
diagnosis O
presentation O
consistent O
nutritional O
deficiency O
appropriate O
start O
topical O
steroid O
cream O
diagnosis O
determine O
patient O
zinc O
level O
29 O
ugdl O
normal O
range O
56134 O
ugdl O
receive O
zinc O
supplementation O
tpn O
month O
patient O
complete O
resolution O
rash O
fatigue B-SYMPTOMS
gradual O
return O
hair B-SYMPTOMS
growth I-SYMPTOMS
figure O
2 O
repeat O
zinc O
level O
follow O
supplementation O
90 O
ugdl O
patient O
recover O
zinc O
deficiency O
later O
pass O
away O

present O
case O
16yearold O
girl B-SEX
admit O
clinic O
severe O
abdominal O
pain B-SYMPTOMS
loss O
appetite O
nausea B-SYMPTOMS
vomit B-SYMPTOMS
anamnesis O
reveal O
girl O
come O
family O
potter O
participate O
process O
pottery O
father O
diagnose O
lead B-DISEASE
poisoning I-DISEASE
2 O
year O
patient O
personal O
history O
underline O
approximately O
1 O
year O
ago O
present O
severe O
abdominal O
pain O
diagnose O
acute O
appendicitis B-DISEASE
undergo O
appendectomy O
pain O
persist O
family O
history O
lead O
poison O
suspicion O
saturnine B-DISEASE
colic I-DISEASE
rise O
diagnose O
lead O
poison O
urinary O
lead O
219 O
gl O
receive O
symptomatic O
treatment O
approximately O
3 O
week O
admission O
clinic O
admit O
regional O
hospital O
episode O
saturnine O
colic O
blood O
lead O
1132 O
gdl O
chelation O
therapy O
edta O
4 O
day O
admission O
clinic O
initiate O
dose O
2 O
tablet O
daily O
morning O
evening O
associate O
calcium O
supplement O
clinical O
examination O
perform O
time O
admission O
reveal O
follow O
pathological O
element O
influence O
general O
status O
ail O
face O
jaundice B-SYMPTOMS
sclera O
blue O
pigmentation B-SYMPTOMS
nail O
painful B-SYMPTOMS
abdoman O
palpation O
weight O
45 O
kg O
laboratory O
test O
perform O
admission O
reveal O
hypochromic O
anemia B-SYMPTOMS
hemoglobin O
hb O
109 O
gdl O
hematocrit O
htc O
316 O
medium O
cellular O
volume O
mcv O
776 O
fl O
increase O
level O
liver O
transaminase O
alanineaminotransferase O
alat O
1589 O
ul O
aspartateaminotransferase O
asat O
63 O
ul O
gammaglutamyltransferase O
ggt O
128 O
ul O
conjugate O
hyperbilirubinemia O
direct O
bilirubin O
dbi O
1432 O
mgdl O
hyponatremia B-SYMPTOMS
na O
132 O
mmoll O
hypopotassemia B-SYMPTOMS
k O
285 O
mmoll O
systolic O
arterial O
pressure O
156 O
mm O
hg O
diastolic O
96 O
mm O
hg O
blood O
lead O
level O
6628 O
gdl O
urinary O
4197 O
gl O
normal O
50 O
gl O
value O
deltaaminolevulinic O
acid O
766 O
mgl O
normal O
45 O
mgl O
perform O
abdominal O
ultrasound O
reveal O
disappearance B-SYMPTOMS
delimitation O
cortical O
medullar O
part O
kidney O
request O
consultation O
occupational O
healthcare O
specialist O
recommend O
continuation O
chelation O
therapy O
edta O
increase O
dose O
4 O
tabletsday O
require O
neurological O
consultation O
specialist O
establish O
diagnosis O
behavioral O
disorder O
depressive B-DISEASE
element O
recommend O
psychotherapy O
base O
clinical O
laboratory O
finding O
establish O
diagnosis O
lead O
poisoning O
initiate O
intense O
iv O
hydration O
order O
favor O
lead O
elimination O
approximately O
3 O
liter O
24 O
hour O
initially O
decrease O
progressively O
quantity O
cease O
vomit O
able O
consume O
liquid O
associate O
diuretic O
initially O
furosemide O
vein O
value O
arterial O
pressure O
persist O
upper O
limit O
force O
introduce O
angiotensinconverte O
enzyme O
inhibitor O
remission O
arterial B-SYMPTOMS
hypertension I-SYMPTOMS
liver O
function O
administer O
amino O
acid O
intravenously O
associate O
liver O
protector O
mouth O
administer O
vitamin O
b O
complex O
order O
improve O
neurological O
impairment O
evolution O
slightly O
favorable O
3 O
day O
admission O
patient O
continue O
present O
severe O
abdominal O
pain O
vomiting B-SYMPTOMS
complain O
pain O
lumbar O
area O
laboratory O
parameter O
present O
normalization O
value O
approximately O
10 O
day O
treatment O
6th O
day O
admission O
cease O
chelation O
therapy O
edta O
repeat O
blood O
urinary O
lead O
level O
blood O
level O
4557 O
gdl O
urinary O
8364 O
gl O
discharge O
patient O
abdominal O
ultrasound O
reevaluation O
reveal O
pathological O
modification O
14 O
day O
admission O
patient O
discharge O
complaint O
recommend O
exposure O
lead O
avoid O
contact O
working O
pottery O
process O
longterm O
outcome O
case O
depend O
exposure O
heavy O
metal O
intend O
repeat O
blood O
lead O
level O
12 O
24 O
month O
assess O
renal O
urea O
creatinine O
urinary O
exam O
hepatic O
function O
asat O
alat O
ggt O
bilirubin O

proband O
19yearold O
woman B-SEX
child O
healthy O
unrelated O
parent O
family O
history O
unremarkable O
bear O
term O
normal O
pregnancy O
perinatal O
period O
uneventful O
early O
development O
refer O
normal O
1 O
year O
age O
psychomotor B-DISEASE
delay I-DISEASE
evident O
start O
walk O
autonomously O
22 O
month O
poor O
balance O
frequent O
fall O
3 O
year O
age O
develop O
demyelinate O
sensorimotor O
neuropathy O
brain O
mri O
disclose O
supratentorial O
leukodystrophy B-DISEASE
childhood O
clinical O
sign O
remain O
stable O
10 O
year O
walk O
difficulty O
worsen O
limb O
weakness B-SYMPTOMS
tremor B-SYMPTOMS
ensue O
neurological O
evaluation O
show O
dysarthria B-SYMPTOMS
dysmetria B-SYMPTOMS
ataxic O
gait O
hyporeflexia B-SYMPTOMS
limb O
muscle O
waste O
able O
walk O
step O
ataxic O
gait O
mild O
cognitive B-DISEASE
impairment I-DISEASE
document O
iq O
75 O
wiscr O
scale O
histological O
analysis O
muscle O
biopsy O
show O
hypoatrophy O
fibre O
clinical O
evolution O
slowly O
progressive O
followup O
examination O
19 O
year O
age O
able O
walk O
anklefoot O
orthotic O
aid O
develop O
marked O
dorsallumbar O
scoliosis B-DISEASE
clinical O
sign O
stable O
neurophysiological O
study O
confirm O
worsen O
mixed O
axonal O
demyelinate O
peripheral O
neuropathy O
brain O
spinal O
cord O
mri O
show O
mild O
extension O
signal O
abnormality O
extensive O
cavitation O
cerebral O
white O
matter O
cerebellum O
brainstem O
spare O
spinal O
cord O
thin B-SYMPTOMS
obvious O
focal O
lesion O
figure O
1a O
plasma O
lactate O
29 O
mm O
nv O
21 O

54yearold O
patient O
admit O
fever B-SYMPTOMS
diarrhea B-SYMPTOMS
acute O
renal B-DISEASE
failure I-DISEASE
significant O
medical O
history O
medication O
travel O
recently O
relevant O
familial O
history O
day O
admission O
develop O
fever O
fluctuant O
rash B-SYMPTOMS
diarrhea O
pain B-SYMPTOMS
joint O
admission O
blood O
pressure O
14070 O
mm O
hg O
temperature O
39c O
physical O
examination O
show O
severe O
edema B-SYMPTOMS
involve O
low O
upper O
limb O
ascite O
pleural B-SYMPTOMS
effusion I-SYMPTOMS
cervical O
axillar O
infracentimetric O
lymphadenopathy O
present O
hepatosplenomegaly B-DISEASE
confirm O
compute O
tomography O
ct O
scan O
bilateral O
arthritis B-DISEASE
ankle O
resolve O
spontaneously O
blood O
analysis O
reveal O
table O
table11 O
leukocytosis B-SYMPTOMS
normal O
hemoglobin O
platelet O
level O
biologic O
sign O
hemolysis B-SYMPTOMS
elevate O
creactive O
protein O
low O
albumin O
elevate O
serum O
creatinin O
mild O
proteinuria B-SYMPTOMS
hematuria B-SYMPTOMS
despite O
intravenous O
rehydration O
saline O
albumin O
renal O
function O
worsen O
patient O
require O
dialysis O
diagnostic O
investigation O
perform O
hemiplegia B-DISEASE
occur O
brain O
mri O
show O
multifocal O
ischemic O
lesion O
echographic O
rythmologic O
study O
rule O
cardiologic B-DISEASE
cause I-DISEASE
stroke B-DISEASE
renal O
biopsy O
perform O
fig1a O
b O
periodic O
acidschiff O
pas O
staining O
show O
endotheliosis B-DISEASE
glomerulus O
fig1a O
arrow O
associate O
mesangiolysis B-DISEASE
double O
contour O
silver O
stain O
fig1b O
arrow O
arteriolar O
thrombus B-SYMPTOMS
moderate O
cd20 O
b B-SYMPTOMS
lymphocyte I-SYMPTOMS
infiltrate I-SYMPTOMS
present O
interstitium O
peritubularcapillaritis B-SYMPTOMS
immunofluorescence O
study O
deposit B-SYMPTOMS
lymph O
node O
biopsy O
fig2a O
b O
show O
abnormal B-SYMPTOMS
follicle O
hyalinization B-SYMPTOMS
germinal O
center O
onionskin O
aspect O
mantle O
zone O
clinical O
presentation O
lymph O
node O
histology O
consistent O
hyalinevascular O
multicentric B-DISEASE
castleman I-DISEASE
disease I-DISEASE
mcd B-DISEASE
hiv O
hhv8 O
serology O
hhv8 O
lymph O
node O
tissue O
staining O
negative O
serum O
vascular O
endothelium O
growth O
factor O
vegf O
highly O
elevate O
biologic O
manifestation O
thrombotic B-DISEASE
microangiopathy I-DISEASE
tma B-DISEASE
renal O
biopsy O
brain O
mri O
consistent O
glomerular O
neurologic O
tma O
lesion O
apparent O
cause O
thrombotic O
microvascular B-SYMPTOMS
involvement I-SYMPTOMS
note O
notably O
evidence O
infection O
shiga O
toxinproducing O
germ O
adamts13 O
activity O
decrease O
14 O
remain O
5 O
alternative O
complement O
pathway O
normal O
plasma O
exchange O
initiate O
kidney O
histological O
lesion O
multifocal O
ischemic O
brain O
lesion O
discontinue O
1 O
month O
onset O
disease O
patient O
condition O
remain O
stable O
furthermore O
chemotherapy O
include O
6 O
course O
rituximab O
375 O
mgm2 O
cyclophosphamide O
750 O
mgm2 O
dexamethasone O
40 O
mgday O
day O
1 O
day O
4 O
start O
plasma O
exchange O
chemotherapy O
perform O
immediately O
plasma O
exchange O
course O
perform O
3 O
week O
clinical O
manifestation O
vascular B-DISEASE
leak I-DISEASE
syndrome I-DISEASE
regress O
renal O
function O
normalize O
serum O
vegf O
level O
decrease O
825 O
pgml O
1 O
course O
chemotherapy O
patient O
discharge O
43 O
day O
admission O
neurological B-DISEASE
event I-DISEASE
occur O
initiate O
treatment O
thoracoabdominal O
ct O
scan O
perform O
6 O
course O
chemotherapy O
show O
normal O
liver O
spleen O
size O
lymph O
node O
enlargement B-SYMPTOMS
year O
diagnosis O
remission O
mcd O
persistent O
plasma O
creatinine O
86 O
moll O
proteinuria O

patient O
18yearold O
han O
female B-SEX
admit O
peke O
union O
medical O
college O
hospital O
adrenal B-DISEASE
crisis I-DISEASE
trigger O
pneumonia B-DISEASE
develop O
recurrent O
respiratory O
infection B-DISEASE
age O
5 O
fail O
respond O
multiple O
hepatitis O
b O
virus O
hbv O
vaccination O
reduce O
serum O
cortisol O
acth O
level O
discover O
16 O
glucocorticoid O
replacement O
initiate O
addition O
hair B-SYMPTOMS
loss I-SYMPTOMS
start O
age O
4 O
absence O
pubic O
axillary O
hair O
notice O
development O
regular O
menstruation O
history O
include O
nephrotic B-DISEASE
syndrome I-DISEASE
confirm O
minimal B-DISEASE
change I-DISEASE
nephropathy I-DISEASE
renal O
biopsy O
physical O
examination O
admission O
reveal O
alopecia B-DISEASE
totalis I-DISEASE
oral O
candidiasis B-DISEASE
hypohidrosis B-DISEASE
trachyonychia B-SYMPTOMS
facial O
dental O
abnormality O
note O
child O
family O
symptom O
sign O
disorder O
identify O
nonconsanguineous O
parent O
initial O
immunologic O
test O
reveal O
remarkable O
panhypogammaglobulinemia B-SYMPTOMS
reduce O
cell O
count O
b O
cell O
t O
cell O
natural O
killer O
nk O
cell O
table O
table11 O
cd4cd8 O
ratio O
expression O
level O
tcell O
activation O
marker O
normal O
range O
increase O
proportion O
cd8hladr O
subset O
antinuclear O
antibodie O
ana O
antineutrophil O
cytoplasmic O
antibody O
anca O
negative O
regular O
hydrocortisone O
replacement O
suspend O
800 O
serum O
cortisol O
measure O
093 O
gdl O
acth O
500 O
pgml O
serum O
level O
anterior O
pituitary O
hormone O
serum O
urine O
osmolality O
reference O
range O
antiperoxidase O
antibody O
antithyroglobulin O
antibody O
negative O
positive O
antiprotein O
tyrosine O
phosphatase O
antibody O
fast O
blood O
glucose O
59 O
mmoll O
magnetic O
resonance O
image O
contrast O
suggest O
normal O
pituitary O
diagnose O
cvid B-DISEASE
isolate O
acth O
deficiency O
ectodermal B-DISEASE
dysplasia I-DISEASE
symptom O
fever B-SYMPTOMS
cough B-SYMPTOMS
vomiting B-SYMPTOMS
clear O
antibiotic O
stressdose O
hydrocortisone O
treatment O
intravenous O
immunoglobulin O
ivig O
therapy O
suggest O
deny O
parent O
followup O
1 O
year O
discharge O
report O
infection O
event O
previous O
year O
stay O
home O
avoid O
outdoor O
activity O
glucocorticoid O
replacement O
withdraw O
4 O
month O
discharge O
receive O
traditional O
chinese O
medicine O
lymphocyte O
subset O
test O
followup O
document O
increase O
level O
b O
cell O
t O
cell O
nk O
cell O
count O
remain O
normal O
limit O
assess O
nkcell O
activity O
flow O
cytometric O
procedure O
follow O
previously O
describe O
method1011 O
effector O
target O
cell O
ratio O
set O
101 O
apoptosis O
target O
cell O
line O
1243 O
reference O
range O
15112691 O
observe O
coculture O
patient O
peripheral O
blood O
mononuclear O
cell O
pbmc O
indicate O
deficient O
nkcell O
cytotoxicity O

69yearold O
male B-SEX
diabetic O
patient O
admit O
acute O
leave O
ventricular O
lv O
failure O
treat O
intensive O
decongestive O
therapy O
severe O
peripheral O
edema B-SYMPTOMS
bilateral O
basal O
crepitation O
initial O
workup O
reveal O
normal O
level O
troponine O
001 O
ngml O
cpkmb O
46 O
ngml O
rule O
acute B-DISEASE
coronary I-DISEASE
syndrome I-DISEASE
level O
bnp O
1230 O
pgml O
confirm O
diagnosis O
heart B-DISEASE
failure I-DISEASE
echocardiographic O
assessment O
reveal O
lvef O
10 O
dilate O
cardiac O
chamber O
estimate O
pulmonary O
artery O
systolic O
pressure O
pasp O
70 O
mm O
hg O
feature O
raise O
lv O
diastolic O
pressure O
angiography O
perform O
3 O
day O
decongestive O
therapy O
reveal O
critical O
triple B-DISEASE
vessel I-DISEASE
disease I-DISEASE
left O
main O
coronary B-DISEASE
artery I-DISEASE
disease I-DISEASE
fig1 O
refer O
cabg O
patient O
frusemide O
infusion O
oral O
ramipril O
aldactone O
take O
elective O
opcab O
1 O
week O
angiography O
renal O
function O
monitor O
regularly O
adjust O
diuretic O
dose O
feature O
end B-DISEASE
organ I-DISEASE
dysfunction I-DISEASE
st O
risk O
mortality O
24 O
repeat O
echocardiographic O
assessment O
reveal O
improvement O
lvef O
15 O
decrease O
pasp O
30 O
mm O
hg O
decrease O
lv O
fill O
pressure O
opcab O
perform O
median O
sternotomy O
leave O
ita O
grafting O
leave O
anterior O
descend O
artery O
lad O
revascularize O
lad O
right O
ita O
rita O
ra O
composite O
graft O
prepare O
distal O
end O
rita O
revascularize O
diagonal O
artery O
significant O
improvement O
systolic O
blood O
pressure O
distal O
anastomosis O
graft O
heart O
lift O
lateral O
posterior O
wall O
vessel O
long O
skin O
incision O
open O
sternum O
widely O
release O
pericardium O
right O
displace O
heart O
gradually O
supplement O
headlow O
lateral O
tilt O
position O
liberal O
dose O
inotropic O
support O
ra O
sequential O
grafting O
obtuse O
marginal O
posterior O
lv O
branch O
posterior O
descend O
artery O
distal O
anastamose O
perform O
uneventfully O
patient O
electively O
ventilate O
2 O
day O
echocardiography O
1st O
pod O
reveal O
improvement O
lvef O
20 O
start O
low O
dose O
beta O
blocker O
inotropic O
support O
wean O
slow O
uneventful O
recovery O
echocardiography O
4th O
pod O
reveal O
improvement O
lvef O
30 O
table O
1 O
persistent O
pleural B-SYMPTOMS
drainage I-SYMPTOMS
require O
prolong O
intensive O
care O
unit O
stay O
pleural O
drainage O
subside O
drain O
remove O
discharge O
diuretics O
low O
dose O
beta O
blocker O
ramipril O

70yearold O
male B-SEX
admit O
hospital O
perioperative O
cardiac O
evaluation O
abdominal O
aortic O
aneurysm B-DISEASE
patient O
undergo O
coronary O
artery O
bypass O
grafting O
cabg O
severe O
stenosis B-SYMPTOMS
left O
main O
coronary O
artery O
lmca O
4 O
year O
consist O
right O
internal O
thoracic O
artery O
rita O
left O
anterior O
descend O
artery O
lad O
saphenous O
vein O
graft O
svg O
left O
circumflex O
artery O
lcx O
continual O
growth O
abdominal O
aortic O
aneurysm O
year O
surgery O
indicate O
leave O
coronary O
angiogram O
show O
90 O
   O
stenosis O
lmca O
total O
occlusion B-SYMPTOMS
graft O
pci O
perform O
lmca O
stenosis O
fig1 O
7fr O
sheath O
insert O
right O
femoral O
artery O
cls4 O
guide O
catheter O
boston O
scientific O
natick O
ma O
usa O
engage O
left O
coronary O
artery O
lca O
ostium O
guidewire O
sion O
blue O
asahi O
intecc O
aichi O
japan O
insert O
distal O
lad O
guidewire O
hitorque O
pilot O
50 O
abbott O
vascular O
santa O
clara O
california O
usa O
insert O
distal O
lcx O
intravascular O
ultrasound O
ivus O
intrafocus O
wr O
terumo O
corp O
tokyo O
japan O
demonstrate O
heavy O
circumferential O
calcification B-SYMPTOMS
lmca O
lesion B-SYMPTOMS
40 O
   O
15 O
mm O
quantum O
maverick O
balloon O
catheter O
boston O
scientific O
inflate O
lesion O
lca O
angiogram O
reveal O
large O
dissection B-SYMPTOMS
fig2 O
40 O
   O
28 O
mm O
multilink O
vision O
stent O
abbott O
vascular O
immediately O
deploy O
angiographic O
image O
residual O
dissection O
disappear O
stent O
dilate O
50 O
   O
15 O
mm O
quantum O
maverick O
balloon O
catheter O
absence O
residual O
dissection O
confirm O
angiography O
stent O
implantation O
lmcalad O
lmcalcx O
kiss O
balloon O
angioplasty O
initiate O
40 O
   O
28 O
mm O
stent O
delivery O
balloon O
lad O
30 O
mm O
   O
15 O
mm O
ikazuchi O
balloon O
kaneka O
medics O
tokyo O
japan O
lcx O
final O
angiographic O
imaging O
show O
optimal O
result O
ivus O
imaging O
lesion O
show O
completely O
seal O
stent O
fig3 O
large O
hematoma B-SYMPTOMS
femoral O
puncture O
site O
local O
bleeding B-SYMPTOMS
observe O
removal O
femoral O
sheath O
manual O
compression O
apply O
haemostasis O
hematoma O
appear O
spread O
day O
patient O
discharge O
hospital O
fifth O
day O
pci O
unexpectedly O
patient O
admit O
emergency O
room O
newonset O
chest O
pain B-SYMPTOMS
dyspnoea B-SYMPTOMS
day O
discharge O
vital O
sign O
indicate O
cardiogenic B-SYMPTOMS
shock I-SYMPTOMS
electrocardiogram O
show O
st B-SYMPTOMS
elevation I-SYMPTOMS
lead O
v1v3 O
echocardiography O
detect O
leave O
ventricular O
asynergy B-SYMPTOMS
large O
mass B-SYMPTOMS
outflow O
tract O
right O
ventricular O
chamber O
observe O
fig4 O
contrastenhance O
compute O
tomography O
show O
40 O
mm O
hematoma O
compress O
main O
pulmonary O
artery O
trunk O
right O
ventricle O
fig5 O
examination O
patient O
suffer O
sudden O
cardiopulmonary B-DISEASE
arrest I-DISEASE
receive O
immediate O
cardiopulmonary O
resuscitation O
return O
spontaneous B-SYMPTOMS
circulation I-SYMPTOMS
insertion O
percutaneous O
cardiopulmonary O
support O
device O
patient O
undergo O
emergent O
surgery O
removal O
hematoma O
inform O
consent O
obtain O
patient O
family O
surgery O
large O
dark O
red O
clot O
pulmonary O
artery O
trunk O
aorta O
observe O
suspect O
origin O
epicardial O
hematoma O
blood O
ooze O
lmca O
stent O
site O
despite O
successful O
surgical O
repair O
patient O
die O
aortic B-DISEASE
rupture I-DISEASE
induce O
external O
cardiac O
massage O

patient O
59yearold O
man B-SEX
diagnose O
pd B-DISEASE
age O
49 O
year O
fluctuation O
recur O
state O
peak O
dose O
dyskinesias B-DISEASE
severely O
diminish O
patient O
quality O
life O
patient O
deem O
candidate O
bilateral O
subthalamic O
dbs O
multidisciplinary O
evaluation O
75 O
   O
positive O
response O
standardized O
levodopa O
test O
exclusion O
cognitive B-DISEASE
decline I-DISEASE
psychiatric B-DISEASE
comorbitity I-DISEASE
absence O
structural O
brain B-DISEASE
damage I-DISEASE
potentially O
relevant O
lead O
placement O
lead O
unanimous O
decision O
dbs O
placement O
decision O
proceed O
surgery O
medication O
consist O
11125 O
mg O
levodopa O
150 O
mg O
piribedil O
history O
orofacial O
cervical O
dystonia B-DISEASE
state O
patient O
alert B-SYMPTOMS
sign O
psychiatric O
comorbidity O
neuropsychological O
testing O
adequate O
cranial O
nerve O
deficit O
find O
swallow O
normal O
gait O
postural O
stability O
normal O
minimal O
rigidity B-SYMPTOMS
neck O
right O
arm O
coordinative O
motor O
skill O
rapid O
pro O
supination O
restrict O
left O
hand O
dyskinesias O
evident O
moderate O
impairment B-SYMPTOMS
state O
medication O
hold O
12 O
h O
patient O
show O
mild O
dysarthria B-SYMPTOMS
dysphonia B-SYMPTOMS
rest O
tremor B-SYMPTOMS
right O
arm O
leg O
slight O
action O
tremor O
right O
hand O
rigidity O
severe O
neck O
mark O
right O
mild O
left O
motor O
skill O
hand O
markedly O
impair O
gait O
slow O
unaided O
comprised O
intermittent O
freezing B-SYMPTOMS
mild O
dystonic B-SYMPTOMS
posturing I-SYMPTOMS
right O
foot O
sign O
laryngeal O
spasm B-SYMPTOMS
day O
surgery O
dose O
dopaminergic O
medication O
administer O
0700 O
pm O
bedtime O
dose O
levodopa O
hold O
facilitate O
intraoperative O
testing O
day O
operation O
patient O
underwent O
placement O
stereotactic O
frame O
local O
anaesthesia O
0900 O
plan O
standard O
stn O
coordinate O
trajectorie O
patient O
place O
semisitting O
position O
table O
frame O
attach O
table O
patient O
request O
head O
slightly O
flex O
anteriorly O
comfort O
left O
electrode O
place O
uneventfully O
perform O
bur O
hole O
right O
patient O
complain O
cramp O
neck O
facial O
muscle O
difficulty O
breathe O
point O
pulse O
oximetry O
show O
good O
saturation O
reading O
95 O
   O
progress O
dystonic B-SYMPTOMS
dysarthria I-SYMPTOMS
6 O
microelectrode O
recording O
macroelectrode O
test O
stimulation O
begin O
patient O
show O
highpitche O
inspiratory O
stridor B-SYMPTOMS
pulse O
oximetry O
show O
decrease O
oxygen O
saturation O
0215 O
pm O
shortly O
narrow O
complex O
tachycardia B-SYMPTOMS
note O
minute O
patient O
unresponsive B-SYMPTOMS
cardiac O
resuscitation O
initiate O
patient O
fiberoptically O
intubate O
removal O
bar O
stereotactic O
frame O
fiberoptic O
intubation O
laryngeal O
spasm O
confirm O
visually O
transthoracic O
echocardiogram O
obtain O
immediately O
successful O
resuscitation O
show O
cardiac O
pathology B-SYMPTOMS
air O
bubble O
stimulation O
implant O
lead O
resolve O
symptom O
possible O
time O
lead O
subcutaneously O
tunnel O
impulse O
generator O
attach O
right O
permanent O
electrode O
place O
testing O
accord O
microelectrode O
recording O
50 O
mg O
levodopa O
administer O
nasogastric O
tube O
hour O
subsequent O
postoperative O
period O
postoperative O
head O
ct O
scan O
immediately O
procedure O
normal O
patient O
transfer O
intensive O
care O
unit O
extubate O
0200 O
pm O
follow O
day O
neurological B-SYMPTOMS
deficit I-SYMPTOMS
sign O
laryngeal O
spasm O
nasogastric O
tube O
discontinue O
preoperative O
medication O
resume O
cardiac O
workup O
negative O
impulse O
generator O
implant O
7 O
day O
later O
patient O
show O
good O
symptom O
control O
pd O

47yearold O
woman B-SEX
present O
hospital O
1month O
history O
abdominal O
distention B-SYMPTOMS
physical O
examination O
reveal O
huge O
mass B-SYMPTOMS
low O
abdoman O
peripheral O
blood O
test O
show O
elevated O
level O
carcinoembryonic O
antigen O
cea O
3352 O
ngml O
normal O
5 O
ngml O
carbohydrate O
antigen O
125 O
219 O
uml O
normal O
45 O
uml O
normal O
level O
ca199 O
9 O
uml O
normal O
37 O
uml O
compute O
tomography O
ct O
demonstrate O
large O
round O
mass O
maximum O
diameter O
15 O
cm O
pelvic O
cavity O
presence O
ascite O
pleural B-SYMPTOMS
effusion I-SYMPTOMS
fig1a O
b O
colonoscopy O
identify O
elevated O
lesion B-SYMPTOMS
severe O
stenosis B-SYMPTOMS
sigmoid O
colon O
histopathological O
examination O
biopsy O
specimen O
tumor O
show O
moderately O
differentiate O
adenocarcinoma B-DISEASE
schedule O
early O
operation O
patient O
develop O
acute O
dyspnea B-SYMPTOMS
general O
edema B-SYMPTOMS
2 O
week O
ct O
scan O
second O
ct O
scan O
examination O
demonstrate O
massive O
bilateral O
pleural O
effusion O
atelectasis B-SYMPTOMS
ascite O
fig2a O
b O
thoracic O
drainage O
laparotomy O
emergently O
perform O
macroscopically O
tumor O
sigmoid O
colon O
invade O
serosa O
huge O
pelvic O
mass O
find O
contain O
right O
ovarian B-DISEASE
tumor I-DISEASE
small O
nodule O
peritoneal O
dissemination B-SYMPTOMS
distribute O
great O
omentum O
perioperatively O
3800 O
ml O
serous O
ascitic B-SYMPTOMS
fluid B-SYMPTOMS
drain O
cytodiagnosis O
fluid O
drain O
ascite O
pleural O
effusion O
reveal O
tumor O
cell O
bilateral O
oophorectomy O
total O
hysterectomy O
omentectomy O
sigmoidectomy O
regional O
node O
dissection O
perform O
fig3a O
histopathological O
examination O
resect O
specimen O
show O
moderately O
differentiate O
adenocarcinoma O
tumor O
ovary O
sigmoid O
colon O
fig3b O
dissect O
paracolic O
node O
show O
malignant O
cell O
immunohistochemically O
tumor O
cell O
ovary O
colon O
show O
positive O
expression O
cytokeratin O
20 O
ck20 O
expression O
cytokeratin O
7 O
ck7 O
confirm O
ovarian O
tumor O
metastasis O
primary B-DISEASE
colon I-DISEASE
cancer I-DISEASE
fig4a O
b O
postoperative O
course O
uneventful O
pleural O
effusion O
ascite O
rapidly O
resolve O
postoperatively O
regimen O
5fluorouracil O
5fu O
leucovorin O
oxaliplatin O
folfox O
administer O
2 O
week O
5 O
month O
29 O
month O
operation O
patient O
require O
curative O
hepatic O
resection O
liver O
metastasis O
78 O
month O
operation O
patient O
remain O
alive B-SYMPTOMS
evidence O
disease B-DISEASE

76yearold O
woman B-SEX
present O
hospital O
complaint O
epigastralgia B-SYMPTOMS
day O
prior O
admission O
laboratory O
datum O
admission O
reveal O
elevation O
aminotransferase O
alanine O
aminotransferase O
guanosine O
triphosphate O
alkaline O
phosphatase O
serum O
total O
bilirubin O
tumor B-SYMPTOMS
marker O
carcinoembryonic O
antigen O
cea O
carbohydrate O
antigen O
199 O
ca199 O
span1 O
neuronspecific O
enolase O
nse O
normal O
range O
abdominal O
compute O
tomography O
ct O
magnetic O
resonance O
cholangiopancreatography O
mrcp O
show O
mass B-SYMPTOMS
enlarged B-SYMPTOMS
gallbladder O
bulky B-SYMPTOMS
hepatic O
lymph O
node O
surround O
hepatic O
hilum O
fig1a O
b O
apparent O
lesion O
upper O
low O
gastrointestinal O
endoscopy O
endoscopic O
ultrasoundguided O
fineneedle O
aspiration O
eusfna O
perform O
obtain O
tissue O
hilar O
lymph O
node O
immunohistochemical O
staining O
speciman O
identify O
diffuse O
positivity O
keratin O
cd56 O
synaptophysin O
tumor O
cell O
consistent O
nec B-DISEASE
endoscopic O
nasogallbladder O
drainage O
engbd O
catheter O
place O
bile O
cytology O
reveal O
class O
v O
malignant O
cell O
positron O
emission O
tomographycompute O
tomography O
petct O
examination O
perform O
evaluate O
primary O
metastatic O
lesion O
reveal O
accumulate O
lesion O
identify O
accumulation O
18f O
fluorodeoxyglucose O
fdg O
gallbladder O
suvmax O
78 O
lymph O
node O
suvmax O
134 O
fig1c O
d O
basis O
finding O
likely O
diagnosis O
gallbladder O
nec O
confine O
regional O
hepatic O
hilar O
lymph O
node O
metastasis B-DISEASE
finally O
decide O
perform O
surgical O
resection O
prior O
chemotherapy O
concern O
complication O
develop O
mechanical O
obstruction B-DISEASE
hepatic O
hilum O
enlarged O
lymph O
node O
undergo O
cholecystectomy O
hepatic O
hilar O
lymphadenectomy O
extrahepatic O
biliary O
duct O
resection O
hepaticojejunostomy O
bulky O
lymph O
node O
totally O
resect O
en O
bloc O
apparent O
residual O
lesion O
surgically O
postoperative O
course O
uneventful O
discharge O
tenth O
day O
surgery O
macroscopically O
tumor O
58 O
   O
42 O
mm O
size O
locate O
fundus O
contain O
yellowish O
gallstone B-SYMPTOMS
fig2a O
portion O
hepatic O
hilar O
lymph O
node O
71 O
   O
37 O
mm O
excise O
separately O
fig2b O
microscopic O
examination O
gallbladder O
reveal O
moderate O
differentiate O
tubular O
adenocarcinoma B-DISEASE
infiltrate O
mucosa O
muscular O
layer O
serosal O
surface O
nec O
component O
fig2c O
d O
tumor O
cell O
gallbladder O
slightly O
positive O
synaptophysin O
cd56 O
negative O
chromogranin O
fig2eg O
resection O
margin O
liver O
bed O
negative O
tumor O
cell O
epithelium O
carcinoma B-DISEASE
show O
intestinal O
metaplasia B-SYMPTOMS
goblet O
cell O
fig4a O
area O
stain O
alcian O
blue O
fig4b O
hand O
hepatic O
hilar O
lymph O
node O
compose O
small O
round O
tumor O
cell O
hyperchromatic O
nucleus O
scant O
cytoplasm O
fig3a O
tumor O
cell O
large O
vesicular O
nucleus O
tumor O
cell O
arrange O
sheet O
cord O
trabecular O
rosette O
fashion O
intersperse O
focal O
necrosis B-SYMPTOMS
immunohistochemically O
positive O
cd56 O
synaptophysin O
chromogranin O
fig3b3d O
mitotic O
count O
24 O
10 O
highpower O
microscopic O
field O
ki67 O
proliferation O
index O
7080 O
consistent O
nec O
surgical O
dissection O
margin O
hepatic O
lymph O
node O
microscopically O
cauterize O
tumor O
cell O
invasion B-SYMPTOMS
extrahepatic O
biliary O
duct O
result O
thorough O
pathological O
reevaluation O
total O
segmentation O
negligible O
area O
adenocarcinoma O
detect O
lymph O
node O
fig3e O
f O
adenocarcinoma O
component O
intestinal O
metaplastic O
epithelium O
gallbladder O
positive O
cdx2 O
fig4a O
neuroendocrine O
component O
hilar O
lymph O
node O
negative O
cdx2 O
fig4b O
postoperatively O
patient O
receive O
cycle O
carboplatin O
area O
curve O
5 O
day O
1 O
repeat O
21 O
day O
etoposide O
80 O
mgm2 O
day O
1 O
3 O
repeat O
21 O
day O
course O
grade O
4 O
neutropenia B-SYMPTOMS
occur O
manage O
prophylactic O
fluoroquinolone O
4 O
month O
multiple O
recurrence O
paraaortic O
lymph O
node O
detect O
pathologically O
demonstrate O
eusfna O
nec O
patient O
underwent O
secondline O
chemotherapy O
amrubicin O
24 O
mgm2 O
day O
1 O
3 O
repeat O
21 O
day O
grade O
4 O
neutropenia O
anemia B-SYMPTOMS
develop O
course O
need O
receive O
pegylate O
granulocyte O
colonystimulate O
factor O
red O
blood O
cell O
transfusion O
die O
progressive B-DISEASE
disease I-DISEASE
8 O
month O
surgery O

20yearold O
previously O
healthy O
bengali O
man B-SEX
present O
hospital O
anuria B-SYMPTOMS
feature O
uremic O
encephalopathy B-DISEASE
day O
prior O
presentation O
experience O
severe O
upper O
abdominal O
pain B-SYMPTOMS
vomiting B-SYMPTOMS
treat O
primary O
care O
facility O
have O
case O
acute O
pancreatitis B-DISEASE
initial O
symptom O
improve O
gradually O
anuric B-SYMPTOMS
disorient O
transfer O
hospital O
management O
presentation O
hospital O
severely O
agitated B-SYMPTOMS
restless B-SYMPTOMS
disorient O
tachypneic B-SYMPTOMS
acidotic B-SYMPTOMS
breath I-SYMPTOMS
mild O
pedal O
edema B-SYMPTOMS
present O
jugular O
venous O
pressure O
raise O
pulse O
112 O
beatsminute O
blood O
pressure O
14090 O
mmhg O
body O
temperature O
98 O
f O
sign O
meningeal O
irritation B-SYMPTOMS
absent O
plantar O
response O
bilaterally O
extensor O
fundus O
evaluate O
examination O
system O
unremarkable O
laboratory O
parameter O
show O
feature O
renal B-DISEASE
dysfunction I-DISEASE
serum O
creatinine O
13 O
mgdl O
serum O
urea O
293 O
mgdl O
raise O
pancreatic O
enzyme O
serum O
amylase O
249 O
ul O
reference O
100 O
ul O
serum O
lipase O
227 O
ul O
reference O
1360 O
ul O
normal O
liver O
function O
test O
serum O
bilirubin O
09 O
mgdl O
alanine O
aminotransferase O
38 O
ul O
aspartate O
aminotransferase O
35 O
ul O
alkaline O
phosphatase O
122 O
ul O
serum O
albumin O
37 O
gl O
normal O
potassium O
51 O
mmoll O
normal O
bicarbonate O
19 O
mmoll O
normal O
triglyceride O
173 O
mgdl O
serological O
marker O
include O
antinuclear O
antibodie O
cytoplasmic O
antineutrophil O
cytoplasmic O
antibodie O
perinuclear O
antineutrophil O
cytoplasmic O
antibodie O
c3 O
c4 O
normal O
limit O
ultrasonogram O
abdoman O
unremarkable O
noncontrastenhanced O
computed O
tomography O
ct O
finding O
suggestive O
acute O
pancreatitis O
fig1 O
kidney O
unremarkable O
patient O
manage O
have O
case O
aki B-DISEASE
acute O
pancreatitis O
urgent O
hemodialysis O
initiate O
receive O
session O
hemodialysis O
level O
consciousness O
improve O
complain O
profound O
visual B-DISEASE
loss I-DISEASE
assessment O
reveal O
perception O
light O
funduscopic O
examination O
show O
retinal B-SYMPTOMS
whitening I-SYMPTOMS
extensive O
cotton B-SYMPTOMS
wool I-SYMPTOMS
exudate I-SYMPTOMS
purtscher O
flecken O
fig2 O
compatible O
purtscher O
retinopathy O
highdose O
parenteral O
methylprednisolone O
1 O
g O
intravenously O
daily O
3 O
day O
administer O
evaluation O
renal O
dysfunction O
renal O
biopsy O
histopathological O
finding O
compatible O
renal B-DISEASE
cortical I-DISEASE
necrosis I-DISEASE
fig3 O
patient O
deny O
substance O
abuse O
alcohol O
ingestion O
consume O
nephrotoxic O
drug O
herbal O
product O
recent O
past O
history O
suggest O
connective O
tissue O
disease O
available O
history O
hypotension B-SYMPTOMS
course O
current O
illness O
patient O
finally O
diagnose O
acute O
pancreatitis O
complicate O
renal O
cortical O
necrosis O
lead O
aki O
purtscher O
retinopathy O
lead O
complete O
bilateral O
blindness B-DISEASE
die O
16 O
month O
initial O
presentation O
result O
recurrent O
attack O
acute O
pancreatitis O
undergo O
maintenance O
hemodialysis O
renal O
function O
recover O
vision O
improve O
fingercounte O
2 O
foot O

female B-SEX
outpatient O
50 O
routinely O
visit O
hospital O
liver B-DISEASE
cirrhosis I-DISEASE
result O
hepatitis B-DISEASE
b I-DISEASE
virus I-DISEASE
biliary O
duct O
stone O
65 O
year O
age O
suffer O
hcc B-DISEASE
bclc O
early O
stage O
liver O
function O
preserved O
childpugh O
score O
underwent O
leave O
lateral O
segmentectomy O
hcc O
preoperative O
treatment O
histopathological O
finding O
reveal O
bridge O
fibrosis B-DISEASE
pseudolobule B-DISEASE
formation I-DISEASE
serum O
level O
alphafetoprotein O
afp O
protein O
induce O
vitamin O
k O
absenceii O
normalize O
primary O
resection O
figure O
1 O
image O
study O
ln O
metastasis B-SYMPTOMS
detect O
time O
primary O
resection O
hcc O
half O
year O
postoperatively O
patient O
afp O
level O
increase O
dramatically O
7802 O
ngml O
lobular O
lesion B-SYMPTOMS
fine O
enhancement B-SYMPTOMS
detect O
contrastenhanced O
magnetic O
resonance O
image O
tumor B-SYMPTOMS
measure O
27 O
mm O
diameter O
locate O
caudally O
left O
kidney O
contrastenhance O
computed O
tomography O
tumor O
show O
strong O
enhancement O
arterial O
phase O
figure O
2a O
2b O
relatively O
low O
density B-SYMPTOMS
portal O
phase O
figure O
2c O
2d O
enhancement O
finding O
appear O
consistent O
typical O
hcc O
pattern O
detail O
imaging O
study O
magnetic O
resonance O
imaging O
computed O
tomography O
perform O
case O
rare O
metastatic O
ln O
initially O
debatable O
need O
rule O
exclusion O
diagnose O
threedimensional O
imaging O
prove O
tumor O
feed O
main O
vessel O
inferior O
mesenteric O
artery O
red O
arrow O
accessory O
feeder O
superior O
mesenteric O
artery O
figure O
3 O
fluorine18fluorodeoxyglucose O
positron O
emission O
tomography O
fdgpet O
positron O
emission O
tomographycompute O
tomography O
detect O
tumor O
figure O
4 O
think O
positron O
emission O
tomographycompute O
tomography O
helpful O
identify O
metastatic O
tumor O
image O
finding O
reveal O
intrahepatic O
extrahepatic O
metastasis O
base O
tumor O
location O
clinical O
diagnosis O
solitary O
metastasis O
mesocolic O
ln O
hcc O
dissemination O
determine O
ideal O
therapeutic O
strategy O
solitary O
extrahepatic O
rare O
metastasis O
difficult O
rapid O
growth O
critical O
concern O
case O
tumor O
solitary O
accompany O
metastasis O
consider O
diagnostic O
therapeutic O
viewpoint O
finally O
choose O
surgical O
resection O
case O
disseminative O
nodule B-SYMPTOMS
lymphadenopathy B-DISEASE
ascite O
observe O
surgery O
tumor O
locate O
mesocolon O
nearly O
wall O
descend O
colon O
partial O
resection O
descend O
colon O
regional O
mesocolon O
perform O
patient O
postoperative O
course O
uneventful O
discharge O
postoperative O
day O
8 O
serum O
level O
tumor O
marker O
decrease O
immediately O
surgery O
figure O
1 O
macroscopically O
mesocolic O
tumor O
solid O
elastic O
mass O
smooth O
surface O
figure O
5a O
yellowish O
nodule O
encapsulate O
cut O
surface O
figure O
5b O
enlarge O
ln O
contain O
metastatic O
hcc O
ductal O
structure O
figure O
6a O
immunohistochemically O
tumor O
positive O
afp O
negative O
ck20 O
consistent O
pattern O
primary O
hcc O
figure O
6b O
histopathological O
diagnosis O
metastatic O
hcc O
mesocolic O
ln O
writing O
report O
patient O
remain O
free O
recurrence B-SYMPTOMS
13 O
month O
second O
surgery O
carefully O
follow O
adjuvant O
therapy O
perform O

case O
58yearold O
white O
hispanic O
woman B-SEX
history O
uveal O
melanoma B-DISEASE
right O
eye O
fig1 O
admit O
hospital O
jaundice B-SYMPTOMS
abdominal O
pain B-SYMPTOMS
10 O
day O
admission O
laboratory O
test O
obtain O
complete O
blood O
count O
normal O
limit O
amylase O
136 O
ul O
total O
bilirubin O
637 O
mgdl O
direct O
fraction O
530 O
mgdl O
crosssectional O
abdominal O
compute O
tomography O
ct O
contrast O
show O
lowattenuating O
lesion B-SYMPTOMS
localize O
pancreatic O
head O
measure O
4 O
   O
3 O
cm O
thin O
section O
distal O
bile O
duct O
suspicious O
compression O
multidisciplinary O
meeting O
patient O
schedule O
eusfna O
eus O
show O
solid O
heteroechoic O
predominantly O
hypoechoic O
area O
welldefine O
lesion O
regular O
contour O
measure O
31 O
   O
26 O
cm O
localize O
head O
neck O
pancreas O
fig2 O
vascular O
lymph O
node O
invasion O
identify O
eusfna O
perform O
22 O
g O
needle O
fanning O
technique O
cytology O
specimen O
fig3 O
cell O
present O
discohesive O
disperse O
pattern O
marked O
variation O
size O
shape O
include O
epithelioid O
spindleshape O
cell O
plasmacytoid O
round O
nucleus O
nuclear O
chromatin O
clumping O
irregular O
excessive O
parachromatin O
clearing O
single O
multiple O
macronucleoli O
abundant O
cytoplasm O
deep O
brownishblack O
granule O
obscure O
cell O
detail O
background O
show O
necrosis B-SYMPTOMS
hemorrhage B-SYMPTOMS
patient O
underwent O
right O
orbital O
exenteration O
follow O
duodenopancreatectomy O
whipple O
procedure O
complication O
fig4 O
surgical O
speciman O
show O
undifferentiated O
cell O
extended O
disposition O
brown O
pigment O
infiltrate O
pancrea O
serosa O
duodenal O
wall O
immunohistochemistry O
positive O
melana O
hmb45 O
vimentin O
s100 O
protein O
negative O
cytokeratin O
consistent O
metastatic O
malignant O
melanoma O
moment O
patient O
receive O
adjuvant O
chemotherapy O
outside O
oncology O
clinic O

28yearold O
african O
american O
woman B-SEX
present O
r O
adam O
cowley O
shock O
trauma O
center O
baltimore O
maryland O
evaluation O
rightside O
paralysis B-DISEASE
leftsided O
paresthesia O
find O
home O
nightstand O
bed O
symptom O
begin O
eat O
local O
restaurant O
chain O
consume O
alcohol O
smoke O
cigarette O
dip O
liquid O
phencyclidine O
pcp O
asymptomatic B-SYMPTOMS
night O
go O
bed O
complication O
find O
bed O
follow O
morning O
unable O
patient O
deny O
physical B-DISEASE
trauma I-DISEASE
fall O
bed O
history O
seizure O
sickle O
cell O
anemia O
fever O
urinary O
bowel O
incontinence O
pain B-SYMPTOMS
patient O
history O
viral B-DISEASE
meningitis I-DISEASE
residual O
deficit O
year O
prior O
gastric O
bypass O
surgery O
cholecystectomy O
treat O
presume O
urinary B-DISEASE
tract I-DISEASE
infection I-DISEASE
day O
prior O
admission O
outside O
institution O
triage O
vital O
sign O
follow O
temperature O
368c O
blood O
pressure O
155100 O
mm O
hg O
heart O
rate O
90 O
beat O
minute O
respiratory O
rate O
16 O
breath O
minute O
oxygen O
saturation O
95 O
room O
air O
physical O
exam O
patient O
alert B-SYMPTOMS
orient O
person O
place O
time O
cranial O
nerve O
iixii O
grossly O
intact O
25 O
strength O
right O
low O
extremity O
35 O
left O
low O
extremity O
45 O
bilaterally O
upper O
extremity O
sensation O
intact O
open O
eye O
spontaneously O
verbal O
response O
orient O
appropriate O
obey O
command O
result O
glasgow O
coma O
scale O
score O
15 O
pupil O
equal O
round O
reactive O
light O
tenderness B-SYMPTOMS
palpation O
cervical O
thoracic O
lumbar O
spine O
obvious O
external O
sign O
trauma O
anal O
sphincter O
tone O
intact O
multiple O
laboratory O
abnormality O
note O
admission O
include O
hyperlactemia B-SYMPTOMS
elevate O
liver O
function O
test O
electrolyte O
derangement O
complete O
blood O
count O
remainder O
complete O
metabolic O
panel O
normal O
limit O
value O
summarize O
reference O
range O
table O
1 O
toxicology O
screen O
positive O
pcp O
blood O
culture O
draw O
admission O
grow O
aerobic O
bacteria O
salmonella B-DISEASE
enterica I-DISEASE
serotype O
412 O
repeat O
culture O
draw O
day O
later O
grow O
group O
b O
streptococcus B-DISEASE
aerobic O
nonaerobic O
subsequent O
blood O
culture O
negative O
stool O
culture O
metronidazole O
vancomycin O
therapy O
initiate O
empirically O
transition O
ceftriaxone O
learning O
culture O
result O
addition O
detailed O
autoimmunity O
workup O
include O
antinuclear O
antibody O
ana O
hlab27 O
return O
normal O
limit O
admission O
computerized O
tomography O
scan O
cervical O
thoracic O
lumbar O
spine O
reveal O
spinal O
fracture O
magnetic O
resonance O
imaging O
mri O
reveal O
acute O
intracranial O
abnormality O
enhancement O
central O
aspect O
c3t2 O
suggest O
spinal O
cord O
edema B-SYMPTOMS
disc O
protrusion O
c34 O
c45 O
c56 O
bilateral O
posterior O
neck O
muscle O
edema O
lumbar O
puncture O
initially O
perform O
patient O
admission O
concern O
raise O
intracranial O
pressure O
suspect O
trauma O
hour O
presentation O
strength O
progressively O
deteriorate O
15 O
extremity O
lose O
proprioception O
toe O
bilaterally O
develop O
absent O
anal O
sphincter O
tone O
patient O
admit O
neurotrauma O
intensive O
care O
unit O
deterioration O
ultimately O
require O
endotracheal O
intubation O
respiratory B-DISEASE
failure I-DISEASE
positive O
blood O
culture O
result O
lumbar O
puncture O
perform O
demonstrate O
pattern O
consistent O
atm B-DISEASE
result O
summarize O
table O
2 O
extensive O
workup O
infectious O
etiology O
complete O
result O
summarize O
table O
3 O
plasma O
exchange O
therapy O
initiate O
suspect O
diagnosis O
atm O
despite O
maximal O
medical O
therapy O
patient O
remain O
quadriplegic B-DISEASE
experience O
neurologic O
pain O
receive O
tracheostomy O
prolong O
respiratory O
failure O
require O
feed O
jejunostomy O
tube O
placement O
time O
report O

21yearold O
patient O
present O
close O
emergency O
department O
8 O
pm O
nausea B-SYMPTOMS
numbness B-SYMPTOMS
left O
limb O
incoordination O
walk O
dysarthria B-SYMPTOMS
symptomatology B-SYMPTOMS
instal O
progressive O
mode O
4 O
hour O
presentation O
nausea O
initial O
symptom O
start O
4 O
pm O
headache B-SYMPTOMS
nuchal O
pain B-SYMPTOMS
vomit B-SYMPTOMS
530 O
pm O
numbness O
left O
limb O
incoordination O
walk O
7 O
pm O
dysarthria O
add O
entire O
clinical O
constellation O
patient O
medical O
history O
current O
medication O
student O
smoke O
use O
recreational O
drug O
drink O
alcohol O
occasionally O
family O
history O
thromboembolism O
cardiovascular O
problem O
hematologic O
disease O
evaluate O
neurosurgeon O
emergency O
unit O
brain O
ct O
scan O
highlight O
infracentimetric O
hypodensity B-SYMPTOMS
thalamic O
nucleus O
left O
level O
right O
cerebellar O
hemisphere O
pica O
territory O
chest O
xray O
reveal O
widen O
projection O
area O
right O
hilum O
pathological O
finding O
follow O
evaluation O
send O
national O
institute O
neurology O
cerebrovascular O
disease O
consultation O
special O
treatment O
ambulance O
transportation O
repeat O
episode O
vomit O
initial O
physical O
examination O
10 O
pm O
show O
normal O
vital O
sign O
blood O
pressure O
130 O
80mmhg O
heart O
rate O
100 O
beat O
minute O
normal O
body O
temperature O
368c O
cardiopulmonary O
exam O
normal O
carotid O
bruit O
register O
neurological O
examination O
notable O
normal O
orientation O
patient O
equal O
reactive O
pupil O
divergent O
strabismu O
left O
eye O
horizontal O
nystagmus B-SYMPTOMS
normal O
deglutition O
mild O
paresis B-DISEASE
left O
arm O
ataxia B-DISEASE
limb O
accent O
left O
extremity O
numbness O
left O
limbs O
bilateral O
response O
present O
deep O
tendon O
reflex O
babinski B-SYMPTOMS
sign I-SYMPTOMS
left O
stereotypical O
language O
patient O
able O
repeat O
word O
fragment O
phrase O
perform O
simple O
command O
medium O
complexity O
laboratory O
analysis O
highlight O
normal O
hemoleucogram O
normal O
blood O
glucose O
level O
911 O
mmol O
l O
normal O
range O
3958mmol O
l O
serum O
creatinine O
069mmol O
l O
range O
0509mmol O
l O
total O
serum O
cholesterol O
52mmol O
l O
normal O
range O
   O
52 O
mmol O
l O
test O
thrombophilia O
negative O
present O
normal O
sinus O
rhythm O
ecg O
brain O
ct O
perform O
emergency O
unit O
mention O
reveal O
infracentimetric O
hypodensity O
level O
left O
thalamic O
nucleus O
level O
right O
cerebellar O
hemisphere O
pica O
territory O
doppler O
ultrasound O
cerebral O
cervical O
blood O
vessel O
highlight O
marked O
frena O
flow O
velocity O
v2 O
segment O
right O
vertebral O
artery O
accentuate O
aspect O
high O
v2 O
segment O
complete O
disappearance O
flow O
v3 O
segment O
carotid O
atheromatous O
lesion O
modification O
trajectory O
arterial O
caliber O
overall O
possibility O
dissection B-DISEASE
right O
vertebral O
artery O
high O
segment O
indication O
cerebral O
angio O
mri O
cerebral O
angio O
mri O
show O
area O
t2 O
flair O
hypersignal O
important O
restriction O
diffusion O
low O
adc O
situate O
right O
cerebellar O
area O
posteroinferior O
territory O
anterior O
bilateral O
cerebellar O
territory O
leave O
cerebellar O
peduncle O
right O
   O
leave O
thalamic O
nucleus O
subcortical O
occipital O
bilateral O
ischemic B-SYMPTOMS
aspect I-SYMPTOMS
recently O
constitute O
vertebrobasilar O
territory O
t1 O
fs O
hypersignal O
present O
entire O
intracranial O
segment O
right O
vertebral O
artery O
craniospinal O
junction O
angiographic O
arterial O
3d O
tof O
sequence O
presence O
rapid O
flow O
right O
vertebral O
artery O
view O
c2 O
segment O
progressive O
pinch O
aspect O
flute O
beak O
shape O
distal O
level O
absence O
rapid O
flow O
signal O
lack O
right O
pica O
visualization O
mri O
aspect O
suggest O
subacute O
dissection O
right O
vertebral O
artery O
cerebral O
ventricular O
system O
normal O
dimension O
shape O
topography O
pericerebral O
fluid O
space O
basal O
cistern O
normal O
conclusion O
ischemic O
lesion O
recently O
constitute O
vertebrobasilar O
territory O
subacute O
dissection O
right O
vertebral O
artery O
heparin O
administration O
start O
immediately O
process O
hospitalization O
dissection O
aptt O
value O
keep O
range O
5070 O
second O
prophylactic O
therapy O
stress O
ulcer O
perform O
7 O
day O
debut O
patient O
transition O
acenocumarol O
longterm O
anticoagulation O
treatment O
acenocumarol O
institute O
heparin O
overlap O
get O
inr O
therapeutic O
23 O
interval O
evolution O
favorable O
patient O
regain O
verbal O
fluency O
capacity O
autonomy O
movement O
ataxia O
remit O
right O
limb O
persist O
left O
extremity O
register O
lot O
improvement O
patient O
discharge O
home O
recommendation O
continue O
treatment O
acenocumarol O
6 O
month O
clinical O
paraclinical O
treatment O
reevaluation O
6 O
month O
follow O
possible O
patient O
return O
hospital O
6 O
month O

73yearold O
man B-SEX
transfer O
emergency O
room O
sudden O
chest O
pain B-SYMPTOMS
diagnose O
stsegment O
elevation O
myocardial O
infarction B-SYMPTOMS
stemi B-DISEASE
coronary O
risk O
factor O
history O
smoking O
50 O
year O
primary O
percutaneous O
coronary O
intervention O
perform O
long O
stringshape O
contrast B-SYMPTOMS
defect I-SYMPTOMS
observe O
left O
anterior O
descend O
artery O
fig1a O
optical O
coherence O
tomography O
oct O
imaging O
reveal O
odd O
smoothsurfaced O
50 O
mm O
long O
object B-SYMPTOMS
fig1b O
long O
white O
object O
look O
like O
parasitic O
worm O
retrieve O
intracoronary O
aspiration O
revascularization O
successfully O
complete O
plaque B-SYMPTOMS
rupture I-SYMPTOMS
presence O
thrombus B-SYMPTOMS
detect O
oct O
fig1c O
eleventh O
hospital O
day O
transthoracic O
echocardiography O
reveal O
new O
float O
object O
left O
atrium O
contrast O
compute O
tomography O
reveal O
huge O
76 O
cm O
mass B-SYMPTOMS
recognize O
admission O
right O
upper O
pulmonary O
lobe O
direct O
pulmonary O
vein O
invasion O
fig1d O
bronchoscopic O
finding O
negative O
lung B-SYMPTOMS
tumor I-SYMPTOMS
histopathologic O
examination O
aspirate O
coronary O
object O
reveal O
pleomorphic O
lung O
carcinoma B-DISEASE
fig2 O
patient O
diagnose O
stemi O
coronary O
embolization B-SYMPTOMS
associate O
lung O
carcinoma O
brain O
mri O
reveal O
patient O
asymptomatic O
cerebral O
infarction O
right O
frontal O
lobe O
small O
parietal O
lobe O
lesion B-SYMPTOMS
diagnose O
metastasis B-SYMPTOMS
give O
observation O
diagnose O
right O
lung O
carcinoma O
stage O
iv O
ct2bn2m1b O
treat O
accord O
chemotherapy O
regimen O
carboplatin O
   O
paclitaxel O
know O
effective O
treatment O
advanced O
nonsmall O
cell O
lung O
cancer O
respond O
treatment O
show O
good O
clinical O
course O
fig3 O
chemotherapy O
total O
9 O
cycle O
regimen O
carcinoma O
progression O
suppress O
year O
pci O
followedup O
regularly O

76yearold O
japanese O
man B-SEX
experience O
decrease O
appetite O
nausea B-SYMPTOMS
abdominal O
distension B-SYMPTOMS
late O
february O
2011 O
patient O
pass O
loose O
soft O
stool O
watery O
daily O
result O
blood O
test O
perform O
primary O
care O
physician O
pcp O
april O
june O
normal O
upper O
low O
gastrointestinal O
endoscopy O
show O
atrophic O
gastritis B-DISEASE
assess O
patient O
helicobacter O
pylori O
antibodie O
perform O
rapid O
urease O
test O
histopathological O
evaluation O
negative O
june O
patient O
receive O
medication O
mental O
health O
clinic O
symptom O
improve O
body O
weight O
decrease O
23 O
kg O
stop O
medication O
refer O
department O
november O
patient O
suffer O
hypertension O
30 O
amlodipine O
5 O
mgday O
administration O
initiate O
2005 O
olmesartan O
2008 O
patient O
currently O
receive O
30 O
mgday O
olmesartan O
deny O
use O
new O
medication O
nonsteroidal O
antiinflammatory O
drug O
history O
smoking O
alcohol O
consumption O
physical O
examination O
show O
patient O
height O
165 O
cm O
body O
weight O
47 O
kg O
body O
mass O
index O
17 O
kgm2 O
body O
temperature O
363 O
pulse O
rate O
101min O
blood O
pressure O
10181 O
mmhg O
respiratory O
rate O
12 O
breathsmin O
saturation O
pulse O
oximetry O
spo2 O
98 O
patient O
heart B-SYMPTOMS
murmur I-SYMPTOMS
heart O
sound O
jugular O
venous O
distension O
patient O
bilateral O
pitting O
edema B-SYMPTOMS
low O
leg O
present O
unilateral O
gazeevoked O
nystagmus B-SYMPTOMS
mildly O
reduce O
tactile O
sensation O
thermal O
nociception B-SYMPTOMS
toe O
dorsal O
region O
foot O
fingertonose O
test O
result O
tandem O
gait O
poor O
patellar O
achille O
tendon O
reflex O
disappear O
confabulation B-SYMPTOMS
observe O
patient O
revise O
hasegawa O
dementia O
scale O
hdsr O
score O
1730 O
cutoff O
point O
20 O
hematologic O
finding O
follow O
white O
blood O
cell O
count O
6200 O
l O
hemoglobin O
level O
125 O
gdl O
mean O
corpuscular O
volume O
884 O
platelet O
count O
230000 O
l O
sodium O
level O
136 O
meql O
potassium O
level O
38 O
meql O
chlorine O
level O
103 O
meql O
iron O
level O
57 O
gdl O
reference O
value O
64187 O
gdl O
ferritin O
level O
366 O
ngml O
reference O
value O
50200 O
ngml O
btype O
natriuretic O
peptide O
bnp O
level O
1253 O
pgml O
reference O
value O
184 O
pgml O
vitamin O
b1 O
level O
8 O
ngml O
reference O
value O
2466 O
ngml O
electrocardiogram O
normal O
chest O
xray O
show O
normal O
cardiothoracic O
ratio O
408 O
pulmonary B-SYMPTOMS
congestion I-SYMPTOMS
pleural B-DISEASE
effusion I-DISEASE
cranial O
fluidattenuate O
inversion O
recoverymagnetic O
resonance O
imaging O
finding O
reveal O
periaqueductal O
hyperintensitie O
fig1 O
wernicke B-DISEASE
encephalopathy I-DISEASE
diagnose O
sinus O
tachycardia B-SYMPTOMS
tendency O
hypotension B-SYMPTOMS
note O
clear O
symptom O
heart B-DISEASE
failure I-DISEASE
dehydration B-SYMPTOMS
observe O
infer O
vitamin B-DISEASE
b1 I-DISEASE
deficiency I-DISEASE
likely O
play O
role O
condition O
antihypertensive O
agent O
discontinue O
10 O
day O
intravenous O
administration O
vitamin O
b1 O
patient O
loss O
appetite O
nausea O
gait B-SYMPTOMS
disturbance I-SYMPTOMS
disappear O
body O
weight O
increase O
3 O
kg O
nystagmus O
ameliorate O
physical O
examination O
patient O
confabulation O
hdsr O
score O
absence O
deep O
tendon O
reflex O
improve O
gastrointestinal O
symptom O
ameliorate O
blood O
pressure O
increase O
16090 O
mmhg O
pcp O
resume O
administration O
olmesartan O
late O
december O
2011 O
week O
later O
patient O
complain O
recurrent O
decrease O
appetite O
nausea O
experience O
diarrhea B-SYMPTOMS
bowel O
movement O
2day O
period O
pass O
soft O
stool O
daily O
body O
weight O
decrease O
47 O
kg O
come O
hospital O
3 O
week O
resumption O
olmesartan O
treatment O
vital O
sign O
follow O
body O
temperature O
351 O
pulse O
rate O
93min O
blood O
pressure O
13275 O
mmhg O
neurologic O
finding O
show O
worsening O
symptom O
laboratory O
finding O
follow O
sodium O
level O
139 O
meql O
potassium O
level O
29 O
meql O
chlorine O
level O
116 O
meql O
hyperchloremia B-SYMPTOMS
note O
serum O
sodium O
level O
minus O
chloride O
level O
139116 O
23 O
meql O
additionally O
arterial O
blood O
gas O
finding O
follow O
ph O
725 O
pco2 O
25 O
mmhg O
hco3 O
11 O
mmoll O
urinalysis O
finding O
follow O
sodium O
level O
15 O
meql O
potassium O
level O
13 O
meql O
chlorine O
level O
100 O
meql O
urine O
anion O
gap O
72 O
meql O
apparent O
increase O
bowel O
movement O
absence O
hco3 O
gastrointestinal O
tract O
6 O
plain O
abdominal O
radiography O
abdominal O
compute O
tomography O
finding O
reveal O
continuous O
dilation B-SYMPTOMS
entire O
intestinal O
tract O
fig2 O
patient O
diagnose O
intestinal O
pseudoobstruction O
discontinue O
olmesartan O
nausea O
body O
weight O
decrease O
promptly O
ameliorate O
duodenal O
biopsy O
finding O
discontinue O
olmesartan O
show O
inflammation B-SYMPTOMS
observe O
discontinuation O
fold B-SYMPTOMS
structure I-SYMPTOMS
clearly O
ameliorate O
fig3 O

73yearold O
hispanic O
male B-SEX
history O
stage O
iv O
chronic B-DISEASE
kidney I-DISEASE
disease I-DISEASE
threevessel O
coronary B-DISEASE
artery I-DISEASE
disease I-DISEASE
admit O
coronary O
artery O
bypass O
graft O
surgery O
mitral O
valve O
repair O
postoperative O
day O
patient O
develop O
cardiac B-SYMPTOMS
tamponade I-SYMPTOMS
subsequently O
progress O
cardiac B-DISEASE
arrest I-DISEASE
temporary O
pacing O
wire O
remove O
advanced O
cardiovascular O
life O
support O
emergent O
exploratory O
sternotomy O
perform O
patient O
transfer O
intensive O
care O
unit O
icu O
care O
patient O
icu O
admission O
renal B-DISEASE
failure I-DISEASE
progress O
require O
hemodialysis O
nasogastric O
tube O
place O
postoperative O
day O
establish O
early O
enteral O
nutrition O
peg O
tube O
insertion O
suggest O
give O
cognitive B-SYMPTOMS
impairment I-SYMPTOMS
poor O
swallowing O
function O
modify O
barium O
swallow O
test O
coagulation O
profile O
prior O
procedure O
reveal O
international O
normalize O
ratio O
104 O
partial O
thromboplastin O
time O
36 O
second O
complete O
blood O
count O
show O
hemoglobin O
116 O
gram O
deciliter O
hematocrit O
349 O
281103 O
platelet O
microliter O
blood O
urea O
nitrogen O
55 O
milligramsdeciliter O
serum O
creatinine O
522 O
milligramsdeciliter O
patient O
take O
aspirin O
81 O
mg O
day O
recent O
cardiac O
surgery O
anticoagulant O
agent O
history O
coagulopathy B-DISEASE
peg O
tube O
insertion O
perform O
postoperative O
day O
intravenous O
anesthesia O
esophagogastroduodenoscopy O
egd O
accomplish O
difficulty O
reveal O
diffuse O
moderately O
erythematous B-SYMPTOMS
mucosa O
bleed O
gastric O
antrum O
attempt O
peg O
tube O
placement O
rapidly O
expand O
hematoma B-SYMPTOMS
figure O
1 O
develop O
needle O
insertion O
site O
procedure O
stop O
patient O
send O
icu O
nasogastric O
tube O
single O
dose O
intravenous O
desmopressin O
03 O
microgramkilogram O
administer O
suspicion O
uremic B-SYMPTOMS
bleeding B-SYMPTOMS
gastrointestinal O
bleeding O
event O
note O
assess O
platelet O
function O
platelet O
function O
assay O
pfa O
order O
desmopressin O
injection O
pfa O
collagenepinephrine O
closure O
time O
195 O
second O
normal O
174 O
second O
collagenadp O
closure O
time O
76 O
second O
normal O
120 O
second O
indicate O
platelet B-DISEASE
dysfunction I-DISEASE
aspirin O
uremia B-DISEASE
aspirin O
discontinue O
monitor O
daily O
complete O
blood O
count O
metabolic O
panel O
day O
later O
patient O
undergo O
second O
attempt O
peg O
tube O
placement O
pfa O
collagenepinephrine O
closure O
time O
prior O
procedure O
go O
141 O
second O
possibly O
withhold O
aspirin O
improvement O
renal O
function O
egd O
show O
area O
flat O
bluish O
gastric O
submucosal O
bruise O
site O
previous O
hematoma O
figure O
2 O
peg O
tube O
place O
successfully O
adjacent O
site O
course O
following O
month O
patient O
continue O
undergo O
feed O
peg O
tube O
adverse O
event O

46yearold O
caucasian O
woman B-SEX
type O
2 O
diabetes O
mellitus O
bipolar O
disorder O
present O
emergency O
department O
vague O
abdominal O
symptom O
vomit O
pertinent O
history O
include O
leave O
knee O
amputation O
right O
toe O
amputation O
complication O
secondary O
diabetic O
neuropathy O
time O
admission O
undergo O
care O
infect O
diabetic O
ulcer B-SYMPTOMS
right O
foot O
note O
history O
capd B-DISEASE
history O
renal B-DISEASE
disease I-DISEASE
creatinine O
123 O
mgdl O
blood O
urea O
nitrogen O
bun O
16 O
mgdl O
blood O
glucose O
level O
poorly O
control O
subcutaneous O
insulin O
injection O
report O
range O
400 O
500 O
mgdl O
home O
poor O
drug O
compliance O
blood O
glucose O
level O
decrease O
range O
175 O
378 O
mgdl O
implementation O
strict O
insulin O
regiman O
admission O
noncontrast O
ct O
scan O
show O
confluent O
bilobar O
geographic O
region O
hypoattenuation B-SYMPTOMS
subcapsular O
distribution O
liver O
fig1 O
mri O
liver O
protocol O
perform O
evaluation O
indeterminate O
finding O
assess O
possible O
vascular O
etiology O
area O
infarction O
possible O
patient O
inphase O
gradient O
echo O
image O
demonstrate O
hyperintense O
foci B-SYMPTOMS
liver O
distribution O
correspond O
hypoattenuate O
region O
see O
ct O
opposedphase O
sequence O
loss O
signal O
area O
indicate O
presence O
intracellular O
fat O
water O
fig2 O
addition O
area O
hypointense O
remain O
hepatic O
parenchyma O
fat O
suppression O
mr O
sequence O
confirm O
presence O
fat O
establish O
diagnosis O
shs B-DISEASE
furthermore O
followup O
ct O
abdomen O
pelvis O
perform O
3 O
month O
later O
show O
near B-SYMPTOMS
complete I-SYMPTOMS
resolution I-SYMPTOMS
finding O
fig3 O
note O
strict O
glucose O
control O
decrease O
average O
blood O
glucose O
level O
200 O
mgdl O

36yearold O
male B-SEX
patient O
case O
6year O
history O
diffuse O
cutaneous O
ssc B-DISEASE
fig1 O
receive O
regular O
followup O
medication O
therapy O
experience O
malaise B-SYMPTOMS
poor B-SYMPTOMS
appetite I-SYMPTOMS
progressive O
shortness O
breath O
1 O
month O
oligouria B-SYMPTOMS
3 O
day O
admit O
hospital O
renal B-DISEASE
failure I-DISEASE
pulmonary O
edema B-SYMPTOMS
emergency O
department O
blood O
pressure O
pulse O
rate O
respiratory O
rate O
174127 O
mm O
hg O
88min O
22min O
respectively O
laboratory O
analysis O
reveal O
follow O
value O
white O
blood O
cell O
count O
7730l O
350011000l O
hemoglobin O
86 O
gdl O
1216 O
gdl O
platelet O
count O
87000l O
150000400000l O
blood O
urea O
nitrogen O
78 O
mgdl O
621 O
mgdl O
creatinine O
89 O
mgdl O
1115 O
mgdl O
calcium O
82 O
mgdl O
88103 O
mgdl O
phosphorus O
54 O
mgdl O
2745 O
mgdl O
haptoglobin O
656 O
mgdl O
30200 O
mgdl O
lactate O
dehydrogenase O
547 O
ul O
106211 O
ul O
routine O
urinalysis O
reveal O
proteinuria O
score O
2 O
200 O
mgdl O
white O
blood O
cell O
count O
35high O
power O
field O
red O
blood O
cell O
count O
2550high O
power O
field O
autoimmune O
profile O
indicate O
antinuclear O
antibody O
level O
1320 O
speckle O
normal O
140 O
test O
antiscl70 O
antidoublestrande O
dna O
antiro O
antila O
anticardiolipin O
antibody O
negative O
kidney O
echogram O
show O
decrease O
bilateral O
kidney O
size O
hydronephrosis B-SYMPTOMS
despite O
chronic O
change O
visible O
echogram O
patient O
develop O
acute O
pulmonary O
edema O
oligouria O
3 O
day O
admission O
accordingly O
clinical O
diagnosis O
acuteonchronic O
renal O
failure O
diagnosis O
src B-DISEASE
support O
presence O
renal O
failure O
microangiopathic O
hemolytic O
anemia B-SYMPTOMS
hypertension B-SYMPTOMS
patient O
start O
captopril O
therapy O
sustain O
deterioration O
renal O
function O
anuria B-SYMPTOMS
lead O
requirement O
regular O
hemodialysis O
admission O
3 O
day O
captopril O
change O
amlodipine O
patient O
develop O
severe O
intolerable O
cough B-SYMPTOMS
think O
associate O
captopril O
systolic O
blood O
pressure O
control O
140 O
180 O
mm O
hg O
approximately O
3 O
week O
initiation O
maintenance O
hemodialysis O
patient O
newly O
develop O
generalized O
tonicclonic O
seizure B-DISEASE
disorder I-DISEASE
brain O
compute O
tomography O
ct O
scan O
reveal O
small O
lacunar O
infarct B-DISEASE
left O
basal O
ganglion O
intracranial O
hemorrhage B-DISEASE
large O
infarct O
seizure O
resolve O
spontaneously O
anticonvulsant O
patient O
finally O
discharge O
home O
incident O
schedule O
regular O
hemodialysis O
thrice O
weekly O
1 O
week O
discharge O
patient O
develop O
suddenonset O
headache B-SYMPTOMS
vomit O
confusion B-SYMPTOMS
recurrence O
generalized O
tonicclonic O
seizure O
present O
emergency O
department O
blood O
pressure O
183100 O
mm O
hg O
platelet O
count O
149000l O
serum O
ldh O
332 O
ul O
peripheral O
blood O
smear O
contain O
23 O
schizocyteshpf O
fig2 O
brain O
ct O
reveal O
interval O
change O
lumbar O
puncture O
reveal O
traumatic O
tap O
cerebrospinal O
fluid O
culture O
negative O
bacteria O
mycobacterium O
virus O
brain O
magnetic O
resonance O
imaging O
mri O
show O
bilateral O
hyperintensity B-SYMPTOMS
occipital O
parietal O
lobe O
fluidattenuate O
inversion O
recovery O
flair O
sequence O
fig3 O
finally O
patient O
diagnose O
pre O
resume O
captopril O
therapy O
dose O
25 O
mg O
thrice O
daily O
difficult O
differentiate O
src O
ttp O
consider O
plasma O
exchange O
treatment O
patient O
mental O
status O
return O
normal O
3 O
day O
absence O
plasma O
exchange O
followup O
mri O
brain O
2 O
month O
later O
show O
complete O
resolution O
cerebral O
edema O
fig4 O
srcrelate O
pre O
confirm O
patient O
experience O
neurologic O
recovery O
renal O
function O
improve O
remain O
dialysis O
dependent O

53yearold O
woman B-SEX
present O
institution O
progressive O
abdominal O
distention B-SYMPTOMS
irregular O
vaginal O
bleeding B-SYMPTOMS
week O
duration O
contrast O
ct O
abdomen O
pelvis O
reveal O
illdefined O
irregular O
mass B-SYMPTOMS
low O
uterinecervical O
region O
figure O
1 O
multiple O
peritoneal O
omental O
masse O
enlarge O
pelvic O
paraaortic O
lymph O
node O
largevolume O
ascite O
initial O
cbc O
significant O
hemoglobin O
92 O
gdl O
leukocytosis B-SYMPTOMS
36 O
790 O
microliter O
thrombocytosis B-SYMPTOMS
625 O
000 O
microliter O
serum O
calcium O
elevate O
131 O
mgdl O
bun O
creatinine O
normal O
limit O
hepatic O
function O
normal O
limit O
pelvic O
exam O
reveal O
fungate O
vaginal O
mass O
patient O
underwent O
biopsy O
endometrium O
vaginal O
mass O
reveal O
highgrade O
tumor B-SYMPTOMS
predominantly O
ovalshape O
cell O
immunohistochemical O
staining O
positive O
vimentin O
cd10 O
cyclin O
d1 O
consistent O
diagnosis O
highgrade O
endometrial B-DISEASE
stromal I-DISEASE
sarcoma I-DISEASE
figure O
2 O
tumor O
negative O
er O
rare O
cell O
positive O
pr O
immunohistochemical O
staining O
cytokeratin O
negative O
biphasic B-SYMPTOMS
component I-SYMPTOMS
entirely O
rule O
give O
small O
size O
biopsy O
specimen O
relative O
tumor O
patient O
ca125 O
markedly O
elevate O
1624 O
uml O
nl O
34 O
contrast O
ct O
chest O
reveal O
rightside O
pleural B-DISEASE
effusion I-DISEASE
suspicious O
nodule O
lymphadenopathy B-DISEASE
patient O
deem O
operable B-DISEASE
disease I-DISEASE
schedule O
debulke O
surgery O
preoperative O
laboratory O
study O
show O
serum O
calcium O
increase O
192 O
mgdl O
develop O
evidence O
acute O
kidney O
injury B-DISEASE
bun O
rise O
37 O
mgdl O
creatinine O
181 O
mgdl O
physical O
exam O
note O
lethargic B-SYMPTOMS
dry B-SYMPTOMS
mucous O
membrane O
surgery O
cancel O
patient O
medical B-DISEASE
instability I-DISEASE
workup O
reveal O
elevated O
pthrp O
301 O
pgml O
nl O
1427 O
depressed O
pth O
level O
3 O
pgml O
nl O
1565 O
depressed O
25oh O
vitamin O
d O
level O
16 O
ngml O
nl O
30100 O
consistent O
humoral O
hypercalcemia B-SYMPTOMS
malignancy O
patient O
treat O
pamidronate O
calcitonin O
intravenous O
fluid O
eventually O
require O
temporary O
hemodialysis O
denosumab O
refractory O
hypercalcemia O
patient O
improve O
regard O
electrolyte O
abnormality O
give O
extent O
disease O
plan O
neoadjuvant O
chemotherapy O
follow O
surgery O
good O
response O
achieve O
start O
regimen O
carboplatin O
paclitaxel O
receive O
3 O
cycle O
palliative O
radiation O
uterus O
control O
bleeding O
disease O
fail O
respond O
significantly O
chemotherapy O
ultimately O
die O
complication O
malignancy O

67yearold O
woman B-SEX
send O
emergency O
department O
fever B-SYMPTOMS
sore B-SYMPTOMS
throat O
medical O
history O
include O
esrd B-DISEASE
regular O
hemodialysis O
3 O
time O
week O
15 O
year O
hyperuricemia B-DISEASE
gout B-DISEASE
comorbidity O
dyslipidemia B-DISEASE
hypertension B-SYMPTOMS
secondary O
hyperparathyroidism B-DISEASE
diabete O
hemogram O
reveal O
white O
blood O
cell O
count O
wbc O
700l O
2 O
neutrophil O
94 O
lymphocyte O
2 O
monocyte O
hemoglobin O
111 O
gdl O
platelet O
count O
131000l O
impression O
febrile O
neutropenia B-SYMPTOMS
acute O
pharyngitis B-DISEASE
admit O
hematologic O
ward O
survey O
management O
broadspectrum O
antibiotic O
piperacillin O
2 O
g O
tazobactam O
025 O
gm O
iv O
q8h O
administer O
infection B-SYMPTOMS
sign I-SYMPTOMS
resolve O
gradually O
admission O
review O
oral O
medication O
glipizide O
5 O
mg O
tid O
saxagliptin O
25 O
mg O
qd O
fenofibrate O
600 O
mg O
qd O
aluminum O
hydroxide O
324 O
mg O
tid O
folic O
acid O
5 O
mg O
qd O
calcium O
carbonate O
1000 O
mg O
tid O
febuxostat O
40 O
mg O
qd O
receive O
epoetinbeta O
2000 O
iu O
ivtiw O
febuxostat O
drug O
1 O
year O
febuxostat O
administer O
2 O
month O
admission O
inadequate O
serum O
uric O
acid O
control O
allopurinol O
50 O
mg O
qd O
week O
febuxostat O
exposure O
routine O
laboratory O
test O
reveal O
wbc O
6000l O
serum O
uric O
acid O
level O
98 O
mgdl O
febuxostat O
discontinue O
causal O
relationship O
agranulocytosis B-DISEASE
exclude O
survey O
viral O
infection O
autoimmune O
disorder O
clinical O
laboratory O
evidence O
epsteinbarr O
virus O
cytomegalovirus O
human O
immunodeficiency O
virus O
infection O
antinuclear O
antibody O
ana O
antiextractable O
nuclear O
antigen O
antiena O
negative O
bone O
marrow O
examination O
hospitalization O
show O
hypocellular B-SYMPTOMS
marrow O
marked O
decrease O
myeloid O
component O
evidence O
hematologic O
neoplasm O
chromosome O
analysis O
bone O
marrow O
normal O
karyotype O
patient O
deny O
history O
radiation O
chemical O
exposure O
stop O
febuxostat O
17 O
day O
neutropenia O
improve O
significantly O
wbc O
2100l O
neutrophil O
66 O
granulocyte O
colonystimulate O
factor O
gcsf O
support O
discharge O
wbc O
differential O
count O
completely O
normal O
followup O
fig1 O
study O
approve O
institutional O
review O
board O

46yearold O
woman B-SEX
history O
grave O
disease O
gd B-DISEASE
transfer O
emergency O
department O
suspicion O
dka B-DISEASE
notice O
polydipsia B-SYMPTOMS
polyuria B-SYMPTOMS
fatigue B-SYMPTOMS
approximately O
month O
prior O
admission O
suffer O
1month O
complaint O
appetite B-SYMPTOMS
loss I-SYMPTOMS
approximately O
7 O
kg O
weight B-SYMPTOMS
loss I-SYMPTOMS
fatigue O
nausea B-SYMPTOMS
sweat O
medical O
history O
include O
gd O
diagnose O
42 O
year O
age O
manage O
methimazole O
poor O
compliance O
antithyroid O
drug O
deny O
family O
history O
thyroid O
disease O
diabete O
day O
admission O
diagnose O
influenza O
nearby O
hospital O
oseltamivir O
phosphate O
prescribe O
emergency O
department O
present O
drowsiness B-SYMPTOMS
body O
temperature O
370 O
blood O
pressure O
9060 O
mmhg O
heart O
rate O
200 O
bpm O
respiratory O
rate O
32 O
breathsmin O
oxygen O
saturation O
99 O
5 O
l O
nasal O
air O
glasgow O
coma O
scale O
gcs O
score O
14 O
clinical O
examination O
reveal O
diffuse O
goiter B-SYMPTOMS
bilateral O
exophthalmos O
lung O
clear O
auscultate O
abdomen O
soft O
nontender O
skin O
warm O
wet O
low O
extremity O
edema B-SYMPTOMS
electrocardiogram O
show O
mark O
tachycardia B-SYMPTOMS
atrial B-DISEASE
fibrillation I-DISEASE
chest O
radiograph O
normal O
laboratory O
datum O
show O
table O
1 O
initial O
laboratory O
datum O
demonstrate O
mark O
metabolic O
acidosi O
increase O
plasma O
glucose O
level O
472 O
mgdl O
increase O
hba1c O
level O
137 O
increase O
free O
triiodothyronine O
level O
6440 O
pgml O
free O
thyroxine O
level O
2830 O
ngdl O
suppressed O
thyrotropin O
tsh O
level O
0005 O
iuml O
score O
55 O
diagnostic O
criterion O
burch O
   O
wartofsky O
thyroid B-DISEASE
storm I-DISEASE
diagnostic O
criterion O
japan O
thyroid O
association O
thyroid O
storm O
satisfied O
thyrotoxicosis B-DISEASE
symptom O
involve O
central O
nervous O
system O
tachycardia O
gastrointestinal O
symptom O
4 O
accordingly O
diagnose O
dka O
thyroid O
storm O
admit O
medical O
intensive O
care O
unit O
monitoring O
treatment O
clinical O
course O
show O
figure O
treat O
intravenous O
insulin O
drip O
aggressive O
intravenous O
fluid O
therapy O
thyroid O
storm O
gd O
treat O
intravenous O
hydrocortisone O
100 O
mg O
8 O
hour O
oral O
potassium O
iodine O
50 O
mg O
6 O
hour O
oral O
methimazole O
20 O
mg O
6 O
hour O
history O
asthma O
landiolol O
hydrochloride O
shortacte O
betaadrenoceptor O
blocker O
412 O
gkgmin O
control O
heart O
rate O
day O
3 O
tachycardia O
resolve O
landiolol O
hydrochloride O
discontinue O
day O
6 O
white O
blood O
cell O
count O
decrease O
2800 O
cellsmm3 O
neutrophil O
442 O
1238 O
cellsmm3 O
methimazole O
discontinue O
methimazoleinduced O
neutropenia B-SYMPTOMS
suspect O
patient O
refer O
endocrine O
surgeon O
thyroidectomy O
perform O
day O
32 O
discharge O
hospital O
day O
37 O
maintain O
multiple O
daily O
insulin O
infusion O
levothyroxine O
sodium O
hydrate O
immunological O
investigation O
reveal O
elevated O
level O
antiglutamic O
acid O
decarboxylase O
gad O
antibody O
antiinsulinoma O
antigen O
2 O
ia2 O
antibody O
insulin O
autoantibody O
consistent O
t1d B-DISEASE
intravenous O
glucagon O
stimulation O
test O
perform O
blood O
sample O
glucose O
cpeptide O
take O
baseline O
6 O
minute O
plasma O
glucose O
level O
139 O
152 O
mgdl O
baseline O
6 O
minute O
respectively O
corresponding O
serum O
cpeptide O
level O
08 O
13 O
ngml O
baseline O
6 O
minute O
respectively O

61yearold O
male B-SEX
refer O
emergency O
department O
general O
practitioner O
april O
2010 O
investigation O
loose O
bowel O
motion O
episode O
black B-SYMPTOMS
stool I-SYMPTOMS
patient O
history O
insulindependent O
type O
ii O
diabete O
mellitus O
hypertension O
ischaemic O
heart O
disease O
previous O
ischaemic O
event O
obstructive O
sleep O
apnoea O
depression O
schizophrenia O
previous O
incisional O
hernia O
repair O
examination O
morbidly B-DISEASE
obese I-DISEASE
bmi O
45 O
note O
mark O
hepatomegaly B-DISEASE
associate O
recent O
weight B-SYMPTOMS
loss I-SYMPTOMS
haematemesis B-SYMPTOMS
jaundice B-SYMPTOMS
abdominal O
pain B-SYMPTOMS
patient O
deny O
previous O
blood O
transfusion O
usage O
intravenous O
drug O
drink O
alcohol O
faecal O
occult O
blood O
test O
negative O
patient O
colonoscopy O
2 O
year O
prior O
unremarkable O
refer O
tertiary O
centre O
management O
ultrasound O
scan O
uss O
display O
ovoid O
mass B-SYMPTOMS
mixed O
echogenicity O
arise O
liver O
measure O
12 O
   O
9 O
cm O
compute O
tomography O
ct O
scan O
confirm O
malignant O
appear O
pedunculate O
lesion B-SYMPTOMS
attach O
segment O
iv O
fig1 O
subsequent O
magnetic O
resonance O
imaging O
mri O
confirm O
t2 O
weight O
image O
wi O
lesion O
isointense O
liver O
peripherally O
central O
branch O
hyperintensitie O
fig2a O
correspond O
hypointensitie O
see O
t1wi O
fig2b O
enhancement O
lesion O
note O
arterial O
phase O
fig3a O
portal O
venous O
phase O
fig3b O
2 O
min O
fig3c O
central O
area O
nonenhancement O
lesion O
slightly O
hypointense O
delay O
image O
10 O
fig3d O
20 O
min O
compare O
surround O
liver O
laboratory O
investigation O
reveal O
mildly O
elevate O
gammaglutamyl O
transpeptidase O
137 O
iul O
normal O
550 O
iul O
hepatitis O
screen O
alphafetoprotein O
carcinoembryonic O
antigen O
cancer O
antigen O
199 O
unremarkable O
patient O
undergo O
subsegmental O
resection O
15 O
cm O
segment O
ivb O
mass O
june O
2010 O
severe O
hepatic B-DISEASE
steatosis I-DISEASE
cirrhosis B-DISEASE
patient O
discharge O
postoperative O
day O
seven O
complication O
pathology O
resection O
speciman O
confirm O
sftl B-DISEASE
speciman O
display O
pale O
tan O
nodular O
appearance O
firm O
rubbery O
cut O
surface O
histological O
examination O
reveal O
fascicle O
spindle O
cell O
storiform O
arrangement O
push O
margin O
evidence O
extracellular O
collagen O
deposition O
area O
myxoid O
stroma O
branch O
vessel O
hyalinisation O
speciman O
display O
high O
mitotic O
rate O
9 O
10 O
highpower O
field O
hpf O
necrotic O
haemorrhagic O
feature O
immunohistochemistry O
show O
positive O
staining O
cd34 O
cd99 O
bcl2 O
tumour O
negative O
ckit O
cd31 O
sma O
desmin O
cytokeratin O
ae1ae3 O
mnf116 O
cam O
52 O
ema O
s100 O
margin O
clear O
nonneoplastic O
remainder O
liver O
display O
pericellular O
fibrosis B-SYMPTOMS
indicative O
steatohepatitis B-DISEASE
patient O
followedup O
regularly O
4 O
6 O
month O
ct O
scan O
local O
general O
practitioner O
liaise O
consultant O
surgeon O
episode O
readmission O
investigation O
recurrent O
right O
upper O
quadrant O
pain O
2011 O
2013 O
multiple O
mri O
scan O
perform O
period O
reveal O
expect O
postsurgical O
change O
tumour B-SYMPTOMS
recurrence I-SYMPTOMS
2016 O
patient O
present O
local O
emergency O
department O
progressively O
worsen O
right O
upper O
quadrant O
pain O
increase O
dyspnoea B-SYMPTOMS
oxygen O
demand O
ct O
chest O
abdoman O
pelvis O
reveal O
extensive O
tumour O
recurrence O
adjacent O
previous O
resection O
site O
fig4 O
addition O
clinically O
significant O
rightside O
pleural B-DISEASE
effusion I-DISEASE
pleural O
mass O
right O
lung O
base O
measure O
38 O
cm O
fig5 O
pleurocentesis O
perform O
drain O
1400 O
ml O
serosanguineous O
fluid O
cytology O
negative O
malignant O
cell O
case O
discuss O
extensively O
multidisciplinary O
setting O
decide O
give O
patient O
site O
disease O
significant O
perioperative O
risk O
candidate O
radical O
reoperation O
suitable O
chemo O
radiotherapeutic O
therapy O
available O
patient O
subsequently O
refer O
palliative O
team O
management O
symptom O
discharge O
community O
alive B-SYMPTOMS
1 O
month O
discharge O

39yearold O
korean O
male B-SEX
come O
hospital O
complaining O
cough B-SYMPTOMS
myalgia B-SYMPTOMS
fever B-SYMPTOMS
last O
5 O
day O
company O
worker O
deny O
previous O
medical O
history O
current O
smoker O
drink O
alcohol O
month O
vital O
sign O
blood O
pressure O
10060 O
mmhg O
heart O
rate O
100min O
respiratory O
rate O
25 O
breathsmin O
body O
temperature O
39 O
c O
physical O
examination O
decrease O
breathing O
sound O
note O
right O
low O
lung O
laboratory O
test O
reveal O
creactive O
protein O
crp O
level O
119 O
mgdl O
total O
bilirubin O
level O
18 O
mgdl O
alanine O
transaminase O
aspartate O
transaminase O
level O
250 O
172 O
iul O
respectively O
platelet O
count O
98000mm3 O
white O
cell O
count O
8150mm3 O
neutrophil O
85 O
arterial O
blood O
gas O
analysis O
check O
room O
air O
ph O
paco2 O
pao2 O
bicarbonate O
oxygen O
saturation O
level O
750 O
34 O
mmhg O
67 O
mmhg O
265 O
mmoll O
95 O
respectively O
test O
human O
immunodeficiency O
virus O
negative O
mycoplasma O
chlamydia O
antibody O
negative O
streptococcal O
legionella O
urinary O
antigen O
negative O
antinuclear O
antineutrophilic O
cytoplasmic O
antibody O
negative O
chest O
xray O
show O
consolidation B-SYMPTOMS
right O
mid O
low O
lung O
field O
chest O
compute O
tomography O
show O
consolidation O
surround O
ground O
glass O
opacity O
right O
middle O
lobe O
small O
pleural B-DISEASE
effusion I-DISEASE
right O
hemithorax O
fig1 O
abdominal O
sonography O
reveal O
abnormal O
finding O
hepatobiliary O
system O
begin O
administer O
4 O
lmin O
oxygen O
nasally O
empirical O
antibiotic O
generation O
cephalosporin O
macrolide O
follow O
diagnosis O
communityacquire O
pneumonia B-DISEASE
second O
day O
hospital O
patient O
fever O
sustain O
complain O
dyspnea B-SYMPTOMS
hypoxemia B-SYMPTOMS
aggravate O
require O
7 O
lmin O
oxygen O
simple O
mask O
consolidation O
pleural O
effusion O
markedly O
progress O
fig2a O
perform O
bronchoscopy O
thoracentesis O
multiplex O
realtime O
reverse O
transcriptase O
polymerase O
chain O
reaction O
rtpcr O
respiratory O
virus O
bronchoalveolar O
lavage O
fluid O
positive O
human O
adenovirus O
microbiological O
study O
negative O
pleural O
fluid O
lymphocytedominant O
exudate O
positive O
human O
adenovirus O
diagnosis O
adenovirus B-DISEASE
pneumonia I-DISEASE
start O
antiviral O
therapy O
oral O
ribavirin O
400 O
mg O
q O
12 O
h O
maintain O
antibiotic O
hospital O
day O
4 O
fever O
subside O
symptom O
improve O
transaminase O
level O
crp O
platelet O
count O
gradually O
normalize O
fig3 O
followup O
chest O
xray O
clear O
fig2b O
discharge O
hospital O
day O
13 O
complication O

patient O
7yearold O
italian O
boy B-SEX
bear O
uneventful O
gestation O
normal O
duration O
age O
16 O
month O
present O
clinically O
evident O
enlarge O
abdomen O
refer O
oncological O
examination O
initial O
test O
reveal O
anemia B-SYMPTOMS
thrombocytopenia B-SYMPTOMS
splenomegaly B-SYMPTOMS
bone O
marrow O
biopsy O
reveal O
presence O
foam O
cell O
lead O
suspicion O
lysosomal B-DISEASE
storage I-DISEASE
disease I-DISEASE
biochemical O
testing O
reveal O
elevated O
level O
acid O
phosphatase O
478 O
iul O
normal O
range O
57 O
iul O
chitotriosidase O
activity O
508 O
nmolmg O
protein O
normal O
range O
59410 O
nmolmg O
protein O
reduce O
betaglucosidase O
activity O
2 O
nmolmgprotein O
normal O
range O
45180 O
nmolmgprotein O
molecular O
analysis O
show O
homozygous O
l444p O
mutation O
gba O
gene O
omim O
reference O
606463 O
confirm O
diagnosis O
chronic O
ngd B-DISEASE
patient O
begin O
ert O
dosage O
60 O
ukg O
2 O
week O
age O
18 O
month O
patient O
reach O
age O
30 O
month O
decide O
combine O
ert O
srt O
miglustat O
clinical O
decision O
approve O
institution O
ethics O
committee O
informed O
consent O
obtain O
patient O
parent O
commence O
combination O
therapy O
dose O
miglustat O
adjust O
accord O
patient O
body O
surface O
area O
uptitrated O
4 O
week O
follow O
scheme O
onethird O
target O
dose O
week O
1 O
2 O
twothird O
target O
dose O
week O
3 O
4 O
target O
dose O
100 O
mg O
time O
daily O
1 O
month O
2 O
week O
start O
miglustat O
therapy O
patient O
follow O
specific O
dietary O
modification O
avoid O
high O
intake O
carbohydratecontaine O
food O
single O
meal O
especially O
food O
high O
disaccharide O
sucrose O
maltose O
ensure O
acceptable O
gastrointestinal O
tolerability O
experience O
mild O
episode O
diarrhea B-SYMPTOMS
commence O
miglustat O
therapy O
decrease O
frequencyseverity O
time O
start O
ertmiglustat O
combination O
treatment O
observe O
reduction O
splenomegaly O
gradual O
normalization O
hematological O
value O
plasma O
angiotensinconverte O
enzyme O
activity O
table O
1 O
plasma O
chitotriosidase O
evaluate O
time O
diagnosis O
approximately O
6 O
month O
followup O
value O
show O
initial O
reduction O
start O
ert O
substantial O
sustained O
decrease O
commencement O
miglustat O
treatment O
fig1 O
patient O
follow O
accord O
recommend O
guideline O
gd O
specify O
complete O
neurological O
examination O
clinical O
evaluation O
ocular O
movement O
psychological O
evaluation O
612 O
month O
10 O
5 O
year O
combination O
therapy O
followup O
patient O
sign O
neurological B-SYMPTOMS
impairment I-SYMPTOMS
february O
2016 O
display O
epileptic O
crisis O
demonstrate O
clinical B-SYMPTOMS
performance I-SYMPTOMS
cooperation O
show O
good O
muscular O
tone O
trophism O
normal O
reflex O
slight O
hyperreflexia B-SYMPTOMS
leg O
negative O
romberg O
sign O
toe O
heel O
deambulation O
normal O
particular O
ocular O
evaluation O
reveal O
evidence O
saccadic B-SYMPTOMS
movement I-SYMPTOMS
velocity I-SYMPTOMS
reduction I-SYMPTOMS
normal O
visual O
evoke O
potential O
patient O
auditory O
brain O
response O
normal O
addition O
demonstrate O
cognitive B-SYMPTOMS
impairment I-SYMPTOMS
regularly O
attend O
school O
good O
performance O
age O
5 O
year O

64yearold O
female B-SEX
find O
lie O
1012 O
hour O
binge O
drink O
take O
outlying O
emergency O
department O
ed O
subsequently O
transfer O
hospital O
mental O
status O
change O
respiratory B-SYMPTOMS
distress I-SYMPTOMS
hypoxia B-SYMPTOMS
management O
past O
history O
rheumatoid O
arthritis O
congestive O
heart O
failure O
control O
hypertension O
alcoholism O
smoke O
pack O
day O
past O
50 O
year O
presentation O
blood O
pressure O
17680 O
mmhg O
heart O
rate O
80 O
bpm O
respiration O
24 O
bpm O
temperature O
98f O
367c O
arterial O
blood O
gas O
room O
air B-SYMPTOMS
show O
ph O
730 O
paco2 O
60 O
pao2 O
61 O
mmhg O
hco3 O
29 O
meql O
saturation O
92 O
improve O
95 O
oxygen O
high O
flow O
nonrebreather O
mask O
physical O
examination O
lethargic B-SYMPTOMS
disorient O
dysarthritic B-SYMPTOMS
neurological B-SYMPTOMS
focalization I-SYMPTOMS
scatter O
expiratory O
wheeze O
note O
bilaterally O
normal O
heart O
sound O
remain O
result O
physical O
examination O
routine O
laboratory O
result O
unremarkable O
exception O
leukocyte O
count O
14000dl O
88 O
neutrophil O
repeat O
vital O
sign O
consistent O
normal O
blood O
pressure O
evidence O
tachycardia B-SYMPTOMS
monitor O
repeat O
abgs O
nonrebreather O
mask O
show O
ph O
722 O
paco2 O
78 O
pao2 O
140 O
mm O
hg O
hco3 O
30 O
meql O
hemoglobin O
sao2 O
97 O
ed O
start O
iv O
steroid O
antibiotic O
copd B-DISEASE
exacerbation O
diagnostic O
workup O
undergo O
chest O
x O
ray O
infiltrate O
major O
abnormal O
finding O
ecg O
significant O
sinus O
tachycardia O
give O
negative O
finding O
chest O
x O
ray O
sinus O
tachycardia O
ecg O
increase O
aa O
gradient O
patient O
send O
spiral O
chest O
ct O
contrast O
rule O
pulmonary O
embolism B-DISEASE
ct O
100150 O
ml O
air O
inadvertently O
inject O
right O
antecubital O
vein O
power O
contrast O
injector O
estimate O
technician O
approximation O
volume O
available O
imaging O
concurrent O
imaging O
ct O
show O
significant O
air O
right O
atrium O
right O
ventricular O
cavity O
figure O
1 O
air O
mix O
contrast O
main O
pulmonary O
artery O
proximal O
branch O
division O
pulmonary O
circulation O
figure O
2 O
concurrently O
filling B-SYMPTOMS
defect I-SYMPTOMS
note O
right O
low O
lobe O
artery O
consistent O
pulmonary O
thromboembolism B-DISEASE
figure O
3 O
44 O
patient O
maintain O
hemodynamic O
stability O
trendelenburg O
leave O
lateral O
decubitus O
position O
durant O
maneuver O
supportive O
care O
transfer O
intensive O
care O
unit O
icu O
observation O
respiratory O
distress O
worsen O
place O
temporarily O
noninvasive O
positive O
pressure O
ventilation O
nippv O
improvement B-SYMPTOMS
hour O
later O
intubate O
place O
mechanical O
ventilation O
intravenous O
dose O
heparin O
infusion O
initial O
bolus O
80 O
unitskg O
follow O
18 O
unitskghour O
initiate O
treatment O
concurrent O
thromboembolism O
echocardiography O
evidence O
right O
leave O
ventricular O
failure O
subsequent O
echocardiography O
24 O
hour O
later O
evidence O
intracardiac O
air O
complete O
resolution O
air O
embolism O
48 O
hour O
remain O
hemodynamically O
stable O
requirement O
vasoactive O
agent O
finally O
extubate O
48 O
hour O
initial O
presentation O
later O
discharge O
home O
warfarin O
subsequent O
outpatient O
followup O

73yearold O
female B-SEX
history O
coronary O
artery O
disease O
situs O
inversus O
recently O
notice O
left O
arm O
exercise O
weakness B-SYMPTOMS
magnetic O
resonance O
angiogram O
computer O
tomography O
upper O
limb O
vessel O
show O
critical O
stenosis B-SYMPTOMS
leftside O
sca O
calcification B-SYMPTOMS
near O
orifice O
fig1 O
percutaneous O
revascularization O
right O
femoral O
artery O
approach O
severe O
left O
sca O
stenosis O
confirm O
fig2a O
supplementary O
video O
1 O
online O
direct O
stenting O
left O
sca O
carry O
balloonexpansible O
express O
ld O
1025 O
mm O
stent O
boston O
scientific O
corporation O
natick O
ma O
usa O
fig2b O
8 O
atmosphere O
13 O
second O
severe O
shortness O
breath O
hypotension B-SYMPTOMS
develop O
stente O
blood O
pressure O
8856 O
heart O
rate O
90 O
oxygen O
saturation O
74 O
emergent O
intubation O
fluid O
infusion O
inotropic O
agent O
norepinephrine O
give O
immediate O
angiography O
show O
vascular B-SYMPTOMS
perforation I-SYMPTOMS
stented O
segment O
left O
sca O
fig2c O
supplementary O
video O
2 O
online O
emergency O
balloon O
inflation O
stent O
840 O
mm O
balloon O
cardiovascular O
surgeon O
consult O
high O
surgical O
risk O
bypass O
endovascular O
treatment O
suggest O
decide O
retrograde O
approach O
left O
brachial O
artery O
surgical O
cutdown O
suitable O
graft O
stent O
cath O
lab O
modify O
cut O
iliac O
extension O
selfexpande O
endurant O
ii O
graft O
stent O
1082 O
mm O
medtronic O
inc O
minneapolis O
mn O
usa O
originally O
design O
treat O
abdominal O
aortic O
aneurysm O
aaa O
suitable O
length O
30 O
mm O
fig3 O
retrograde O
wire O
operatormodifie O
endurant O
ii O
graft O
stent O
deploy O
stent O
segment O
fig2d O
perforation O
seal O
successfully O
stente O
graft O
stent O
slow O
flow O
left O
common O
carotid O
artery O
lcca O
note O
angiography O
confirm O
near O
total O
occlusion B-SYMPTOMS
lcca O
occlude O
sca O
graft O
stent O
fig2e O
supplementary O
video O
3 O
online O
firm O
wire O
conquest O
pro O
asahi O
inc O
seto O
japan O
successfully O
advance O
outside O
graft O
stent O
lcca O
despite O
sequent O
balloon O
dilation O
bifurcation O
site O
flow O
lcca O
poor O
intravascular O
ultrasound O
confirm O
severe O
compromise B-SYMPTOMS
lcca O
ostium O
cause O
graft O
stent O
fig2f O
balloonexpansible O
carotid O
stent O
express O
737 O
mm O
boston O
scientific O
corporation O
lcca O
left O
brachiocephalic O
artery O
fig4a O
timi O
iii O
flow O
lcca O
restore O
stente O
fig4be O
supplementary O
video O
4 O
online O
intravascular O
ultrasound O
confirm O
proper O
expansion B-SYMPTOMS
lcca O
stent O
fig4f O
followup O
chest O
radiography O
reveal O
leftside O
hemothorax B-SYMPTOMS
thoracocentesis O
drainage O
proper O
care O
patient O
discharge O
till O
patient O
free O
symptom O
month O

68yearold O
female B-SEX
smoker O
history O
pulmonary O
embolism O
diabetes O
mellitus O
diagnose O
stage O
iiib O
t4n2m0 O
squamous O
nsclc B-DISEASE
treat O
definitive O
chemoradiotherapy O
cisplatin O
vinorelbine O
september O
2014 O
october O
2014 O
positron O
emission O
tomographycompute O
tomography O
petct O
scan O
demonstrate O
good O
response O
primary O
lesion B-SYMPTOMS
new O
metastasis O
right O
adrenal O
gland O
right O
femur O
develop O
irradiate O
november O
2014 O
month O
later O
disease O
progress O
development O
multiple O
bone O
subcutaneous O
metastasis O
point O
patient O
suffer O
severe O
dyspnea B-SYMPTOMS
oxygendependent O
receive O
cycle O
carboplatin O
gemcitabine O
follow O
severe O
pancytopenia B-SYMPTOMS
treatment O
switch O
nivolumab O
3 O
mgkg O
q14 O
day O
january O
2015 O
week O
cycle O
nivolumab O
subcutaneous O
lesion O
upper O
grow O
substantially O
accompany O
severe O
pain B-SYMPTOMS
significant O
inflammatory B-SYMPTOMS
reaction I-SYMPTOMS
fig1 O
subcutaneous O
metastasis O
grow O
slightly O
second O
cycle O
treatment O
mark O
symptomatic B-SYMPTOMS
improvement I-SYMPTOMS
observe O
include O
improvement O
general O
appearance O
dyspnea O
reduction O
bone O
pain O
patient O
long O
require O
oxygen O
supplementation O
subcutaneous O
lesion O
start O
regress O
complete O
resolution O
12th O
week O
improvement O
bone O
lesion O
figs1 O
2 O
patient O
continue O
nivolumab O
june O
2015 O
tolerate O
treatment O
unfortunately O
develop O
bacterial O
aspiration O
pneumonia B-SYMPTOMS
pass O
away O
june O
2015 O

60yearold O
woman B-SEX
patient O
admit O
hospital O
feb O
18 O
2016 O
frequent O
episode O
hemoptysis B-SYMPTOMS
2 O
week O
previous O
decade O
patient O
frequent O
severe O
episode O
hemoptysis O
typically O
ensue O
follow O
upper O
respiratory O
tract O
infection B-DISEASE
ear O
nose O
throat O
examination O
laryngoscope O
fail O
identify O
apparent O
source O
bleed O
ct O
chest O
scan O
reveal O
abnormality B-SYMPTOMS
recent O
episode O
occur O
upper O
respiratory O
tract O
infection O
2 O
week O
ago O
patient O
cough O
500 O
ml O
fresh B-SYMPTOMS
blood I-SYMPTOMS
episode O
hemoptysis O
alleviate O
antitussive O
therapy O
patient O
deny O
history O
smoking O
illicit O
drug O
use O
diagnostic O
workup O
reveal O
evidence O
coagulopathy B-DISEASE
admission O
physical O
examination O
reveal O
sign O
rhonchi B-SYMPTOMS
reduce O
breath O
sound O
bronchoscopy O
show O
1 O
cm O
lesion B-SYMPTOMS
membranous O
trachea O
2 O
cm O
carina O
tortuous O
blood O
vessel O
observe O
run O
submucosa O
trachea O
fig1 O
ct O
angiography O
perform O
demonstrate O
artery O
extend O
submucosa O
descend O
aorta O
fig2 O
diagnosis O
dieulafoy O
disease O
trachea O
entertain O
blood O
vessel O
consider O
culprit O
hemoptysis O
selective O
arterial O
embolization O
perform O
1 O
week O
later O
fresh O
episode O
acute O
hemoptysis O
observe O
patient O
follow O
time O
write O
report O
study O
approve O
ethics O
committee O
shanghai O
jiao O
tong O
university O
affiliate O
sixth O
people O
hospital O
get O
inform O
write O
consent O
patient O

65yearold O
woman B-SEX
report O
persistent O
pain B-SYMPTOMS
3 O
month O
symptom O
severe O
walk O
change O
position O
slightly O
relieve B-SYMPTOMS
take O
painkiller O
patient O
describe O
pain O
numbness B-SYMPTOMS
leg O
describe O
bowel O
bladder O
voiding O
difficulty O
patient O
report O
past O
medical O
history O
hypertension O
coronary O
heart O
disease O
cerebral O
infarction O
asthma O
control O
physical O
exam O
demonstrate O
kyphosis B-DISEASE
thoracic O
spine O
stand O
position O
lumbar O
vertebra O
bend O
forward O
backward O
straight O
activity O
limit O
obvious O
rap O
pain O
t12 O
level O
patient O
general O
medical O
examination O
unremarkable O
upper O
low O
extremity O
motor O
stretch O
reflex O
sensory O
examination O
xray O
compute O
tomography O
ct O
magnetic O
resonance O
imaging O
mri O
exam O
perform O
patient O
hospital O
fig1 O
lateral O
xray O
show O
t12 O
fracture B-DISEASE
40 O
kyphotic O
cobb O
angle O
ct O
show O
intravertebral B-SYMPTOMS
vacuum I-SYMPTOMS
sign I-SYMPTOMS
sagittal O
t1weighted O
mri O
show O
decrease O
signal O
intravertebral B-SYMPTOMS
vacuum I-SYMPTOMS
cleft I-SYMPTOMS
posterior O
cortex O
breakage B-DISEASE
cord B-SYMPTOMS
compression I-SYMPTOMS
t12 O
sagittal O
t2weighte O
mri O
show O
increase O
signal O
intravertebral O
vacuum O
cleft O
patient O
diagnose O
kmmell O
disease O
stage O
iii9 O
operation O
perform O
general O
anesthesia O
prone O
position O
standard O
posterior O
exposure O
spine O
give O
pedicle O
screw O
insert O
target O
vertebrae O
t10 O
t11 O
l1 O
l2 O
carm O
guidance10 O
screw O
connect O
left O
temporary O
stabilize O
rod O
laminectomy O
perform O
decompress O
fully O
visualize O
spinal O
cord10 O
careful O
subperiosteal O
dissection O
carry O
right O
exposure O
lateral O
wall O
t12 O
vertebral O
body O
anterior O
aspect O
reach O
right O
pedicle O
articular O
process O
t12 O
vertebral O
body O
remove O
t11t12 O
t12l1 O
intervertebral O
disk O
remove O
temporary O
stabilize O
rod O
replace O
rod O
bend O
desire O
contour O
autologous O
bone O
graft O
titanium O
mesh O
place O
intervertebral O
space O
rod O
desire O
contour O
connect O
right O
adequate O
hemostasis O
ensure O
wound O
thoroughly O
irrigate O
saline O
drainage O
tube O
insert O
surgical O
wound O
close O
layerbylayer10 O
time O
skin O
incision O
completion O
wound O
closure O
last O
150 O
minute O
estimate O
blood B-DISEASE
loss I-DISEASE
total O
600 O
ml O
postoperatively O
patient O
give O
preventive O
antibiotic O
treatment O
1 O
day O
pain O
treatment O
3 O
day O
anticoagulant O
therapy O
1 O
week O
drainage O
tube O
remove O
3 O
day O
postoperative O
volume O
drainage O
50 O
ml O
24 O
hour O
patient O
allow O
bed O
custommade O
plastic O
orthosis O
1 O
week O
operation O
plastic O
orthosis O
keep O
3 O
month O
patient O
allow O
hospital O
12 O
day O
operation O
surgical O
suture O
remove O
pain O
assessment O
conduct O
visual O
analogue O
scale O
vas O
vas O
preoperative O
1 O
week O
operation O
1 O
year O
operation O
9 O
score O
3 O
score O
2 O
score O
respectively O
demonstrate O
significant O
improvement O
patient O
resume O
normal O
activity O
return O
work O
3 O
month O
operation O
kyphotic O
cobb O
angle O
preoperative O
1 O
week O
operation O
1 O
year O
operation O
40 O
8 O
17 O
respectively O
demonstrate O
significant O
improvement O
fig2 O

18yearold O
man B-SEX
present O
history O
palpable O
lump B-SYMPTOMS
presternal O
area O
find O
incidentally O
weight B-SYMPTOMS
reduction I-SYMPTOMS
patient O
relevant O
medical O
trauma O
history O
physical O
examination O
lesion B-SYMPTOMS
find O
nonmovable O
firm O
mass B-SYMPTOMS
tenderness B-SYMPTOMS
associated O
skin O
change O
detect O
midline O
position O
sternum O
manubrium O
level O
visible O
fistulous B-SYMPTOMS
opening I-SYMPTOMS
discharge B-SYMPTOMS
lesion O
ultrasonography O
detect O
wellcircumscribe O
oval O
anechoic O
mass O
posterior O
acoustic O
enhancement O
measure O
33 O
   O
17 O
   O
31 O
cm O
locate O
subcutaneous O
fat O
layer O
sternum O
dependent O
portion O
mass O
internal O
wellcircumscribe O
heterogeneously O
hypoechoic O
eggshape O
lesion O
fig1a O
b O
show O
movement O
accord O
patient O
movement O
mass O
compress O
linear O
transducer O
fig2a O
b O
color O
doppler O
study O
show O
vascularity B-SYMPTOMS
cystic O
mass O
internal O
hypoechoic O
lesion O
fig1c O
surgical O
excision O
mass O
perform O
postoperative O
complication O
grossly O
excise O
mass O
welldefine O
ovoid O
cystic O
mass O
graytan O
color O
section O
find O
unilocular O
cyst B-SYMPTOMS
fill O
whitish O
mucous B-SYMPTOMS
material I-SYMPTOMS
microscopically O
mass O
line O
ciliated O
pseudostratifie O
columnar O
epithelium O
suggestive O
respiratory O
typemucosa O
fig3 O
nonspecific O
collagenous O
fibrosis B-SYMPTOMS
cyst O
differential O
diagnosis O
subcutaneous O
cyst O
include O
epidermal B-DISEASE
inclusion I-DISEASE
cyst I-DISEASE
thyroglossal B-DISEASE
duct I-DISEASE
cyst I-DISEASE
branchial B-DISEASE
cleft I-DISEASE
cyst I-DISEASE
dermoid B-DISEASE
cyst I-DISEASE
histological B-SYMPTOMS
evidence I-SYMPTOMS
squamous O
epithelium O
keratin O
thyroid O
tissue O
skin O
appendage O
cystic O
wall O
present O
case O
mass O
diagnose O
bronchogenic B-DISEASE
cyst I-DISEASE

23yearold O
man B-SEX
history O
severe B-DISEASE
aplastic I-DISEASE
anemia I-DISEASE
saa B-DISEASE
undergo O
bone O
marrow O
transplantation O
hlahaploidentical O
mother O
january O
2014 O
conditioning O
regimen O
consist O
busulphan O
cyclophosphamide O
antithymocyte O
globulin O
bucyatg O
10 O
cyclosporine O
csa O
shortterm O
methotrexate O
mtx O
plus O
mycophenolate O
mofetil O
mmf O
prophylaxis O
graftversushost O
disease O
gvhd B-DISEASE
11 O
standard O
measure O
adopt O
prevention O
infectious O
complication O
include O
fluconazole O
antifungal O
prophylaxis O
acyclovir O
prevent O
herpesrelated O
infection B-DISEASE
hemogram O
reveal O
reconstruction O
granulocyte O
anc05109l O
day O
12 O
posttransplantation O
patient O
develop O
grade O
ii O
acute O
gvhd O
skin O
day O
42 O
posttransplantation O
treat O
treatment O
standarddose O
methylprednisolone O
achieve O
complete B-SYMPTOMS
response I-SYMPTOMS
cr B-SYMPTOMS
patient O
chronic B-DISEASE
gvhd I-DISEASE
cgvhd B-DISEASE
skin O
gradually O
progress O
day O
100 O
posttransplantation O
treat O
prednisolone O
csa O
day O
120 O
posttransplantation O
complain O
cough B-SYMPTOMS
antibiotic O
administer O
blood O
analysis O
reveal O
follow O
wbc O
234109l O
anc O
172109l O
hemoglobin O
85 O
gl O
platelet O
72109l O
chest O
compute O
tomography O
ct O
scan O
test O
pathogen O
routine O
culturing O
include O
blood O
test O
betad O
glucan O
gtest O
galactomannan O
gmtest O
negative O
patient O
cough O
respond O
antibiotic O
empirically O
initiate O
treatment O
voriconazole O
6 O
mgkg12h O
day O
follow O
4 O
mgkg12h O
liver O
toxicity B-SYMPTOMS
occur O
voriconazole O
treatment O
antifungal O
regimen O
change O
micafungin O
100 O
mgd O
persistent O
cough O
improve O
hoarseness B-SYMPTOMS
develop O
week O
treatment O
   O
ulcer O
observe O
throat O
laryngoscopy O
fig1a O
patient O
develop O
severe O
dyspnea B-SYMPTOMS
following O
week O
antiinfection O
topical O
treatment O
apply O
fiberoptic O
bronchoscopy O
reveal O
irregular O
nodular O
material B-SYMPTOMS
white O
moss O
nearly O
obstruct O
bronchus O
chest O
ct O
imaging O
negative O
fig1b O
c O
histopathological O
examination O
biopsy O
specimen O
reveal O
aspergillus B-DISEASE
species O
fig1d O
patient O
diagnose O
pseudomembranous O
aspergillus O
tracheobronchitis B-DISEASE
type O
itba O
base O
result O
bronchoscopy O
pathological O
examination O
12 O
antibiotic O
micafungin O
treatment O
cease O
liposomal O
amphotericin O
b O
liposomal O
amb O
administer O
daily O
target O
dose O
3 O
mgkg O
patient O
serum O
creatinine O
level O
rise O
604 O
moll O
168 O
moll O
7 O
day O
liposomal O
amb O
treatment O
progressive O
renal B-DISEASE
dysfunction I-DISEASE
antifungal O
regimen O
switch O
combination O
posaconazole O
400 O
mg12 O
h O
caspofungin O
50 O
mg O
daily O
70 O
mg O
dose O
combination O
therapy O
continue O
2 O
week O
previous O
nodule O
throat O
completely O
disappear O
bronchoscopy O
fig2a O
repeat O
chest O
ct O
scan O
show O
progression B-SYMPTOMS
fig2b O
symptom O
dyspnea O
gradually O
progress O
fiberoptic O
bronchoscopy O
perform O
remove O
obstructive B-SYMPTOMS
material I-SYMPTOMS
patient O
airway O
week O
week O
symptom O
relieve O
final O
chest O
ct O
scan O
show O
negative O
result O
discontinuation O
antifungal O
therapy O
test O
negative O
aspergillus O
posaconazole O
administer O
secondary O
prophylactic O
treatment O
patient O
discharge O
hospital O
patient O
follow O
remain O
free O
recurrence O
invasive O
fungal O
infection O

73yearold O
man B-SEX
diagnose O
type B-DISEASE
2 I-DISEASE
diabetes I-DISEASE
mellitus I-DISEASE
35 O
year O
age O
severe O
diabetic B-DISEASE
neuropathy I-DISEASE
diabeticesrd O
complain O
respiratory B-SYMPTOMS
distress I-SYMPTOMS
sudden O
chest O
pain B-SYMPTOMS
day O
treatment O
visit O
emergency O
room O
physical O
examination O
reveal O
body O
temperature O
354c O
heart O
rate O
90 O
beatsmin O
regular O
rhythm O
blood O
pressure O
13077 O
mmhg O
physical O
examination O
reveal O
coarse O
crackle O
bilateral O
lung O
auscultation O
laboratory O
datum O
show O
wbc O
count O
8800l O
shift O
left O
neutrophil O
82 O
hb O
102 O
gdl O
blood O
urea O
nitrogen O
bun O
822 O
mgdl O
creatinine O
cre O
650 O
mgdl O
hba1c O
59 O
creatine O
kinase O
ck O
189 O
iul O
creactive O
protein O
crp O
851 O
mgdl O
braintype O
natriuretic O
peptide O
bnp O
1274 O
pgml O
chest O
radiograph O
reveal O
perihilar O
consolidation O
air O
bronchogram O
fig1 O
electrocardiogram O
reveal O
stsegment O
elevation O
poor O
rwave O
progression O
lead O
v1v3 O
echocardiography O
reveal O
apical O
ventricular O
asynergy O
patient O
diagnose O
acute O
myocardial B-DISEASE
infarction I-DISEASE
congestive O
heart B-DISEASE
failure I-DISEASE
coronary O
angiography O
perform O
reveal O
severe O
angiostenosis B-SYMPTOMS
septal O
branch O
pci O
perform O
patient O
require O
continuous O
maintenance O
dialysis O
follow O
day O
patient O
go O
cardiorespiratory B-DISEASE
arrest I-DISEASE
cardiopulmonary O
resuscitation O
perform O
follow O
mechanical O
ventilation O
day O
8 O
ventilator O
assistance O
discontinue O
patient O
produce O
increase O
volume O
sputum B-SYMPTOMS
begin O
appear O
purulent O
pseudomonas B-SYMPTOMS
aeruginosa I-SYMPTOMS
identify O
sputum O
culture O
tazobactampiperacillin O
tazpipc O
45 O
g O
q12h O
administer O
despite O
therapy O
patient O
respiratory O
condition O
worsen O
chest O
compute O
tomography O
ct O
scan O
day O
15 O
reveal O
bilateral O
perihilar O
opacity O
pleural B-DISEASE
effusion I-DISEASE
atelectasisfig2 O
suspect O
development O
complication O
microbial B-DISEASE
substitution I-DISEASE
pneumomycosis B-DISEASE
perform O
sputum O
culturing O
serum O
fungal O
antigen O
test O
administration O
tazpipc O
change O
meropenem O
05 O
gday O
day O
16 O
patient O
serum O
test O
positive O
cryptococcus O
antigen O
day O
21 O
cryptococcal O
body O
identify O
set O
blood O
culture O
liposomal O
amphotericin O
b O
lamb O
3 O
mgkgday O
administer O
day O
23 O
cryptococcal O
body O
identify O
sputum O
cerebrospinal O
fluid O
bilateral O
pleural O
effusion O
fig3 O
patient O
diagnose O
disseminate O
cryptococcosis B-DISEASE
day O
25 O
brain O
ct O
reveal O
absence O
intracranial O
hypertension B-SYMPTOMS
brain O
abscess B-DISEASE
patient O
infect O
human B-DISEASE
immunodeficiency I-DISEASE
virus I-DISEASE
hiv B-DISEASE
administration O
lamb O
3 O
mgkgday O
continue O
day O
31 O
chest O
ct O
reveal O
solitary O
nodule B-SYMPTOMS
left O
lingular O
segment O
time O
suspect O
pulmonary O
cryptococcus B-DISEASE
lesion I-DISEASE
fig4a O
day O
sputum O
blood O
bilateral O
pleural O
effusion O
cerebrospinal O
fluid O
culture O
test O
negative O
day O
52 O
chest O
ct O
reveal O
lung O
nodule O
right O
pulmonary O
apical O
region O
nodule O
gradually O
decrease O
size O
day O
79 O
fig4b O
c O
lamb O
consider O
effective O
creactive O
protein O
level O
remain O
elevate O
bilateral O
pleural O
effusion O
continuously O
increase O
patient O
lose O
consciousness O
decrease O
vital O
capacity O
increase O
bilateral O
pleural O
effusion O
diagnose O
co2 B-DISEASE
narcosis I-DISEASE
patient O
general O
condition O
deteriorate O
day O
87 O
ventricular B-DISEASE
fibrillation I-DISEASE
occur O
patient O
die O
autopsy O
perform O
later O
date O
cryptococcus O
isolate O
identify O
classify O
cryptococcus O
neoformans O
var O
grubii O
serotype O
genetic O
analysis O

82yearold O
male B-SEX
admit O
outside O
hospital O
emergency O
room O
abdominal O
pain B-SYMPTOMS
faint B-SYMPTOMS
previous O
history O
auricular B-SYMPTOMS
fibrillation I-SYMPTOMS
treatment O
dicumarinic O
anticoagulant O
previous O
episode O
abdominal O
pain O
diagnose O
spontaneous O
mesenchimal B-DISEASE
haematoma I-DISEASE
treat O
non O
operatively O
deny O
kind O
trauma B-SYMPTOMS
hematemesis B-SYMPTOMS
melena B-SYMPTOMS
physical O
examination O
patient O
stable O
suffer O
intense O
pain O
right O
low O
abdoman O
defense O
blood O
test O
show O
haemoglobin O
level O
10 O
gdl O
coagulation O
alter O
expect O
ct O
scan O
show O
massive O
hemoperitoneum B-SYMPTOMS
figure O
1 O
know O
mesenteric B-DISEASE
hematoma I-DISEASE
figure O
2 O
assume O
diagnosis O
expansive O
mesenteric O
hematoma O
plus O
ongoing O
bleed O
laparotomy O
perform O
exploration O
3 O
liter O
fresh O
old O
blood O
clot O
find O
90 O
cm O
ileocecal O
valve O
torsionate O
perforate O
meckel B-DISEASE
diverticulum I-DISEASE
intradiverticular O
bleeding B-SYMPTOMS
find O
figure O
3 O
diverticular O
resection O
perform O
postoperatory O
uneventful O
patient O
discharge O
home O
9th O
postoperative O
day O

present O
case O
pancreatic B-DISEASE
tumor I-DISEASE
history O
trauma B-DISEASE
panceratitis B-DISEASE
47yearold O
tunisian O
man B-SEX
history O
crohns O
disease O
admit O
university O
hospital O
2015 O
fluid O
chronic O
diarrhea B-SYMPTOMS
4 O
stool O
day O
daytime O
ooddebr O
associate O
vomit O
abdominal O
pain B-SYMPTOMS
fever B-SYMPTOMS
weight B-SYMPTOMS
loss I-SYMPTOMS
encrypt O
date O
6 O
month O
laboratory O
test O
normal O
nonspecific O
elevation O
serum O
pancreatic O
enzyme O
patient O
undergo O
abdominal O
ultrasound O
compute O
tomography O
ct O
reveal O
aspect O
ileitis B-DISEASE
ileal O
loop O
extend O
300 O
mm O
distended B-SYMPTOMS
ileal O
loop O
upstream O
cystic O
image B-SYMPTOMS
tail O
pancrea O
clean O
wall O
uncalcified B-SYMPTOMS
hypodense O
content O
fluid O
density O
endoluminal O
bourgeon B-SYMPTOMS
pancreatic O
duct O
dilatation B-SYMPTOMS
measure O
28 O
x O
22 O
mm O
figure O
1 O
size O
head O
normal O
enlarged B-SYMPTOMS
lymph O
node O
figure O
2 O
aspect O
bilateral O
sacroiliitis B-DISEASE
bilateral O
coxarthrosis B-DISEASE
mri O
aspect O
ileitis O
ileal O
loop O
cystic O
nature O
pancreatic O
lesion B-SYMPTOMS
parietal O
enhancement B-SYMPTOMS
caudal O
portion O
pancrea O
slight O
dilation B-SYMPTOMS
wirsung O
gallbladder O
contain O
multiple O
gallstone O
biliary B-SYMPTOMS
sludge I-SYMPTOMS
tumor O
marker O
normalon O
hand O
colonoscopy O
terminal O
ileum O
appear O
swollen B-SYMPTOMS
inflame O
frequent O
ulceration O
biopsy O
biopsy O
take O
subacute O
ulcerative O
ileitis O
compatible O
crohns O
disease O
esophagogastroduodenoscopy O
normal O
patient O
operate O
laparoscopy O
caudal O
pancreatectomy O
cholecystectomy O
15 O
cm O
cystic O
tumor O
tail O
pancrea O
resect O
send O
pathological O
examination O
postoperative O
course O
uneventful O
patient O
discharge O
home O
7 O
day O
good O
general O
condition O
symptom O
glucose O
intolerance O
normal O
diet O
administration O
microscopic O
examination O
reveal O
differentiate O
cystic O
neuro B-DISEASE
endocrine I-DISEASE
tumor I-DISEASE
tail O
pancreas O
grade O
accord O
classification O
2010 O
mitosis O
210cfg O
ki672 O
   O
associate O
neuroendocrine O
hyperplasia O
lesion O
islet O
langerhan O
surgical O
limit O
healthy O
ptnm O
pt2 O
ectopic B-SYMPTOMS
spleen O
chronic O
cholecystitis B-DISEASE
patient O
come O
outpatient O
consultation O
hospital O
feel O
severe O
complaint O
correct O
periodic O
finding O
normal O
glucose O
metabolism O

54yearold O
asian O
man B-SEX
iga O
nephropathy O
underwent O
livingdonor O
kidney O
transplantation O
14 O
year O
previously O
medical O
condition O
stable O
14 O
year O
develop O
multifocal O
salmonpink O
skin O
discoloration B-SYMPTOMS
swelling B-SYMPTOMS
spontaneous O
pain B-SYMPTOMS
left O
knee O
leg O
symptom O
gradually O
expand O
right O
forearm O
outside O
right O
thigh O
admit O
hospital O
evaluation O
fever B-SYMPTOMS
39 O
c O
multifocal O
cellulitis B-DISEASE
fig1 O
month O
admission O
develop O
chronic O
diarrhea B-SYMPTOMS
serum O
creatinine O
level O
stabilize O
17 O
mgdl O
maintenance O
immunosuppressive O
therapy O
comprise O
tacrolimus O
3 O
mgday O
mycophenolate O
mofetil O
1500 O
mgday O
prednisone O
4 O
mg O
day O
tacrolimus O
trough O
concentration O
63 O
ngml O
patient O
dog O
breeder O
12 O
year O
admission O
white O
blood O
cell O
count O
12400l O
creactive O
protein O
level O
39 O
mgdl O
patient O
initially O
treat O
ampicillinsulbactam O
9 O
gday O
intravenously O
day O
initiation O
therapy O
afebrile B-SYMPTOMS
day O
later O
automate O
blood O
culture O
bactec O
fx O
bectondickinson O
company O
spark O
md O
usa O
show O
positivity O
gramnegative O
spiral O
bacilli O
colony O
obtain O
patient O
blood O
culture O
analyze O
malditof O
ms O
biotyper O
ver O
30 O
bruker O
corporation O
germany O
identification O
score O
2064 O
20 O
indicate O
accurate O
identification O
h O
cinaedi O
fig2 O
additional O
evaluation O
patient O
blood O
specifically O
h O
cinaedi O
mean O
gyrase O
subunit O
b O
gyrbtargete O
pcr O
assay O
forward O
primer O
agggattccacaaagtgagc O
reverse O
primer O
tcttgtcctgtgcgttcatc O
amplify O
region O
gyrb O
gene O
yield O
positive O
result O
perform O
gyrbtargete O
pcr O
single O
colony O
isolate O
blood O
culture O
distilled O
water O
dna O
dnasefree O
water O
negative O
control O
prevent O
contamination O
gyrbtargete O
pcr O
fig3 O
addition O
perform O
16 O
rrna O
gene O
sequence O
strain O
result O
   O
99 O
consistent O
exist O
sequence O
fig4 O
give O
result O
diagnose O
patient O
h O
cinaedi O
bacteremia B-DISEASE
cellulitis O
examine O
genomic O
heat O
shock O
protein O
hsp O
60 O
sequence O
blood O
culture O
isolate O
result O
identification O
cluster O
b O
h O
cinaedi O
blood O
culture O
obtain O
11 O
day O
positive O
h O
cinaedi O
culture O
obtain O
15 O
day O
negative O
patient O
cellulitis O
gradually O
resolve O
patient O
continue O
antibiotic O
treatment O
total O
6 O
week O
ampicillinsulbactam O
drip O
2 O
week O
oral O
levofloxacin O
4 O
week O
recurrence B-SYMPTOMS
6 O
month O
therapy O
stool O
culture O
negative O
take O
treatment O
apply O
enteric O
bacteria O
elimination O
case O

37yearold O
african O
american O
female B-SEX
past O
medical O
history O
significant O
stage O
1 O
sarcoidosis B-DISEASE
present O
facility O
chief O
complaint O
shortness O
breath O
year O
prior O
present O
bilateral O
uveitis B-DISEASE
lupus B-SYMPTOMS
pernio I-SYMPTOMS
lp B-SYMPTOMS
right O
ear O
subsequently O
diagnose O
sarcoidosis O
successfully O
treat O
condition O
sarcoidosis O
remain O
quiescent O
year O
ago O
outside O
institution O
discover O
laryngeal O
involvement B-SYMPTOMS
treat O
prednisone O
60 O
mg O
daily O
month O
eventually O
taper O
10 O
mg O
daily O
sarcoidosis O
remain O
wellcontrolled O
maintenance O
dose O
prednisone O
month O
prior O
time O
selfdiscontinue O
prednisone O
favor O
homeopathic O
treatment O
nopalea O
cactus O
juice O
unsubstantially O
claim O
antiinflammatory O
property O
4 O
subsequently O
develop O
dyspnea B-SYMPTOMS
exertion O
progressing O
dyspnea O
rest O
time O
voice O
increasingly O
hoarse B-SYMPTOMS
experience O
frequent O
episode O
difficulty O
swallow O
emergency O
department O
physical O
examination O
concern O
respiratory B-SYMPTOMS
distress I-SYMPTOMS
present O
inspiratory B-SYMPTOMS
stridor I-SYMPTOMS
hoarseness B-SYMPTOMS
chronicappeare O
indurate O
lesion O
right O
ear O
give O
sign O
upper B-DISEASE
airway I-DISEASE
disease I-DISEASE
impend O
respiratory B-DISEASE
failure I-DISEASE
emergent O
bedside O
laryngoscopy O
perform O
reveal O
obstruct O
airway O
epiglottis O
retroflex O
glottis O
significant O
edema B-SYMPTOMS
arytenoid O
aryepiglottic O
fold O
immediately O
treat O
highdose O
intravenous O
dexamethasone O
take O
emergently O
operating O
room O
secure O
airway O
concern O
complete O
upper O
airway O
obstruction B-DISEASE
confirm O
direct O
visualization O
larynx O
intubate O
surgical O
airway O
take O
biopsy O
lingual O
surface O
epiglottis O
4 O
cuff O
shiley O
tracheostomy O
place O
respiratory O
status O
immediately O
stabilize O
extubate O
transfer O
medical O
intensive O
care O
unit O
tracheostomy O
exchange O
4 O
cuffless O
shiley O
postoperative O
day O
5 O
time O
transition O
intravenous O
dexamethasone O
prednisone O
60 O
mg O
daily O
biopsy O
ultimately O
reveal O
nonnecrotizing O
epithelioid O
granuloma O
consistent O
sarcoidosis O
figure O
1 O
prescribe O
highdose O
prednisone O
month O
receive O
education O
selftracheostomy O
care O
discharge O
home O
subsequent O
onemonth O
threemonth O
followup O
visit O
deny O
respiratory O
issue O
repeat O
laryngoscopie O
show O
significant O
improvement O
edema O
arytenoid O
aryepiglottic O
fold O
epiglottis O
continue O
obscure B-DISEASE
glottis O
despite O
therapy O
highdose O
prednisone O
methotrexate O
initiate O
prednisone O
taper O
10 O
mg O
daily O
regimen O
fail O
prednisone O
dosage O
increase O
20 O
mg O
daily O
reduce O
edema O
decline O
surgical O
treatment O
continue O
medical O
management O
immunosuppressive O
therapy O
facilitate O
eventual O
decannulation O

62yearold O
female B-SEX
present O
outpatient O
department O
wuhan O
central O
hospital O
tongji O
medical O
college O
september O
2015with O
complaint O
recurrent O
infection O
umbilical O
region O
report O
abdominal O
pain B-SYMPTOMS
similar O
burn O
sensation O
accompany O
discharge O
faecal O
matter O
symptom O
sign O
wax O
wane O
last O
5year O
attention O
pique O
fact O
patient O
family O
describe O
patient O
individual O
cry O
easily O
patient O
history O
diarrhoea B-SYMPTOMS
constipation B-SYMPTOMS
abdominal O
disturbance O
surgical O
treatment O
mention O
prior O
medical O
history O
acoordinate O
physical O
examination O
reveal O
normal O
vital O
sign O
external O
fistula B-SYMPTOMS
locate O
umbilical O
region O
redness B-SYMPTOMS
surround O
skin O
morphological O
examination O
indicate O
fistula O
secretion O
mainly O
consist O
small O
intestinal O
juice O
abdominal O
wall O
soft B-SYMPTOMS
tenderness B-SYMPTOMS
bowel O
sound O
regular O
escherichia B-DISEASE
coli I-DISEASE
enterococcus O
faecali O
detect O
fistula O
secretion O
culture O
finding O
laboratory O
examination O
normal O
ct O
scan O
abdoman O
reveal O
intestinal O
wall O
adhere O
abdominal O
wall O
navel O
region O
bowel O
obstruction B-SYMPTOMS
detect O
fig1 O
presumptive O
diagnosis O
ecf B-DISEASE
reach O
diagnosis O
mainly O
base O
digital O
radiography O
fistulous O
tract O
conduct O
iopamidol370 O
contrast O
agent O
procedure O
perform O
local O
anaesthesia O
reveal O
distal O
ileum O
approximately O
40 O
cm O
ileocaecal O
junction O
entrap O
fig2 O
patient O
agree O
surgery O
clear O
preoperative O
conversation O
understand O
operative O
risk O
factor O
sign O
inform O
consent O
bowel O
preparation O
patient O
receive O
exploratory O
laparotomy O
abdominal O
cavity O
completely O
expose O
loop O
terminal O
ileum O
approximately O
40 O
cm O
proximal O
ileocaecal O
junction O
find O
entrap O
internal O
hernia B-DISEASE
ring O
finding O
consistent O
preoperative O
contrast O
image O
defect B-SYMPTOMS
abdominal O
wall O
10 O
cm O
extremely O
small O
portion O
bowel O
wall O
stuck B-SYMPTOMS
retrieve O
cavity O
fig3 O
nonetheless O
defect O
result O
perforation B-DISEASE
loop O
fig4 O
sidetoside O
ileoileal O
anastomosis O
complete O
utilize O
75 O
mm O
linear O
stapler O
remove O
affected O
ileum O
segment O
internal O
hernia O
ring O
close O
plication O
suture O
instead O
mesh O
repair O
patient O
small O
defect O
infection O
risk O
abdominal O
cavity O
thoroughly O
clean O
saline O
solution O
rubber O
drainage O
tube O
place O
pelvis O
scar O
tissue O
remove O
improve O
wound O
healing O
subsequently O
relaxation O
suture O
available O
close O
abdomen O
layer O
final O
diagnosis O
richter O
hernia O
present O
spontaneous O
ecf O
reach O
patient O
discharge O
2 O
week O
surgery O
complication O
hernia O
recurrence O
observe O
10 O
month O
followup O

3monthold O
infant O
uae O
geneticallyconfirmed O
diagnosis O
jarcholevin O
syndrome O
dependent O
mechanical O
ventilation O
birth O
admit O
centre O
implantation O
veptrs O
receive O
intubated O
patient O
mechanically O
ventilate O
volumecontrolled O
mode O
030045 O
fraction O
inspire O
oxygen O
fio2 O
peak O
inspiratory O
pressure O
pip O
2345 O
cm O
h2o O
positive O
endexpiratory O
pressure O
peep O
7 O
cm O
h2o O
backup O
respiratory O
rate O
rr O
34 O
chest O
xray O
thorax O
perform O
admission O
figure O
1a O
month O
surgery O
figure O
1b O
show O
improvement O
bilateral O
posterior O
atelectasis B-DISEASE
base O
lung O
owe O
difficulty O
progress O
weaning O
process O
mechanical O
ventilation O
veptrs O
implant O
expand O
thorax O
bronchoscopy O
perform O
show O
bronchomalacia B-DISEASE
predominantly O
upper O
lobar O
bronchi O
prolong O
mechanical O
ventilation O
expect O
tracheostomy O
previously O
perform O
initial O
ct O
scan O
figure O
2a O
followup O
ct O
scan O
figure O
2b O
month O
surgery O
show O
resolution O
posteriorbasal O
atelectasis O
coincide O
decrease O
fio2 O
021 O
postoperatively O
patient O
servoi O
ventilator O
volumecontrolled O
mode O
need O
variable O
pip O
25 O
45 O
cm O
h2o O
peep O
value O
711 O
cm O
h2o O
attempt O
wean O
patient O
ventilator O
following O
month O
unable O
activate O
inspiratory O
flow O
trigger O
require O
significant O
sedoanalgesia O
adapt O
ventilator O
repeat O
episode O
desaturation B-SYMPTOMS
occasion O
bradycardia B-SYMPTOMS
associate O
bronchial B-DISEASE
collapse I-DISEASE
continue O
asynchrony B-SYMPTOMS
require O
bolus O
sedation O
addition O
exist O
medication O
initially O
receive O
fentanyl O
midazolam O
continuous O
infusion O
pump O
progressive O
increase O
dose O
continuous O
cisatracurium O
muscular O
relaxant O
adapt O
mechanical O
ventilation O
figure O
3 O
clinical B-SYMPTOMS
stabilisation I-SYMPTOMS
achieve O
muscular O
relaxant O
withdraw O
progressive O
decrease O
sedation O
initiate O
change O
drug O
regimen O
period O
patient O
develop O
ocular B-SYMPTOMS
flutter I-SYMPTOMS
attribute O
pharmacological O
cause O
neurological O
alteration O
rule O
normal O
eeg O
ophthalmoscopy O
metabolic O
workup O
cranial O
mri O
5 O
month O
age O
nava O
mode O
start O
improve O
patient O
adaptation O
ventilator O
use O
neural O
trigger O
nava O
catheter O
additionally O
cost O
200 O
catheter O
accord O
manufacturer O
change O
5 O
day O
require O
7 O
month O
catheter O
change O
15 O
day O
observe O
deterioration O
edi O
signal O
accord O
literature O
jarcholevin O
syndrome O
appear O
mental O
retardation O
life O
expectancy O
pretty O
long O
ethically O
consider O
patient O
opportunity O
overcome O
thoracic O
insufficiency O
technically O
possible O
tachypnoea B-SYMPTOMS
initially O
observe O
rr O
55 O
sign O
increase O
work O
breathing O
rr O
eventually O
return O
normal O
age O
40 O
day O
synchrony B-SYMPTOMS
achieve O
ventilator O
allow O
progressive O
decrease O
sedoanalgesia O
receive O
completely O
withdraw O
10 O
day O
need O
extra O
bolus O
sedation O
reduce O
zero O
concurrently O
reduction O
sedation O
ocular O
flutter O
disappear O
show O
significant O
progress O
psychomotor O
development O
setting O
nava O
level O
1 O
cm O
h2ov O
peep O
11 O
cm O
h2o O
edi O
trigger O
05 O
v O
patient O
tidal O
volume O
vt O
67 O
mlkg O
figure O
3 O
10 O
day O
nava O
mode O
require O
type O
sedation O
sporadic O
episode O
bronchial O
collapse O
resolve O
quick O
increase O
peep O
20 O
cm O
h2o O
manual O
ventilation O
selfinflate O
bag O
stabilise O
nava O
mode O
pip O
oscillate O
15 O
45 O
cm O
h2o O
nava O
level O
04 O
edi O
peak O
15 O
100 O
v O
posterior O
pulmonary O
ct O
scan O
perform O
2 O
month O
surgery O
1 O
month O
start O
nava O
prior O
thoracic O
expansion O
show O
significant O
reduction O
posterobasal O
atelectase O
previously O
observe O
figure O
2b O
turn O
1 O
year O
old O
attempt O
different O
device O
trilogy O
100 O
philip O
astral O
150 O
resme O
patient O
finally O
tolerate B-SYMPTOMS
mechanical O
ventilation O
home O
ventilator O
monnal O
t50 O
air O
liquide O
volume O
assistedcontrolle O
mode O
follow O
setting O
vt O
80 O
ml O
9 O
mlkg O
peep O
10 O
cm O
h2o O
flow O
trigger O
05 O
lmin O
pip O
30 O
cm O
h2o O
tolerate O
decrease O
peep O
9 O
cm O
h2o O
short O
disconnection O
ventilator O
currently O
patient O
19 O
month O
old O
able O
walk O
neurodevelopment O
normal O

40yearold O
woman B-SEX
visit O
department O
obstetric O
gynecology O
hospital O
complaint O
sudden O
dyspnea B-SYMPTOMS
effort O
previously O
diagnose O
endometriosis B-DISEASE
prescribe O
combination O
oral O
contraceptive O
pill O
drospirenoneethinylestradiol O
betadex O
trade O
yaz O
bayer O
leverkusen O
germany O
follow O
kumamoto O
earthquake O
subsequent O
aftershock O
april O
2016 O
spend O
7 O
night O
vehicle O
notice O
sudden O
dyspnea O
effort O
walk O
outside O
car O
8th O
morning O
earthquake O
walk O
personal O
reason O
daytime O
spend O
night O
small O
car O
leg O
hang O
position O
notice O
swelling B-SYMPTOMS
pain B-SYMPTOMS
left O
low O
extremity O
serum O
ddimer O
level O
132 O
gml O
deep B-DISEASE
vein I-DISEASE
thrombosis B-DISEASE
dvt B-DISEASE
suspect O
home O
doctor O
contrastenhance O
compute O
tomography O
ctscan O
reveal O
contrast B-SYMPTOMS
deficit I-SYMPTOMS
bilateral O
pulmonary O
artery O
fig2a O
left O
low O
extremity O
posterior O
tibial O
soleus O
gastrocnemius O
vein O
fig2b O
right O
ventricular O
function O
intact O
estimate O
pulmonary O
artery O
pressure298 O
mmhg O
cardiac O
ultrasound O
plasma O
brain O
natriuretic O
peptide O
highsense O
troponin O
t O
concentration O
level O
972 O
pgml O
00061 O
ngml O
respectively O
diagnose O
pte B-DISEASE
admit O
department O
admission O
blood O
pressure O
12980 O
mmhg O
heart O
rate O
72 O
beat O
minute O
degree O
oxygen O
saturation O
sao2 O
arterial O
blood O
gas O
977 O
body O
mass O
index O
244 O
kgm2 O
electrocardiography O
cardiac O
ultrasound O
indicate O
heart B-DISEASE
failure I-DISEASE
investigation O
factor O
relate O
thrombus O
formation O
include O
protein O
c O
protein O
s O
antithrombin O
antiphospholipid O
antibody O
reveal O
factor O
normal O
discontinuation O
oral O
contraceptive O
administration O
rivaroxaban O
30 O
mg O
daily O
direct O
oral O
anticoagulant O
trade O
xarelto O
bayer O
initiate O
accord O
result O
einsteinpe O
trial O
3 O
7 O
day O
followup O
contrastenhance O
ct O
scan O
reveal O
reduction O
thrombosis O
fig3 O
patient O
follow O
rivaroxaban O
patient O
give O
consent O
publication O
study O

patient O
48yearold O
man B-SEX
previously O
hospitalize O
hemoptysis B-SYMPTOMS
42 O
year O
age O
time O
chest O
radiograph O
chest O
compute O
tomography O
ct O
reveal O
diffuse O
groundglass O
opacity O
ggo B-SYMPTOMS
bilateral O
lung O
field O
fig12 O
bronchoscopic O
examination O
reveal O
accumulation B-SYMPTOMS
large O
amount O
blood O
trachea O
bronchi O
fig3 O
patient O
bronchoalveolar O
lavage O
fluid O
balf O
bloody O
contain O
numerous O
hemosiderinladen O
macrophage O
culture O
test O
balf O
reveal O
finding O
electrocardiogram O
transthoracic O
echocardiogram O
reveal O
abnormality O
questionnaire O
complete O
time O
reveal O
patient O
hemorrhagic B-SYMPTOMS
episode I-SYMPTOMS
family O
history O
bleed O
disease O
exception O
young O
brother O
diagnose O
hepatitis B-DISEASE
c I-DISEASE
furthermore O
receive O
drug O
potential O
cause O
dah B-DISEASE
follow O
abovementione O
examination O
dah O
sort O
vasculitis B-DISEASE
suspect O
treatment O
highdose O
intravenous O
methylprednisolone O
1000 O
mg O
daily O
3 O
day O
follow O
prednisolone O
25 O
mg O
daily O
initiate O
relieve O
symptom O
chest O
ct O
show O
resolution O
ggo O
patient O
prednisolone O
dose O
taper O
eventually O
discontinue O
twoandahalf O
year O
discharge O
hospital O
patient O
readmitte O
hospital O
recurrence O
hemoptysis O
46 O
year O
age O
abovedescribe O
therapy O
initiate O
lead O
improvement O
condition O
prednisolone O
dose O
taper O
60 O
mg O
daily O
maintenance O
dose O
5 O
mg O
daily O
48 O
year O
age O
readmitte O
hospital O
recurrence O
hemoptysis O
point O
steroidinduce O
diabetes B-DISEASE
mellitus I-DISEASE
treat O
glimepiride O
3 O
mg O
daily O
admission O
weight O
75 O
kg O
height O
167 O
cm O
vital O
sign O
follow O
blood O
pressure O
178102 O
mmhg O
pulse O
rate O
109 O
beatsmin O
pulse O
oximetry O
97 O
room O
air O
body O
temperature O
368c O
chest O
auscultation O
reveal O
fine O
crackle O
right O
lung O
field O
skin O
rash B-SYMPTOMS
subcutaneous O
bleeding B-DISEASE
joint O
swelling B-SYMPTOMS
present O
chest O
radiograph O
ct O
show O
presence O
diffuse O
ggo O
bilateral O
lung O
field O
mild O
anemia B-SYMPTOMS
observe O
hemoglobin O
113 O
gdl O
hemoglobin O
level O
146 O
gdl O
prior O
hemoptysis O
episode O
activate O
partial O
thromboplastin O
time O
aptt O
prolong O
535 O
second O
normal O
range O
251407 O
second O
laboratory O
test O
show O
patient O
blood O
glucose O
hemoglobin O
a1c O
level O
299 O
mgdl O
82 O
respectively O
steroidinduce O
diabetes O
mellitus O
autoantibody O
collagen O
disease O
negative O
table O
diagnose O
condition O
recurrence O
dah O
administer O
highdose O
intravenous O
methylprednisolone O
3 O
day O
follow O
prednisolone O
60 O
mg O
daily O
condition O
improve O
observe O
previous O
episode O
detailed O
inquiry O
patient O
medical O
history O
reveal O
elementary O
school O
student O
hospitalize O
receive O
blood O
transfusion O
twice O
follow O
abnormally O
heavy O
bleeding O
tooth O
extraction O
specific O
congenital O
bleeding B-DISEASE
disorder I-DISEASE
diagnose O
time O
reveal O
young O
brother O
diagnose O
hemophilia B-DISEASE
b I-DISEASE
adolescence O
consider O
possibility O
hemophilia O
blood O
coagulation O
factor O
examine O
reveal O
factor O
ix O
activity O
3 O
patient O
subsequently O
diagnose O
moderate O
hemophilia O
b O
time O
diagnosis O
patient O
dah O
resolve O
corticosteroid O
therapy O
decide O
continue O
treat O
patient O
prednisolone O
coagulation O
factor O
ix O
replacement O
therapy O
recurrence O
dah O
hemorrhagic O
symptom O
observe O
3 O
year O
tapering O
discontinuation O
prednisolone O

34yearold O
japanese O
woman B-SEX
diagnosis O
mctd B-DISEASE
presence O
raynauds O
phenomenon O
pancytopenia B-SYMPTOMS
elevate O
plasma O
creatinine O
kinase O
antibodie O
u1ribonucleoprotein O
2005 O
receive O
10 O
mg O
prednisolone O
daily O
pulmonary O
arterial O
systolic O
pressure O
estimate O
echocardiography O
slightly O
elevate O
48 O
mmhg O
2006 O
feel O
progressive O
shortness O
breath O
physical O
effort O
2011 O
pulmonary B-DISEASE
arterial I-DISEASE
hypertension I-DISEASE
diagnose O
74 O
mmhg O
mean O
pulmonary O
arterial O
pressure O
mpap O
evaluate O
right O
heart O
catheterization O
rhc O
2012 O
cyclophosphamidebase O
immunosuppressive O
therapy O
propose O
refuse O
possible O
early O
menopausal O
symptom O
treatment O
250 O
mgday O
bosentan O
120 O
gday O
beraprost O
initiate O
january O
2014 O
dyspnea B-SYMPTOMS
deteriorate O
functional O
class O
iv O
admit O
hospital O
physical O
examination O
show O
low O
systemic O
blood O
pressure O
8961 O
mmhg O
tachycardia B-SYMPTOMS
104min O
low O
blood O
oxygen O
level O
percutaneous O
oxygen O
saturation O
spo2 O
95 O
jugular O
venous O
distension B-SYMPTOMS
severe O
systemic O
edema B-SYMPTOMS
coarse O
crackle O
loud O
pulmonic O
valve O
closure O
sound O
detect O
unable O
undergo O
6minute O
walk O
test O
severe O
dyspnea O
laboratory O
examination O
show O
elevated O
plasma O
brain O
natriuretic O
peptide O
bnp O
level O
9294 O
pgml O
hypoxemia B-SYMPTOMS
pao2 O
625 O
mmhg O
paco2 O
271 O
mmhg O
presence O
antibody O
u1ribonucleoprotein O
979 O
uml O
antinuclear O
antibodie O
1640 O
speckled O
pattern O
chest O
xray O
show O
enlarged B-SYMPTOMS
pulmonary O
artery O
cardiomegaly B-SYMPTOMS
figure O
electrocardiogram O
show O
p B-SYMPTOMS
wave I-SYMPTOMS
elevation I-SYMPTOMS
v1v2 O
lead O
rhc O
demonstrate O
elevate O
mpap O
65 O
mmhg O
normal O
pulmonary O
arterial O
wedge O
pressure O
12 O
mmhg O
high O
pulmonary O
vascular O
resistance O
1547 O
dyneseccm5 O
decrease O
cardiac O
output O
cardiac O
index O
169 O
lminm2 O
ventilationperfusion O
scan O
show O
sign O
pulmonary B-DISEASE
thromboembolism I-DISEASE
sign O
chronic B-DISEASE
obstructive I-DISEASE
pulmonary I-DISEASE
disease I-DISEASE
interstitial O
lung O
disease O
find O
compute O
tomography O
dyspnea O
consider O
mctdassociate O
pah B-DISEASE
refractory O
bosentan O
beraprost O
therapy O
addition O
supportive O
therapy O
oxygen O
supplementation O
diuretic O
40 O
mgday O
furosemide O
initiation O
60 O
mgday O
sildenafil O
gradual O
increment O
dose O
beraprost O
choose O
additional O
treatment O
dyspnea O
remain O
unchanged O
plasma O
bnp O
level O
increase O
ivcy O
750 O
mgm2 O
4 O
week O
initiate O
dose O
prednisolone O
increase O
60 O
mg O
daily O
dyspnea O
ameliorate O
able O
undergo O
6minute O
walk O
test O
260 O
m O
minimum O
spo2 O
95 O
   O
plasma O
bnp O
level O
decrease O
initiation O
ivcy O
figure O
month O
admission O
followup O
rhc O
reveal O
improved O
mpap O
65 O
53 O
mmhg O
pulmonary O
vascular O
resistance O
1547 O
1116 O
dyneseccm5 O
cardiac O
index O
169 O
183 O
lminm2 O
table O
remain O
stable B-SYMPTOMS
obtain O
improvement O
18 O
month O
admission O
table O
consider O
parenteral O
prostanoid O
lung O
transplantation O
subsequent O
treatment O

22yearold O
tibetan O
man B-SEX
significant O
past O
medical O
history O
diagnose O
pulmonary B-DISEASE
tuberculosis I-DISEASE
ptb B-DISEASE
routine O
medical O
examination O
receive O
antitb O
therapy O
include O
isoniazid O
inh O
300 O
mgd O
rmp O
450 O
mgd O
ethambutol O
emb O
750 O
mgd O
pyrazinamide O
pza O
1500 O
mgd O
1 O
week O
continuous O
therapy O
admit O
tibet O
people O
hospital O
nasal O
hemorrhage B-SYMPTOMS
platelet O
plt O
count O
04 O
   O
109l O
normal O
range O
100300 O
   O
109l O
epistaxis B-SYMPTOMS
cure O
symptomatic O
treatment O
day O
later O
develop O
hematochezia B-SYMPTOMS
hematuria B-SYMPTOMS
purpura B-SYMPTOMS
require O
transfusion O
freshfrozen O
plasma O
platelet O
local O
hospital O
day O
later O
november O
18 O
2015 O
transfer O
west O
china O
hospital O
ineffective O
treatment O
physical O
examination O
present O
pallor B-SYMPTOMS
mild O
jaundice B-SYMPTOMS
sclera O
purpura O
tachycardia B-SYMPTOMS
heart O
rate O
132min O
weak O
breath O
sound O
base O
left O
lung O
laboratory O
result O
admission O
indicate O
dic B-DISEASE
prothrombin O
time O
178 O
second O
normal O
range O
96128 O
second O
international O
normalize O
ratio O
153 O
normal O
range O
088115 O
fibrinogen O
113 O
gl O
normal O
range O
2040 O
gl O
ddimer O
2345 O
mgl O
normal O
range O
055 O
mgl O
fibrin O
degradation O
product O
604 O
mgl O
normal O
range5 O
mgl O
plt O
2 O
   O
109l O
normal O
range O
100300 O
   O
109l O
abnormal O
datum O
follow O
white O
blood O
cell O
wbc O
4838 O
   O
109l O
normal O
range O
3595 O
hemoglobin O
65 O
gl O
normal O
range O
130175 O
gl O
total O
bilirubin O
308 O
umoll O
normal O
range O
50280 O
umoll O
direct O
bilirubin O
166 O
umoll O
normal O
range O
   O
88 O
umoll O
aspartate O
aminotransferase O
75 O
ul O
normal O
range O
40 O
ul O
alanine O
aminotransferase O
293 O
ul O
normal O
range O
50 O
ul O
lactate O
dehydrogenase O
380 O
ul O
normal O
range O
110220 O
ul O
serum O
urea O
nitrogen O
1301 O
mmoll O
normal O
range O
32779 O
mmoll O
creactive O
protein O
1670 O
mgl O
normal O
range O
5 O
mgl O
complement O
3 O
041 O
gl O
normal O
range O
07851520 O
gl O
complement O
4 O
00797 O
gl O
normal O
range O
01450360 O
gl O
routine O
urine O
test O
show O
blood O
cell O
330 O
cellul O
leukocyte O
250 O
cellul O
protein O
2 O
gl O
urobilinogen O
70 O
umoll O
routine O
stool O
test O
show O
red O
blood O
cell O
4hp O
white O
blood O
cell O
1hp O
occult O
blood O
test O
   O
tspot O
result O
positive O
realtime O
polymerase O
chain O
reaction O
analysis O
mycobacterium O
tb O
sputum O
positive O
acid O
fast O
stain O
test O
sputum O
smear O
negative O
chest O
compute O
tomography O
ct O
admission O
november O
18 O
2015 O
fig1 O
show O
infiltrate O
upper O
lobe O
left O
lung O
leave O
pleural B-DISEASE
effusion I-DISEASE
pericardial B-DISEASE
effusion I-DISEASE
accompany O
enlargement B-SYMPTOMS
mediastinal O
lymph O
nodes O
abdominal O
ultrasound O
show O
small O
fluid B-SYMPTOMS
adjacent O
liver O
spleen O
serologic O
marker O
negative O
acute O
chronic O
viral B-DISEASE
hepatitis I-DISEASE
hiv B-DISEASE
direct O
coomb O
test O
autoimmune B-DISEASE
hepatitis I-DISEASE
peripheral O
blood O
film O
culture O
negative O
bone O
marrow O
smear O
medulloculture O
negative O
antituberculosis O
drug O
discontinue O
immediately O
admission O
fast O
initiate O
infusion O
freshfrozen O
plasma O
platelet O
pack O
red O
blood O
cell O
intravenous O
immune O
globulin O
recombinant O
human O
thrombopoietin O
omeprazole O
polyene O
phosphatidylcholine O
nutrition O
supportive O
treatment O
day O
fast O
november O
23 O
2015 O
patient O
start O
therapy O
consist O
emb O
moxifloxacin O
amikacin O
active O
hemorrhage O
day O
admission O
november O
26 O
2015 O
platelet O
count O
rise O
gradually O
inh O
200 O
mgd O
intravenously O
guttae O
administer O
24 O
day O
admission O
december O
11 O
2015 O
liver O
function O
test O
platelet O
count O
return O
normal O
main O
laboratory O
feature O
summarize O
table O
1 O
month O
later O
december O
17 O
2015 O
review O
chest O
ct O
fig1 O
indicate O
infiltration B-SYMPTOMS
hydrothorax B-SYMPTOMS
pericardial O
effusion O
absorb O
4 O
week O
admission O
patient O
recover O
leave O
hospital O
inh O
300 O
mgd O
emb O
750 O
mgd O
levofloxacin O
500 O
mgd O
streptomycin O
750000 O
ud O
intramuscular O
injection O
recurrence O
dic O
hemorrhage O
8 O
month O
followup O
unfortunately O
patient O
refuse O
followup O
chest O
ct O
discharge O
table O
2 O
show O
timeline O
case O

34yearold O
hispanic O
male B-SEX
significant O
past O
medical O
history O
present O
hospital O
month O
history O
cough B-SYMPTOMS
productive O
whitish O
sputum B-SYMPTOMS
presentation O
deny O
fever B-SYMPTOMS
chill O
night O
sweat O
chest O
pain B-SYMPTOMS
hemoptysis B-SYMPTOMS
pain O
recent O
travel O
sick O
contact O
report O
approximately O
1520 O
pound O
weight B-SYMPTOMS
loss I-SYMPTOMS
month O
deny O
smoking O
socially O
drank O
alcohol O
unprotected O
sexual O
intercourse O
multiple O
partner O
past O
admission O
temperature O
979f O
heart O
rate O
85 O
beat O
minute O
respiratory O
rate O
16 O
breath O
minute O
blood O
pressure O
10766 O
mm O
hg O
oxygen O
saturation O
100 O
room O
air O
examination O
show O
oral O
thrush B-SYMPTOMS
decrease O
breath O
sound O
crackle O
right O
low O
lung O
base O
cutaneous O
lesion O
report O
rest O
clinical O
examination O
unremarkable O
complete O
blood O
count O
cbc O
show O
hemoglobin O
97 O
gdl O
wbcs O
23109l O
platelet O
164109l O
creatinine O
062 O
mgdl O
blood O
urea O
nitrogen O
10 O
mgdl O
radiograph O
chest O
show O
extensive O
right O
leave O
perihilar O
opacity B-SYMPTOMS
right O
compute O
tomography O
ct O
scan O
chest O
show O
right O
side O
large O
perihilar O
mass B-SYMPTOMS
figure O
1 O
multiple O
thoracic O
lumbar O
vertebrae O
rib O
sternal O
tiny O
lytic O
lesion O
consistent O
bony O
metastasis B-DISEASE
figure O
2 O
blood O
sputum O
culture O
negative O
tuberculosis B-DISEASE
rule O
consecutive O
negative O
sputum O
smear O
acid O
fast O
bacilli O
negative O
quantiferon O
gold O
test O
test O
positive O
human B-DISEASE
immunodeficiency I-DISEASE
virus I-DISEASE
hiv B-DISEASE
cd4 O
count O
come O
7 O
cellsul O
start O
prophylaxis O
bactrim O
80160 O
mg O
daily O
azithromycin O
1200 O
mg O
weekly O
opportunistic O
infection O
bronchoscopy O
biopsy O
perform O
unreveale O
undergo O
video O
assist O
mediastinoscopy O
biopsy O
right O
hilar O
mass O
pathology O
show O
spindle O
cell O
positive O
cd34 O
bcl2 O
vimentin O
hhv8 O
diffuse O
positivity O
cd31 O
diagnostic O
ks B-DISEASE
start O
treatment O
haart O
form O
emtricitabine O
tenofovir O
disoproxil O
fumarate O
200300 O
mg O
dolutegravir O
50 O
mg O
patient O
actively O
involve O
decision O
management O
option O
favor O
haart O
isolated O
regimen O
additional O
chemotherapy O
condition O
show O
continue O
clinical B-SYMPTOMS
improvement I-SYMPTOMS
repeat O
ct O
scan O
chest O
month O
show O
profound O
regression B-SYMPTOMS
disease O
disappearance O
lesion O
figure O
3 O

58yearold O
white O
american O
male B-SEX
present O
emergency O
department O
ed O
acute O
onset O
confusion B-SYMPTOMS
disorientation B-SYMPTOMS
inability O
walk O
steadily O
dehydration B-SYMPTOMS
associate O
generalized O
weakness B-SYMPTOMS
polyuria B-SYMPTOMS
polydipsia B-SYMPTOMS
previous O
week O
diagnose O
cml B-DISEASE
year O
early O
hematological B-SYMPTOMS
response I-SYMPTOMS
multiple O
chemotherapy O
regimen O
time O
treatment O
allopurinol O
await O
allogenic O
bone O
marrow O
transplant O
vital O
sign O
admission O
ed O
include O
heart O
rate O
104 O
bpm O
blood O
pressure O
12268 O
mm O
hg O
temperature O
997f O
376c O
remarkable O
finding O
physical O
examination O
altered B-SYMPTOMS
mental I-SYMPTOMS
status I-SYMPTOMS
dehydration O
laboratory O
evaluation O
hemoglobin O
133 O
gdl O
white O
blood O
cell O
count O
183109l O
neutrophil O
796 O
lymphocyte O
72 O
monocyte O
83 O
platelet O
count O
910109l O
serum O
level O
calcium O
186 O
mgdl O
phosphate O
46 O
mgdl O
sodium O
135 O
meql O
potassium O
27 O
mgdl O
albumin O
40 O
gdl O
creatinine O
22 O
mgdl O
total O
bilirubin O
09 O
mgdl O
alkaline O
phosphatase O
125 O
iul O
aspartate O
aminotransferase O
41 O
iul O
alanine O
aminotransferase O
71 O
iul O
spep O
negative O
m O
spike O
hormone O
vitamin O
level O
pth O
85 O
pgl O
1565 O
pgl O
phtrp O
14 O
pgl O
2 O
pgl O
25oh O
vitamin O
d O
304 O
ngml O
2050 O
ngml O
125 O
oh O
vitamin O
d3 O
337 O
ngml O
1864 O
ngml O
chest O
ct O
scan O
show O
diffuse O
lytic O
lesion O
bone B-SYMPTOMS
destruction I-SYMPTOMS
visualize O
thoracic O
skeleton O
concern O
diffuse O
bone B-SYMPTOMS
marrow I-SYMPTOMS
involvement I-SYMPTOMS
clinical O
history O
biochemical O
finding O
lead O
diagnosis O
cmlassociate O
hypercalcemia B-SYMPTOMS
context O
blast B-SYMPTOMS
phase I-SYMPTOMS
treatment O
aggressive O
hydration O
09 O
saline O
calcitonin O
400 O
unit O
subcutaneous O
administer O
additionally O
zoledronic O
acid O
33 O
mg O
intravenous O
adjust O
renal O
insufficiency O
give O
day O
treatment O
normalization O
symptom O
serum O
calcium O
level O
achieve O
discharge O
hospital O
patient O
continue O
palliative O
treatment O
ponatinib O
radiotherapy O
acceptable O
serum O
calcium O
level O
maintain O
zoledronic O
acid O
4 O
mg O
week O
despite O
therapy O
cancer B-DISEASE
progress O
pass O
away O
approximately O
month O
initial O
admission O
hypercalcemia O

31yearold O
man B-SEX
develop O
diabete O
insipidu O
urine O
volume O
10 O
20 O
l O
24 O
hour O
2003 O
year O
later O
complain O
fatigue B-SYMPTOMS
anorexia B-SYMPTOMS
jaundice B-SYMPTOMS
pruritus B-SYMPTOMS
symptomatic O
occipital O
mass B-SYMPTOMS
laboratory O
test O
show O
abnormal O
liver O
enzyme O
table O
1 O
patient O
negative O
hepatitis O
virus O
show O
fig1 O
abdominal O
mri O
show O
multiple O
lowdensity O
lesion O
liver O
t1weighte O
image O
obvious O
expansion B-SYMPTOMS
intrahepatic O
bile O
duct O
t2weighte O
image O
magnetic O
resonance O
cholangiopancreatography O
reveal O
multifocal O
intrahepatic O
bile O
duct O
stricture O
dilatation B-SYMPTOMS
common O
hepatic O
duct O
normal O
highly O
suggestive O
sc B-DISEASE
neurohypophyseal O
area O
mri O
show O
thicken O
hypothalamic O
nucleus O
lowdensity O
signal B-SYMPTOMS
49 O
   O
56 O
mm O
size O
hypothalamicpituitary O
area O
multisystem O
highrisk O
organ O
lch B-DISEASE
confirm O
occipital O
mass O
biopsie O
local O
hospital O
patient O
give O
ursodeoxycholic O
acid O
150 O
mg O
3 O
time O
day O
begin O
receive O
course O
coep O
chemotherapy O
cyclophosphamide O
1000 O
mg O
vincristine O
2 O
mg O
epirubicin O
90 O
mg O
prednisone O
90 O
mg O
2009 O
5th O
day O
1st O
coep O
chemotherapy O
patient O
appear O
severe O
liver O
function B-DISEASE
injury I-DISEASE
obvious O
increase O
serum O
bilirubin O
table O
1 O
refuse O
chemotherapy O
year O
later O
patient O
develop O
liver O
decompensation B-DISEASE
bleed O
esophageal O
varix O
ascite O
splenomegaly B-SYMPTOMS
refer O
lt O
model O
end O
stage O
liver O
disease O
score O
17 O
undergo O
successful O
orthotopic O
lt O
november O
2011 O
center O
donor O
come O
voluntary O
deceased O
citizen O
organ O
donation O
china O
liver O
histopathology O
lt O
reveal O
micronodular O
cirrhosis B-DISEASE
sc O
positive O
immunostaine O
cd1a O
s100 O
suggestive O
lch O
involve O
liver O
fig2 O
postoperatively O
man O
continue O
immunosuppresse O
tacrolimus O
mycofenolate O
mofetil O
patient O
currently O
normal O
liver O
function O
evidence O
recurrence B-SYMPTOMS
lch O
4 O
half O
year O
followup O

december O
28 O
2014 O
70yearold O
man B-SEX
complain O
abdominal O
pain B-SYMPTOMS
dizziness B-SYMPTOMS
nausea B-SYMPTOMS
refer O
hebei O
general O
hospital O
hebei O
china O
gastroscopy O
show O
irregular O
hemorrhagic O
ulcerative O
lesion O
extend O
gastric O
body O
less O
curvature O
pyloric B-DISEASE
stenosis I-DISEASE
stomach O
gastric O
biopsy O
reveal O
adenocarcinoma B-DISEASE
january O
7 O
2015 O
palliative O
gastrectomy O
plus O
rouxeny O
near O
esophagojejunostomy O
perform O
diffuse O
enlarge O
paraaortic O
anterior O
superior O
pancreatic O
lymph O
node O
lymph O
node O
common O
hepatic O
artery O
resect O
postoperative O
pathology O
demonstrate O
moderately O
differentiate O
gastric B-DISEASE
adenocarcinoma I-DISEASE
fig1a O
immunohistochemistry O
show O
follow O
human O
epidermal O
growth O
factor O
receptor O
2 O
her2 O
   O
vascular O
endothelial O
growth O
factor O
vegf O
   O
cd31 O
   O
cd105 O
   O
fig1be O
triple O
positive O
tp O
   O
glutathione O
stransferase O
   O
gst O
   O
topoisomerase O
enzyme O
ii O
   O
topoii O
   O
p53 O
   O
ki67 O
70 O
diagnosis O
stage O
iv O
gastric O
adenocarcinoma O
multiple O
lymphnode O
metastasis B-DISEASE
t4n2m1 O
patient O
administer O
1 O
cycle O
chemotherapy O
oxaliplatin O
s1 O
treatment O
terminate O
patient O
tolerate O
associate O
gastrointestinal O
disturbance O
february O
2 O
2015 O
adjuvant O
radiotherapy O
administer O
radiotherapy O
positronemission O
tomography O
compute O
tomography O
petct O
show O
extensive O
distant O
metastasis O
leave O
supraclavicular O
mediastinal O
lymph O
node O
lymph O
node O
abdominal O
cavity O
patient O
eastern O
cooperative O
oncology O
group O
ecog O
performance O
status O
2 O
body O
mass O
index O
bmi O
19 O
consider O
risk O
malnutrition B-SYMPTOMS
oral O
apatinib O
850 O
mg O
day O
combine O
follow O
radiotherapy O
prescribe O
informed O
consent O
obtain O
patient O
prior O
treatment O
attempt O
improve O
tolerance O
treatment O
palliative O
intensity O
modulate O
radiation O
therapy O
imrt O
patient O
receive O
dose O
64 O
gy O
30 O
fraction O
mediastinum O
dose O
52 O
gy O
26 O
fraction O
abdominal O
metastatic O
lesion O
n O
   O
5 O
left O
supraclavicular O
lymph O
node O
treat O
apatinib O
figs2 O
3ac O
petct O
scan O
perform O
2 O
week O
radiotherapy O
show O
80 O
reduction O
maximum O
standardized O
uptake O
value O
suvmax O
2deoxy218ffluorodglucose O
fdg O
fdg O
uptake O
high O
left O
supraclavicular O
lymph O
node O
compare O
metastatic O
region O
treat O
concurrent O
apatinib O
radiation O
therapy O
accord O
response O
evaluation O
criterion O
solid O
tumor O
recist O
clinical O
effect O
partial O
response O
fig2 O
patient O
receive O
radiotherapy O
66 O
gy O
28 O
fraction O
left O
supraclavicular O
lymph O
node O
residual B-DISEASE
metastasis I-DISEASE
tumor O
marker O
biochemical O
analysis O
evaluate O
2 O
month O
month O
therapy O
chest O
abdominal O
ct O
scan O
indicate O
stable O
disease B-DISEASE
anemia B-SYMPTOMS
gastrointestinal O
symptom O
improve O
ecog O
performance O
status O
0 O
bmi O
22 O
hematologic B-SYMPTOMS
toxicity I-SYMPTOMS
hypertension B-SYMPTOMS
renal B-SYMPTOMS
dysfunction I-SYMPTOMS
proteinuria B-SYMPTOMS
handfoot O
syndrome O
observe O
apatinib O
therapy O
september O
2015 O
followup O
examination O
show O
increase O
carbohydrate O
antigen O
125 O
ferritin O
gastroscopy O
abdominal O
ct O
reveal O
abnormality O
november O
2015 O
patient O
difficulty O
swallow O
experience O
intermittent O
hematochezia B-SYMPTOMS
apatinib O
terminate O
gastrointestinal B-SYMPTOMS
bleeding I-SYMPTOMS
gastroscopy O
reveal O
anastomotic B-SYMPTOMS
stenosis I-SYMPTOMS
gastric B-DISEASE
cancer I-DISEASE
intragastric O
hemorrhage O
fig3df O
patient O
family O
refuse O
chemoradiotherapy O
symptomatic O
treatment O
hemostatic O
drug O
good O
supportive O
care O
prescribe O
1 O
week O
therapy O
hemorrhaging B-DISEASE
resolve O
month O
later O
patient O
experience O
intermittent O
hematochezia O
december O
20 O
2015 O
petct O
demonstrate O
extensive O
metastasis O
patient O
family O
request O
good O
supportive O
care O
april O
16 O
2016 O
patient O
die O
pulmonary O
infection B-DISEASE

44yearold O
man B-SEX
diagnose O
lcnec B-DISEASE
thymus O
bone O
metastasis B-SYMPTOMS
different O
hospital O
3 O
year O
previously O
serum O
level O
acth O
cortisol O
elevate O
brain O
magnetic O
resonance O
imaging O
reveal O
pituitary O
gland O
normal O
immunohistochemical O
staining O
thymic O
tumor B-SYMPTOMS
tissue O
reveal O
partial O
antiacth O
antibody O
positivity O
tumor O
determined O
ectopically O
produce O
acth O
patient O
underwent O
chemotherapy O
cisplatin O
irinotecan O
continuation O
chemotherapy O
problematic O
lack O
tolerance O
treatment O
hypertension B-SYMPTOMS
diabete O
cause O
ectopic B-DISEASE
acth I-DISEASE
syndrome I-DISEASE
initiate O
treatment O
zoledronic O
acid O
bone O
metastasis O
patient O
refer O
endocrine O
center O
hospital O
3 O
month O
sensation O
weakness O
worsening O
hyperglycemia B-DISEASE
physical O
examination O
reveal O
hypertension O
subcutaneous O
mass B-SYMPTOMS
palpable O
anterior O
chest O
redness B-SYMPTOMS
swelling B-SYMPTOMS
left O
low O
leg O
fever B-SYMPTOMS
respiratory O
symptom O
hypoxemia B-SYMPTOMS
abnormal O
chest O
sound O
oxygen O
saturation O
pulse O
oximeter O
room O
air O
97 O
respiratory O
rate O
13 O
breath O
minute O
laboratory O
finding O
white O
blood O
cell O
neutrophil O
count O
blood O
sugar O
triglyceride O
lowdensity O
lipoprotein O
cholesterol O
level O
find O
elevate O
patient O
potassium O
level O
decrease O
28 O
meql O
patient O
lactate O
dehydrogenase O
468 O
iul O
betad O
glucan O
3708 O
pgml O
acth O
3541 O
pgml O
cortisol O
491 O
gdl O
level O
elevate O
patient O
serum O
negative O
aspergillus O
candida O
cryptococcus O
antigen O
cytomegalovirus O
pp65 O
antigenemia O
test O
yield O
negative O
result O
datum O
suggest O
increase O
production O
acth O
tumor O
progression O
disease O
promote O
elevation O
patient O
serum O
level O
acth O
cortisol O
compute O
tomography O
ct O
reveal O
progression O
disease O
thymic O
metastatic O
bone O
lesion O
multiple O
groundglass O
opacity O
lung O
fig1 O
2 O
patient O
underwent O
bronchoalveolar O
lavage O
bal O
right O
b5 O
segment O
150 O
ml O
saline O
627 O
bal O
fluid O
recover O
cell O
count O
bal O
fluid O
061105 O
ml O
cell O
differentiation O
bal O
fluid O
170 O
macrophage O
810 O
lymphocyte O
20 O
neutrophil O
cd O
48 O
ratio O
057 O
gram O
ziehlneelsen O
grocott O
staining O
negative O
polymerase O
chain O
reaction O
reveal O
patient O
bal O
fluid O
positive O
pneumocystis O
jirovecii O
pcp B-DISEASE
diagnose O
base O
result O
patient O
treat O
sulfamethoxazoletrimethoprim O
12 O
gday O
3 O
week O
anticortisol O
therapy O
metyrapone O
initiate O
time O
small O
dose O
slowly O
correct O
hypercortisolemia B-DISEASE
intensive O
insulin O
therapy O
potassium O
supplementation O
initiate O
cefazolin O
administer O
treat O
cellulitis B-DISEASE
left O
low O
leg O
patient O
pcp O
fully O
improve O
exacerbation B-SYMPTOMS
respiratory O
status O
continue O
administer O
sulfamethoxazoletrimethoprim O
prophylactic O
dose O
metyrapone O
dosage O
gradually O
increase O
250 O
mgday O
blood O
cortisol O
value O
observe O
decline O
slowly O
fig3 O
order O
prevent O
hypocortisolemia O
patient O
temporarily O
treat O
hydrocortisone O
improvement O
left O
low O
leg O
cellulitis O
pcp O
hyperglycemia O
patient O
underwent O
laminectomy O
radiation O
therapy O
spinal B-DISEASE
cord I-DISEASE
compression I-DISEASE
cause O
metastatic O
spinal O
tumor O
octreotide O
therapy O
initiate O
discharge O
68th O
day O
hospitalization O

68yearold O
man B-SEX
refer O
internal O
medicine O
department O
razi O
hospital O
rasht O
city O
north O
iran O
hypogastric O
region O
discomfort B-SYMPTOMS
especially O
right O
low O
quadrant O
month O
pain O
colicky O
form O
episode O
day O
episode O
last O
45 O
minute O
pain O
radiate O
alleviate O
rest O
association O
pain O
defecation O
eating O
report O
furthermore O
patient O
complain O
23 O
kg O
weight B-SYMPTOMS
loss I-SYMPTOMS
month O
follow O
anorexia B-SYMPTOMS
symptom O
nausea B-SYMPTOMS
vomiting B-SYMPTOMS
fever B-SYMPTOMS
shake O
chill O
demonstrate O
admit O
center O
week O
refer O
hospital O
evaluation O
patient O
undergo O
surgery O
prostatectomy O
seven O
year O
presentation O
center O
history O
endoscopy O
year O
early O
dyspepsia B-DISEASE
find O
helicobacter O
pylori O
positive O
time O
eradicate O
treatment O
course O
history O
hiv O
diabete O
smoking O
alcohol O
consumption O
record O
vital O
sign O
normal O
time O
admission O
physical O
examination O
abdoman O
soft B-SYMPTOMS
distention B-SYMPTOMS
bowel O
sound O
normoactive O
tenderness B-SYMPTOMS
right O
low O
quadrant O
abdoman O
rebound O
state O
note O
peripheral O
blood O
analysis O
show O
table O
1 O
stool O
examination O
urine O
analysis O
evaluation O
electrolyte O
normal O
abdominal O
ct O
scan O
show O
welldemarcated O
homogenous O
solitary O
mass B-SYMPTOMS
cecum O
distention O
ileum O
ileum O
wall O
thicken O
figure O
1 O
colonoscopy O
reveal O
large O
mass O
like O
lesion B-SYMPTOMS
cecum O
figure O
2 O
procedure O
biopsy O
take O
cecum O
lamina O
propria O
infiltrate O
number O
pmnc O
admix O
eosinophil O
figure O
3 O
immunohistochemical O
evaluation O
positive O
vimentin O
cd68 O
ckit O
cd117 O
negative O
cd34 O
smooth O
muscle O
actin O
sma O
alk O
focally O
positive O
report O
cyclin O
d1 O
desmin O
pancytokeratin O
figure O
4when O
colonoscopy O
perform O
evidence O
invasive O
obstruction O
lead O
suspicion O
malignant B-DISEASE
tumor I-DISEASE
pathological O
confirmation O
imt B-DISEASE
patient O
refer O
surgery O
order O
remove O
mass O
surgery O
approximately O
40 O
ml O
ascite O
find O
abdomen O
mass O
see O
cecum O
ileocolic O
intussusception B-SYMPTOMS
patient O
undergo O
right O
hemicolectomy O
endtoend O
anastomosis O
ileocolic O
enlarge B-SYMPTOMS
lymph O
node O
observe O
patient O
discharge O
seven O
day O
surgery O
complication O
followup O

51yearold O
g1p1 O
caucasian O
female B-SEX
lifelong O
neurogenic O
bladder O
secondary O
spina O
bifida O
occulta O
refer O
symptom O
constipation B-SYMPTOMS
fi B-SYMPTOMS
average O
bristol O
type O
12 O
stool O
5 O
day O
require O
frequent O
manual O
disimpaction O
additionally O
report O
twice O
weekly O
episode O
urgent O
fecal B-SYMPTOMS
seepage I-SYMPTOMS
require O
use O
daily O
continence O
pad O
symptom O
improve O
addition O
psyllium O
bisacodyl O
suppositorie O
defecography O
suggest O
atrophy B-SYMPTOMS
puborectalis O
poor B-SYMPTOMS
squeeze I-SYMPTOMS
eas O
muscle O
atrophy O
anorectal O
manometry O
arm O
show O
normal O
resting O
pressure O
augmentation O
squeeze O
pressure O
consistent O
weak B-DISEASE
eas I-DISEASE
figure O
1 O
bear O
fix O
perineal O
descent O
note O
inability O
widen O
posterior O
anorectal O
angle O
poor O
evacuation O
contrast O
strain O
consistent O
dd B-DISEASE
push O
arm O
similarly O
demonstrate O
type O
iv O
dd O
classify O
inability O
generate O
adequate O
propulsive O
force O
absent O
incomplete O
relaxation O
anal O
sphincter O
8 O
figure O
2 O
reflex O
sensory O
testing O
indicate O
intact O
rectoanal O
inhibitory O
reflex O
rectal O
hypersensitivity B-SYMPTOMS
patient O
fail O
management B-SYMPTOMS
home O
conventional O
biofeedback O
therapy O
follow O
successful O
trial O
temporary O
sns O
improvement O
fi O
symptom O
75 O
patient O
permanent O
sns O
place O
year O
later O
patient O
report O
sustain O
improvement O
constipation O
fi O
symptom O

52yearold O
man B-SEX
30year O
history O
smoking O
present O
abnormal O
nodule B-SYMPTOMS
measure O
08 O
   O
15 O
cm O
left O
upper O
lung O
lobe O
image O
chest O
compute O
tomography O
ct O
scanning O
march O
2012 O
community O
hospital O
previously O
additional O
relevant O
abnormal O
symptom O
physical O
examination O
suggest O
significant O
abnormality O
laboratory O
finding O
normal O
range O
carcinoembryonic O
antigen O
cea O
level O
3025 O
ngml O
normal O
range O
05 O
ngml O
find O
serum O
subsequently O
positron O
emission O
tomography O
petct O
scan O
show O
lung O
lesion B-SYMPTOMS
standardized O
uptake O
value O
794 O
highly O
suspect O
malignant B-DISEASE
tumor I-DISEASE
fig1 O
subsequently O
undergo O
leave O
upper O
lung O
lobectomy O
lymph O
node O
dissection O
postoperative O
pathological O
examination O
reveal O
adenocarcinoma B-DISEASE
adc B-DISEASE
fig2a O
immunohistochemistry O
ihc O
stain O
result O
positive O
ck7 O
ttf1 O
p63 O
napsina O
negative O
ck O
56 O
syn O
cga O
ki67 O
2030 O
clinical O
stage O
classify O
ia2 O
pt1bn0m0 O
tumor O
early O
stage O
patient O
receive O
adjuvant O
treatment O
continue O
monitor O
regular O
hospital O
visit O
3 O
month O
patient O
condition O
stable O
onset O
left O
chest O
pain B-SYMPTOMS
april O
2015 O
patient O
transfer O
hospital O
tertiary O
care O
hospital O
treatment O
physical O
examination O
suggest O
significant O
tender B-SYMPTOMS
point I-SYMPTOMS
left O
chest O
wall O
laboratory O
finding O
show O
single O
parameter O
outside O
normal O
range O
cytokeratin19 O
fragment O
antigen O
211 O
cyfra211 O
level O
1745 O
ngml O
serum O
normal O
range O
   O
033 O
ngml O
ct O
petct O
scan O
highlight O
involvement B-SYMPTOMS
left O
pleura O
show O
bilateral O
lung O
lesion O
fig3a O
e O
point O
clinical O
stage O
upgrade O
ivb O
ctguide O
left O
pleura O
puncture O
pathological O
ihc O
analysis O
show O
positive O
staining O
p63 O
p40 O
ck O
7 O
ck O
56 O
ttf1 O
napsina O
staining O
absent O
support O
diagnosis O
squamous B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
scc B-DISEASE
fig2b O
molecular O
evaluation O
confirm O
l858r B-SYMPTOMS
mutation I-SYMPTOMS
exon O
21 O
t790 B-SYMPTOMS
m I-SYMPTOMS
mutation I-SYMPTOMS
exon O
20 O
fig4b O
c O
consider O
pathology O
scc O
distinct O
compare O
originally O
resect O
nsclc O
speciman O
retrospectively O
reassess O
surgery O
speciman O
verify O
primary O
diagnosis O
morphologic O
ihc O
result O
complete O
agreement O
initial O
diagnosis O
l858r O
mutation O
identify O
newly O
add O
molecular O
evaluation O
fig4a O
relieve O
acute O
pain O
left O
pleura O
quickly O
possible O
palliative O
threedimensional O
conformal O
radiotherapy O
3dcrt O
chest O
lesion O
deliver O
total O
dose O
42 O
gy14 O
fraction O
f O
daily O
5fweek O
fig5 O
volume O
radiation O
dose O
5 O
gy O
v5 O
value O
left O
right O
total O
lung O
20 O
0 O
78 O
respectively O
volume O
radiation O
dose O
20 O
gy O
v20 O
value O
10 O
0 O
5 O
respectively O
mean O
lung O
dose O
mld O
5 O
gy O
consider O
mst O
pathology O
scc O
patient O
receive O
gp O
chemotherapy O
cisplatin O
75 O
mgm2 O
d1 O
gemcitabine O
1250 O
mgm2 O
d1 O
d8 O
21 O
day O
cycle O
4 O
cycle O
patient O
achieve O
partial O
remission B-SYMPTOMS
pr O
2 O
cycle O
follow O
stable B-DISEASE
disease I-DISEASE
sd B-DISEASE
4 O
cycle O
fig3b3b O
f O
c O
g O
accord O
response O
evaluation O
criterion O
solid O
tumor O
recist O
11 O
gefitinib O
150 O
mg O
qd O
maintenance O
treatment O
november O
2015 O
onward O
treatment O
ibandronate O
sodium O
give O
monthly O
skeletalrelate O
event O
patient O
currently O
surveillance O
sd O
fig3d O
h O
ps O
score O
0 O

57yearold O
male B-SEX
admit O
hospital O
5 O
month O
history O
massive O
rectal O
bleeding B-SYMPTOMS
rectorrhagia O
past O
history O
passage O
fresh B-SYMPTOMS
blood I-SYMPTOMS
mix O
stool O
55 O
year O
complain O
rectal O
bleeding O
age O
2 O
go O
hospital O
numerous O
time O
symptom B-SYMPTOMS
multiple O
intervention O
disease O
cure O
completely O
hospital O
visit O
past O
patient O
forget O
date O
diagnose O
treat O
hemorrhoid O
symptom O
relieve O
recur O
thirty O
year O
ago O
diagnose O
rectal O
hemangioma B-DISEASE
manage O
cryotherapy O
hospital O
relieve O
symptom O
year O
recur O
consult O
hospital O
shortterm O
symptomatic B-SYMPTOMS
relief I-SYMPTOMS
proper O
treatment O
cause O
5 O
month O
severity O
rectal O
bleeding O
increase O
go O
local O
hospital O
intervention O
control O
bleeding O
symptomatic O
treatment O
intravenous O
fluid O
blood O
transfusion O
finally O
refer O
hospital O
evaluation O
intermediate O
rectal O
bleeding O
fresh O
blood O
present O
admission O
patient O
complain O
dizziness B-SYMPTOMS
stand O
shortness O
breath O
palpitation B-SYMPTOMS
walk O
short O
distance O
history O
similar O
illness O
family O
general O
examination O
patient O
appear O
pale B-SYMPTOMS
heart O
rate O
blood O
pressure O
normal O
limit O
rest O
lose O
5 O
kg O
body O
weight O
5 O
month O
rectal O
examination O
fresh O
blood O
see O
anal O
region O
soft O
mass B-SYMPTOMS
feel O
digital O
rectal O
examination O
proctoscopy O
anal O
cavity O
rectum O
see O
fill O
fresh O
blood O
active O
site O
bleed O
polyp B-SYMPTOMS
ulcer B-SYMPTOMS
detect O
laboratory O
examination O
red O
blood O
cell O
count O
309 O
   O
1012l O
normal O
432572 O
   O
1012l O
hemoglobin O
86 O
gl O
normal O
135175 O
gl O
parameter O
normal O
limit O
enhance O
ct O
show O
isodense O
35 O
hu O
homogenous O
bowel O
wall O
thicken O
contrastenhance O
ct O
venous O
phase O
enhance O
heterogeneously O
multiple O
calcification O
see O
thicken O
bowel O
wall O
perirectal O
area O
lesion B-SYMPTOMS
see O
extend O
distal O
sigmoid O
rectum O
fig1 O
multiple O
hypodense O
lesion O
see O
spleen O
fig2 O
initial O
management O
anemia B-SYMPTOMS
patient O
underwent O
abdominal O
laparotomy O
follow O
surgical O
excision O
surgery O
25 O
cm O
long O
lesion O
find O
extend O
distal O
sigmoid O
rectum O
rectum O
sigmoid O
colon O
excise O
sigmoidanus O
anastomosis O
postsurgical O
histopathological O
examination O
excise O
speciman O
show O
submucosal O
multiple O
thinwalle O
vessel O
vary O
size O
interpose O
stroma O
vessel O
luman O
consist O
blood O
cell O
consistent O
blood O
vessel O
consist O
clear O
fluid O
consistent O
lymph O
vessel O
immunohistochemistry O
speciman O
show O
endothelial O
cell O
positive O
cd O
31 O
cd O
34 O
cell O
positive O
d240 O
negative O
d240 O
fig3 O
basis O
histopathological O
report O
immunohistochemistry O
hemolymphangioma B-DISEASE
diagnose O
surgery O
follow O
complication B-SYMPTOMS
intestinal O
infection B-DISEASE
manage O
patient O
discharge O
hospital O
23rd O
day O
surgery O
complication O
recurrence B-SYMPTOMS
notice O
6 O
month O
followup O
study O
approve O
affiliated O
hospital O
sun O
yatsen O
university O
institutional O
review O
board O
write O
consent O
case O
report O
obtain O
patient O

report O
case O
68yearold O
female B-SEX
past O
medical O
history O
present O
upper O
gastrointestinal O
bleeding B-SYMPTOMS
pain B-SYMPTOMS
leave O
upper O
abdoman O
physical O
examination O
find O
splenomegaly B-SYMPTOMS
sign O
portosystemic B-DISEASE
collateral I-DISEASE
formation I-DISEASE
include O
abdominal O
wall O
dilate O
vein O
rectal O
haemorrhoid O
biological O
abnormality O
note O
hypersplenism B-DISEASE
anaemia B-SYMPTOMS
thrombocytopenia B-SYMPTOMS
patient O
undergo O
upper O
gastrointestinal O
endoscopy O
show O
stage O
iii O
oesophageal O
varix O
portal B-DISEASE
hypertensive I-DISEASE
gastropathy I-DISEASE
red O
sign O
ultrasonography O
reveal O
fusiform B-SYMPTOMS
dilatation I-SYMPTOMS
portal O
bifurcation O
measure O
40 O
mm O
diameter O
dilate O
branch O
sign O
portal O
thrombosis O
detect O
figure O
1 O
portal O
doppler O
study O
show O
normal O
hepatopetal O
flow O
sign O
portal O
hypertension O
find O
include O
splenomegaly O
repermeation B-SYMPTOMS
umbilical O
vein O
splenorenal O
collateral B-SYMPTOMS
circulation I-SYMPTOMS
complementary O
angioct O
allow O
well O
assessment O
portal O
system O
contain O
thin O
calcification O
aneurysmal O
wall O
main O
portal O
trunk O
figure O
2 O
figure O
3 O
figure O
4 O
sign O
portal O
hypertension O
note O
oesophageal O
gastric O
varix O
parietal O
collateral O
circulation O
associate O
ultrasonography O
finding O
liver B-DISEASE
cirrhosis I-DISEASE
confirm O
transcient O
elastometry O
biopsy O

64yearold O
man B-SEX
admit O
department O
gastroenterology O
affiliated O
hospital O
qingdao O
university O
medical O
college O
qingdao O
china O
epigastric O
pain O
physical O
examination O
reveal O
palpable O
mass B-SYMPTOMS
lymphadenopathy B-SYMPTOMS
organomegaly B-SYMPTOMS
endoscopy O
submucosal O
lesion O
identify O
gastric O
antrum O
duodenal O
bulb O
fig1 O
endoscopic O
ultrasonography O
eus O
olympus O
eus O
eume2 O
miniprobe O
sonography O
demonstrate O
lesion O
05 O
cm O
homogeneously O
hypoechoic O
neoplasm O
originate O
submucous O
layer O
fig2 O
initial O
diagnosis O
digestive O
neuroendocrine O
tumor O
compute O
tomography O
reveal O
enlarged O
lymph O
node O
multiple O
region O
mediastinal O
retroperitoneal O
mesenteric O
inguinal O
intracavitary O
nodule O
duodenum O
reach O
definitive O
diagnosis O
patient O
underwent O
repeat O
eus O
biopsy O
perform O
endoscopy O
2 O
   O
1 O
cm O
columnar B-SYMPTOMS
uplift I-SYMPTOMS
terminal O
ileum O
multiple O
submucosal O
lesion O
rectum O
identify O
fig3 O
eus O
reveal O
lesion O
terminal O
ileum O
size O
16 O
   O
12 O
cm O
lesion O
rectum O
size O
06 O
   O
10 O
cm O
homogeneously O
hypoechoic O
originate O
muscularis O
mucosa O
layer O
pathological O
examination O
biopsie O
specimen O
lesion O
rectum O
show O
diffuse O
lymphomatous O
proliferation O
dense O
infiltration O
monomorphic O
small O
cleaved O
cell O
irregularly O
shape O
nuclei O
fig4 O
immunohistochemical O
analysis O
cell O
positive O
cyclin O
d1 O
cd20 O
cd21 O
sox11 O
bcl2 O
negative O
cd3 O
cd10 O
compatible O
diagnosis O
mcl B-DISEASE
ki67 O
staining O
reveal O
proliferative O
index O
30 O
base O
finding O
diagnosis O
ann O
arbor O
stage O
iv O
mcl O
confirm O
patient O
refer O
combination O
chemotherapy O
rituximab O
cyclophosphamide O
doxorubicin O
vincristine O
prednisone O
rchop O
regimen O
patient O
remission B-SYMPTOMS
clinically O

78yearold O
previously O
healthy O
male B-SEX
heavy O
smoker O
present O
emergency O
department O
generalized O
jaundice B-SYMPTOMS
sclera O
skin O
ascite O
hepatic B-DISEASE
coma I-DISEASE
relative O
declare O
know O
urinary B-DISEASE
bladder B-DISEASE
carcinoma I-DISEASE
diagnose O
routine O
control O
perform O
3 O
month O
medical O
paper O
prove O
diagnosis O
show O
mention O
2month O
history O
progressive O
jaundice O
somnolence B-SYMPTOMS
temporary O
loss O
consciousness O
weight B-SYMPTOMS
loss I-SYMPTOMS
clinical O
sign O
mention O
previously O
viral B-DISEASE
hepatitis I-DISEASE
drug O
excess O
report O
family O
history O
cancer O
declare O
present O
admission O
abdominal O
ct O
scan O
show O
mark O
hepatomegaly B-SYMPTOMS
multiple O
small O
nodule B-SYMPTOMS
210 O
mm O
diameter O
suppose O
hepatic O
metastasis O
bladder O
carcinoma O
thoracic O
xray O
show O
bilateral O
bronchopneumonia B-SYMPTOMS
abnormal O
opacity O
patient O
die O
hepatic B-DISEASE
encephalopathy B-DISEASE
7 O
hour O
admission O
prior O
autopsy O
sign O
informed O
consent O
relative O
obtain O
case O
publication O
case O
report O
ethical O
committee O
approval O
necessary O
autopsy O
macroscopic O
examination O
show O
huge O
liver O
65 O
kg O
widely O
distribute O
white O
nodule O
vary O
size O
fig1 O
urinary O
bladder O
modify O
30 O
   O
30 O
   O
50 O
mm O
prostate O
nodule O
infiltrative O
aspect O
observe O
fig2 O
bilateral O
bronchopneumonia O
confirm O
central O
tumor B-SYMPTOMS
mass I-SYMPTOMS
10 O
mm O
white O
nodule O
identify O
encase O
small O
bronchus O
middle O
lobe O
right O
lung O
peripheral O
nodule O
fig3 O
moderate O
edema B-SYMPTOMS
brain O
lesion O
identify O
organ O
modification O
tissue O
fix O
10 O
neutral O
formalin O
embed O
paraffin O
iliac O
crest O
bone O
graft O
microscopic O
examination O
prostate O
show O
33 O
gleason O
grade O
2 O
occult O
adenocarcinoma B-DISEASE
fig2 O
cluster O
sheet O
small O
round O
cell O
see O
liver O
parenchyma O
fig1 O
lymph O
node O
hepatic O
hilum O
examination O
lung O
parenchyma O
show O
peribronchial O
sclc B-DISEASE
multiple O
tumor O
embolus O
vein O
lymphatic O
vessel O
multiple O
coinshape O
tumor O
nodule O
1 O
2 O
mm O
diameter O
pleura O
fig3 O
small O
round O
tumor O
cell O
see O
bone O
marrow O
iliac O
crest O
bone O
fig3 O
brain O
metastasis O
detect O
base O
macro O
microscopic O
feature O
clinical O
picture O
final O
diagnosis O
peribronchial O
coinlike O
peripheral O
sclc O
massive O
angiolymphatic O
invasion B-DISEASE
metastasis O
lymph O
node O
liver O
bone O
associate O
encephalopathy O
synchronous O
occult O
adenocarcinoma O
prostate O

18yearold O
college O
student O
refer O
university O
clinic O
have O
low O
hemoglobin O
hg O
47 O
gdl O
completely O
till O
month O
present O
easy O
fatigability B-SYMPTOMS
postural O
dizziness B-SYMPTOMS
palpitation B-SYMPTOMS
dyspnea B-SYMPTOMS
give O
history O
30 O
kg O
weight B-SYMPTOMS
loss I-SYMPTOMS
past O
6 O
month O
physical O
examination O
look O
pale B-SYMPTOMS
jaundice O
cyanose O
vital O
sign O
normal O
limit O
elevated O
heart O
rate O
98min O
cardiovascular O
respiratory O
abdominal O
examination O
unremarkable O
primary O
investigation O
hospital O
reveal O
low O
hemoglobin O
level O
51 O
gdl O
low O
iron O
10 O
ugdl O
positive O
occult O
blood O
test O
provisional O
diagnosis O
microcytic B-DISEASE
hypochromic I-DISEASE
anemia I-DISEASE
workup O
bone O
marrow O
aspirate O
trephine O
biopsy O
reveal O
normocellular O
marrow O
depict O
normal O
trilineage O
hematopoiesis O
upper O
gi O
endoscopy O
show O
erosive O
antral O
gastritis B-DISEASE
patchy O
ulcerative O
inflammation B-SYMPTOMS
abdominal O
ultrasound O
show O
slightly O
enlarged B-SYMPTOMS
liver O
rounded O
echogenic O
lesion B-SYMPTOMS
anterior O
wall O
right O
lobe O
suggestive O
hemangioma B-DISEASE
spleen O
slightly O
enlarge O
normal O
echogenicity O
focal O
lesion O
compute O
tomography O
ct O
scan O
abdomen O
pelvis O
show O
fairly O
large O
define O
soft O
tissue O
mass B-SYMPTOMS
locate O
anterior O
upper O
pelvis O
engulf O
jejunal O
loop O
cause O
bowel O
wall O
thicken O
patient O
undergo O
exploratory O
laparotomy O
excision O
jejunal O
mass O
macroscopic O
examination O
reveal O
11 O
   O
8 O
   O
2 O
cm O
annular O
mass O
locate O
jejunal O
wall O
ulcerate O
mucosa O
extend O
serosal O
surface O
microscopic O
examination O
reveal O
tumor B-SYMPTOMS
situate O
muscularis O
propria O
extend O
mucosa O
serosa O
neoplastic O
cell O
arrange O
predominantly O
pseudoalveolar O
pattern O
fig1ab O
polygonal O
shape O
variable O
eosinophilic O
clear O
cytoplasm O
fig1c O
nucleus O
oval O
vesicular O
chromatin O
inconspicuous O
nucleolus O
scatter O
osteoclastlike O
multinucleate O
giant O
cell O
identify O
fig1bc O
frequent O
mitotic O
figure O
necrosis B-SYMPTOMS
note O
lymph O
node O
involve O
tumor O
immunohistochemically O
neoplastic O
cell O
strongly O
diffusely O
positive O
s100 O
protein O
fig1d O
positive O
vimentin O
melanocytic O
marker O
hmb45 O
melan O
neuroendocrine O
marker O
chromogranin O
synaptophysin O
cd56 O
smooth O
muscle O
actin O
desmin O
cd34 O
cd117 O
cytokeratin O
lca O
negative O
neoplastic O
cell O
fluorescein O
situ O
hybridization O
fish O
analysis O
ewsr1 O
break O
apart O
probe O
paraffinembedde O
tumor O
show O
evidence O
22q12 B-SYMPTOMS
rearrangement I-SYMPTOMS
197 O
205 O
96 O
interphase O
nucleus O
score O
native O
state O
ewsr1 O
break O
apart O
probe O
see O
adjacent O
fuse O
overlap O
redgreen O
yellow O
signal O
ewsr1 O
gene O
rearrangement O
present O
red O
green O
separate O
signal O
fig1e O
patient O
receive O
chemotherapy O
radiotherapy O
clinical O
follow O
patient O
remain O
disease B-SYMPTOMS
free I-SYMPTOMS
3 O
year O
present O
local O
recurrence B-SYMPTOMS
treatment O
plan O
surgical O
resection O
patient O
seek O
medical O
advice O
different O
institution O
die O
disease O
year O
later O

84yearold O
woman B-SEX
present O
local O
clinic O
dyspnea B-SYMPTOMS
exertion O
leave O
pain B-SYMPTOMS
persist O
month O
admit O
hospital O
leave O
pleural B-SYMPTOMS
effusion I-SYMPTOMS
chest O
xray O
suffer O
hypertension O
dyslipidemia O
history O
pleural O
tuberculosis O
chronic O
pyothorax O
smoking O
history O
dust O
exposure O
examination O
vital O
sign O
oxygen O
saturation O
normal O
spo2 O
96 O
ambient O
air O
chest O
examination O
reveal O
mass B-SYMPTOMS
left O
pain O
decrease O
breathing O
sound O
left O
lowerlung O
field O
rest O
examination O
finding O
normal O
laboratory O
test O
reveal O
elevated O
level O
c O
reactive O
protein O
lactate O
dehydrogenase O
ldh O
soluble O
interleukin2 O
receptor O
sil2r O
table O
1 O
chest O
xray O
fig1 O
show O
leave O
pleural O
effusion O
mediastinal O
shift O
hospital O
day O
intercostal O
drainage O
tube O
insert O
drainage O
chest O
compute O
tomography O
ct O
fig2 O
reveal O
irregular O
pleural O
mass O
invade O
left O
chest O
wall O
rib O
destruction B-SYMPTOMS
pleural O
effusion O
mass O
adjacent O
posterior O
mediastinum O
lateral O
mass O
thick O
invade O
chest O
wall O
diagnose O
mass O
chest B-DISEASE
wall I-DISEASE
tumor I-DISEASE
pleural O
fluid O
serous B-SYMPTOMS
purulent B-SYMPTOMS
fluid O
analysis O
show O
exudative O
81 O
white O
blood O
cell O
lymphocyte O
fluid O
culture O
negative O
cytology O
evidence O
malignancy B-SYMPTOMS
table O
1 O
ctguided O
needle O
biopsy O
perform O
histopathology O
result O
support O
diagnosis O
diffuse O
large O
bcell O
lymphoma O
dlbcl B-DISEASE
positive O
cd10 O
cd20 O
negative O
cd3 O
cd5 O
fig3 O
18fluorodeoxyglucose O
positron O
emission O
tomographycompute O
tomography O
fdgpetct O
reveal O
high B-SYMPTOMS
fdg I-SYMPTOMS
uptake I-SYMPTOMS
left O
chest O
wall O
mass O
uptake O
fig4a O
b O
diagnose O
primary B-DISEASE
malignant I-DISEASE
lymphoma I-DISEASE
originate O
chest O
wall O
reconfirm O
medical O
history O
tuberculous O
pleurisy O
pyothorax O
performance O
status O
ps O
3 O
pain O
fatigue B-SYMPTOMS
owe O
bad O
ps O
age O
difficult O
perform O
operation O
administer O
combination O
chemotherapy O
rituximab O
lowdose O
oral O
etoposide O
50 O
mgday O
d114 O
q28 O
administer O
pleural O
effusion O
disappear O
week O
pain O
disappear O
ps O
improve O
1 O
month O
chest O
ct O
perform O
month O
later O
show O
complete O
response O
fig4c O
d O
continue O
oral O
chemotherapy O
maintain O
good O
ps O
year O
diagnosis O

82yearold O
woman B-SEX
transfer O
hospital O
dyspnea B-SYMPTOMS
massive O
hemoptysis B-SYMPTOMS
patient O
history O
bronchial O
asthma O
wellcontrolle O
bronchodilator O
medication O
history O
tuberculosis O
nontuberculous O
mycobacterial O
infection O
smoke O
physical O
examination O
reveal O
diffuse O
bilateral O
crackle O
suffer O
severe O
hypoxemia B-SYMPTOMS
ph O
7362 O
pco2 O
351 O
mmhg O
po2 O
610 O
mmhg O
hco3 O
201 O
mmhg O
55 O
mmhg O
spo2 O
905 O
10 O
l O
o2min O
reservoir O
mask O
tracheal O
intubation O
100 O
ml O
brightred O
blood O
aspirate O
chest O
radiograph O
show O
bilateral O
infiltrate O
fig1 O
chest O
ct O
demonstrate O
multiple O
consolidation O
ground O
glass O
opacity B-SYMPTOMS
focal O
bronchiectasis B-DISEASE
right O
segment O
4 O
s4 O
fig2 O
spaceoccupye O
lesion O
day O
admission O
respiratory O
condition O
improve O
active O
hemorrhaging B-SYMPTOMS
tracheal O
tube O
extubate O
small O
bloody O
sputum B-SYMPTOMS
cough O
determine O
origin O
bleed O
undergo O
contrastenhance O
ct O
show O
bronchiectasis O
right O
s4 O
regression O
infiltration B-SYMPTOMS
cta O
reveal O
abnormal O
vascular O
anastomosis B-DISEASE
right O
inferior O
phrenic O
artery O
right O
pulmonary O
artery O
focal O
bronchiectasis O
right O
middle O
lobe O
fig3 O
lead O
suspect O
possible O
source O
massive O
hemoptysis O
perform O
embolization O
superselecte O
right O
inferior O
phrenic O
artery O
22fr O
microcatheter O
fig4 O
angiogram O
right O
bronchial O
artery O
show O
obvious O
active O
bleeding B-SYMPTOMS
week O
embolization O
successfully O
discharge O
free O
recurrent O
hemoptysis O
year O

65yearold O
man B-SEX
45year O
history O
cigarette O
smoking O
visit O
hospital O
diagnosis O
abnormal O
chest O
shadow B-SYMPTOMS
xray O
remarkable O
medical O
history O
prescribe O
anticoagulant O
antiplatelet O
agent O
compute O
tomography O
ct O
scan O
reveal O
huge O
mass B-SYMPTOMS
left O
upper O
lobe O
maximum O
size O
110 O
cm O
diameter O
subsequently O
expand O
left O
hilum O
mediastinum O
intrapulmonary O
metastasis B-SYMPTOMS
locate O
left O
low O
lobe O
pleural B-DISEASE
effusion I-DISEASE
left O
multiple O
liver O
tumor B-SYMPTOMS
range O
05 O
47 O
cm O
diameter O
fig1 O
note O
liver O
metastasis O
locate O
subcapsularly O
liver O
surface O
irregularly O
distort O
laboratory O
finding O
follow O
white O
blood O
cell O
count O
11900mm3 O
hemoglobin O
148 O
gdl O
platelet O
count O
214000mm3 O
aspartate O
transaminase O
31 O
iul O
alanine O
transaminase O
19 O
iul O
lactate O
dehydrogenase O
ldh O
749 O
iul O
coagulation O
abnormality O
find O
subsequent O
histological O
examination O
tumor O
speciman O
obtain O
bronchoscopy O
confirm O
diagnosis O
small B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
consider O
clinical O
diagnosis O
performance O
status O
age O
patient O
decide O
regimen O
antitumor O
chemotherapy O
consist O
cisplatin O
60 O
mgm2 O
body O
surface O
area O
day O
1 O
etoposide O
100 O
mgm2 O
body O
surface O
area O
day O
13 O
day O
2 O
week O
initial O
ct O
scan O
start O
chemotherapy O
session O
day O
3 O
initiate O
chemotherapy O
complain O
abdominal O
discomfort B-SYMPTOMS
vital O
sign O
show O
tachycardia B-SYMPTOMS
120 O
beat O
minute O
hypotension B-SYMPTOMS
8555 O
mmhg O
hematological O
examination O
show O
severe O
anemia B-SYMPTOMS
hemoglobin O
67 O
gdl O
dramatically O
drop O
148 O
gdl O
10 O
day O
attempt O
identify O
bleeding O
site O
gastrointestinal O
endoscopy O
avail O
ct O
scan O
reveal O
rapid O
enlargement B-SYMPTOMS
liver O
tumor O
left O
lobe O
contain O
partial O
highdensity O
area O
plain O
scan O
novel O
finding O
ascite O
show O
high O
density O
usual O
suggest O
ruptured O
liver O
metastasis O
associate O
hemorrhagic O
ascite O
fig2 O
subsequent O
contrastenhance O
ct O
image O
negative O
extravasation B-SYMPTOMS
undergo O
angiography O
left O
right O
hepatic O
artery O
observe O
obscure O
tumor O
vessel O
left O
hepatic O
lobe O
extravasation O
fig3a O
suspect O
hypovascularity O
metastatic O
tumor O
inactive O
bleeding O
time O
benefit O
therapeutic O
embolization O
hepatic O
artery O
uncertain O
base O
finding O
angiography O
perform O
transcatheter O
arterial O
embolization O
tae O
left O
main O
hepatic O
artery O
gelform O
particle O
prevent O
future O
rebleeding O
postembolization O
angiography O
reveal O
slow O
blood O
flow O
left O
hepatic O
artery O
peripheral O
vessel O
weakly O
visualize O
fig3b O
embolization O
concomitant O
supportive O
therapy O
include O
rbc O
transfusion O
6 O
u O
total O
clinical O
course O
patient O
stabilize O
blood O
pressure O
remain O
12070 O
mmhg O
tachycardia O
disappear O
anemia O
improve O
transfusion O
progress O
liver O
dysfunction B-SYMPTOMS
appear O
month O
embolization O
relatively O
good O
health O
restart O
antitumor O
chemotherapy O
continue O
firstline O
regiman O
course O
good O
partial O
response O
gain O
chemotherapy O
lung O
liver O
lesion O

33yearold O
moroccan O
man B-SEX
5month O
history O
recur O
sinusitis B-DISEASE
present O
temperature B-SYMPTOMS
myalgia B-SYMPTOMS
cough B-SYMPTOMS
hemoptysis B-SYMPTOMS
thoracic O
physical O
examination O
reveal O
reduce O
vesicular O
murmur O
chest O
xray O
show O
bilateral O
diffuse O
alveolar O
infiltrate O
laboratory O
analysis O
show O
elevation O
acutephase O
protein O
crp O
26 O
mgdl O
creatinine O
12 O
mgdl O
nonnephrotic O
proteinuria B-SYMPTOMS
microscopic O
glomerular O
hematuria B-SYMPTOMS
antibiotic O
therapy O
community O
acquire O
atypical O
pneumoniae B-DISEASE
levofloxacin O
500 O
mg O
daily O
iv O
establish O
3rd O
day O
admission O
patient O
develop O
respiratory B-DISEASE
failure I-DISEASE
unresponsive O
noninvasive O
ventilation O
intubate O
white O
lung O
consolidation O
ground O
glass O
area O
compute O
tomography O
scan O
fig1 O
diffuse O
airway O
bleed O
fiberoptic O
bronchoscopy O
mild O
normocytic O
anemia B-SYMPTOMS
9 O
gdl O
ancapr3 O
positivity O
189 O
uml O
consistent O
diagnosis O
gpa B-DISEASE
despite O
maximal O
ventilatory O
support O
gas O
exchange O
improve O
ph O
733 O
pao2 O
71 O
mm O
hg O
paco2 O
51 O
mm O
hg O
hco3 O
25 O
mmoll O
sao2 O
94 O
require O
extracorporeal O
membrane O
oxygenation O
ecmo O
treatment O
highdose O
methylprednisolone O
1 O
g O
daily O
3 O
day O
1 O
mgkg O
daily O
cyclophosphamide O
12 O
gpulse O
2 O
week O
1st O
3 O
pulse O
follow O
infusion O
3 O
week O
2 O
pulse O
plasma O
exchange O
pe O
accord O
european O
vasculitis O
study O
group O
recommendations4 O
immediately O
start O
respiratory O
improvement O
allow O
ecmo O
orotracheal O
tube O
withdrawal O
subsequent O
discharge O
intensive O
care O
unit O
9 O
day O
beginning O
treatment O
ancapr3 O
level O
normalize O
3 O
uml O
month O
later O
5th O
bolus O
cyclophosphamide O
prednisone O
03 O
mgkgday O
patient O
complain O
arthromyalgia B-SYMPTOMS
testicular O
pain B-SYMPTOMS
edema B-SYMPTOMS
cough O
shortness O
breath O
laboratory O
datum O
show O
worsen O
renal O
function O
mild O
anemia O
hypoxemia B-SYMPTOMS
pao2 O
61 O
mm O
hg O
epididymitis B-DISEASE
confirm O
ultrasound O
rapidly O
progressive O
renal B-DISEASE
failure I-DISEASE
estimate O
glomerular O
filtration O
rate O
35 O
mlmin O
renal O
biopsy O
perform O
show O
prominent O
intracapillary O
extracapillary O
proliferation B-SYMPTOMS
formation O
fibrocellular O
crescent O
focal O
capillary O
necrosis B-SYMPTOMS
fig2 O
lung O
compute O
tomographyscan O
fiberoptic O
bronchoscopy O
confirm O
alveolar O
hemorrhage B-SYMPTOMS
relapse O
treatment O
highdose O
methylprednisolone O
1 O
g O
daily O
3 O
consecutive O
day O
rituximab O
375 O
mgm2 O
weekly O
4 O
week O
start O
rapid O
resolution O
urologic O
pulmonary O
involvement B-SYMPTOMS
delayed O
partial O
improvement O
renal O
function O
1year O
followup O
patient O
alive B-SYMPTOMS
treatment O
azathioprine O
150 O
mg O
daily O
prednisone O
15 O
mg O
daily O
renal O
function O
markedly O
improve O
estimate O
glomerular O
filtration O
rate O
94 O
mlmin O
gasexchange O
ph O
742 O
pao2 O
86 O
mm O
hg O
paco2 O
36 O
mm O
hg O
hco3 O
23 O
mmoll O
sao2 O
95 O
patient O
sign O
institutional O
inform O
consent O
form O
time O
admission O
hospitalization O
approval O
ethic O
committee O
necessary O
routine O
health O
care O

41yearold O
caucasian O
woman B-SEX
undergo O
primary O
double O
lung O
transplantation O
cystic O
fibrosis O
2006 O
medical O
history O
unremarkable O
patient O
know O
history O
pulmonary O
tuberculosis O
tuberculosis O
contact O
december O
2015 O
undergo O
retransplantation O
chronic O
lung B-DISEASE
allograft I-DISEASE
dysfunction I-DISEASE
month O
precede O
retransplantation O
4 O
sputum O
specimen O
remain O
negative O
acidfast O
bacilli O
specific O
m O
tuberculosis O
culture O
realtime O
polymerase O
chain O
reaction O
pcr O
testing O
postoperative O
day O
42 O
deterioration O
respiratory O
status O
prompt O
chestcomputerize O
tomography O
ct O
scan O
reveal O
subcentimeter O
bilateral O
nodule O
primarily O
locate O
apical O
posterior O
lobe O
bilateral O
pleural B-DISEASE
effusion I-DISEASE
fig1 O
day O
bronchoalveolar O
lavage O
bal O
yield O
positive O
realtime O
pcr O
rifampicinsusceptible O
m O
tuberculosis O
confirm O
culture O
postoperative O
day O
62 O
tuberculin O
skin O
test O
tst O
interferon O
release O
assay O
igra O
test O
perform O
bal O
perform O
postoperative O
period O
yield O
pathogen O
perform O
day O
60 O
cultured O
pseudomonas O
aeruginosa O
adjunctive O
antibiotic O
therapy O
imipenemcilastatin O
3 O
gd O
histological O
examination O
lung O
biopsy O
perform O
6 O
week O
retransplantation O
reveal O
caseate O
granuloma O
necrosis O
acidfast O
bacilli O
identify O
rifampicinsusceptible O
m O
tuberculosis O
realtime O
pcr O
postoperative O
day O
65 O
patient O
status O
worsen O
severe O
hypoxemia B-SYMPTOMS
shock B-DISEASE
unresponsive O
high O
dose O
cathecolamine O
multiorgan B-DISEASE
failure I-DISEASE
patient O
die O
postoperative O
day O
70 O
despite O
treatment O
combine O
isoniazid O
rifampicin O
ethambutol O
pyrazinamide O
retrospective O
realtime O
pcr O
testing O
explanted O
lung O
bal O
perform O
postoperative O
day O
1 O
7 O
21 O
remain O
negative O
organ O
donor O
die O
posttraumatic O
intracerebral O
hemorrhage O
47yearold O
man O
history O
lung O
disease O
risk O
factor O
tuberculosis O
chronic O
alcohol O
use O
smoking O
tst O
result O
available O
hospitalization O
lung O
ctscan O
show O
sign O
active O
previous O
tuberculosis O
tst O
igra O
test O
result O
available O
routine O
culture O
pertransplantation O
right O
lung O
biopsy O
yield O
candida O
albican O
retrospective O
m O
tuberculosis O
realtime O
pcr O
yield O
negative O
result O
left O
right O
donorlung O
biopsy O
kidney O
donor O
transplant O
2 O
recipient O
month O
transplantation O
kidney O
recipient O
develop O
sign O
symptom O
suggestive O
active O
tuberculosis O

16yearold O
female B-SEX
suffer O
abdominal O
pain B-SYMPTOMS
right O
upper O
quadrant O
last O
10 O
day O
shortly O
ahead O
medical O
consultation O
4 O
ascarislike O
worm O
vomit O
individually O
length O
10 O
cm O
previous O
onset O
ascariasis B-DISEASE
lowgrade O
fever B-SYMPTOMS
384c O
occur O
apparent O
jaundice B-SYMPTOMS
diarrhea B-SYMPTOMS
anemia B-SYMPTOMS
physical O
examination O
reveal O
tenderness B-SYMPTOMS
right O
upper O
quadrant O
total O
leukocyte O
count O
112 O
gl O
consist O
52 O
eosinophil O
serum O
urine O
amylase O
386 O
928 O
ul O
respectively O
term O
liver O
functionality O
level O
total O
bilirubin O
rise O
232 O
ml O
hepatic O
enzyme O
similarly O
elevate O
alanine O
aminotransferase O
163 O
ul O
aspartate O
aminotransferase O
96 O
ul O
abdominal O
ultrasound O
describe O
enlargement B-SYMPTOMS
gallbladder O
upper O
segment O
common O
bile O
duct O
15 O
cm O
diameter O
intrahepatic O
bile O
duct O
13 O
cm O
diameter O
furthermore O
intrahepatic O
bile O
duct O
discover O
fill O
echogenic B-SYMPTOMS
band O
substance O
base O
evidence O
clinically O
diagnose O
biliary O
ascariasis O
concomitant O
manifestation O
biliary O
duct O
infection B-DISEASE
laparoscopic O
exploration O
enlarged B-SYMPTOMS
gallbladder O
common O
bile O
duct O
visually O
confirm O
massive O
storage O
worm O
biliary O
tract O
subsequently O
1 O
cm O
incision O
common O
bile O
duct O
order O
facilitate O
extraction O
pathogenic O
worm O
place O
specimen O
bag O
laparoscopically O
fig1 O
contain O
worm O
virtually O
clear O
laparoscope O
chodedochoscopy O
employ O
seek O
hidden O
worm O
inside O
biliary O
system O
fig2 O
finish O
removal O
ascaride O
biliary O
duct O
incision O
suture O
ttube O
place O
situ O
fig3 O
eventually O
standard O
laparoscopic O
cholecystectomy O
perform O
follow O
removal O
speciman O
bag O
drainage O
tube O
placement O
fig4 O
total O
worm O
inside O
common O
bile O
duct O
sum O
100 O
fig5 O
postoperatively O
treat O
oral O
antihelminthic O
drug O
3 O
day O
ttube O
rinse O
saline O
day O
3 O
day O
6 O
worm O
additionally O
wash O
patient O
experience O
smooth O
postoperative O
recovery O
finally O
discharge O
hospital O
complication O

41yearold O
man B-SEX
history O
alcoholism O
10 O
year O
sober O
3 O
year O
recurrent O
alcoholic O
pancreatitis O
known O
liver O
disease O
present O
episode O
hematemesis B-SYMPTOMS
abdominal O
pain B-SYMPTOMS
2 O
day O
esophagogastroduodenoscopy O
egd O
perform O
3 O
year O
early O
abdominal O
pain O
reveal O
esophageal O
varix O
gastric O
varix O
portal B-DISEASE
hypertensive I-DISEASE
gastropathy I-DISEASE
gi O
lesion O
physical O
examination O
reveal O
blood O
pressure O
   O
10060 O
mm O
hg O
pulse O
   O
60 O
beatsmin O
jaundice B-SYMPTOMS
stigmata O
chronic O
liver O
disease O
soft B-SYMPTOMS
abdoman O
mild O
epigastric O
tenderness B-SYMPTOMS
rebound O
tenderness O
abdominal O
bruit B-SYMPTOMS
pulsatile O
abdominal O
mass B-SYMPTOMS
rectal O
examination O
reveal O
gross O
melena B-SYMPTOMS
laboratory O
test O
reveal O
hemoglobin O
   O
125 O
gdl O
platelet O
   O
301000ml O
inr O
international O
normalize O
ratio O
   O
10 O
blood O
urea O
nitrogen O
   O
20 O
mgdl O
creatinine O
   O
11 O
mgdl O
serum O
aspartate O
aminotransferase O
   O
21 O
iul O
alanine O
aminotransferase O
   O
16 O
iul O
total O
bilirubin O
   O
06 O
mgdl O
alkaline O
phosphatase O
   O
64 O
iul O
albumin O
   O
44 O
gmdl O
lipase O
   O
32 O
udl O
hemoglobin O
decline O
acutely O
93 O
gdl O
abdominopelvic O
computerized O
tomography O
ct O
intravenous O
contrast O
reveal O
5 O
cm O
wide O
irregular O
pancreaticperipancreatic O
mass O
compress O
less O
curvature O
stomach O
sv O
fig1a O
b O
normal O
portal O
vein O
normal O
liver O
parenchyma O
sv O
compression B-SYMPTOMS
pathophysiologically O
significant O
indicate O
proximal O
sv O
dilatation B-SYMPTOMS
egd O
reveal O
proximal O
stomach O
fine O
reticular O
palewhite O
polygonal O
mucosal O
network B-SYMPTOMS
snakeskin O
pattern O
characteristic O
portal O
hypertensive O
gastropathy O
actively O
ooze O
extensive O
coffeeground O
blood O
clot O
stomach O
small O
gastric O
cardial O
fundal O
varix O
stigmata O
recent O
hemorrhage O
srh B-SYMPTOMS
esophageal O
varix O
fig2 O
extrinsic O
mass O
produce O
large O
round O
bulge B-SYMPTOMS
extend O
luman O
proximal O
gastric O
body O
less O
curvature O
fig2 O
magnetic O
resonance O
cholangiopancreatography O
mrcp O
reveal O
5 O
cm O
wide O
enhance O
vascular O
mass O
likely O
arise O
lga O
locate O
gastric O
less O
curvature O
distal O
pancreatic O
body O
compress O
stomach O
compress O
middle O
sv O
result O
large O
collateral O
vein O
drain O
sv O
superior O
mesenteric O
vein O
fig3a O
b O
abdominal O
ultrasound O
doppler O
study O
demonstrate O
large O
turbulent O
arterial O
flow B-SYMPTOMS
vascular O
mass O
suggest O
large O
pa B-DISEASE
fig4 O
visceral O
arteriogram O
show O
53 O
   O
22cmwide O
pa O
supply O
lga O
branch O
fig5a O
embolize O
occlude O
microcoil O
fig5b O
week O
later O
patient O
stable O
hemoglobin O
level O
gi O
bleed O
abdominopelvic O
ct O
angiography O
demonstrate O
pa O
markedly O
decrease O
diameter O
contain O
numerous O
microcoil O
blood O
flow O
fig1c O

75yearold O
man B-SEX
refer O
hospital O
evaluation O
dysphagia B-SYMPTOMS
9 O
month O
associate O
symptom O
nausea B-SYMPTOMS
vomiting B-SYMPTOMS
deny O
hematemesis B-SYMPTOMS
hematochezia B-SYMPTOMS
lethargy B-SYMPTOMS
dyspnea B-SYMPTOMS
active O
smoker O
consume O
alcohol O
30 O
year O
physical O
examination O
reveal O
peripheral O
lymphadenopathy B-SYMPTOMS
thyromegaly B-SYMPTOMS
ascite O
mass B-SYMPTOMS
abdomen O
laboratory O
datum O
normal O
hbsag O
negative O
hiv O
negative O
syphilis O
negative O
test O
serum O
antibody O
helicobacter O
pylori O
negative O
chest O
compute O
tomography O
ct O
notable O
huge O
wellcircumscribed O
homogeneous O
cylindrical O
mesenchymal O
neoplasm B-SYMPTOMS
measure O
1555940 O
cm O
low O
middle O
esophagus O
mild O
contrast O
enhancement O
fig1a O
ct O
reveal O
abnormality O
lung O
heart O
rib O
mediastinum O
endoscopic O
examination O
show O
submucosal O
lesion B-SYMPTOMS
esophagus O
start O
20 O
cm O
incisor O
tooth O
extend O
cardia O
fig1b O
endoscopic O
ultrasonography O
eus O
reveal O
hypoechoic O
lesion O
clear O
boundary O
locate O
4th O
layer O
mass O
appear O
benign B-SYMPTOMS
tumor I-SYMPTOMS
preoperatively O
diagnose O
esophageal B-DISEASE
leiomyoma I-DISEASE
base O
chest O
ct O
endoscopic O
examination O
eus O
findings O
endoscopic O
mucosal O
resection O
endoscopic O
submucosal O
resection O
possible O
large O
size O
surgical O
resection O
plan O
inform O
write O
consent O
take O
patient O
underwent O
thoracoscopicassiste O
resection O
mass O
gastroesophageal O
anastomosis O
thoracic O
duct O
ligation O
jejunostomy O
postoperative O
course O
uneventful O
grossly O
spindle O
shape O
lump B-SYMPTOMS
measure O
14 O
   O
35 O
   O
25 O
cm O
observe O
resect O
esophagus O
grow O
esophageal O
luman O
block O
luman O
lump O
locate O
submucosa O
cover O
intact O
mucosa O
erosion B-SYMPTOMS
ulcer B-DISEASE
hemorrhage B-DISEASE
cut O
surface O
homogenously O
white O
grayishwhite O
color O
histological O
examination O
hematoxylin O
eosin O
stain O
reveal O
tumor O
cover O
intact O
squamous O
epithelium O
arise O
submucosal O
layer O
expand O
muscular O
layer O
tumor O
compose O
nodule O
vary O
size O
separate O
collagen O
fiber O
numerous O
cytoplasmrich O
cell O
observe O
collagenous O
septation O
invasive O
growth O
pattern O
fig2ac O
nodule O
mainly O
compose O
small O
midsized O
centrocytelike O
monocytelike O
cell O
arrange O
diffuse O
pattern O
atypical O
lymphocyte O
possess O
clear O
boundary O
pale O
cytoplasm O
irregular O
nucleus O
occasional O
nucleolus O
fig2d O
mitosis O
rare O
lymphoepithelial O
lesion O
recognize O
lesion O
immunohistochemical O
staining O
epithelium O
diffusely O
positive O
cytokeratin O
fig3a O
tumor O
cell O
diffusely O
positive O
cluster O
differentiation O
cd20 O
pair O
box O
5 O
fig3b O
bcell O
lymphoma O
bcl2 O
fig3d O
small O
deposit O
tumor O
cell O
distribute O
mainly O
collagen O
fiber O
positive O
multiple O
myeloma O
oncogene O
1 O
cd138 O
cd43 O
tumor O
cell O
positive O
cd30 O
small O
lymphocyte O
positive O
cd3 O
cd5 O
follicular O
dendritic O
cell O
positive O
cd21 O
cd23 O
fig3c O
cell O
negative O
cyclind1 O
cd10 O
bcl6 O
b O
lymphocyte O
specific O
activation O
oct O
bind O
protein O
1 O
follicular O
dendritic O
cell O
arrange O
nodule O
tumor O
cell O
relatively O
evenly O
distribute O
pattern O
suggestive O
follicular O
colonization O
see O
malt B-DISEASE
lymphoma I-DISEASE
case O
gene O
rearragement O
clonality O
analysis O
immunoglobulin O
heavy O
chain O
gene O
kappa O
light O
chain O
gene O
lambda O
light O
chain O
gene O
perform O
identiclonetm O
ighigkigl O
gene O
clonality O
assay O
invivoscribe O
technology O
monoclonal O
gene O
rearrangement O
1 O
band O
appear O
150 O
175 O
base O
pair O
bp O
heavy O
chain O
gene O
2 O
discrete O
band O
225 O
250 O
bp O
kappa O
light O
chain O
gene O
1 O
band O
125 O
150 O
bp O
lambda O
light O
chain O
gene O
fig4 O
addition O
epsteinbarr O
virus O
observe O
lymphoma O
situ O
hybridization O
eb O
virusencode O
small O
rna O
fig3e O
f O
base O
clinical O
datum O
pathological O
immunohistochemical O
gene O
rearragement O
analysis O
final O
diagnosis O
primary O
esophageal O
malt O
lymphoma O
surgical O
resection O
additional O
therapy O
form O
chemotherapy O
radiotherapy O
administer O
8 O
month O
followup O
evidence O
recurrence B-SYMPTOMS
metastasis O
find O
ct O
patient O
asymptomatic B-SYMPTOMS
ethical O
approval O
study O
obtain O
medical O
ethic O
committee O
affiliated O
hospital O
military O
medical O
university O
write O
inform O
consent O
obtain O
patient O
publication O
case O
report O
accompany O
image O

47yearold O
female B-SEX
patient O
present O
progressively O
worsen O
pain B-SYMPTOMS
chest O
wall O
bilateral O
low O
extremity O
muscle B-SYMPTOMS
weakness I-SYMPTOMS
family O
history O
bone O
disease O
fracture O
physical O
examination O
unremarkable O
exclude O
bone O
muscular O
abnormality O
bone O
scintigraphy O
technetium99 O
m O
methylenediphosphate O
show O
increase O
uptake B-SYMPTOMS
shoulder O
multiple O
rib O
thoracic O
lumbar O
spine O
bilateral O
sacroiliac O
joint O
leave O
ilium O
leave O
foot O
fig1 O
plain O
radiograph O
reveal O
osteoporosis B-DISEASE
change O
thoracic O
lumbar O
spine O
compression B-SYMPTOMS
change O
spine O
consistent O
finding O
magnetic O
resonance O
imaging O
compute O
tomography O
ct O
fig1 O
decrease O
bone O
mass O
present O
lumbar O
spine O
tscore O
34 O
femoral O
neck O
tscore O
31 O
hip O
tscore O
35 O
main O
laboratory O
datum O
show O
table O
1 O
demonstrate O
hypophosphatemia B-SYMPTOMS
hypokalemia B-SYMPTOMS
hypouricemia B-SYMPTOMS
elevated O
level O
alp O
ctelopeptide O
chloride O
decrease O
carbon O
dioxide O
combine O
power O
urinalysis O
reveal O
high O
ph O
value O
increase O
level O
potassium O
decrease O
level O
specific O
gravity O
chlorine O
phosphate O
persistent O
glycosuria B-SYMPTOMS
proteinuria B-SYMPTOMS
repeatedly O
find O
despite O
normal O
hba1c O
plasma O
glucose O
level O
laboratory O
test O
result O
include O
thyroid O
function O
test O
serum O
parathyroid O
hormone O
25hydroxyvitamin O
d O
protein O
electrophoresis O
normal O
range O
addition O
serum O
tumor B-SYMPTOMS
marker O
negative O
limited O
technique O
determine O
level O
serum O
fibroblast O
growth O
factor O
23 O
clinical O
diagnosis O
ho B-DISEASE
fluorodeoxyglucose O
positron O
emission O
tomographycompute O
tomography O
18ffdg O
petct O
technetium99 O
m O
octreotide O
99mtcoct O
scintigraphy O
perform O
confirm O
occult O
causative O
tumor O
exist O
result O
2 O
test O
negative O
mild O
uptake O
seventh O
rib O
find O
petct O
identify O
evidence O
neoplastic O
lesion B-SYMPTOMS
potentially O
responsible O
ho O
fig2 O
immunological O
examination O
show O
elevated O
level O
serum O
igg O
igm O
iga O
positive O
antinuclear O
antibody O
antissa O
antibody O
rheumatic O
factor O
subsequently O
schirmer O
test O
abnormal O
lip O
biopsy O
support O
diagnosis O
ss B-DISEASE
fig3 O
eventually O
patient O
diagnose O
ho O
secondary O
ss O
treat O
alkalinization O
citrate O
4 O
gday O
potassium O
citrate O
3 O
gday O
2 O
week O
steroid O
prednisone O
20 O
mgday O
1 O
month O
10 O
mgday O
4 O
month O
neutral O
phosphate O
10 O
gday O
5 O
month O
calcium O
supplement O
600 O
mgday O
5 O
month O
activate O
vitamin O
d O
05 O
gday O
5 O
month O
far O
recover O
uneventfully O
relieve O
pain O
increase O
serum O
phosphorus O
level O
case O
report O
approve O
ethics O
committee O
west O
china O
hospital O
sichuan O
university O
chengdu O
china O
write O
inform O
consent O
obtain O

69yearold O
man B-SEX
aware O
onset O
exertional O
dyspnea B-SYMPTOMS
july O
2010 O
history O
smoke O
40 O
year O
20 O
cigarette O
day O
parent O
1 O
brother O
lung O
cancer O
past O
medical O
history O
unremarkable O
occupational O
exposure O
exertional O
dyspnea O
admit O
people O
hospital O
shunde O
district O
echocardiography O
compute O
tomography O
pulmonary O
angiography O
ctpa O
echocardiography O
indicate O
severe O
pah B-DISEASE
pulmonary O
arterial O
pressure O
pap O
104 O
mmhg O
right O
heart O
enlarge O
right O
ventricle O
diameter O
57 O
mm O
ctpa O
show O
pah O
thrombus B-DISEASE
upper O
lobe O
artery O
right O
lung O
region O
lung O
affect O
pe B-DISEASE
consider O
small O
induce O
severe O
pah O
addition O
connective O
tissue O
disease O
drug O
use O
history O
chemotherapy O
hiv O
test O
   O
diagnose O
ipah B-DISEASE
combine O
pe O
treat O
warfarin O
25 O
mg O
day O
target O
international O
normalize O
ratio O
inr O
15 O
25 O
slidenafil O
target O
pah O
therapy O
20 O
mg O
twice O
day O
patient O
dyspnea O
relieve O
slightly O
use O
medication O
1 O
month O
reteste O
pap O
echocardiography O
decrease O
72 O
mmhg O
symptom O
sign O
fail O
improve O
take O
medication O
6 O
month O
march O
2011 O
go O
kyorin O
university O
affiliated O
hospital O
japan O
treatment O
right O
heart O
catheterization O
reveal O
pap O
723447 O
mmhg O
pulmonary O
capillary O
wedge O
pressure O
pcwp O
17510 O
mmhg O
cardiac O
output O
43 O
lmin O
cardiac O
ejection O
index O
236 O
lminm2 O
pulmonary O
vascular O
resistance O
73 O
wood O
unit O
reteste O
ctpa O
show O
thrombus O
upper O
lobe O
artery O
right O
lung O
disappear O
diagnose O
have O
ipah O
treat O
sildenafil O
20 O
mg O
3 O
time O
day O
sorafenib O
400 O
mg O
day O
target O
pah O
therapy O
oral O
warfarin O
anticoagulation O
therapy O
25375 O
mg O
day O
daily O
dose O
adjust O
inr O
2 O
3 O
disappointingly O
dyspnea O
relieve O
pap O
test O
echocardiography O
95 O
mmhg O
september O
2011 O
visit O
shanghai O
pulmonary O
hospital O
china O
relief O
dyspnea O
arterial O
blood O
gas O
analysis O
show O
pao2 O
63 O
mmhg O
oxygen O
saturation O
93 O
lung O
function O
test O
reveal O
mild O
obstructive B-DISEASE
dysfunction I-DISEASE
pulmonary O
ventilation O
fev1fvc O
6206 O
fev1 O
prediction O
809 O
severe O
reduction O
diffuse O
capacity O
lung O
carbon O
monoxide O
dlco O
42 O
6minute O
walk O
test O
385 O
m O
chest O
highresolution O
compute O
tomography O
hrct O
fig1a O
b O
show O
smooth O
thickening B-SYMPTOMS
interlobular O
septum O
diffuse O
centrilobular O
nodule O
enlargement B-SYMPTOMS
mediastinal O
lymph O
nod O
right O
heart O
catheterization O
reveal O
pap O
833453 O
mmhg O
pcwp O
14611 O
mmhg O
acute O
vasodilator O
testing O
negative O
coronary O
angiography O
ctpa O
normal O
pulmonary O
ventilationperfusion O
vq O
lung O
scan O
show O
match O
ventilation O
perfusion O
defect O
bronchoalveolar O
lavage O
show O
elevated O
percentage O
65 O
hemosiderinladen O
macrophage O
golde O
score O
80 O
normal O
range O
020 O
diagnose O
have O
ipah O
suspect O
actually O
have O
pvod B-DISEASE
continuously O
treat O
target O
pah O
therapy O
ask O
continue O
anticoagulation O
treatment O
stop O
warfarin O
anticoagulation O
treatment O
2014 O
fail O
recall O
exact O
date O
feel O
cumbersome O
frequently O
test O
inr O
blood O
coagulation O
monitoring O
furthermore O
discontinue O
warfarin O
therapy O
fail O
monitor O
ddimer O
prevent O
pe O
recurrence O
dyspnea O
relatively O
stable O
develop O
fatal O
episode O
pulmonary B-DISEASE
edema I-DISEASE
therapy O
january O
2015 O
rush O
hospital O
dyspnea O
suddenly O
exacerbate O
ctpa O
show O
thrombus O
right O
main O
pulmonary O
artery O
fig1c O
rivaroxaban O
administer O
anticoagulation O
treatment O
medication O
relieve O
dyspnea O
ill O
walk O
instead O
bind O
wheelchair O
half O
year O
severe O
pah O
suspect O
pvod O
combine O
lifethreatening O
pe O
mandate O
lung O
transplantation O
survival O
month O
later O
undergo O
bilateral O
sequential O
allogenic O
lung O
transplantation O
assist O
venoarterial O
extracorporeal O
membrane O
oxygenation O
vaecmo O
sign O
write O
consent O
july O
29 O
2015 O
histology O
explanted O
lung O
speciman O
show O
pulmonary O
vein O
occlusion O
fig1df O
pulmonary O
embolism O
right O
pulmonary O
artery O
confirm O
have O
pvod O
combine O
pe O
instead O
ipah O
live O
dyspnea O
1 O
year O
lung O
transplantation O
echocardiography O
show O
normalization O
pap O
enlarge O
right O
ventricle O
heart O
study O
approve O
ethic O
committee O
people O
hospital O
zhongshan O
city O
write O
inform O
consent O
obtain O
patient O

58yearold O
cotton O
farmer O
present O
west O
china O
hospital O
sichuan O
university O
1month O
history O
recurrent O
fever B-SYMPTOMS
38 O
40 O
c O
productive O
cough B-SYMPTOMS
dyspnea B-SYMPTOMS
prior O
admission O
diagnose O
pneumonia B-DISEASE
treat O
latamoxef O
ofloxacin O
vancomycin O
voriconazole O
local O
hospital O
remission O
symptom O
observe O
hepatitis O
b O
virus O
carrier O
10 O
packyear O
smoke O
history O
history O
diabetes O
mellitus O
tuberculosis O
use O
glucocorticoid O
past O
inform O
admission O
blood O
pressure O
14595 O
mm O
hg O
heart O
rate O
120 O
minute O
respiratory O
rate O
30 O
minute O
temperature O
393 O
c O
physical O
examination O
reveal O
diminish O
breath O
sound O
rale O
hear O
evaluation O
system O
unremarkable O
moderate O
edema B-SYMPTOMS
low O
limb O
arterial O
blood O
gas O
analysis O
show O
ph O
7361 O
pco2 O
535 O
mm O
hg O
po2 O
628 O
mm O
hg O
laboratory O
datum O
table O
table11 O
reveal O
leukocytosis B-SYMPTOMS
49500mm3 O
974 O
neutrophil O
elevated O
procalcitonin O
516 O
ngml O
chest O
compute O
tomography O
presence O
nodule O
mass O
patchy O
consolidation O
bilateral B-SYMPTOMS
pleural I-SYMPTOMS
effusion I-SYMPTOMS
note O
fig1a O
soon O
alert O
sputum O
smear O
presence O
filamentous O
grampositive O
weakly O
acidfast O
bead O
bacilli B-SYMPTOMS
possible O
diagnosis O
nocardia B-DISEASE
infection I-DISEASE
fig1b O
c O
trimethoprimsulfamethoxazole O
3 O
pill O
6 O
hour O
noninvasive O
ventilation O
promptly O
administer O
sputum O
culture O
show O
growth O
numerous O
bacteria O
precisely O
determined O
n B-SYMPTOMS
otitidiscaviarum I-SYMPTOMS
method O
mass O
spectroscopy O
day O
6 O
admission O
fig1d O
antibiotic O
modify O
amikacin O
imipenem O
addition O
trimethoprimsulfamethoxazole O
accordance O
sensitivity O
test O
patient O
improve O
expect O
eventually O
die O
severe O
respiratory B-SYMPTOMS
insufficiency I-SYMPTOMS
13th O
hospital O
day O

n O
march O
2015 O
62yearold O
woman B-SEX
admit O
hospital O
complain O
progressive O
visual B-SYMPTOMS
disturbance I-SYMPTOMS
begin O
4 O
year O
ago O
treat O
cataract B-DISEASE
local O
hospital O
relief B-SYMPTOMS
see O
contrary O
symptom O
aggravate O
half O
year O
ago O
headache B-SYMPTOMS
leave O
eye O
pain B-SYMPTOMS
tearing B-SYMPTOMS
increase O
secretion O
compute O
tomography O
ct O
scan O
brain O
local O
hospital O
show O
sellar O
region O
lesion B-SYMPTOMS
2 O
year O
early O
patient O
underwent O
resection O
melanoma B-DISEASE
left O
heel O
t2n0m0 O
ki67 O
35 O
stage O
ii O
follow O
resection O
recur O
melanoma O
nearby O
primary O
site O
15 O
month O
later O
t3n3m0 O
stage O
iii O
lymphadenectomy O
family O
history O
melanoma O
physical O
examination O
patient O
bilateral O
temporal O
hemianopsia B-SYMPTOMS
right O
finger O
counting O
1 O
m O
left O
finger O
counting O
05 O
m O
enlarge O
lymph O
node O
palpable O
right O
groin O
ophthalmologic O
examination O
patient O
right O
vision O
04 O
leave O
vision O
008 O
intraocular O
pressure O
15 O
mm O
hg O
bilaterally O
optometry O
find O
right O
eye O
600ds025dc65 O
left O
eye O
625ds050dc20 O
patient O
maculopathy B-DISEASE
eye O
optic B-DISEASE
atrophy I-DISEASE
left O
eye O
light O
reflex O
eye O
movement O
eye O
normal O
ct O
scan O
brain O
parenchyma O
orbital O
chest O
unremarkable O
ct O
scan O
ultrasound O
examination O
abdoman O
show O
hepatic O
portal O
retroperitoneal O
lymphadenectasis B-SYMPTOMS
enlarge O
leave O
lobe O
liver O
substantial O
placeholder O
lesion O
ultrasound O
examination O
bilateral O
inguinal O
lymph O
node O
discover O
multiple O
low O
echo O
light O
group O
large O
31 O
mm O
diameter O
hilu O
echo O
asymmetrical O
thickening B-SYMPTOMS
skin O
ct O
scan O
sellar O
region O
reveal O
crumby O
mass B-SYMPTOMS
protrude O
sphenoid O
sinus O
obscure O
boundary O
bone O
destruction O
average O
ct O
value O
mass O
46 O
hu O
sellar O
region O
magnetic O
resonance O
imaging O
mri O
reveal O
round O
mass O
30 O
mm O
diameter O
enlarged B-SYMPTOMS
sellae O
fig1a O
b O
mass O
show O
isointense B-SYMPTOMS
t1weighte O
image O
t1wi O
t2weighte O
image O
t2wi O
homogeneous O
enhancement B-SYMPTOMS
gadoliniumdtpa O
injection O
dural O
tail O
sign O
see O
small O
foci O
inside O
tumor B-SYMPTOMS
show O
hyperintense O
signal O
t1wi O
hypointense O
signal O
t2wi O
enhancement O
see O
mass O
penetrate O
meninge O
surround O
left O
internal O
carotid O
artery O
blur O
left O
optic O
nerve O
pituitary O
stalk O
short O
right O
displacement O
laboratory O
finding O
reveal O
increase O
level O
prolactin O
11908 O
gl O
normal O
range O
5993004 O
gl O
cortisol O
67710 O
nmoll O
normal O
range O
1186061800 O
nmoll O
decrease O
level O
free O
thyroxine O
ft4 O
604 O
pmoll O
normal O
range O
12002200 O
pmoll O
free O
triiodothyronine O
ft3 O
209 O
pmoll O
normal O
range O
350650 O
pmoll O
patient O
diagnose O
giant O
prolactinoma B-DISEASE
patient O
underwent O
transnasal O
transsphenoidal O
surgery O
remove O
tumor O
relieve O
compression O
optic O
nerve O
intraoperatively O
see O
tumor O
invade O
fill O
left O
interval O
sphenoid O
sinus O
bone O
sellar O
floor O
leave O
parasellar O
destroy O
absorb O
little O
normal O
pituitary O
tissue O
see O
right O
tumor O
sellar O
turcica O
tumor O
reddish O
black O
extremely O
rich O
blood O
supply O
close O
adhesion O
surround O
structure O
texture O
center O
tumor O
soft O
tough O
rim O
intraoperative O
frozensection O
examination O
find O
melanin O
granule O
consider O
malignant B-DISEASE
melanoma I-DISEASE
meningioma B-DISEASE
tumor O
cell O
compose O
eosinophilic O
stain O
epithelial O
cell O
cell O
nucleus O
round O
reniform O
hippocrepiform O
evident O
nucleolus O
nuclear O
fission O
see O
tumor O
show O
evidence O
necrosis B-SYMPTOMS
fig2 O
tumor O
immunopositive O
focally O
melanomaspecific O
marker O
s100 O
hmb45 O
vimentin O
immunopositive O
neuroendocrine O
tumor O
marker O
cga O
syn O
fig3 O
ki67 O
index O
3 O
5 O
high O
metastatic O
melanoma O
adenomatous O
component O
take O
melanoma O
history O
suspect O
lymph O
node O
hepatic O
metastasis O
consideration O
patient O
diagnosise O
mmpa B-DISEASE
surgery O
significant O
relief O
see O
visual O
field O
headache O
level O
prolactin O
cortisol O
ft4 O
return O
normal O
hormone O
replacement O
therapy O
focal O
liver O
lesion O
lymphadenectasis O
cause O
discomfort B-SYMPTOMS
patient O
refuse O
surgical O
intervention O
treatment O
discharge O
hospital O
immediately O
disease B-DISEASE
free O
2 O
month O
surgery O
patient O
successively O
find O
new O
melanoma O
metastatic O
site O
skin O
low O
left O
leg O
knee O
upper O
left O
leg O
left O
groin O
right O
groin O
right O
leg O
followup O
late O
january O
2016 O
patient O
walk O
live O
depress O
late O
followup O
late O
january O
2017 O
patient O
alive B-SYMPTOMS
bad O
symptom O
sensory O
deficit O
leg O
hyperalgesia B-SYMPTOMS
hand O
mouth O
impaired B-SYMPTOMS
intelligence I-SYMPTOMS
live O
disease O
careful O
nursing O
daughter O

2013 O
50yearold O
man B-SEX
patient O
visit O
hospital O
complaining O
local O
bone O
pain B-SYMPTOMS
left O
leg O
august O
14 O
2013 O
patient O
undergo O
left O
distal O
femoral O
tumor B-SYMPTOMS
en O
bloc O
resection O
reconstruction O
modular O
femoral O
prosthetic O
system O
pathology O
diagnosis O
confirm O
osteoblastic O
osteosarcoma B-DISEASE
fig2 O
cycle O
neoadjuvant O
chemotherapy O
4 O
cycle O
adjuvant O
chemotherapy O
map O
regiman O
highdose O
methotrexate O
cisplatin O
doxorubicin O
administer O
january O
2015 O
mass B-SYMPTOMS
find O
left O
upper O
crus O
area O
tumor O
recurrence B-SYMPTOMS
confirm O
biopsy O
january O
23 O
2015 O
upper O
femur O
amputation O
carry O
patient O
refuse O
hip O
joint O
replacement O
wound O
heal O
patient O
go O
normal O
life O
help O
artificial O
limb O
refuse O
receive O
chemotherapy O
concern O
chemotherapy O
toxicity O
nausea O
vomiting O
leucopenia O
deadlimb O
headache O
half O
year O
amputation O
patient O
get O
occasional O
cough B-SYMPTOMS
chest O
tightness B-SYMPTOMS
thin O
chest O
compute O
tomography O
ct O
perform O
july O
15 O
2015 O
ct O
result O
reveal O
multiple O
pulmonary O
nodule B-SYMPTOMS
table O
1 O
consider O
possibility O
metastasis O
patient O
reject O
chemotherapy O
immunophenotype O
suggestive O
cd31 O
cd34 O
tumor O
cell O
fig3 O
furthermore O
cell O
show O
strong O
positive O
staining O
vegfr2 O
fig3 O
apatinib O
administer O
dose O
500 O
mg O
daily O
half O
month O
later O
symptom O
disappear O
progressive O
wound B-SYMPTOMS
necrosis I-SYMPTOMS
appear O
debridement O
surgery O
finally O
conduct O
enlarged B-SYMPTOMS
lymph O
node O
near O
iliac O
vessel O
resect O
february O
24 O
2016 O
figfig44 O
result O
pathological O
examination O
reveal O
inflammatory O
hyperplasia B-SYMPTOMS
lymph O
node O
apatinib O
administration O
stop O
3 O
week O
wound O
healing O
period O
thin O
chest O
ct O
perform O
7 O
11 O
month O
follow O
apatinib O
administration O
7month O
followup O
time O
point O
2 O
5 O
measurable O
9 O
17 O
nonmeasurable O
lesion O
disappear O
1 O
new O
measurable O
nodule O
6 O
new O
nonmeasurable O
lesion O
observe O
table O
1 O
fig5 O
consider O
pd O
accord O
response O
evaluation O
criterion O
solid O
tumor O
recist O
11 O
standard O
11month O
followup O
time O
point O
total O
9 O
lesion O
disappear O
include O
1 O
measurable O
nodule O
2 O
nonmeasurable O
lesion O
present O
apatinib O
treatment O
6 O
nonmeasureable O
lesion O
present O
7 O
month O
apatinib O
treatment O
new O
lesion O
raise O
target O
lesion O
measurement O
accord O
recist O
11 O
standard O
narrowly O
consider O
pr O
toxicity O
patient O
experience O
include O
mild O
handfoot O
syndrome O
slight O
high B-SYMPTOMS
blood I-SYMPTOMS
pressure I-SYMPTOMS
control O
appropriate O
treatment O
severe O
toxicity O
treatmentrelate O
adverse O
event O
observe O
patient O
continue O
use O
apatinib O
maintenance O
therapy O
major O
toxic O
effect O
go O
normal O
life O
drive O
automatic O
car O

61yearold O
chinese O
woman B-SEX
complain O
dizziness B-SYMPTOMS
3 O
week O
admit O
hospital O
bifrontal O
mass B-SYMPTOMS
find O
radiologically O
dizziness O
patient O
present O
sign O
symptom O
commonly O
associate O
neurological O
disease O
headache B-SYMPTOMS
vomit O
sensory O
disturbance O
alter O
consciousness B-SYMPTOMS
seizure O
20year O
history O
hypertension O
properly O
control O
angiotensinconverte O
enzyme O
inhibitor O
patient O
healthy B-SYMPTOMS
special O
circumstance O
identify O
personal O
family O
history O
patient O
find O
normal O
neurological O
examination O
plain O
contrastenhance O
magnetic O
resonance O
imaging O
mri O
head O
show O
spaceoccupye O
lesion B-SYMPTOMS
bifrontal O
lobe O
mainly O
right O
cling O
sagittal O
sinus O
cerebral O
falx O
57 O
   O
50 O
   O
50 O
cm O
duralbase O
mass O
grow O
sagittal O
midline O
reveal O
isointensity B-SYMPTOMS
t1weighte O
image O
slight O
hyperintensity B-SYMPTOMS
t2weighte O
image O
homogenously O
enhance O
characteristic O
duraltail O
sign O
fig1 O
diagnosis O
parasagittalparafalcine O
meningioma B-DISEASE
craniotomic O
meningioma O
resection O
choose O
treatment O
blood O
cell O
examination O
coagulation O
function O
liver O
renal O
function O
test O
urinalysis O
chest O
xray O
electrocardiogram O
normal O
albumin O
36 O
gl O
total O
bilirubin O
tbil O
122 O
moll O
direct O
bilirubin O
dbil O
41 O
moll O
alanine O
transaminase O
alt O
17 O
ul O
international O
normalize O
ratio O
inr O
coagulation O
value O
102 O
patient O
advanced O
age O
history O
hypertension O
perform O
echocardiograph O
blood O
gas O
analysis O
test O
creatine O
kinase O
level O
pulmonary O
function O
result O
reveal O
surgical O
contraindication O
write O
consent O
obtain O
patient O
milligram O
vpa O
twice O
day O
initiate O
3 O
day O
operation O
patient O
tolerate O
administration O
craniotomy O
perform O
radical O
tumor B-SYMPTOMS
resection O
simpson O
ii O
tumor O
pink O
solid O
moderate O
blood O
supply O
texture O
medium O
thirty O
minute O
end O
surgery O
800 O
mg O
vpa O
administer O
intravenous O
infusion O
operation O
patient O
regain O
consciousness O
30 O
minute O
score O
15 O
glasgow O
coma B-DISEASE
scale O
gc O
hour O
later O
transport O
ward O
patient O
undergo O
ugh B-DISEASE
vomitus B-SYMPTOMS
approximately O
50 O
ml O
compose O
coffeecolore O
blood O
exclude O
possible O
etiology O
endotracheal O
intubation O
damage B-SYMPTOMS
diagnose O
patient O
experience O
acute O
erosivehemorrhagic O
gastritis B-DISEASE
reaction O
craniotomy O
injury B-SYMPTOMS
patient O
give O
omeprazole O
inhibit O
gastric O
acid O
secretion O
hematemesis B-SYMPTOMS
cease O
patient O
administer O
vpa O
1200 O
mg O
intravenously O
2 O
postoperative O
day O
stomach O
intestine O
functional O
recovery O
vpa O
dosage O
change O
500 O
mg O
oral O
administration O
twice O
day O
brain O
mri O
perform O
postoperative O
day O
3 O
reveal O
tumor O
radically O
remove O
operative O
field O
clean O
fig2a O
b O
subsequent O
paraffin O
histological O
examination O
confirm O
diagnosis O
meningioma O
3 O
postoperative O
day O
4 O
patient O
suddenly O
find O
deep O
coma O
pupil O
dilate O
30 O
mm O
round O
light O
reflex O
sensitive O
neurological O
examination O
unremarkable O
vital O
sign O
stable O
mental O
state O
gradually O
change O
deep O
coma O
gcs O
   O
8 O
believe O
cause O
intracranial O
lesion O
computerized O
tomography O
ct O
scan O
brain O
immediately O
perform O
fail O
reveal O
abnormality O
severe O
brain O
swell O
intracranial B-DISEASE
hemorrhage I-DISEASE
cerebral B-DISEASE
infarction I-DISEASE
fig2c O
possible O
cerebral O
infarction O
exclude O
24 O
hour O
glucocorticoid O
mannitol O
vasodilator O
patient O
routine O
laboratory O
result O
blood O
cell O
liver O
renal O
function O
relatively O
normal O
range O
albumin O
33 O
gl O
tbil O
133 O
moll O
dbil O
45 O
moll O
alt O
12 O
ul O
inr O
coagulation O
value O
101 O
history O
ugh O
check O
blood O
ammonia O
level O
perform O
fecal O
occult O
blood O
test O
blood O
gas O
analysis O
blood O
ammonia O
elevate O
1816 O
moll O
normal O
range O
1132 O
moll O
fecal O
occult O
blood O
test O
positive O
consider O
history O
elevated O
blood O
ammonia O
diagnose O
ughinduced O
hepatic B-DISEASE
encephalopathy I-DISEASE
oral O
administration O
vpa O
change O
intravenous O
administration O
prevent O
seizure O
lactulose O
vitamin O
b O
larginine O
administer O
clysis O
vinegar O
perform O
patient O
fast O
patient O
blood O
ammonia O
level O
fluctuate O
14482077 O
moll O
remain O
unconscious B-SYMPTOMS
follow O
3 O
day O
unremarkable O
progress O
patient O
mental O
state O
blood O
ammonia O
level O
hold O
multidisciplinary O
conference O
discuss O
diagnosis O
treatment O
initially O
consider O
hemodialysis O
peritoneal O
dialysis O
multidisciplinary O
discussion O
suspect O
diagnosis O
vhe B-DISEASE
finally O
blood O
vpa O
level O
normal O
range O
decide O
stop O
vpa O
administration O
perform O
dialysis O
administer O
levetiracetam O
instead O
vpa O
patient O
blood O
vpa O
ammonia O
level O
routinely O
monitor O
patient O
mental O
state O
begin O
improve O
24 O
hour O
vpa O
discontinuation O
achieve O
complete O
consciousness O
48 O
hour O
gcs O
   O
15 O
ammonia O
level O
blood O
decrease O
dramatically O
return O
normal O
4 O
day O
fig3 O
postoperative O
day O
15 O
8 O
day O
discontinuation O
vpa O
patient O
discharge O
complication O
followup O
interview O
postoperative O
month O
5 O
witness O
consciousness O
nonrecurrence O
primary O
tumor O
fig2d O
patient O
gcs O
score O
15 O
report O
enjoy O
satisfying O
quality O
postoperative O
life O

60yearold O
man B-SEX
present O
retroperitoneal O
metastatic B-SYMPTOMS
lymph O
node O
magnetic O
resonance O
mr O
image O
history O
right O
liver O
resection O
2010 O
pulmonary O
wedge O
resection O
2012 O
transarterial O
chemoembolization O
twice O
2014 O
postoperative O
pathology O
suggest O
mixed O
liver B-DISEASE
cancer I-DISEASE
poorly O
differentiate O
lung B-DISEASE
cancer I-DISEASE
liver O
metastasis B-SYMPTOMS
examination O
tumor B-SYMPTOMS
close O
duodenum O
pancrea O
stomach O
hepatic O
portal O
vein O
patient O
unresectable O
masse O
hypertension B-SYMPTOMS
10 O
year O
chronic O
hbvrelate O
cirrhosis O
30 O
year O
treat O
lamivudine O
100 O
mg O
qd O
adefovir O
dipivoxil O
10 O
mg O
qd O
6 O
year O
keep O
constant O
body O
temperature O
37 O
c O
blood O
pressure O
14896 O
mm O
hg O
pulse O
77 O
beat O
minute O
patient O
obvious O
sense O
abdominal O
pain B-SYMPTOMS
abdominal O
distention B-SYMPTOMS
nausea B-SYMPTOMS
vomit O
test O
tumor O
marker O
level O
result O
normal O
show O
carcinoembryonic O
antigen O
37 O
ngml O
alpha O
fetoprotein O
173 O
ngml O
carbohydrate O
antigen O
199 O
level O
61 O
uml O
study O
procedure O
approve O
ethic O
committee O
affiliated O
hospital O
zhejiang O
university O
efficacy O
local O
ablation O
estimate O
choi O
criterion O
appraise O
variation O
tumor O
size O
lesion B-SYMPTOMS
density O
compute O
tomography O
ct O
image O
complete O
response O
disappearance O
lesion O
new O
lesion O
partial O
response O
pr O
decrease O
size O
10 O
decrease O
tumor O
density O
15 O
ct O
new O
lesion O
stable O
disease O
fit O
complete O
response O
pr O
progressive O
disease O
progressive O
disease O
increase O
tumor O
size O
10 O
fit O
pr O
tumor O
density O
ct O
new O
lesions19 O
preoperative O
mr O
imaging O
scan O
show O
mass B-SYMPTOMS
28 O
   O
35 O
cm O
size O
close O
duodenum O
pancrea O
blood O
vessel O
fig1a O
substance O
phase O
mr O
image O
indicate O
mildly O
high O
signal B-SYMPTOMS
intensity I-SYMPTOMS
tumor O
intermediate O
low O
signal O
intensity O
solid O
component O
wall O
fig1b O
initial O
ablation O
retroperitoneal O
mild O
hyperechoic B-SYMPTOMS
area I-SYMPTOMS
axial O
image O
fig1c O
study O
inpatient O
underwent O
percutaneous O
transhepatic O
biopsy O
ablation O
avoid O
nearby O
blood O
vessel O
procedure O
perform O
40 O
minute O
local O
anesthesia O
mild O
sedation O
ultrasonography O
realtimely O
guide O
inserting O
2 O
ndyag O
laser O
fiber O
echolaser O
x4 O
esaote O
italy O
03 O
mm O
diameter O
21gauge O
chiba O
needle O
lesion O
fig1d O
heat O
run O
blood O
flow20 O
ablation O
valid O
area O
12 O
15 O
mm O
power O
5 O
w O
5 O
6 O
minute O
subsequently O
immediate O
ultrasonography O
show O
lesion O
cover O
hyperechoic B-SYMPTOMS
zone I-SYMPTOMS
figfig1e O
f O
day O
contrastenhance O
ultrasound O
ceus O
reveal O
abnormal B-SYMPTOMS
residual I-SYMPTOMS
proximal O
pancreatic O
head O
fig2a O
5day O
followup O
contrastenhance O
ct O
image O
low O
mass O
low O
signal O
intensity O
upper O
tumor O
reveal O
intermediate O
high O
signal O
intensity O
residual O
substance O
phase O
fig2b O
c O
surprizingly O
1week O
followup O
ceus O
image O
show O
enlarged B-SYMPTOMS
retroperitoneal O
lymph O
node O
locate O
near O
pancreatic O
head O
fusion O
residuary O
small O
nodule O
fig2d O
patient O
undergo O
2nd O
ablation O
2 O
laser O
fiber O
show O
lesion O
welldefine O
hyperechoic O
zone O
fig2e O
f O
2nd O
day O
postoperative O
ceus O
image O
show O
remanent O
fig2 O
g O
correspond O
mr O
image O
show O
left O
tumor O
fig2h O
3rd O
laser O
ablation O
perform O
fig2j2j O
3 O
day O
later O
ceus O
find O
minor O
lesion O
locate O
separation O
gap O
2 O
needle O
fig3a O
subsequently O
patient O
4th O
ablation O
separation O
gap O
hyperechoic O
overlay O
fig3bd O
3 O
day O
later O
base O
4 O
treatment O
enhance O
ct O
image O
retroperitoneal O
mass O
suggest O
complete O
necrosis B-SYMPTOMS
fig3eg3eg O
follow O
1 O
month O
substance O
phase O
mr O
reveal O
lowintensity O
signal O
tumor O
necrosis O
resolution O
problem O
fig3h O
5 O
month O
4 O
ablation O
ct O
show O
tumor O
pr O
little O
enhanced O
recurrence B-SYMPTOMS
yellow O
arrow O
locate O
left O
low O
edge O
original O
lesion O
fig4a O
b O
laboratory O
test O
tumor O
marker O
level O
carcinoembryonic O
antigen O
alpha O
fetoprotein O
carbohydrate O
antigen O
199 O
indicate O
36 O
ngml O
267 O
ngml O
81 O
uml O
respectively O
obvious O
effect O
discover O
case O
procedure O

61yearold O
male B-SEX
patient O
history O
chronic O
obstructive O
pulmonary O
disease O
regular O
bronchodilator O
treatment O
2014 O
suffer O
severe O
productive O
cough B-SYMPTOMS
mucus O
sputum O
month O
unintentional O
body O
weight B-SYMPTOMS
loss I-SYMPTOMS
6 O
kg O
6 O
month O
sputum O
analysis O
chest O
imaging O
examination O
2014 O
diagnose O
squamous B-DISEASE
cell I-DISEASE
carcinoma I-DISEASE
right O
upper O
lobe O
lung O
ct3n2m0 O
stage O
iiia O
receive O
neoadjuvant O
chemoradiotherapy O
etoposide O
70 O
mg O
45 O
mgm2 O
   O
cisplatin O
79 O
mg O
50 O
mgm2 O
4500 O
cgy O
25 O
fraction O
june O
july O
2014 O
october O
2014 O
surgical O
intervention O
arrange O
tumor B-SYMPTOMS
locate O
right O
hilum O
invade O
main O
bronchus O
major O
vessel O
videoassiste O
thoracoscopic O
surgery O
right O
intrapericardial O
pneumonectomy O
perform O
postoperatively O
pathological O
exam O
reveal O
squamous O
cell O
carcinoma O
t3n0m0 O
stage O
iib O
postoperative O
course O
smooth O
suffer O
severe O
cough O
right O
chest O
pain B-SYMPTOMS
month O
later O
laboratory O
exam O
reveal O
leukocytosis B-SYMPTOMS
white O
blood O
cell O
   O
21860 O
l O
elevate O
creactive O
protein O
2394 O
mgdl O
chest O
xray O
show O
cavitary O
lesion B-SYMPTOMS
compute O
tomography O
show O
pleural B-SYMPTOMS
effusion I-SYMPTOMS
fluid B-SYMPTOMS
collection I-SYMPTOMS
mottled O
gas O
appearance O
dependent O
portion O
right O
hemithorax O
fig1a O
accord O
patient O
history O
result O
laboratory O
exam O
image O
finding O
postpneumonectomy O
empyema B-SYMPTOMS
diagnose O
bronchopleural B-DISEASE
fistula I-DISEASE
highly O
suspect O
admission O
chest O
tube O
drainage O
insert O
bronchoscopic O
tissue O
glue O
sealing O
perform O
persistent O
air B-SYMPTOMS
leakage I-SYMPTOMS
present O
decide O
repair O
bronchial O
stump O
flap O
coverage O
patient O
receive O
neoadjuvant O
chemoradiotherapy O
month O
ago O
flap O
harvest O
chest O
area O
appropriate O
pedicle O
artery O
injure O
irradiation O
discuss O
plastic O
surgeon O
decide O
repair O
bronchial O
stump O
tram O
flap O
intraoperatively O
patient O
place O
supine O
right O
exploratory O
thoracotomy O
perform O
bronchial O
stump O
locate O
superior O
epigastric O
vascular O
artery O
right O
rectus O
abdominis O
muscle O
identify O
location O
tram O
flap O
mark O
skin O
fig2a O
tram O
flap O
harvest O
right O
rectus O
abdominis O
fig2b O
deepithelialize O
fig2c O
subcutaneous O
tunnel O
tram O
flap O
move O
right O
thoracic O
space O
tension B-SYMPTOMS
kink O
pedicle O
fig2d O
tram O
flap O
fix O
posterior O
chest O
wall O
cover O
bronchial O
stump O
fig2e O
tissue O
glue O
apply O
bronchial O
stump O
bronchoscope O
donor O
site O
flap O
close O
mesh O
repair O
postoperative O
course O
smooth O
air B-SYMPTOMS
leak I-SYMPTOMS
diminish O
gradually O
patient O
discharge O
stable B-SYMPTOMS
condition I-SYMPTOMS
free O
air O
leak O
follow O
12 O
month O
fig1b O
patient O
provide O
write O
informed O
consent O
publication O
report O
accompany O
image O

63yearold O
male B-SEX
patient O
smoking O
drinking O
history O
admit O
june O
11 O
2014 O
major O
complaint O
gradually O
aggravate O
dysphagia B-SYMPTOMS
fatigue B-SYMPTOMS
suspicion O
obstructive B-DISEASE
disease I-DISEASE
upper O
digestive O
tract O
athlete O
retire O
good O
physical O
status O
admission O
family O
social O
history O
indicate O
abnormal O
thorough O
physical O
examination O
skin O
oral O
mucosa O
eye O
genital O
area O
fail O
identify O
superficial O
lesion O
additionally O
laboratory O
test O
include O
hepatic O
function O
renal O
function O
serum O
tumor B-SYMPTOMS
marker O
carcinoembryonic O
antigen O
cytokeratin O
19 O
fragment O
squamous O
cell O
carcinoma O
neuronspecific O
enolase O
carbohydrate O
antigen O
125 O
normal O
range O
endoscopic O
radiological O
examination O
carry O
accurate O
diagnosis O
endoscopic O
examination O
reveal O
slightly O
pigment O
irregular O
mass B-SYMPTOMS
locate O
low O
esophagus O
measure O
50 O
cm O
   O
30 O
cm O
size O
fine O
needle O
biopsy O
lesion O
reveal O
esophageal O
melanoma B-DISEASE
confirm O
histopathology O
chest O
abdomen O
compute O
tomography O
ct O
enhance O
cranial O
magnetic O
resonance O
image O
mri O
bone O
emission O
compute O
tomography O
ect O
show O
enlarge O
mediastinal O
nd O
celiac O
lymph O
node O
fig1a O
obvious O
involvement B-SYMPTOMS
supraclavicular O
lymph O
node O
concurrently O
ct O
show O
isolated O
irregular O
pulmonary O
tumor O
fig1b O
positron O
emission O
tomography O
carry O
cover O
health O
insurance O
patient O
patient O
clinically O
stage O
ct3nxm1 O
accord O
7th O
edition O
american O
joint O
committee O
cancer O
tnm O
staging O
system O
esophageal B-DISEASE
cancer I-DISEASE
ctguide O
percutaneous O
pulmonary O
biopsy O
avoid O
aim O
diminish O
risk O
tumor O
dissemination O
singlestage O
resection O
esophageal O
pulmonary O
lesion O
assume O
reasonable O
multidisciplinary O
consultation O
approve O
ethical O
committee O
xuzhou O
central O
hospital O
prognosis O
patient O
probably O
extremely O
poor O
target O
antibody O
afford O
financial O
reason O
inform O
consent O
simultaneous O
ivorlewis O
esophagectomy O
right O
upper O
lobectomy O
perform O
successfully O
general O
anesthesia O
doubleluman O
endotracheal O
intubation O
follow O
systemic O
dissection O
lymph O
node O
locate O
mediastinum O
abdomen O
accordance O
principle O
oncological O
surgery O
operation O
time O
290 O
minute O
obvious O
bleeding B-SYMPTOMS
surgery O
postoperative O
pathological O
staining O
speciman O
reveal O
pleomorphic O
cell O
abundant O
melanin O
granule O
fig1c O
immunohistochemical O
test O
demonstrate O
positive O
expression O
human O
melanoma O
black O
45 O
hmb45 O
microtubuleassociate O
protein O
tau O
1 O
mapt1 O
melan O
s100 O
negative O
expression O
desmin O
synaptophysin O
epithelial O
membrane O
antigen O
ema O
consistent O
melanoma O
resection O
margin O
dissect O
lymph O
node O
pathologically O
tumornegative O
addition O
molecular O
study O
patient O
indicate O
mutation O
vraf O
murine O
sarcoma O
viral O
oncogene O
homolog O
b1 O
braf O
v600e O
base O
finding O
diagnosis O
advanced O
pmme B-DISEASE
tentatively O
establish O
stage O
iv O
pt3n0m1 O
insufficient O
evidence O
distinguish O
synchronous O
primary O
pulmonary O
melanoma O
metastasis B-SYMPTOMS
patient O
postoperative O
recovery O
mainly O
uneventful O
patient O
discharge O
14 O
day O
surgery O
subsequently O
4 O
cycle O
adjuvant O
conventional O
chemotherapy O
interval O
3 O
week O
complete O
control O
moderate O
toxic O
effect O
include O
thrombocytopenia B-SYMPTOMS
leukopenia B-SYMPTOMS
nausea B-SYMPTOMS
vomiting B-SYMPTOMS
diarrhea B-SYMPTOMS
detailed O
chemotherapy O
regimen O
follow O
paclitaxel O
liposome O
injection O
day O
1 O
day O
8 O
135 O
mg O
square O
meter O
body O
surface O
area O
nanjing O
luye O
sike O
pharmaceutical O
co O
ltd O
jiangsu O
china O
tegafur O
injection O
day O
2 O
4 O
1000 O
mg O
square O
meter O
bodysurface O
area O
shandong O
qilu O
pharmaceutical O
co O
ltd O
jinan O
china O
plus O
cisplatinum O
day O
2 O
3 O
75 O
mg O
square O
meter O
bodysurface O
area O
shandong O
qilu O
pharmaceutical O
co O
ltd O
jinan O
china O
patient O
suffer O
moderate O
leukopenia O
myelosuppression B-SYMPTOMS
second O
cycle O
tpf O
chemotherapy O
recover O
quickly O
administration O
granulocyte O
colonystimulate O
factor O
gcsf O
concurrently O
recombinant O
human O
interferon O
alpha2b O
harbin O
pharmaceutical O
group O
biological O
engineering O
co O
ltd O
harbin O
china O
administrate O
hypodermic O
injection O
6000 O
unit O
3 O
day O
fig2 O
last O
1 O
year O
patient O
follow O
continuously O
surgery O
chest O
abdomen O
ct O
cranial O
mri O
bone O
ect O
thorough O
physical O
examination O
carry O
3 O
month O
encouragingly O
patient O
survive O
locoregional O
recurrence B-SYMPTOMS
remote O
metastasis O
followup O
half O
year O
fig3 O

34yearold O
woman B-SEX
1 O
week O
postpartum O
present O
dermatology O
clinic O
intensely O
pruritic O
generalize O
rash B-SYMPTOMS
day O
delivery O
child O
patient O
develop O
itchy O
rash O
abdomen O
discharge O
instruct O
follow O
dermatology O
department O
rash O
resolve O
leave O
hospital O
report O
eruption B-SYMPTOMS
progressively O
spread O
buttock O
leg O
itching B-SYMPTOMS
bad O
patient O
prenatal B-SYMPTOMS
course I-SYMPTOMS
uneventful O
gain O
13 O
kg O
pregnancy O
prepregnancy O
weight O
72 O
kg O
healthy O
male O
neonate O
deliver O
caesarean O
section O
38 O
week O
gestation O
complication B-SYMPTOMS
patient O
medical O
history O
unremarkable O
currently O
take O
medication O
report O
known O
drug O
allergy O
physical O
examination O
patient O
afebrile O
blood O
pressure O
normal O
examination O
skin O
reveal O
erythematous O
papule O
urticarial O
plaque O
involve O
abdominal O
stria O
periumbilical O
spare O
similar O
lesion O
note O
leg O
buttock O
fig1a O
face O
palm O
sol O
uninvolved B-SYMPTOMS
vesicle O
pustule O
note O
base O
characteristic O
clinical O
presentation O
disease O
course O
diagnose O
puppp B-DISEASE
inform O
safety O
profile O
potential O
benefit O
medication O
remain O
reluctant O
use O
medication O
lactation O
despite O
severe O
symptom O
awb O
injection O
consider O
treatment O
venous O
blood O
10 O
ml O
draw O
patient O
follow O
intramuscular O
injection O
5 O
ml O
blood O
buttock O
seven O
day O
later O
subjective O
objective O
improvement O
symptom O
notice O
receive O
1 O
session O
awb O
injection O
fig1b O
followup O
12 O
day O
subjective O
symptom O
improve O
leave O
postinflammatory O
hyperpigmentation B-SYMPTOMS
fig1c O
complication O
infection B-SYMPTOMS
abscess B-SYMPTOMS
formation O
hematoma B-SYMPTOMS
observe O
injection O
site O

proband O
ii2 O
fig2 O
45year O
old O
woman B-SEX
present O
university O
hospital O
age O
35 O
refer O
pregnancy O
congenital O
deafness O
experienced O
syncope B-SYMPTOMS
age O
3 O
diagnose O
epilepsy B-DISEASE
treat O
antiepilepsy O
medication O
subsequently O
experience O
instance O
syncope O
age O
13 O
syncope O
event O
suspect O
have O
jln O
congenital O
deafness O
prolong O
qt O
interval O
syncope O
diagnose O
arrhythmic B-SYMPTOMS
episode I-SYMPTOMS
aware O
tachycardia B-SYMPTOMS
epilepsy O
subarachnoid B-SYMPTOMS
hemorrhage I-SYMPTOMS
age O
29 O
present O
hospital O
take O
betablocker O
history O
asthma O
take O
mexiletine O
addition O
phenytoin O
qtc O
find O
prolong O
584 O
ms O
presentation O
administration O
atenolol O
initiate O
deliver O
baby O
iii1 O
fig2 O
caesarean O
operation O
hospital O
age O
35 O
37 O
deliver O
second O
baby O
iii2 O
fig2 O
caesarean O
operation O
hospital O
despite O
administration O
betablocker O
qtc O
remain O
prolong O
600 O
msec O
age O
37 O
780 O
msec O
44 O
figs2 O
3a O
unexpected O
treatment O
betablocker O
lqts1 O
expect O
overtly O
reduce O
qtc O
18 O
continue O
experience O
occasional O
syncope O
finally O
undergo O
implantable O
cardioverter O
defibrillator O
icd O
operation O
38 O
year O
age O
subsequently O
stable B-SYMPTOMS
clinical I-SYMPTOMS
condition I-SYMPTOMS
proband O
suspect O
jln O
infant O
measure O
qtc O
500 O
m O
great O
1 O
month O
birth O
beta O
blocker O
initiate O
child O
remain O
stable O
condition O
age O
10 O
8 O
figs2 O
3b O
c O
qtc O
son O
iii1 O
fig2 O
measure O
500 O
ms O
month O
birth O
qtc O
sister O
iii2 O
530 O
ms O
birth O
father O
i1 O
mother O
i2 O
proband O
cousin O
history O
sudden O
unexplained O
syncope O
death O
child O
adult O
immediate O
family O
member O
despite O
prolong O
qtc O
child O
clinical O
evaluation O
consultation O
proband O
family O
member O
perform O
chiba O
university O
hospital O
clinical O
phenotype O
deduce O
clinical O
history O
physical O
examination O
ecg O
blood O
sample O
collect O
proband O
family O
member O
follow O
genetic O
counseling O
write O
inform O
consent O
obtain O
prior O
sample O
collection O
genomic O
dna O
isolate O
peripheral O
blood O
lymphocyte O
accord O
establish O
protocol O
laboratory O
19 O
entire O
code O
exon O
include O
intronic O
boundary O
gene O
kcnq1 O
ncbi O
ref O
nm000218 O
lqt O
causative O
gene O
kcnh2 O
scn5a O
kcne1 O
kcne2 O
kcnj2 O
scn4b O
kcnj5 O
amplify O
polymerase O
chain O
reaction O
pcr O
accord O
establish O
protocol O
laboratory O
briefly O
30100 O
ng O
genomic O
dna O
subject O
pcr O
amplification O
dna O
polymerase O
primestar O
gxl O
dna O
polymerase O
takara O
bio O
inc O
kusatsu O
japan O
primer O
set O
amplicon O
subject O
conventional O
sequence O
sanger O
sequencer O
apply O
biosystem O
37303130 O
dna O
analyzer O
thermo O
fisher O
scientific O
waltham O
ma O
usa O
sequence O
datum O
process O
gene O
code O
sequencher O
software O
takara O
bio O
inc O
map O
human O
genome O
sequence O
build O
grch37hg19 O
genetic O
analysis O
perform O
screen O
code O
exon O
exonintron O
boundary O
kcnq1 O
gene O
ncbi O
ref O
nm0002182 O
np0002092 O
concurrent O
screening O
lqt O
causative O
gene O
kcnh2 O
scn5a O
kcne1 O
kcne2 O
kcnj2 O
scn4b O
kcnj5 O
detect O
novel O
homozygous B-SYMPTOMS
nonsense I-SYMPTOMS
variant I-SYMPTOMS
nm0002182c115 O
g O
   O
t O
pglu39x O
exon O
1a O
kcnq1 O
gene O
proband O
homozygous B-SYMPTOMS
common I-SYMPTOMS
variant I-SYMPTOMS
nm0002182c1343c O
   O
g O
ppro448arg O
additional O
file O
1 O
table O
s1 O
genetic O
screening O
mother O
i2 O
child O
iii1 O
iii2 O
reveal O
heterozygous O
nonsense O
variant O
fig2 O
husband O
ii3 O
screen O
find O
heterozygous O
common O
variant O
nm0002182c1343c O
   O
g O
ppro448arg O
proband O
child O
firstcousin O
marriage O
conclude O
homozygous O
nonsense O
variant O
proband O
cause O
jlns1 B-DISEASE
proband O
negative O
pathogenic O
variant O
lqt O
causative O
gene O
include O
kcne1 O
gene O
additional O
file O
1 O
table O
s1 O

4 O
half O
year O
old O
male B-SEX
child O
present O
hospital O
abdominal O
swelling B-SYMPTOMS
child O
occasionally O
feel O
stomach B-SYMPTOMS
ache I-SYMPTOMS
relieve O
reason O
child O
show O
obvious O
tenderness B-SYMPTOMS
rebound B-SYMPTOMS
bear O
premature O
baby O
32nd O
week O
mother O
pregnancy O
medical O
history O
include O
inguinal O
hernia O
2 O
side O
receive O
operation O
left O
inguinal O
hernia O
family O
genetic O
history O
find O
physical O
examination O
child O
show O
abdoman O
obviously O
bulge O
mass B-SYMPTOMS
touch O
umbilicus O
3 O
finger O
positive O
sign O
result O
laboratory O
test O
normal O
include O
alphafetoprotein O
afp O
level O
childpugh O
score O
5 O
abdominal O
ultrasonography O
show O
uneven O
lesion B-SYMPTOMS
liver O
diagnosis O
hb B-DISEASE
consider O
enhancement O
compute O
tomography O
ct O
scanning O
show O
large O
mass O
left O
upper O
abdoman O
leave O
lobe O
liver O
irregular O
edge O
size O
mass O
123 O
   O
102 O
   O
72 O
cm O
fig1 O
uneven O
nodular O
shadow O
edge O
obvious O
mass O
enhance O
calcification B-SYMPTOMS
expand O
bile O
duct O
observe O
left O
branch O
portal O
press O
distant O
show O
unclear O
abnormal B-SYMPTOMS
observe O
right O
branch O
accord O
medical O
history O
diagnosis O
hb O
consider O
recommend O
biopsy O
patient O
cause O
bleeding O
tumor O
diffusion O
operation O
necessary O
patient O
underwent O
dvss O
surgery O
sufficient O
preparation O
exploration O
show O
extrahepatic O
12 O
   O
10 O
cm O
mass O
left O
lobe O
liver O
fig2 O
operation O
sample O
split O
edge O
tumor O
clear O
envelope O
tremelloid O
mesenchyme O
see O
section O
fig2c O
pathological O
examination O
show O
sample O
grey O
red O
14 O
   O
13 O
   O
7 O
cm O
size O
color O
section O
grey O
red O
grey O
white O
mhl B-DISEASE
diagnose O
fig3 O
immunohistochemistry O
result O
fig4 O
follow O
mesenchymal O
cd34 O
   O
d240 O
   O
s100 O
   O
sma O
   O
cd7 O
   O
epithelium O
ck19 O
   O
afp O
   O
hcg O
   O
9 O
day O
recovery O
patient O
return O
home O
complication O
followup O
examination O
include O
blood O
routine O
liver O
renal O
function O
coagulation O
routine O
ultrasound O
scan O
30 O
day O
abnormality B-SYMPTOMS
adverse O
unanticipated O
event O
present O

